{"meta":{"query_hash":"2390c1d24952","filters":{"venue":"Antiviral Research"},"cohort_total":224,"direct_labels_cover":1,"predictions_cover":224,"exported":224,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2390c1d24952","api":"https://metacan.xera.ac/api/v1/cohort?venue=Antiviral+Research"},"results":[{"id":"W1141056041","doi":"10.1016/j.antiviral.2015.08.007","title":"Pokeweed antiviral protein restores levels of cellular APOBEC3G during HIV-1 infection by depurinating Vif mRNA","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"APOBEC3G; Derepression; Biology; Virology; Messenger RNA; Cytidine deaminase; Infectivity; RNA; Virus; Viral replication; Enzyme; Gene expression; Genetics; Gene; Biochemistry","score_opus":0.10949967002758479,"score_gpt":0.38996292176731107,"score_spread":0.2804632517397263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1141056041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954407,0.00102058,0.0017928578,0.00018922523,0.00010724998,0.000026826177,0.0002270952,0.00012948246,0.0010660124],"genre_scores_gemma":[0.9932156,0.00034958048,0.0020776691,0.00007296435,0.000026753582,0.000029944165,0.00042068865,0.00006350349,0.0037432618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997625,0.00003501666,0.000020519492,0.000048942708,0.000049975122,0.00008311552],"domain_scores_gemma":[0.99978226,0.00005615349,0.00004650416,0.00003757018,0.00002075513,0.000056840396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021581091,0.0003275902,0.00035585038,0.00030906298,0.00030832543,0.0006150414,0.0005473384,0.0004373926,0.0016699322],"category_scores_gemma":[0.0002978417,0.00028840647,0.00026020728,0.00016925753,0.0005416741,0.00041758973,0.00027145207,0.0014696529,0.00035075797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028985532,0.00009142325,0.00010500517,0.000026390731,0.0000076149036,0.0000494906,0.000016100747,0.00006960389,0.99757594,0.00017174866,0.0000641374,0.0015327367],"study_design_scores_gemma":[0.000038927734,0.00031388187,0.002559003,0.0000035774408,0.000014261141,0.00014675656,0.000030369352,0.001035543,0.9940177,0.00009058292,0.0017428888,0.000006549107],"about_ca_topic_score_codex":0.0011963038,"about_ca_topic_score_gemma":0.002088171,"teacher_disagreement_score":0.0016699322,"about_ca_system_score_codex":0.0005082304,"about_ca_system_score_gemma":0.0004139969,"threshold_uncertainty_score":0.005586505},"labels":[],"label_agreement":null},{"id":"W1467889550","doi":"10.1128/9781555815493.ch4","title":"Nucleoside Analogue Inhibitors of Human Immunodeficiency Virus Reverse Transcriptase","year":2014,"lang":"en","type":"book-chapter","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Reverse transcriptase; Retrovirus; Virology; Biology; Integrase; Nucleoside analogue; Lamivudine; Integrase inhibitor; Nucleoside Reverse Transcriptase Inhibitor; Context (archaeology); Virus; Viral replication; RNA; Nucleoside; Human immunodeficiency virus (HIV); Genetics; Hepatitis B virus; Gene; Viral load; Antiretroviral therapy","score_opus":0.07815633392520493,"score_gpt":0.36183706447076064,"score_spread":0.2836807305455557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1467889550","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047127977,0.8465132,0.009330699,0.00092746736,0.0012541513,0.00030754737,0.0008882729,0.00035770694,0.09329293],"genre_scores_gemma":[0.30612004,0.61388266,0.019139973,0.0016866,0.00067627395,0.0004719447,0.0019944964,0.00005313795,0.05597493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989104,0.000020655925,0.000009113278,0.00001530958,0.000045965047,0.00001795919],"domain_scores_gemma":[0.9999709,0.000008541192,0.000005788311,0.0000019250122,0.000006642213,0.000006069975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013706196,0.00042904585,0.00029558715,0.00022933783,0.00014767107,0.00034647685,0.00036140086,0.00036177624,0.0031352278],"category_scores_gemma":[0.00015755955,0.00012724222,0.00024769697,0.00019412152,0.00009835811,0.00021724285,0.0002634329,0.0006810945,0.0013909361],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052521355,0.00040601013,0.0007106362,0.0029797486,0.00008835441,0.00087632186,0.00014335894,0.0014822942,0.30192438,0.0107964985,0.016847754,0.66321933],"study_design_scores_gemma":[0.00018957177,0.0015330688,0.0016906117,0.00039520874,0.000060972656,0.0029687744,0.000034860353,0.0011566423,0.08975438,0.0013307801,0.9008556,0.00002947925],"about_ca_topic_score_codex":0.00038544688,"about_ca_topic_score_gemma":0.00124946,"teacher_disagreement_score":0.0031352278,"about_ca_system_score_codex":0.00028767076,"about_ca_system_score_gemma":0.0001801226,"threshold_uncertainty_score":0.010488391},"labels":[],"label_agreement":null},{"id":"W1566796706","doi":"10.1016/j.antiviral.2015.08.016","title":"A lumpy skin disease virus deficient of an IL-10 gene homologue provides protective immunity against virulent capripoxvirus challenge in sheep and goats","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta; University of Saskatchewan; Canadian Food Inspection Agency","funders":"","keywords":"Virology; Virulence; Biology; Immunity; Virus; Immunology; Gene; Immune system; Genetics","score_opus":0.07800638220671052,"score_gpt":0.34971737636711586,"score_spread":0.27171099416040534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1566796706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897337,0.00017046281,0.00040833716,0.00004756333,0.000027262628,0.000011238694,0.00006350284,0.000014096844,0.00028410478],"genre_scores_gemma":[0.99689156,0.00015218329,0.0005092106,0.00007310293,0.000026059439,0.000033075816,0.0002781113,0.000029680597,0.0020070751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996908,0.000057977617,0.00002543253,0.000068121495,0.000053012212,0.00010472782],"domain_scores_gemma":[0.9994124,0.0002155223,0.00010873459,0.000052079806,0.000029095929,0.00018212917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026643317,0.0006053068,0.00039367293,0.00044096424,0.0002290068,0.00043790782,0.00045634806,0.0006774502,0.0013363449],"category_scores_gemma":[0.00041294473,0.0002661412,0.0002609708,0.0000831918,0.0010110702,0.00037100434,0.00023256395,0.0012883561,0.0003826474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043830724,0.0001020722,0.0003134982,0.000022184298,0.0000073261194,0.00024163496,0.000047063113,0.000054052685,0.9983646,0.00008661582,0.000027290798,0.00029523377],"study_design_scores_gemma":[0.00035233522,0.0027847912,0.01835749,0.000032228014,0.000092171205,0.0027038553,0.00043997006,0.0032489921,0.9696121,0.00021567737,0.0021343,0.00002623004],"about_ca_topic_score_codex":0.00077157153,"about_ca_topic_score_gemma":0.00072525727,"teacher_disagreement_score":0.0013363449,"about_ca_system_score_codex":0.0004074525,"about_ca_system_score_gemma":0.00021511303,"threshold_uncertainty_score":0.0044704676},"labels":[],"label_agreement":null},{"id":"W1671096404","doi":"10.1016/j.antiviral.2015.09.003","title":"Harmine blocks herpes simplex virus infection through downregulating cellular NF-κB and MAPK pathways induced by oxidative stress","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Synthesis and bioactivity of alkaloids","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Herpes simplex virus; MAPK/ERK pathway; Oxidative stress; Harmine; NF-κB; Virology; Virus; Biology; Chemistry; Immunology; Cell biology; Inflammation; Signal transduction; Pharmacology; Biochemistry","score_opus":0.10819647722950669,"score_gpt":0.35453320565488994,"score_spread":0.24633672842538323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1671096404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892434,0.004865445,0.0024865551,0.00017931784,0.000059249705,0.000043194173,0.00018172145,0.00010817204,0.0028330106],"genre_scores_gemma":[0.99416625,0.0021845764,0.0010362393,0.000048760223,0.000016390142,0.000018963101,0.00016080464,0.0000073654005,0.0023607153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995804,0.000011769933,0.000004036057,0.0000052345445,0.000009668304,0.0000112308635],"domain_scores_gemma":[0.999962,0.000007765798,0.000010072756,0.0000060865336,0.0000048685165,0.000009239614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008055738,0.00025075822,0.00016605684,0.00016514982,0.00012215269,0.00012438632,0.0002123724,0.00020534788,0.0012498641],"category_scores_gemma":[0.00010835425,0.0000921116,0.00015097196,0.00007988054,0.00023683523,0.00026786537,0.00017000853,0.0004771781,0.00016241132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006605499,0.000089542984,0.00009335208,0.00014006217,0.000010591919,0.00005810841,0.000024344796,0.000073309435,0.993853,0.00020867948,0.00006391176,0.0047247102],"study_design_scores_gemma":[0.00012566728,0.001603116,0.0044494923,0.000018791246,0.0000350599,0.0002605188,0.000041338324,0.0005847865,0.98772484,0.00026718256,0.0048789554,0.000010230919],"about_ca_topic_score_codex":0.00026114626,"about_ca_topic_score_gemma":0.000663562,"teacher_disagreement_score":0.0012498641,"about_ca_system_score_codex":0.000102143305,"about_ca_system_score_gemma":0.00019621034,"threshold_uncertainty_score":0.0041811466},"labels":[],"label_agreement":null},{"id":"W1834034354","doi":"10.1016/j.antiviral.2015.09.007","title":"Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Herpes simplex virus; Medicine; Chemokine; Valaciclovir; Artesunate; Encephalitis; Viral encephalitis; Viral load; Immunology; Pharmacology; Virus; Virology; Herpesviridae; Inflammation; Viral disease","score_opus":0.17225452963641924,"score_gpt":0.43378255078694333,"score_spread":0.2615280211505241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1834034354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917155,0.004048802,0.00045563205,0.0003526608,0.00036921795,0.000039538514,0.00041562575,0.00021520523,0.0023878173],"genre_scores_gemma":[0.99403447,0.0022993141,0.0007426128,0.00010020283,0.000097866236,0.00004915859,0.00045432302,0.000029189596,0.0021928672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978524,0.000042765638,0.0000187431,0.00003984235,0.000035403682,0.00007799755],"domain_scores_gemma":[0.9997496,0.000031713076,0.000057798625,0.000024978366,0.000012837764,0.00012300201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021062062,0.00071357324,0.0012588833,0.0007024408,0.00025561693,0.00053936394,0.000397066,0.0006917175,0.0017235785],"category_scores_gemma":[0.0002149818,0.00019454713,0.00044621775,0.00033512033,0.00057002064,0.00068584847,0.0002084438,0.001687905,0.0003271527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028401894,0.0018642502,0.00079396047,0.00037676306,0.00016725504,0.00020290932,0.000082463215,0.0006386256,0.9387611,0.00036371534,0.0011839146,0.02716305],"study_design_scores_gemma":[0.002109535,0.039855324,0.008240603,0.00007328421,0.00043483463,0.00063570833,0.00015909602,0.001993724,0.94077367,0.00044879736,0.0052129896,0.00006253762],"about_ca_topic_score_codex":0.00060395914,"about_ca_topic_score_gemma":0.00105617,"teacher_disagreement_score":0.0017235785,"about_ca_system_score_codex":0.0002831773,"about_ca_system_score_gemma":0.0005134323,"threshold_uncertainty_score":0.0057659745},"labels":[],"label_agreement":null},{"id":"W1837132695","doi":"10.1016/j.antiviral.2015.09.006","title":"Longitudinal analysis of peripheral and intrahepatic NK cells in chronic HCV patients during antiviral therapy","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Santen","keywords":"Antiviral therapy; Medicine; Peripheral; Immunology; Chronic hepatitis; Virology; Internal medicine; Virus","score_opus":0.05325281740686058,"score_gpt":0.3352460753609724,"score_spread":0.2819932579541118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1837132695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99935013,0.00019441235,0.00006387677,0.000019350053,0.0000042860074,0.0000049261084,0.00010567546,0.0000028464483,0.000254476],"genre_scores_gemma":[0.99954957,0.000056676115,0.000025631287,0.0000148777035,0.0000063584166,0.0000058440555,0.00018144159,0.0000012825841,0.00015832199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995228,0.0001272643,0.000048492395,0.00008609441,0.000067949804,0.00014745188],"domain_scores_gemma":[0.9983412,0.00032371585,0.00061251177,0.00013666411,0.00022153008,0.00036432815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006810754,0.00021709932,0.00041630832,0.00055157713,0.0004923064,0.0007775119,0.00024521534,0.000445491,0.00085746596],"category_scores_gemma":[0.0022074403,0.0001894907,0.00029524692,0.0007022186,0.00026479142,0.0005505203,0.00043530992,0.0007022363,0.00026548002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011375315,0.000055781886,0.99461234,0.0000075730386,0.000027248967,0.0001370779,0.00016398523,0.00005458852,0.001486255,0.000016136844,0.000045926954,0.0022555809],"study_design_scores_gemma":[0.0000074751847,0.0003756378,0.99841535,0.000004306636,0.000029161802,0.00024397165,0.0002759964,0.00016962326,0.00025254017,0.000018068507,0.0002012769,0.000006493971],"about_ca_topic_score_codex":0.0025924759,"about_ca_topic_score_gemma":0.0025231794,"teacher_disagreement_score":0.0025924759,"about_ca_system_score_codex":0.00042711996,"about_ca_system_score_gemma":0.00039934728,"threshold_uncertainty_score":0.005154848},"labels":[],"label_agreement":null},{"id":"W1963713293","doi":"10.1016/j.antiviral.2012.06.005","title":"Is minocycline useful for therapy of acute viral encephalitis?","year":2012,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Minocycline; Medicine; Neuroprotection; Disease; Encephalitis; Clinical trial; Immunology; Virus; Pharmacology; Internal medicine; Antibiotics; Biology","score_opus":0.5484741983498679,"score_gpt":0.515536734200781,"score_spread":0.032937464149086826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963713293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021085865,0.99872917,0.0000892223,0.00028009538,0.00016630004,0.0000028172255,0.000012904652,0.0000041772873,0.00050437654],"genre_scores_gemma":[0.0017016827,0.99690837,0.00024089968,0.00026054448,0.00034380247,0.0000064362307,0.000025960258,0.000002029072,0.0005103843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998796,0.000020187748,0.000028886137,0.000021946176,0.000033328437,0.000016081021],"domain_scores_gemma":[0.99975294,0.000121909325,0.000045145487,0.000007764929,0.000051278163,0.000020944906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049309665,0.000702852,0.0015805396,0.00095905305,0.00022178909,0.0008026157,0.0007218248,0.0010834741,0.0021570965],"category_scores_gemma":[0.0006470951,0.00020363947,0.00044809983,0.0008060318,0.000588468,0.0010281996,0.00033504784,0.0017457595,0.001090163],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027078143,0.00009211784,0.00019602988,0.009456176,0.00008864422,0.00034571957,0.000043157226,0.00019099588,0.0037423095,0.0014626562,0.015812688,0.96829873],"study_design_scores_gemma":[0.0001942632,0.0005255368,0.0024352586,0.0046090884,0.00040366728,0.0039819125,0.00012731711,0.00021612945,0.0031159886,0.002769659,0.9815719,0.000049183047],"about_ca_topic_score_codex":0.0011431354,"about_ca_topic_score_gemma":0.003240188,"teacher_disagreement_score":0.0021570965,"about_ca_system_score_codex":0.00039992444,"about_ca_system_score_gemma":0.0008284387,"threshold_uncertainty_score":0.007216215},"labels":[],"label_agreement":null},{"id":"W1965267706","doi":"10.1016/s0166-3542(03)00133-5","title":"Genomic analysis of a recently identified virus (SEN virus) and genotypes D and H by polymerase chain reaction","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Genotype; Polymerase chain reaction; Biology; Virology; Virus; Hepatitis C virus; DNA sequencing; Genetics; DNA; Gene","score_opus":0.05762883819172862,"score_gpt":0.3236960327803968,"score_spread":0.26606719458866823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965267706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97758657,0.00057337456,0.013673121,0.00015656119,0.00013486897,0.00021826685,0.0032349206,0.00008199055,0.004340267],"genre_scores_gemma":[0.95598996,0.00089421746,0.024299534,0.00050968106,0.00007792448,0.00018904514,0.014007899,0.00006978792,0.003961923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997392,0.000033092696,0.000016920756,0.00011465738,0.00003377485,0.0000623458],"domain_scores_gemma":[0.99914074,0.0004650886,0.00009493944,0.00006580428,0.00012507482,0.000108354056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019545766,0.0007040644,0.00037411755,0.0006381764,0.00039435376,0.00045519613,0.00029375515,0.00059264724,0.0016300225],"category_scores_gemma":[0.00058750465,0.0003339362,0.0007697773,0.00036942444,0.0006370094,0.00025561667,0.00028264054,0.001021256,0.00083102286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027892936,0.000053811185,0.0023263597,0.00007213922,0.000016141646,0.00017864285,0.00009045956,0.00005317584,0.9950051,0.00017706274,0.000052637184,0.0016955329],"study_design_scores_gemma":[0.00010682806,0.0028756156,0.117447324,0.00008464976,0.00031091957,0.0034013325,0.00093504315,0.0019263163,0.8631078,0.0007394089,0.009007247,0.000057456113],"about_ca_topic_score_codex":0.0022546046,"about_ca_topic_score_gemma":0.0022381884,"teacher_disagreement_score":0.0022546046,"about_ca_system_score_codex":0.00028492595,"about_ca_system_score_gemma":0.0004890978,"threshold_uncertainty_score":0.005452931},"labels":[],"label_agreement":null},{"id":"W1965398894","doi":"10.1016/j.antiviral.2011.10.019","title":"Do viral infections mimic bacterial sepsis? The role of microvascular permeability: A review of mechanisms and methods","year":2011,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Dengue virus; Sepsis; Immunology; Context (archaeology); Dengue fever; Biology; Immunosuppression; Pathogenesis; Immune system; Viral pathogenesis; Virus; Virology; Medicine; Viral replication","score_opus":0.13182307340431137,"score_gpt":0.4872482166468658,"score_spread":0.3554251432425544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965398894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004500133,0.99943763,0.00009449335,0.00014872597,0.000099953846,0.0000021371593,0.000006725008,0.0000026608514,0.00016265055],"genre_scores_gemma":[0.0003067671,0.9991636,0.00016721385,0.00012103226,0.00014479642,0.0000042633224,0.000008403916,5.6965206e-7,0.00008332995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965894,0.00006979215,0.00006841053,0.00006185383,0.00011211236,0.000028874803],"domain_scores_gemma":[0.9991641,0.00051544927,0.000109990346,0.000022854963,0.00014313645,0.00004451651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001131337,0.0011437709,0.0024380856,0.0023854407,0.00029698794,0.0014227282,0.0011985552,0.0015700108,0.0017857798],"category_scores_gemma":[0.0011755157,0.0004195969,0.00069250737,0.0018885038,0.0011303341,0.0023515006,0.00078963564,0.002233661,0.0010392223],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020858581,0.00014687773,0.0005173411,0.030152185,0.00015809566,0.0003400758,0.00008291804,0.00031404998,0.0042181127,0.0050807516,0.023329671,0.9354514],"study_design_scores_gemma":[0.000063938925,0.00032832636,0.0023450858,0.0100152185,0.00047607793,0.0046187746,0.00022320283,0.0002381031,0.0023796442,0.006866198,0.97235435,0.00009107474],"about_ca_topic_score_codex":0.0008799118,"about_ca_topic_score_gemma":0.001306167,"teacher_disagreement_score":0.0024380856,"about_ca_system_score_codex":0.00074399,"about_ca_system_score_gemma":0.0015022269,"threshold_uncertainty_score":0.005983174},"labels":[],"label_agreement":null},{"id":"W1966157617","doi":"10.1016/j.antiviral.2010.07.006","title":"Interferon-β modulates type 1 immunity during influenza virus infection","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Immune system; Immunology; Influenza A virus; Biology; Virology; Interferon; Virus; Population; Immunity; Medicine","score_opus":0.18545032678141038,"score_gpt":0.4830819267779633,"score_spread":0.2976315999965529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966157617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970625,0.0014902992,0.000115439645,0.00009515705,0.000057139736,0.000019070234,0.000048613234,0.000004939647,0.0011068549],"genre_scores_gemma":[0.9969733,0.0012284651,0.00021035167,0.00015556772,0.00012280463,0.000027567174,0.0000976376,0.00000413956,0.0011803076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996238,0.00020711734,0.000022766018,0.000025646515,0.000036512494,0.00008416142],"domain_scores_gemma":[0.99970955,0.00010124452,0.000059236918,0.000035355115,0.000037324608,0.00005726303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009432134,0.00019611944,0.00022681596,0.00024765328,0.00017973265,0.00043081737,0.0001362052,0.00031278603,0.000934325],"category_scores_gemma":[0.00075210474,0.0001068359,0.00015188813,0.00012090669,0.00020338857,0.00027116368,0.00015638176,0.0004921908,0.00025698316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075277938,0.0003175511,0.015368633,0.00009477192,0.00003850099,0.00020815544,0.00020618761,0.00007565344,0.95656914,0.00014440468,0.00023195609,0.019217275],"study_design_scores_gemma":[0.00064011273,0.010330304,0.6323642,0.00010199549,0.00022855615,0.001015606,0.0013211368,0.0007695078,0.34700167,0.00057139085,0.0056272787,0.000028207618],"about_ca_topic_score_codex":0.00026605214,"about_ca_topic_score_gemma":0.0004172778,"teacher_disagreement_score":0.0009432134,"about_ca_system_score_codex":0.00021661303,"about_ca_system_score_gemma":0.00016961133,"threshold_uncertainty_score":0.004988253},"labels":[],"label_agreement":null},{"id":"W1967728176","doi":"10.1016/j.antiviral.2004.06.008","title":"Evaluation of a Western Equine Encephalitis recombinant E1 protein for protective immunity and diagnostics","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Defence Research and Development Canada; University of Alberta","funders":"","keywords":"Immunogenicity; Recombinant DNA; Virology; Biology; Inclusion bodies; Protein subunit; Glycoprotein; Escherichia coli; Virus; Antigen; Immune system; Immunization; Immunity; Humoral immunity; Microbiology; Molecular biology; Gene; Immunology; Biochemistry","score_opus":0.2232394123698678,"score_gpt":0.48438324054563925,"score_spread":0.2611438281757714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967728176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947238,0.00077514304,0.00325259,0.00008717171,0.000027041775,0.0001240434,0.0002746355,0.000030601434,0.0007050674],"genre_scores_gemma":[0.9889671,0.00053760357,0.006720628,0.0000869036,0.00001401001,0.000064074055,0.0016187455,0.000018964945,0.0019718693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996183,0.00013723178,0.00003162815,0.000053752934,0.00008580631,0.00007332413],"domain_scores_gemma":[0.99966645,0.00011464029,0.00003254665,0.00004215884,0.000100295496,0.000043873562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009289392,0.00061024906,0.00028143267,0.00033806224,0.00028257372,0.00039163145,0.0003697798,0.00059225113,0.0011327486],"category_scores_gemma":[0.0006059801,0.00014699073,0.00038838756,0.00022960256,0.00035151854,0.00033608096,0.00016511629,0.0006354907,0.00030983207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089728454,0.00040119636,0.0005449772,0.000051723033,0.000017914475,0.0000571263,0.00003413413,0.0003266796,0.9950766,0.000092100556,0.00007362705,0.0024266131],"study_design_scores_gemma":[0.0000909183,0.0028237281,0.0019428922,0.0000059848853,0.000044224802,0.0002575673,0.00003151824,0.0014329042,0.9918229,0.000032915927,0.0015104607,0.0000040284444],"about_ca_topic_score_codex":0.0016311147,"about_ca_topic_score_gemma":0.0011292155,"teacher_disagreement_score":0.0016311147,"about_ca_system_score_codex":0.00063489255,"about_ca_system_score_gemma":0.00034951954,"threshold_uncertainty_score":0.004912734},"labels":[],"label_agreement":null},{"id":"W1967732746","doi":"10.1016/j.antiviral.2011.07.007","title":"High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Tetherin; Flow cytometry; Cell biology; Cell; Viral replication; Stromal cell; Function (biology); Replication (statistics); Biology; Cell culture; Chemistry; Virology; Molecular biology; Virus; Biochemistry; Cancer research; Genetics","score_opus":0.06273332628503661,"score_gpt":0.3541660564287749,"score_spread":0.29143273014373827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967732746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87004703,0.0087272115,0.103362955,0.00054429396,0.00037237143,0.0007496265,0.007036789,0.0015183274,0.007641532],"genre_scores_gemma":[0.91403586,0.0061555626,0.049806323,0.00023085273,0.00010340938,0.0010825449,0.012998652,0.0001204939,0.015466178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999508,0.000084614956,0.000034227134,0.000063726824,0.00022589695,0.000083513274],"domain_scores_gemma":[0.99988353,0.000050527626,0.000015908445,0.000012997561,0.000022324672,0.000014767421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003970246,0.0012669434,0.00083960476,0.0005514764,0.00035204674,0.00064216694,0.00063548825,0.00045961642,0.002378893],"category_scores_gemma":[0.00024387772,0.0004304387,0.00057019206,0.0007109078,0.00018343932,0.00025418476,0.00029895836,0.0012150736,0.0011032342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023124061,0.00022127149,0.0002059741,0.000075567674,0.000040991268,0.000027424972,0.000013531235,0.00052160665,0.9949663,0.000078256824,0.00040173822,0.0032159032],"study_design_scores_gemma":[0.00005272395,0.0004055465,0.00095098256,0.0000038962994,0.000044253782,0.00008131067,0.000008537859,0.0038837977,0.9925655,0.00002667856,0.001968441,0.000008309798],"about_ca_topic_score_codex":0.00094795274,"about_ca_topic_score_gemma":0.0022957406,"teacher_disagreement_score":0.002378893,"about_ca_system_score_codex":0.0005532517,"about_ca_system_score_gemma":0.00037272758,"threshold_uncertainty_score":0.007958174},"labels":[],"label_agreement":null},{"id":"W1968490745","doi":"10.1016/j.antiviral.2005.01.002","title":"Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; Centers for Disease Control and Prevention","keywords":"Cytopathic effect; Interferon; Virology; Virus; In vitro; IC50; Medicine; Immunology; Pharmacology; Biology","score_opus":0.1717717720682427,"score_gpt":0.4396021920681019,"score_spread":0.26783041999985924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968490745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965906,0.011070793,0.00722899,0.0015753115,0.0007973596,0.00025486384,0.0023076758,0.00044160566,0.010417348],"genre_scores_gemma":[0.9823286,0.004154015,0.0035314297,0.0001738951,0.00007965303,0.00019322959,0.002582218,0.00003321531,0.0069236434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996712,0.00012082519,0.000020466807,0.00003353931,0.00008211353,0.00007185749],"domain_scores_gemma":[0.99989045,0.000034585315,0.000015600883,0.000021874659,0.000015980751,0.000021441318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056812086,0.0005871595,0.00062215165,0.00035554485,0.00035071082,0.00048571965,0.0005895469,0.0005980392,0.0027285004],"category_scores_gemma":[0.00022652118,0.00020316392,0.00044987773,0.00028184106,0.00025313755,0.0004440452,0.00016349292,0.0017116023,0.0007232336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004616645,0.0006406879,0.00043482904,0.0002454508,0.00007629184,0.00019989502,0.00007768091,0.0017477748,0.97517747,0.0015486833,0.002811548,0.0124231335],"study_design_scores_gemma":[0.0005223508,0.0028719867,0.0014614064,0.000017461278,0.000070946975,0.0003269059,0.000042795582,0.004800066,0.9747195,0.00035425715,0.014794321,0.000017893866],"about_ca_topic_score_codex":0.0010060271,"about_ca_topic_score_gemma":0.0016963208,"teacher_disagreement_score":0.0027285004,"about_ca_system_score_codex":0.0006460663,"about_ca_system_score_gemma":0.0004255932,"threshold_uncertainty_score":0.009127736},"labels":[],"label_agreement":null},{"id":"W1969487400","doi":"10.1016/j.antiviral.2006.07.004","title":"Resveratrol inhibition of varicella-zoster virus replication in vitro","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Resveratrol; Varicella zoster virus; Virus; Virology; Viral replication; Biology; In vitro; Western blot; Replication (statistics); Pharmacology; Gene; Biochemistry","score_opus":0.05591106995852922,"score_gpt":0.39263303028605123,"score_spread":0.336721960327522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969487400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782507,0.009395882,0.0016381528,0.00031890575,0.00034227825,0.0000684441,0.0008824724,0.00017791826,0.008925299],"genre_scores_gemma":[0.9852153,0.0037395372,0.0012034946,0.00008986198,0.00005505451,0.00003930923,0.0015929973,0.000028707891,0.008035595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997861,0.00007190468,0.000019064511,0.000028340666,0.000035806966,0.000058918948],"domain_scores_gemma":[0.99980503,0.00008160714,0.00001954224,0.00003851901,0.000023633937,0.00003175657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018792263,0.0005328153,0.0005218616,0.00040850998,0.00035468797,0.0003622038,0.00034871793,0.0003495109,0.004161384],"category_scores_gemma":[0.00023858766,0.00021566279,0.0006369872,0.00021655767,0.00027944797,0.00033329814,0.00023253844,0.0009072846,0.0010512993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017968982,0.0002560483,0.0002422294,0.00020726488,0.000055139408,0.000088536726,0.00008370282,0.00014283728,0.9906476,0.0002981644,0.00039295448,0.0057885633],"study_design_scores_gemma":[0.00008868759,0.0014340451,0.0023119198,0.000014404763,0.00006642793,0.00013823963,0.00006548724,0.0003731625,0.9904269,0.00006829719,0.005002475,0.000009969345],"about_ca_topic_score_codex":0.001888503,"about_ca_topic_score_gemma":0.0026704203,"teacher_disagreement_score":0.004161384,"about_ca_system_score_codex":0.00034732412,"about_ca_system_score_gemma":0.00037038888,"threshold_uncertainty_score":0.013921201},"labels":[],"label_agreement":null},{"id":"W1971489080","doi":"10.1016/s0166-3542(02)00212-7","title":"Inhibition of adenovirus infection and adenain by green tea catechins","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Virus; Epigallocatechin gallate; IC50; Green tea extract; Catechin; Titer; Proteases; Virology; Cell culture; Green tea; Chemistry; Biology; Molecular biology; Polyphenol; In vitro; Biochemistry; Antioxidant; Food science; Enzyme","score_opus":0.05105207776088401,"score_gpt":0.37036638308542197,"score_spread":0.319314305324538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971489080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986673,0.0054635,0.0031123688,0.00030446373,0.00019244783,0.0000801832,0.00066711125,0.00020964058,0.0032972316],"genre_scores_gemma":[0.9871912,0.0026646163,0.0025548525,0.00008515037,0.00005311487,0.00009204036,0.0013070059,0.00005198897,0.0060000606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994505,0.00011479273,0.00004864447,0.00007684164,0.00007222756,0.00023705374],"domain_scores_gemma":[0.9994758,0.00024035353,0.00006276344,0.00012240074,0.000028438582,0.0000701984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006002271,0.0013365378,0.00059742643,0.000663304,0.00045964948,0.0007705035,0.00062991376,0.0005290852,0.002288462],"category_scores_gemma":[0.00035412595,0.00047108525,0.0011801275,0.0003837627,0.00087554863,0.0006941864,0.0005814185,0.0016916275,0.0006390269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012029913,0.00016139637,0.00015614038,0.00009115539,0.000025051146,0.00006188415,0.00008157561,0.00010628988,0.99555653,0.0007940417,0.00009692481,0.0016660327],"study_design_scores_gemma":[0.00004013819,0.00032647827,0.0009098754,0.000007014449,0.00001705673,0.000053961285,0.00004752639,0.00028703577,0.997109,0.000077101315,0.0011201996,0.000004673776],"about_ca_topic_score_codex":0.0029883448,"about_ca_topic_score_gemma":0.0023658718,"teacher_disagreement_score":0.0029883448,"about_ca_system_score_codex":0.0012462611,"about_ca_system_score_gemma":0.00078961655,"threshold_uncertainty_score":0.009042263},"labels":[],"label_agreement":null},{"id":"W1971864726","doi":"10.1016/s0166-3542(01)00219-4","title":"Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors","year":2002,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Zanamivir; Neuraminidase; Oseltamivir; Virology; IC50; Neuraminidase inhibitor; Virus; Microbiology; Influenza season; Human influenza; Biology; In vitro; Medicine; Coronavirus disease 2019 (COVID-19); Influenza vaccine; Biochemistry; Internal medicine; Infectious disease (medical specialty)","score_opus":0.26255678178263037,"score_gpt":0.4476073942188827,"score_spread":0.18505061243625232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971864726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963266,0.00065522554,0.00006282889,0.00012905724,0.000021578655,0.000026499405,0.0010199628,0.0000040484742,0.0017540855],"genre_scores_gemma":[0.9963903,0.00067000167,0.00014034504,0.000120970915,0.000015559608,0.0000103903785,0.001042935,0.000003224682,0.0016062513],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993648,0.000060720402,0.000037641796,0.000093008195,0.00025305816,0.00019078275],"domain_scores_gemma":[0.9980405,0.00025680277,0.00019741326,0.00007234466,0.0010929685,0.00034012875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068324676,0.0003749475,0.00037069886,0.0005440535,0.0013463162,0.0004635531,0.0006674121,0.00052437687,0.0018654474],"category_scores_gemma":[0.002767609,0.00024159947,0.00041323536,0.0010621212,0.0005201587,0.000267567,0.00019796946,0.0007110738,0.00021770211],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01676207,0.0009354095,0.8034274,0.00046250096,0.00076364644,0.0013682466,0.0052466462,0.0015696578,0.1266538,0.00077991793,0.004577948,0.0374529],"study_design_scores_gemma":[0.00007927698,0.0015031112,0.9811871,0.000017582168,0.00014621357,0.000601403,0.001331788,0.00026178986,0.009695311,0.000034380675,0.0051078666,0.000034334345],"about_ca_topic_score_codex":0.8790833,"about_ca_topic_score_gemma":0.8744271,"teacher_disagreement_score":0.120916724,"about_ca_system_score_codex":0.006559046,"about_ca_system_score_gemma":0.0043881848,"threshold_uncertainty_score":0.24325758},"labels":[],"label_agreement":null},{"id":"W1973211512","doi":"10.1016/s0166-3542(03)00153-0","title":"Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; U.S. Department of Agriculture","keywords":"Human metapneumovirus; Ribavirin; Virology; Pneumovirinae; Virus; Palivizumab; Antibody; Paramyxoviridae; Metapneumovirus; Biology; Immune system; Monoclonal antibody; Immunology; Respiratory tract infections; Medicine; Respiratory system; Viral disease; Hepatitis C virus","score_opus":0.11421737952203412,"score_gpt":0.45716061104667566,"score_spread":0.34294323152464157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973211512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774883,0.014630189,0.0019388294,0.00013253302,0.00018160853,0.00009127585,0.0008678547,0.000071700575,0.004597758],"genre_scores_gemma":[0.98629737,0.004710935,0.0019297663,0.0000992537,0.000099154364,0.00007891995,0.0021528201,0.00003329072,0.0045984727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929726,0.0003430453,0.000064958316,0.000058711477,0.000104955,0.0001311102],"domain_scores_gemma":[0.9992186,0.0005126144,0.000052394233,0.00006637491,0.00008841328,0.00006157344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006997378,0.0010575937,0.00080705853,0.0005100085,0.0002717675,0.00042995787,0.00059231266,0.0005647886,0.0016836671],"category_scores_gemma":[0.00073630543,0.0003517475,0.00082717853,0.00045964622,0.0003104841,0.00042787712,0.00029188,0.00063478365,0.0008217636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038722632,0.00055213465,0.0009446432,0.00038741637,0.00009610156,0.0001814721,0.00015657127,0.0016632549,0.98363864,0.00028700888,0.00028319887,0.007937372],"study_design_scores_gemma":[0.00011176115,0.004805046,0.004868713,0.000023426566,0.00005215892,0.00017555873,0.00004872338,0.0016196156,0.9863933,0.00005583436,0.0018324413,0.000013422476],"about_ca_topic_score_codex":0.0021353958,"about_ca_topic_score_gemma":0.0020760433,"teacher_disagreement_score":0.0021353958,"about_ca_system_score_codex":0.00041010333,"about_ca_system_score_gemma":0.00038457388,"threshold_uncertainty_score":0.0056324005},"labels":[],"label_agreement":null},{"id":"W1973288655","doi":"10.1016/s0166-3542(00)00085-1","title":"A novel high throughput screening assay for HCV NS3 helicase activity","year":2000,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Helicase; Biotinylation; NS3; Oligonucleotide; Chemistry; DNA; Molecular biology; High-throughput screening; Recombinant DNA; Biochemistry; Escherichia coli; Biology; Enzyme; Protease; RNA; Gene","score_opus":0.22963710279890556,"score_gpt":0.4795701508401942,"score_spread":0.24993304804128866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973288655","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6919268,0.0067412406,0.27079538,0.0012136773,0.00049094035,0.0025212553,0.0097616445,0.005098754,0.011450386],"genre_scores_gemma":[0.7537233,0.0041995067,0.18429741,0.0007963101,0.00023509403,0.00229295,0.024233771,0.00025630047,0.029965468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986565,0.00031353606,0.0000731285,0.00016499184,0.00065303664,0.00013890553],"domain_scores_gemma":[0.99962926,0.00014785386,0.000034996272,0.000044457796,0.00008707278,0.000056294703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008143608,0.0016281605,0.0011304079,0.001424079,0.0005983368,0.0007642862,0.000852732,0.0008331418,0.002339074],"category_scores_gemma":[0.00052055967,0.0005423385,0.0006909434,0.0008662134,0.00033289802,0.0003977762,0.00082824135,0.0011321985,0.0023667668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011118008,0.00020916223,0.00033895642,0.00006681587,0.000026398844,0.0000323583,0.00001501478,0.00010133377,0.9922883,0.000049811886,0.0005575,0.006203256],"study_design_scores_gemma":[0.00007272144,0.0007460003,0.0030608086,0.000010741411,0.00006763371,0.0004090455,0.000022199229,0.003051348,0.9887977,0.00008235007,0.0036474902,0.00003191815],"about_ca_topic_score_codex":0.001227477,"about_ca_topic_score_gemma":0.0035132107,"teacher_disagreement_score":0.002339074,"about_ca_system_score_codex":0.0005584115,"about_ca_system_score_gemma":0.00055765174,"threshold_uncertainty_score":0.007824957},"labels":[],"label_agreement":null},{"id":"W1974685109","doi":"10.1016/j.antiviral.2012.06.003","title":"Countermeasures against viral diseases of farmed fish","year":2012,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Aquaculture disease management and microbiota","field":"Immunology and Microbiology","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; University of Prince Edward Island","funders":"","keywords":"Aquaculture; Biology; Fish farming; Outbreak; Fish <Actinopterygii>; Population; Biotechnology; Fishery; Virology; Environmental health; Medicine","score_opus":0.1246550332103546,"score_gpt":0.4021714001815911,"score_spread":0.2775163669712365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974685109","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015869975,0.99884063,0.00012712991,0.00018760203,0.00024201914,0.0000034870834,0.0000118403495,0.0000043133464,0.000424251],"genre_scores_gemma":[0.0009876201,0.9977622,0.00024899453,0.00019258888,0.00029525522,0.000005374697,0.000026993206,0.0000010051109,0.0004799545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999864,0.000019923074,0.000020934272,0.000027760476,0.00004940102,0.000018034323],"domain_scores_gemma":[0.9996966,0.00013599345,0.000058205103,0.000008117245,0.000070440474,0.00003070307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005430621,0.000999773,0.0013277719,0.0012455003,0.00017781668,0.00068098964,0.0006383975,0.0009447788,0.0018086435],"category_scores_gemma":[0.0005837067,0.00023237865,0.00034222475,0.001003643,0.00046374355,0.0007723387,0.00050489296,0.0015705131,0.00094551593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011689557,0.00008182938,0.00020618275,0.008464739,0.00006107866,0.00012677391,0.000025093947,0.00020499383,0.004288555,0.0009081815,0.014983603,0.9705321],"study_design_scores_gemma":[0.000055613444,0.00032877352,0.0021640323,0.0037288798,0.00026656958,0.0013212187,0.00009253465,0.00015875889,0.0018583847,0.0014812414,0.98851585,0.000028161627],"about_ca_topic_score_codex":0.00068938814,"about_ca_topic_score_gemma":0.001904864,"teacher_disagreement_score":0.0018086435,"about_ca_system_score_codex":0.000398125,"about_ca_system_score_gemma":0.00073447806,"threshold_uncertainty_score":0.006050527},"labels":[],"label_agreement":null},{"id":"W1975018200","doi":"10.1016/j.antiviral.2009.07.009","title":"Novel HCV replication mouse model using human hepatocellular carcinoma xenografts","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Virology; Cell culture; In vivo; Viral replication; Biology; Hepatocellular carcinoma; Virus; Population; Interferon; Hepatitis C virus; Cell; Cancer research; Medicine; Genetics","score_opus":0.2845902453334538,"score_gpt":0.46226274454808347,"score_spread":0.1776724992146297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975018200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479858,0.003444575,0.030579852,0.0013140783,0.00070044916,0.0010426947,0.004664465,0.001501207,0.00876687],"genre_scores_gemma":[0.95855236,0.0022224467,0.018478895,0.0002606,0.000141333,0.00072485814,0.0025958081,0.00021626247,0.016807433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940395,0.00012783984,0.000062298386,0.00014332244,0.0001471871,0.000115489805],"domain_scores_gemma":[0.99928904,0.00014543172,0.00016290437,0.00020175547,0.000055170338,0.00014557215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012873656,0.0015470019,0.00058797403,0.001720403,0.00064705743,0.0008354473,0.0010238102,0.0009619518,0.0033065167],"category_scores_gemma":[0.00032905227,0.0005911911,0.0008107191,0.0005561167,0.00084518216,0.0013574422,0.0004854743,0.0020355994,0.0010958831],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002423911,0.0008389737,0.0004978644,0.000121490055,0.000046663503,0.0005652402,0.00009002632,0.0003753344,0.9888148,0.0028855086,0.000604114,0.002736213],"study_design_scores_gemma":[0.0004509316,0.0036375013,0.0017201669,0.000029675017,0.00012771752,0.0022410273,0.0000623097,0.0030842777,0.98115987,0.00053853606,0.0069170706,0.000030964435],"about_ca_topic_score_codex":0.0010800781,"about_ca_topic_score_gemma":0.0012262907,"teacher_disagreement_score":0.0033065167,"about_ca_system_score_codex":0.00077555206,"about_ca_system_score_gemma":0.00061122526,"threshold_uncertainty_score":0.01106137},"labels":[],"label_agreement":null},{"id":"W1978815542","doi":"10.1016/j.antiviral.2007.06.010","title":"Protease inhibitor resistance in HIV-infected patients: Molecular and clinical perspectives","year":2007,"lang":"en","type":"review","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Ritonavir; Drug resistance; Protease; Protease inhibitor (pharmacology); Virology; Biology; Drug; Human immunodeficiency virus (HIV); Virus; Genetics; Viral load; Pharmacology; Antiretroviral therapy; Enzyme","score_opus":0.10836164955973147,"score_gpt":0.47973365930862316,"score_spread":0.3713720097488917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978815542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064705906,0.9990759,0.000056481753,0.00026208145,0.00011003655,0.0000018259137,0.000007766964,0.000003145691,0.00041811576],"genre_scores_gemma":[0.0003497954,0.99892884,0.000114806804,0.00017903085,0.00019848229,0.0000028447248,0.000012249842,4.402247e-7,0.00021350612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978465,0.000041734093,0.000029191468,0.000039336483,0.000083204046,0.000021933925],"domain_scores_gemma":[0.9995776,0.0002296371,0.00006064247,0.000009421227,0.00009209443,0.000030641913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007261203,0.0010167472,0.0023472302,0.0016197698,0.00022787724,0.0012938387,0.001061543,0.0014605263,0.0031823895],"category_scores_gemma":[0.0007786189,0.00023388682,0.0005435116,0.002188869,0.00046766203,0.0014514164,0.00041910043,0.0021027534,0.0016232429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014808557,0.00010502102,0.00032288063,0.008851888,0.00009840413,0.00039086168,0.000034978624,0.000234859,0.0014285017,0.0025728582,0.030185886,0.9556258],"study_design_scores_gemma":[0.000102148915,0.00023938391,0.002140783,0.004443522,0.00033199353,0.0042577437,0.000095334464,0.00019152832,0.00051982544,0.0027523965,0.98489326,0.000032020413],"about_ca_topic_score_codex":0.00072870706,"about_ca_topic_score_gemma":0.0019506457,"teacher_disagreement_score":0.0031823895,"about_ca_system_score_codex":0.00046592136,"about_ca_system_score_gemma":0.0010251811,"threshold_uncertainty_score":0.010646105},"labels":[],"label_agreement":null},{"id":"W1979574354","doi":"10.1016/j.antiviral.2014.12.005","title":"Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?","year":2014,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Hospital for Sick Children","funders":"","keywords":"RHOA; Fasudil; Rho-associated protein kinase; Medicine; Vascular permeability; Proinflammatory cytokine; Endothelial dysfunction; In vivo; Immunology; Inflammation; Pharmacology; Cancer research; Cell biology; Biology; Kinase; Signal transduction; Pathology; Internal medicine","score_opus":0.08941675248692306,"score_gpt":0.38204714690685576,"score_spread":0.2926303944199327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979574354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021151615,0.99780816,0.00023787479,0.0004638851,0.00048105765,0.0000068724103,0.000026045167,0.000011976418,0.00075254234],"genre_scores_gemma":[0.0013175895,0.9966793,0.00029473932,0.00033971507,0.00033544443,0.000012333657,0.000054270007,0.000002156293,0.00096452737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988246,0.000014622192,0.000016255999,0.000021480422,0.0000436404,0.000021605541],"domain_scores_gemma":[0.99982375,0.000055620123,0.000029072698,0.0000070833935,0.00005875227,0.000025680187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006042433,0.0008286463,0.0014351712,0.0009256878,0.00024243593,0.0008629008,0.0009019279,0.0012422877,0.0027980532],"category_scores_gemma":[0.00053922285,0.00023500582,0.00042147347,0.0007292034,0.0004908338,0.001062578,0.00057640235,0.0023412649,0.001990489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027302394,0.0001382477,0.00015098506,0.009459629,0.0001045143,0.00022355189,0.000028883906,0.00025923597,0.0093974285,0.0038891032,0.037162393,0.93891305],"study_design_scores_gemma":[0.000090651854,0.00020823684,0.0009626461,0.0016713651,0.00018778002,0.00082299364,0.00005019695,0.00014679502,0.0029877222,0.0022710704,0.99057186,0.000028746977],"about_ca_topic_score_codex":0.00066019164,"about_ca_topic_score_gemma":0.0014121736,"teacher_disagreement_score":0.0027980532,"about_ca_system_score_codex":0.0005077142,"about_ca_system_score_gemma":0.0010004287,"threshold_uncertainty_score":0.009360433},"labels":[],"label_agreement":null},{"id":"W1979634477","doi":"10.1016/j.antiviral.2007.03.001","title":"Insertions in the β3–β4 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacity","year":2007,"lang":"en","type":"review","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Reverse transcriptase; Viral replication; Protease; Biology; Virology; Drug resistance; Virus; Mechanism of action; Enzyme; Drug; Gene; Genetics; Pharmacology; In vitro; Polymerase chain reaction; Biochemistry","score_opus":0.23435612412653742,"score_gpt":0.45694309828154583,"score_spread":0.22258697415500842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979634477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006292205,0.99835545,0.00013747299,0.000053555344,0.00006668975,0.000006130622,0.000016910828,0.0000055100745,0.0007290285],"genre_scores_gemma":[0.0016874138,0.9972211,0.00028760757,0.0000691764,0.000046349967,0.0000055378787,0.00004144052,0.0000010416377,0.0006401958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998859,0.000013894852,0.000014309492,0.00002041416,0.00005250643,0.000012850246],"domain_scores_gemma":[0.9998603,0.000066418484,0.00003503572,0.0000035340809,0.000026136693,0.0000085676975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003709062,0.0007264262,0.0012110296,0.0012080203,0.0001410659,0.0006072402,0.00081367046,0.0005304726,0.001585328],"category_scores_gemma":[0.00032282682,0.00024261238,0.0003495647,0.0014359013,0.00035175888,0.0006997022,0.0002733021,0.0008513449,0.0010249658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015287353,0.00007847349,0.00021644818,0.011938417,0.0000702585,0.0002549979,0.0000480304,0.00041966495,0.0139398975,0.0016673859,0.0062721735,0.9649415],"study_design_scores_gemma":[0.000060295482,0.00025270972,0.0019448565,0.0019817313,0.00027283453,0.0023787739,0.00007750707,0.00014986943,0.0075568478,0.001467063,0.9838282,0.000029282723],"about_ca_topic_score_codex":0.00095102447,"about_ca_topic_score_gemma":0.0014592515,"teacher_disagreement_score":0.001585328,"about_ca_system_score_codex":0.00040032304,"about_ca_system_score_gemma":0.0006159052,"threshold_uncertainty_score":0.005303502},"labels":[],"label_agreement":null},{"id":"W1980089445","doi":"10.1016/j.antiviral.2007.03.013","title":"Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"","keywords":"Vesicular stomatitis virus; Biology; Immune system; Proinflammatory cytokine; Microbiology; Virus; Lactobacillus rhamnosus; Innate immune system; Probiotic; Interferon; Chemokine; Cytokine; Lipopolysaccharide; Vesicular stomatitis Indiana virus; Immunology; Virology; Inflammation; Bacteria","score_opus":0.03826843277098236,"score_gpt":0.325582049487448,"score_spread":0.28731361671646566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980089445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973908,0.0010380276,0.00047741272,0.0002335386,0.00009485833,0.00002122664,0.00005524022,0.000017497448,0.00067143055],"genre_scores_gemma":[0.9960525,0.00057086674,0.0010063658,0.0002404201,0.00008759636,0.000094473566,0.00013239213,0.000014403815,0.0018010816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994136,0.00024122378,0.00003399363,0.000053491887,0.0000679074,0.0001897751],"domain_scores_gemma":[0.9997514,0.00007813354,0.000037072623,0.000027925338,0.000033807133,0.00007159496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005521136,0.0006059244,0.0006905201,0.00024232893,0.00033949173,0.00041723563,0.00024705284,0.00088133616,0.0026729398],"category_scores_gemma":[0.00041510756,0.00037348413,0.0005073966,0.000120173136,0.00039404203,0.00028787518,0.00053893204,0.0011914677,0.00051121623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002614827,0.0002209939,0.00048183682,0.00006007423,0.000017357219,0.000103280756,0.000030521085,0.00004911198,0.99457234,0.00006182562,0.000112508416,0.0016755235],"study_design_scores_gemma":[0.0005314086,0.0042532696,0.011722809,0.000028966908,0.00010086502,0.0004519653,0.00022740736,0.00087695505,0.97898716,0.00022921257,0.0025749223,0.000015208458],"about_ca_topic_score_codex":0.000203757,"about_ca_topic_score_gemma":0.00037284824,"teacher_disagreement_score":0.0026729398,"about_ca_system_score_codex":0.0002112316,"about_ca_system_score_gemma":0.00024333422,"threshold_uncertainty_score":0.008941889},"labels":[],"label_agreement":null},{"id":"W1981742167","doi":"10.1016/j.antiviral.2007.06.014","title":"The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Gilead Sciences","keywords":"Virology; Viral replication; Hepatitis B virus; Biology; Reverse transcriptase; Nucleoside analogue; In vitro; Nucleoside; Hepatitis B virus PRE beta; RNA; Transcription (linguistics); Virus; Hepatitis B virus DNA polymerase; Gene; Genetics","score_opus":0.2316583127402806,"score_gpt":0.4500056234932374,"score_spread":0.21834731075295682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981742167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947247,0.00090521865,0.0011228585,0.00009782236,0.000019625279,0.000020605912,0.00008484636,0.00006171792,0.0029624999],"genre_scores_gemma":[0.99669456,0.0007269416,0.00093452574,0.000030194837,0.000015327805,0.00001035546,0.00015589486,0.000012002798,0.0014202021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991035,0.000027473021,0.00000554183,0.0000096236145,0.000021959331,0.000025084393],"domain_scores_gemma":[0.9998939,0.000036293615,0.000025446869,0.000011986389,0.000008374986,0.000024085075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001581211,0.00022761058,0.00017835869,0.00015319356,0.000116552335,0.00022084166,0.00023208461,0.00023380121,0.0016332436],"category_scores_gemma":[0.00019082517,0.00013151749,0.00012712945,0.00008387086,0.00030655097,0.0002898498,0.0001524107,0.0005677552,0.0003830173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040017988,0.000053766285,0.00007194992,0.00002975402,0.000004042776,0.00004419945,0.000012044432,0.00009215542,0.9963846,0.00036476046,0.000073780815,0.0024688554],"study_design_scores_gemma":[0.00006902133,0.0020597316,0.0008217508,0.0000039144807,0.000009103349,0.00020173652,0.00000991344,0.00045805197,0.99503016,0.000095512216,0.0012351768,0.000005747903],"about_ca_topic_score_codex":0.00036665928,"about_ca_topic_score_gemma":0.00031211134,"teacher_disagreement_score":0.0016332436,"about_ca_system_score_codex":0.0001295536,"about_ca_system_score_gemma":0.00025913355,"threshold_uncertainty_score":0.005463779},"labels":[],"label_agreement":null},{"id":"W1982168548","doi":"10.1016/j.antiviral.2014.04.001","title":"E138A in HIV-1 reverse transcriptase is more common in subtype C than B: Implications for rilpivirine use in resource-limited settings","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver","funders":"National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; World Health Organization","keywords":"Rilpivirine; Tenofovir; Emtricitabine; Reverse transcriptase; Virology; Human immunodeficiency virus (HIV); Reverse-transcriptase inhibitor; Biology; Genotype; Coinfection; Viral load; Medicine; Antiretroviral therapy; Genetics; Polymerase chain reaction; Gene","score_opus":0.07436114394507591,"score_gpt":0.36826208167537855,"score_spread":0.2939009377303026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982168548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943159,0.001610419,0.00020743073,0.0008881484,0.000029388944,0.000014153352,0.000570165,0.000009176332,0.0023551853],"genre_scores_gemma":[0.99849224,0.00046895797,0.00024459523,0.00031936422,0.000026357926,0.000005885827,0.00019316532,0.000012565115,0.00023684857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986865,0.0003647205,0.00016374869,0.00028535412,0.00024276978,0.00025694814],"domain_scores_gemma":[0.9963941,0.0012752735,0.0015535337,0.00018227292,0.00023809607,0.00035674954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012730896,0.00025422112,0.00039254292,0.0006014041,0.0006162966,0.0012638085,0.0010712469,0.0007174648,0.007792759],"category_scores_gemma":[0.0041560642,0.00019188871,0.00042921217,0.0015107371,0.0005367832,0.00082579406,0.00032123682,0.0010633447,0.00048289483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005431616,0.00010700892,0.9741417,0.000059713104,0.00011276211,0.0009959087,0.0002909226,0.000061805986,0.0031102728,0.00047625764,0.0008941182,0.01920635],"study_design_scores_gemma":[0.000052597657,0.00018142273,0.98536867,0.00015941754,0.000089456524,0.007199529,0.0028044353,0.00030264602,0.0006718533,0.00073963345,0.0024091678,0.00002112621],"about_ca_topic_score_codex":0.011152888,"about_ca_topic_score_gemma":0.012631329,"teacher_disagreement_score":0.011152888,"about_ca_system_score_codex":0.000566017,"about_ca_system_score_gemma":0.0006414042,"threshold_uncertainty_score":0.026069403},"labels":[],"label_agreement":null},{"id":"W1985314955","doi":"10.1016/j.antiviral.2009.10.022","title":"Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oak Ridge Institute for Science and Education; Public Health Agency of Canada","keywords":"Neuraminidase; Zanamivir; Oseltamivir; Virology; Biology; Pyrosequencing; Virus; Neuraminidase inhibitor; Influenza A virus; Microbiology; Gene; Genetics; Medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.14969893046777089,"score_gpt":0.44321918422021617,"score_spread":0.2935202537524453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985314955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816799,0.00042315584,0.015913932,0.000037984602,0.000015711637,0.000052040792,0.00085375755,0.000043124943,0.0009803058],"genre_scores_gemma":[0.964364,0.00032004996,0.031879626,0.000094899544,0.000012101006,0.00007271948,0.0012391786,0.00003134852,0.0019861176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993616,0.00019474044,0.00003757787,0.00014944914,0.00019902005,0.000057661866],"domain_scores_gemma":[0.99918383,0.00034504148,0.00011648733,0.00008693004,0.0002071759,0.00006053354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088595226,0.00035933734,0.00039920871,0.00056336354,0.0003272163,0.0006221866,0.00026157187,0.0005467359,0.00043487977],"category_scores_gemma":[0.0015990768,0.00029961063,0.0004099784,0.00052303786,0.00029771283,0.0002458636,0.00026450353,0.0006780189,0.0003881262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023092372,0.000032378248,0.0041030776,0.000022406763,0.000027076449,0.00003845947,0.000086900916,0.00028059425,0.99089265,0.00008458329,0.000021841355,0.004179134],"study_design_scores_gemma":[0.000025423213,0.00051964424,0.06042093,0.00001861679,0.00014725275,0.0005627816,0.00015009148,0.009902931,0.9261008,0.00031562566,0.0018123846,0.000023586585],"about_ca_topic_score_codex":0.0011808443,"about_ca_topic_score_gemma":0.0017941641,"teacher_disagreement_score":0.0011808443,"about_ca_system_score_codex":0.0002346722,"about_ca_system_score_gemma":0.00025508544,"threshold_uncertainty_score":0.004685402},"labels":[],"label_agreement":null},{"id":"W1985429202","doi":"10.1016/j.antiviral.2014.06.018","title":"Hepatitis C: The next 25 years","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Hepatitis C; Viral hepatitis; Hepatitis C virus; Blood supply; Hepatitis; Intensive care medicine; Drug; Liver cancer; Virology; Cancer; Immunology; Virus; Pharmacology; Internal medicine; Surgery","score_opus":0.16165426852073508,"score_gpt":0.4389191428899932,"score_spread":0.27726487436925806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985429202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025713937,0.8506688,0.000742207,0.10868074,0.029988548,0.00003384978,0.00046972514,0.00017956195,0.006665217],"genre_scores_gemma":[0.055803463,0.8010354,0.004291904,0.08779717,0.032941584,0.00019088367,0.0014923386,0.000076640645,0.016370596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959778,0.0010311732,0.0005678491,0.00030292475,0.0010344008,0.0010858898],"domain_scores_gemma":[0.9868216,0.0023129852,0.0014641614,0.00034060047,0.0033774115,0.0056833755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012230947,0.0011613801,0.002002504,0.0025937425,0.0020427045,0.0073367497,0.0013581753,0.008594017,0.020872237],"category_scores_gemma":[0.01326742,0.0004669382,0.0016504185,0.0026653567,0.001902495,0.006956472,0.0037289667,0.005254563,0.005892923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010851683,0.00034437998,0.009353861,0.004025402,0.000311233,0.0007506146,0.00042433554,0.0006838075,0.0009824849,0.010483707,0.4569758,0.51457924],"study_design_scores_gemma":[0.00009807399,0.0005313637,0.012271761,0.004087048,0.00024316317,0.0011725944,0.0020560583,0.00031655957,0.00018647507,0.0069863596,0.9719616,0.00008898302],"about_ca_topic_score_codex":0.0077347006,"about_ca_topic_score_gemma":0.014062391,"teacher_disagreement_score":0.020872237,"about_ca_system_score_codex":0.0039565573,"about_ca_system_score_gemma":0.011982208,"threshold_uncertainty_score":0.06982458},"labels":[],"label_agreement":null},{"id":"W1986261107","doi":"10.1016/j.antiviral.2014.08.012","title":"The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Lactoferrin; Innate immune system; Mechanism (biology); Intracellular; Replication (statistics); Mechanism of action; Immune system; Cell biology; Virology; Biology; Chemistry; Immunology; Genetics","score_opus":0.028903829377682773,"score_gpt":0.3240006065069876,"score_spread":0.2950967771293048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986261107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770059,0.0050914506,0.012768748,0.00077340635,0.00009370788,0.00004820904,0.0001747891,0.00013919675,0.003904456],"genre_scores_gemma":[0.9958158,0.00054377184,0.002210536,0.00008475139,0.000018940464,0.000014809187,0.00006745342,0.000008785473,0.0012351674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993026,0.00001424443,0.0000027101478,0.000013366659,0.000012177506,0.000027216724],"domain_scores_gemma":[0.9999422,0.000011967139,0.000016724385,0.000007309626,0.0000056257386,0.000016293649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017342933,0.0003219349,0.00020982267,0.000110564455,0.00018444833,0.00043614727,0.0001668385,0.00034012602,0.0006610967],"category_scores_gemma":[0.00012533429,0.00007751334,0.00023829144,0.000045285316,0.0003804481,0.00028749806,0.00027527596,0.00059116294,0.0001670913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000217498,0.000017003153,0.00023070707,0.000022417786,0.0000047262274,0.00007285472,0.000012843567,0.000059826332,0.9962603,0.0007458524,0.000047298818,0.0023087289],"study_design_scores_gemma":[0.00004252128,0.00039050003,0.0028799337,0.0000073364204,0.000015078214,0.0003343853,0.000021239004,0.0011138871,0.99170625,0.0002162073,0.003265701,0.000006906431],"about_ca_topic_score_codex":0.00049586076,"about_ca_topic_score_gemma":0.00043517875,"teacher_disagreement_score":0.0006610967,"about_ca_system_score_codex":0.0004688138,"about_ca_system_score_gemma":0.00021347316,"threshold_uncertainty_score":0.0034015179},"labels":[],"label_agreement":null},{"id":"W1986568660","doi":"10.1016/s0166-3542(01)00156-5","title":"Preclinical evaluation of docusate as protective agent from herpes simplex viruses","year":2001,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Infectious Diseases Centre; University of British Columbia; Adidas (Canada)","funders":"","keywords":"Vero cell; Microbicide; Herpes simplex virus; Infectivity; Virology; In vitro; Medicine; Transmission (telecommunications); Cytotoxicity; Pharmacology; Virus; Biology; Biochemistry; Human immunodeficiency virus (HIV)","score_opus":0.3997688392587814,"score_gpt":0.5588411416944103,"score_spread":0.15907230243562892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986568660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888165,0.005712593,0.0010297769,0.00033312265,0.00014584702,0.0003980222,0.0004740707,0.000056503937,0.0029684838],"genre_scores_gemma":[0.9863999,0.008181457,0.0012483443,0.0001486595,0.00012314002,0.00015625138,0.0007361296,0.00001517461,0.0029910705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981445,0.000068132395,0.000013388839,0.000019546376,0.000020320249,0.000064241794],"domain_scores_gemma":[0.999663,0.000073990115,0.00005584545,0.000029453866,0.00006148474,0.00011621544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067125354,0.0006781814,0.0006176553,0.0006289584,0.00040847686,0.00050695764,0.0006906416,0.0006473896,0.0035047221],"category_scores_gemma":[0.0004647727,0.00021848317,0.0004949876,0.00026321597,0.00062760274,0.0005933156,0.00019399883,0.0011386024,0.0004645931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06195337,0.023470871,0.0016760826,0.0013454787,0.00032180385,0.0005941036,0.00035826434,0.0019025842,0.8228267,0.0016864709,0.0015227388,0.08234153],"study_design_scores_gemma":[0.004988109,0.34891453,0.0033093758,0.0001427904,0.0005018233,0.00049293024,0.00021306664,0.00075939525,0.6294057,0.00032267522,0.010915645,0.00003395926],"about_ca_topic_score_codex":0.00078140665,"about_ca_topic_score_gemma":0.0012522402,"teacher_disagreement_score":0.0035047221,"about_ca_system_score_codex":0.00029159017,"about_ca_system_score_gemma":0.00087796466,"threshold_uncertainty_score":0.011724472},"labels":[],"label_agreement":null},{"id":"W1987049523","doi":"10.1016/s0166-3542(02)00054-2","title":"Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication","year":2002,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Vero cell; Herpes simplex virus; Virus; Multiplicity of infection; Virology; Dendrimer; Chemistry; Biology; Biochemistry","score_opus":0.24256393751138813,"score_gpt":0.44642734447980914,"score_spread":0.203863406968421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987049523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98868775,0.0020862243,0.004820577,0.00015294352,0.000052577947,0.000050436964,0.00018295484,0.000066085275,0.0039004635],"genre_scores_gemma":[0.9957521,0.0004422018,0.0013080483,0.000030683004,0.0000088731185,0.000021208669,0.00015532161,0.00001358756,0.0022678948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998684,0.000018032579,0.000010358578,0.000025012203,0.00003393031,0.00004416578],"domain_scores_gemma":[0.99985313,0.000046730464,0.000023389053,0.000022227674,0.000022966437,0.000031565123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018037886,0.00034731996,0.00023692448,0.00018127267,0.00018406079,0.00025211123,0.0002979755,0.00049047155,0.0018318205],"category_scores_gemma":[0.00021778121,0.0001651695,0.00019538405,0.000103340324,0.0002546857,0.00028016503,0.00020147618,0.0006297076,0.0006090091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030077004,0.000030237125,0.000057586432,0.000033141405,0.000003670629,0.000024602332,0.000006323495,0.000038007536,0.99835986,0.00012187991,0.000031942705,0.0009919594],"study_design_scores_gemma":[0.000021926558,0.00020602174,0.00043154554,0.00000195219,0.0000065651952,0.0001003347,0.000004563853,0.00022829899,0.9986143,0.00002650562,0.0003566031,0.0000014506114],"about_ca_topic_score_codex":0.00038026535,"about_ca_topic_score_gemma":0.00047622685,"teacher_disagreement_score":0.0018318205,"about_ca_system_score_codex":0.00025087708,"about_ca_system_score_gemma":0.00024744158,"threshold_uncertainty_score":0.0061280727},"labels":[],"label_agreement":null},{"id":"W1987223696","doi":"10.1016/s0166-3542(02)00100-6","title":"Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance","year":2002,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"CTL*; Virology; Reverse transcriptase; Cytotoxic T cell; Epitope; Human immunodeficiency virus (HIV); Drug resistance; Biology; Antiretroviral drug; Lentivirus; Immunology; Viral load; Viral disease; Antiretroviral therapy; Antibody; Polymerase chain reaction; Genetics; In vitro; Gene","score_opus":0.03245605493870297,"score_gpt":0.2868322076955744,"score_spread":0.2543761527568714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987223696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9998217,0.000016833865,0.000019567631,0.000006106569,0.0000021777234,0.0000029784746,0.000031906093,3.992006e-7,0.00009835382],"genre_scores_gemma":[0.9996099,0.00001892568,0.00004115572,0.000019192505,0.0000013029548,0.0000030077492,0.00006681118,0.0000017477248,0.00023799633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997726,0.00005009865,0.000014797218,0.000050075527,0.00002662745,0.00008589005],"domain_scores_gemma":[0.99951875,0.00017556606,0.00009121678,0.000029001336,0.00007876054,0.000106715655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032605228,0.00032710118,0.0002772099,0.0005909762,0.00047210205,0.0005587677,0.00036558896,0.00048069548,0.0008393543],"category_scores_gemma":[0.0010000379,0.00019425705,0.00020020368,0.0005741677,0.0003817618,0.0001421186,0.00018632862,0.0005867536,0.00014817633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006742327,0.00063802325,0.7896526,0.000045111537,0.0001901717,0.0049232915,0.003353078,0.00051698514,0.18239051,0.00031629988,0.0002768373,0.0109547945],"study_design_scores_gemma":[0.00009010672,0.0006760174,0.983685,0.000020069225,0.00009769311,0.0025432718,0.0017303601,0.00037525196,0.010123738,0.000075016505,0.00056807464,0.000015442107],"about_ca_topic_score_codex":0.012749857,"about_ca_topic_score_gemma":0.011837883,"teacher_disagreement_score":0.012749857,"about_ca_system_score_codex":0.000622606,"about_ca_system_score_gemma":0.00041876198,"threshold_uncertainty_score":0.025351286},"labels":[],"label_agreement":null},{"id":"W1988425276","doi":"10.1016/j.antiviral.2004.05.004","title":"Mycophenolic acid inhibits avian reovirus replication","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"IMP dehydrogenase; Mycophenolic acid; Virology; Viral replication; Quail; Inosine; Guanosine; Mycophenolate; Vero cell; Biology; Immunosuppression; Chemistry; Virus; Enzyme; Medicine; Biochemistry; Immunology; Transplantation","score_opus":0.13077872199249463,"score_gpt":0.4509954694682013,"score_spread":0.32021674747570666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988425276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944397,0.0023298392,0.000493652,0.00017815222,0.0000923607,0.000039677383,0.00016466944,0.000044709635,0.002217329],"genre_scores_gemma":[0.99335057,0.0017034479,0.0010831848,0.00010596469,0.00006612339,0.000023954131,0.00032622743,0.000012210351,0.0033284384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998338,0.000066847824,0.000011193329,0.000011409701,0.00002134766,0.00005540077],"domain_scores_gemma":[0.99972945,0.00010129386,0.00003478863,0.000037615337,0.000036775982,0.000060040387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019074767,0.00031112382,0.00023593147,0.00022431734,0.00028916585,0.00023420347,0.0002499052,0.00044287488,0.002469088],"category_scores_gemma":[0.00037579756,0.00015640414,0.0002321448,0.00014739354,0.0002028144,0.00017069203,0.00019142199,0.000443183,0.0004944908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047447677,0.00030633292,0.0010725118,0.00010466219,0.000032939424,0.00016835761,0.000040355873,0.00014991224,0.97826284,0.00014516199,0.00031419253,0.014657996],"study_design_scores_gemma":[0.00033026154,0.0054992936,0.010515057,0.00001720588,0.00003492496,0.0003369588,0.00006874061,0.000453467,0.97893745,0.000058351023,0.0037406427,0.000007714255],"about_ca_topic_score_codex":0.0019780132,"about_ca_topic_score_gemma":0.0029463281,"teacher_disagreement_score":0.002469088,"about_ca_system_score_codex":0.0002152743,"about_ca_system_score_gemma":0.00038611385,"threshold_uncertainty_score":0.008259952},"labels":[],"label_agreement":null},{"id":"W1990365048","doi":"10.1016/j.antiviral.2006.01.006","title":"Treatment of respiratory virus infections","year":2006,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Coronaviridae; Respiratory tract infections; Pneumonia; Virology; Paramyxoviridae; Biology; Virus; Respiratory system; Immunology; Respiratory disease; Viral disease; Medicine; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Disease; Internal medicine; Lung; Infectious disease (medical specialty)","score_opus":0.37923235705705133,"score_gpt":0.5594505361829851,"score_spread":0.1802181791259338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990365048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043529904,0.99895006,0.0000632047,0.00012990301,0.00019644348,0.000006339918,0.00000885405,0.0000045027205,0.000597179],"genre_scores_gemma":[0.00043347466,0.9986091,0.00017341466,0.00022408698,0.0002070348,0.0000075845896,0.000023123277,7.7842157e-7,0.00032140818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996351,0.000077700184,0.00005504831,0.00005630282,0.00013861692,0.00003723615],"domain_scores_gemma":[0.99963737,0.00017416882,0.00007208017,0.000013259133,0.00007615049,0.000026922373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007880477,0.0012620324,0.0026494975,0.0025664114,0.00033800618,0.0009522675,0.0012892927,0.0014448818,0.004542589],"category_scores_gemma":[0.0010209471,0.0003288174,0.0010061916,0.0017281941,0.00053848454,0.0010454038,0.00066563283,0.0024447818,0.0025053513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000124452,0.000115604766,0.00013025018,0.02045999,0.00014916534,0.00018642287,0.00003333948,0.00019333143,0.0014937759,0.0014034887,0.02788395,0.9478263],"study_design_scores_gemma":[0.00015326902,0.00035194366,0.0014349116,0.009807123,0.00039761254,0.0019391049,0.00006378062,0.00008307106,0.0005880604,0.0012954825,0.9838628,0.000022868237],"about_ca_topic_score_codex":0.0011717761,"about_ca_topic_score_gemma":0.0022027274,"teacher_disagreement_score":0.004542589,"about_ca_system_score_codex":0.0005344078,"about_ca_system_score_gemma":0.0009962958,"threshold_uncertainty_score":0.015196502},"labels":[],"label_agreement":null},{"id":"W1991039118","doi":"10.1016/j.antiviral.2011.03.005","title":"Human subtilase Site-1 Protease (S1P): An Emerging Host Cell Target for Hepatitis C Virus (HCV) Infection and HCV-associated Steatogenesis","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Virology; Hepatitis C virus; Host (biology); Virus; Biology; Protease; Enzyme; Genetics","score_opus":0.1554881728256816,"score_gpt":0.4146878387245104,"score_spread":0.2591996658988288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991039118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722205,0.020391565,0.0025108685,0.00095938507,0.000101354206,0.000023529909,0.00019767541,0.00005401404,0.003541196],"genre_scores_gemma":[0.9868281,0.008667753,0.0010051591,0.00011549274,0.00008637246,0.00000828388,0.00034863118,0.00000843317,0.0029318295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999591,0.00000947737,0.0000027341252,0.0000060720686,0.000011267135,0.000011295064],"domain_scores_gemma":[0.99995136,0.000011783826,0.0000124136495,0.0000029606729,0.0000072392572,0.0000142370845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018001426,0.00027247655,0.00017100318,0.00019275903,0.00017064012,0.00041786334,0.00008061263,0.00023531367,0.0011614143],"category_scores_gemma":[0.00012231097,0.00007684654,0.00013363315,0.00014262796,0.00022376749,0.00021016426,0.00014486845,0.00028419343,0.00040162154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009905803,0.000035461446,0.0028279396,0.00015236462,0.00001094323,0.0005925157,0.00004592703,0.00017401548,0.97003233,0.0007731337,0.0005381577,0.023826588],"study_design_scores_gemma":[0.000053304353,0.001074135,0.022594567,0.000024192297,0.00004704586,0.003958445,0.00015623512,0.0019430299,0.9552996,0.00092071324,0.013916237,0.000012564283],"about_ca_topic_score_codex":0.0002741218,"about_ca_topic_score_gemma":0.00035964028,"teacher_disagreement_score":0.0011614143,"about_ca_system_score_codex":0.00021182798,"about_ca_system_score_gemma":0.00017100398,"threshold_uncertainty_score":0.0038853288},"labels":[],"label_agreement":null},{"id":"W1994650473","doi":"10.1016/j.antiviral.2014.12.006","title":"Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; GlaxoSmithKline","keywords":"Oseltamivir; Neuraminidase; Virology; Biology; Microbiology; Virus; Permissive; Coronavirus disease 2019 (COVID-19); Medicine","score_opus":0.09438723836665959,"score_gpt":0.41512561662025416,"score_spread":0.3207383782535946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994650473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988078,0.00016285529,0.0002797413,0.000028820903,0.0000107335445,0.0000047499307,0.00003626111,0.000009685165,0.00065943744],"genre_scores_gemma":[0.99867743,0.00009093744,0.00044710637,0.000028083687,0.000004730895,0.0000043740943,0.000057383346,0.000013666835,0.0006761633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986005,0.000034484965,0.000014111442,0.000019669507,0.000035001976,0.000036703244],"domain_scores_gemma":[0.99987924,0.000026859818,0.000020352285,0.00001905402,0.000016640382,0.000037797905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020345161,0.00031490836,0.00023498632,0.00013850967,0.00017762704,0.00037962152,0.00032971991,0.00028569548,0.0018556877],"category_scores_gemma":[0.0002612638,0.0001385151,0.0002411001,0.000091836475,0.00023692897,0.00029813094,0.00022199686,0.0005097431,0.0003832162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018864179,0.00005337541,0.0005422192,0.000012231737,0.0000070095475,0.000033713437,0.000024375271,0.00006122871,0.9969674,0.00013491666,0.000023581699,0.0019513685],"study_design_scores_gemma":[0.000047422203,0.0012996461,0.023114748,0.000012376131,0.000050462048,0.00036512586,0.00016272425,0.0013412018,0.97186565,0.00022999327,0.0014964627,0.000014094749],"about_ca_topic_score_codex":0.000505332,"about_ca_topic_score_gemma":0.0007229986,"teacher_disagreement_score":0.0018556877,"about_ca_system_score_codex":0.00016090643,"about_ca_system_score_gemma":0.00019991946,"threshold_uncertainty_score":0.006207943},"labels":[],"label_agreement":null},{"id":"W1995785316","doi":"10.1016/j.antiviral.2004.05.006","title":"The synergistic effects of betulin with acyclovir against herpes simplex viruses","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Betulin; Herpes simplex virus; Vero cell; EC50; Cytotoxicity; Chemistry; Virology; Pharmacology; Microbiology; In vitro; Virus; Biology; Biochemistry","score_opus":0.0216731183844416,"score_gpt":0.3243221376922729,"score_spread":0.30264901930783134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995785316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866173,0.00707655,0.00053910405,0.00008405073,0.00009589378,0.000044425724,0.00013802886,0.000035040564,0.0053696414],"genre_scores_gemma":[0.9949012,0.0027418523,0.0007681594,0.000036424513,0.000047424866,0.00002411735,0.00011613681,0.000008430929,0.001356257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998178,0.00005684762,0.000011261138,0.000016256825,0.000028023987,0.00006996833],"domain_scores_gemma":[0.9998896,0.00004385365,0.000011679444,0.000012803271,0.000008831346,0.000033222335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003148108,0.00045667752,0.000426653,0.000546886,0.00033459743,0.00036121174,0.00038850124,0.00025862508,0.001919221],"category_scores_gemma":[0.000247829,0.00026147236,0.00036739127,0.00033781593,0.00026267022,0.0003897402,0.00033734366,0.00044115642,0.00031850778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057324804,0.00034473877,0.0007248462,0.00017499542,0.00007330273,0.00030198196,0.00006296735,0.0016691851,0.96294373,0.0005688255,0.00030175425,0.027101096],"study_design_scores_gemma":[0.00022818339,0.003578612,0.003232641,0.000019589941,0.00011187456,0.00052909617,0.000057128054,0.0007957128,0.986232,0.00014731896,0.005053045,0.000014675336],"about_ca_topic_score_codex":0.0007296403,"about_ca_topic_score_gemma":0.0014852278,"teacher_disagreement_score":0.001919221,"about_ca_system_score_codex":0.00028405554,"about_ca_system_score_gemma":0.00028801188,"threshold_uncertainty_score":0.006420374},"labels":[],"label_agreement":null},{"id":"W1996784803","doi":"10.1016/s0166-3542(01)00154-1","title":"Interactions of human lacrimal and salivary cystatins with adenovirus endopeptidase","year":2001,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Medical Research Council","keywords":"Papain; Cystatin; Chemistry; Biochemistry; Proteolysis; Proteases; Protease; Molecular biology; Cystatin C; Enzyme; Biology","score_opus":0.06773983730893288,"score_gpt":0.4123001302398757,"score_spread":0.3445602929309428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996784803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725914,0.0015102688,0.00039087763,0.00004582225,0.000014829435,0.000007433661,0.00004610977,0.0000088796005,0.0007165529],"genre_scores_gemma":[0.99675864,0.0006217757,0.00059228466,0.00003408582,0.0000056304793,0.0000074533637,0.00018659089,0.0000079108695,0.0017856576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997714,0.00005977449,0.000016499662,0.00003417124,0.000037812937,0.00008039473],"domain_scores_gemma":[0.99981135,0.00007369867,0.000025204608,0.000020697204,0.000024046505,0.000045104574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040796475,0.00025400307,0.000339927,0.00018441246,0.00033491018,0.0007037441,0.00031548142,0.00042037782,0.0009644028],"category_scores_gemma":[0.0004508703,0.00020564473,0.00044725448,0.00020054319,0.00030515715,0.0004075343,0.0002726226,0.0004458157,0.00034803408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015613177,0.00008736813,0.0016311429,0.000090283356,0.00005268216,0.00020856078,0.00012099547,0.0003728928,0.99283785,0.0007543206,0.00016140939,0.0021211677],"study_design_scores_gemma":[0.000040978746,0.00016753396,0.005423314,0.0000067234682,0.00002412506,0.00026422678,0.00011866417,0.0027093603,0.9884553,0.00007385754,0.0027041899,0.0000116584315],"about_ca_topic_score_codex":0.004385271,"about_ca_topic_score_gemma":0.0034808875,"teacher_disagreement_score":0.004385271,"about_ca_system_score_codex":0.0014735698,"about_ca_system_score_gemma":0.00043845293,"threshold_uncertainty_score":0.010691583},"labels":[],"label_agreement":null},{"id":"W1998690587","doi":"10.1016/j.antiviral.2012.09.022","title":"Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis","year":2012,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"TLR9; TLR3; Agonist; Antagonist; Receptor; Chemokine; Herpes simplex virus; Endocrinology; Internal medicine; Chemistry; Virus; Pharmacology; Medicine; Virology; Toll-like receptor; Innate immune system; Biochemistry; Gene expression","score_opus":0.15171504878649436,"score_gpt":0.43918813687914354,"score_spread":0.28747308809264915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998690587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357855,0.001687127,0.0017267755,0.0003443502,0.00020112816,0.00009318569,0.00050533004,0.00015671946,0.0017068409],"genre_scores_gemma":[0.9910806,0.001326894,0.0019927616,0.00013741979,0.000048433416,0.00017573175,0.0003612595,0.000022907952,0.0048540463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964285,0.00007048015,0.000033803495,0.00006489111,0.00007510591,0.00011287073],"domain_scores_gemma":[0.99983037,0.000019758998,0.000051951596,0.000023067278,0.000014630762,0.000060181283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003455639,0.00087065104,0.00045017543,0.0008258027,0.00029416123,0.00041092746,0.00043505148,0.00081246765,0.0018293591],"category_scores_gemma":[0.00016303523,0.000291,0.00049650756,0.00022609351,0.0005780251,0.0004829052,0.00018255711,0.0021508294,0.0004206169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019993016,0.0005472911,0.00020444379,0.000074908385,0.000013668903,0.00014723314,0.000024030156,0.00011857682,0.994574,0.0002449627,0.00012010094,0.001931569],"study_design_scores_gemma":[0.0002906456,0.0048668017,0.0035935699,0.000029608607,0.00007920894,0.00052435335,0.0001012694,0.0013687566,0.98674774,0.00029377927,0.002085465,0.000018760185],"about_ca_topic_score_codex":0.0003940088,"about_ca_topic_score_gemma":0.00067316456,"teacher_disagreement_score":0.0018293591,"about_ca_system_score_codex":0.0004420583,"about_ca_system_score_gemma":0.00028518494,"threshold_uncertainty_score":0.0061197877},"labels":[],"label_agreement":null},{"id":"W2000002965","doi":"10.1016/j.antiviral.2008.09.003","title":"Perspectives on antiviral drug development","year":2008,"lang":"en","type":"review","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Antiviral drug; Drug; Drug resistance; Human immunodeficiency virus (HIV); Drug development; Virology; Transmission (telecommunications); Drug discovery; Medicine; Hepatitis B; Hepatitis C virus; Hepatitis C; Immunology; Biology; Virus; Bioinformatics; Pharmacology; Computer science","score_opus":0.1582562275679278,"score_gpt":0.4559104479425719,"score_spread":0.2976542203746441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000002965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000065124914,0.9959311,0.0001387659,0.0006124501,0.00070467073,0.000008681723,0.000017668639,0.000008562545,0.0025129584],"genre_scores_gemma":[0.00051087036,0.99670357,0.00024862267,0.00059132575,0.0005397024,0.000011698311,0.000026201462,0.0000013365492,0.0013667585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996013,0.00011120261,0.00005238032,0.000053398508,0.00013395876,0.000047754813],"domain_scores_gemma":[0.99949384,0.00022743283,0.00009352803,0.000023116192,0.00010578838,0.000056284982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012998533,0.0016166336,0.0023051898,0.0034261425,0.0004492255,0.0017608671,0.0011148995,0.0018531608,0.0109643545],"category_scores_gemma":[0.0010558923,0.00040049863,0.0006625525,0.003330856,0.0009053447,0.003096891,0.0013132797,0.0030084248,0.0046924134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011596402,0.000105998784,0.000101200414,0.013949313,0.00006756823,0.00023956846,0.000060195372,0.00027748873,0.001583826,0.005965202,0.051981967,0.92555165],"study_design_scores_gemma":[0.000035463818,0.00010217745,0.00023246245,0.002921901,0.00010108032,0.00059579033,0.000041096406,0.000049097333,0.00026566812,0.0023516968,0.9932939,0.000009722936],"about_ca_topic_score_codex":0.00079894654,"about_ca_topic_score_gemma":0.0020347792,"teacher_disagreement_score":0.0109643545,"about_ca_system_score_codex":0.0009068884,"about_ca_system_score_gemma":0.002150153,"threshold_uncertainty_score":0.036679447},"labels":[],"label_agreement":null},{"id":"W2000176602","doi":"10.1016/j.antiviral.2005.07.003","title":"Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Protease; Biology; Virology; HIV-1 protease; Protease inhibitor (pharmacology); Saquinavir; Mutation; Genetics; Virus; Enzyme; Gene; Biochemistry; Viral load; Antiretroviral therapy","score_opus":0.03610441450119085,"score_gpt":0.3331935398410232,"score_spread":0.29708912533983234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000176602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752086,0.00020198147,0.0006633666,0.00007045171,0.000015126551,0.00003852943,0.0005760521,0.000018230623,0.0008954675],"genre_scores_gemma":[0.9934993,0.0002847233,0.0013954191,0.00008533386,0.0000129982345,0.000033975528,0.0021808748,0.00005230671,0.0024551556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997074,0.00005449239,0.000021498261,0.000047998597,0.00006589506,0.000102729566],"domain_scores_gemma":[0.9997867,0.00007664503,0.000030314377,0.000032930493,0.000026497542,0.000047025267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015543346,0.00037407866,0.0003598632,0.00035900518,0.00029454683,0.00061787135,0.00044023138,0.00034090804,0.0018253182],"category_scores_gemma":[0.00044238102,0.00020455626,0.00041589144,0.0003877376,0.00023263601,0.00016450169,0.00031757148,0.0008518943,0.00075012917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012427874,0.00007099047,0.0006552685,0.000008072012,0.0000067939454,0.00012967896,0.000033097644,0.00008346156,0.99752384,0.000061197614,0.00005209166,0.0012512467],"study_design_scores_gemma":[0.00009624525,0.0021684726,0.075626016,0.000019102714,0.00009934672,0.005524126,0.0004172267,0.0034930902,0.90738684,0.00022083515,0.004897923,0.000050767914],"about_ca_topic_score_codex":0.0015983012,"about_ca_topic_score_gemma":0.0013057304,"teacher_disagreement_score":0.0018253182,"about_ca_system_score_codex":0.000230183,"about_ca_system_score_gemma":0.0001862938,"threshold_uncertainty_score":0.006106317},"labels":[],"label_agreement":null},{"id":"W2002008129","doi":"10.1016/j.antiviral.2015.04.003","title":"Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"U.S. Food and Drug Administration; Council of Agriculture","keywords":"Viral entry; Virology; Infectivity; Hepatitis C virus; Viral replication; Gallic acid; Biology; Viral hepatitis; Potency; Virus; In vitro; Biochemistry","score_opus":0.09149164725371801,"score_gpt":0.3952309950796019,"score_spread":0.3037393478258839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002008129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934186,0.0025827193,0.00086797145,0.00025079743,0.00009305054,0.000051390918,0.000084802865,0.000093670315,0.0025570667],"genre_scores_gemma":[0.99398226,0.0013893105,0.0010095758,0.00015479393,0.00004423119,0.000026401576,0.00016619291,0.000013361396,0.0032138424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999114,0.000028925098,0.0000072059615,0.0000070686347,0.000011911072,0.000033555556],"domain_scores_gemma":[0.9998915,0.000024199771,0.000023421602,0.000013945535,0.00000939306,0.000037505757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017838523,0.00036434457,0.0002771721,0.00030007202,0.00016402554,0.00028903875,0.0002490088,0.00039169937,0.0019435274],"category_scores_gemma":[0.00021808024,0.00014090512,0.00036556929,0.000119328935,0.00043674864,0.00030160736,0.00026978867,0.00055988325,0.00043807083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036045087,0.00036081544,0.00045777005,0.00012697972,0.000022839493,0.000092557406,0.000030644987,0.00009721084,0.9827855,0.0002968901,0.0001594558,0.011964872],"study_design_scores_gemma":[0.00066997646,0.006938848,0.007514961,0.000017519693,0.00006041485,0.00026590447,0.00010402953,0.0007438031,0.97965974,0.00028457443,0.00372785,0.000012432899],"about_ca_topic_score_codex":0.00044940604,"about_ca_topic_score_gemma":0.0009297525,"teacher_disagreement_score":0.0019435274,"about_ca_system_score_codex":0.00018991451,"about_ca_system_score_gemma":0.00034202938,"threshold_uncertainty_score":0.0065017343},"labels":[],"label_agreement":null},{"id":"W2002206731","doi":"10.1016/j.antiviral.2009.02.174","title":"Novel Broad-Spectrum Biopharmaceuticals: From HIV-1 to Pandemic Influenza A Virus","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Virology; Pandemic; Broad spectrum; Human immunodeficiency virus (HIV); Virus; Influenza pandemic; Pandemic influenza; Coronavirus disease 2019 (COVID-19); Biology; Influenza A virus; Medicine; Chemistry; Infectious disease (medical specialty); Internal medicine; Disease","score_opus":0.2141721517263861,"score_gpt":0.490463956815787,"score_spread":0.27629180508940093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002206731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75770473,0.18536805,0.02325831,0.0045107324,0.0014026583,0.00025034757,0.0005117397,0.00028627395,0.026707154],"genre_scores_gemma":[0.89526033,0.076570444,0.012284778,0.001868935,0.00042330596,0.000090407506,0.0006050373,0.000023395272,0.012873393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999961,0.000008306486,0.0000023168045,0.0000073130896,0.000010336051,0.0000106923],"domain_scores_gemma":[0.99995494,0.00001034013,0.0000058797054,0.0000033568654,0.000011071588,0.000014379388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023879725,0.0003189639,0.0001770344,0.00026455824,0.00014345151,0.0003548184,0.0002820061,0.00034211334,0.0022074538],"category_scores_gemma":[0.00017462658,0.00011327045,0.00019216264,0.0001299157,0.0001846891,0.00037490032,0.00019254742,0.00065305457,0.0004962251],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006275581,0.00038611365,0.00056037784,0.00041791267,0.00003438428,0.0003451527,0.00006452662,0.00088874646,0.7887849,0.0034721068,0.0029079758,0.20151013],"study_design_scores_gemma":[0.0003814604,0.0060301493,0.005699873,0.00018806156,0.00016271212,0.002816359,0.00013171854,0.0036136238,0.86811596,0.004757107,0.10806592,0.00003711467],"about_ca_topic_score_codex":0.00038156644,"about_ca_topic_score_gemma":0.00058673293,"teacher_disagreement_score":0.0022074538,"about_ca_system_score_codex":0.00027726887,"about_ca_system_score_gemma":0.00017451022,"threshold_uncertainty_score":0.007384658},"labels":[],"label_agreement":null},{"id":"W2003245115","doi":"10.1016/j.antiviral.2011.06.005","title":"In vitro inhibition of CSFV replication by multiple siRNA expression","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Animal Disease Management and Epidemiology","field":"Agricultural and Biological Sciences","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"RNA interference; Small interfering RNA; Biology; NS5B; Plasmid; Virology; Gene; Viral replication; Virus; Transfection; RNA; Genetics; Hepatitis C virus","score_opus":0.17359921168412148,"score_gpt":0.3523805968135741,"score_spread":0.1787813851294526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003245115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95669097,0.0045461035,0.023755113,0.00046033823,0.00052399735,0.0003484507,0.0030604282,0.00058117637,0.010033385],"genre_scores_gemma":[0.96633387,0.0014741442,0.016663622,0.0001857975,0.000057580164,0.0004287129,0.004352925,0.00013544773,0.010367821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992867,0.00014408703,0.000114629525,0.00014990484,0.00013591188,0.00016879573],"domain_scores_gemma":[0.9996105,0.00018997422,0.00005122311,0.000060620296,0.00004867982,0.000038921055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006570497,0.0009719251,0.000751369,0.00049780484,0.0004760074,0.0006957541,0.000537615,0.00065927964,0.0025854057],"category_scores_gemma":[0.0004385969,0.0003841392,0.00087688357,0.00037598444,0.00046073832,0.00038217258,0.00040542864,0.0013769876,0.0007491551],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109287656,0.0000558876,0.000059512127,0.00006686256,0.0000096854765,0.000020311514,0.00002339777,0.0001233421,0.99823606,0.00014861872,0.00013576951,0.001011314],"study_design_scores_gemma":[0.00001576989,0.00018743316,0.00034485201,0.0000037201205,0.00001858865,0.000033636657,0.000010466571,0.00078829535,0.9971624,0.000022629021,0.0014086294,0.0000035307353],"about_ca_topic_score_codex":0.003240408,"about_ca_topic_score_gemma":0.0050851996,"teacher_disagreement_score":0.003240408,"about_ca_system_score_codex":0.00095422514,"about_ca_system_score_gemma":0.000663188,"threshold_uncertainty_score":0.008649051},"labels":[],"label_agreement":null},{"id":"W2003619922","doi":"10.1016/j.antiviral.2011.03.180","title":"Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Neuraminidase; Virus; Influenza A virus; Virology; Viral replication; Biology; Enzyme; In vitro; Context (archaeology); Oseltamivir; Orthomyxoviridae; Chemistry; Stereochemistry; Biochemistry; Medicine","score_opus":0.25990652627166566,"score_gpt":0.4751847363712849,"score_spread":0.21527821009961923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003619922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934337,0.0042476775,0.0003199749,0.00003111632,0.000056618384,0.000021840537,0.00018140637,0.000013465448,0.0016942152],"genre_scores_gemma":[0.9953564,0.0019556065,0.0006982629,0.000018696606,0.000027338094,0.000016748969,0.00043369463,0.000005362469,0.0014879222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987733,0.000038069193,0.00001479146,0.000017441835,0.00001919403,0.000033150747],"domain_scores_gemma":[0.99984944,0.000075634845,0.000016151667,0.000019286874,0.000020176283,0.000019238028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020063634,0.0003396154,0.00031866538,0.00017681762,0.00022022135,0.0001548701,0.00025476437,0.00016859696,0.0016478081],"category_scores_gemma":[0.0002549731,0.0001220848,0.00026644586,0.0001317899,0.0001701355,0.00014635116,0.00011137799,0.00033456713,0.0002373649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001351553,0.00014426006,0.00029421976,0.0001373379,0.000009677041,0.000073692,0.00006149691,0.00029582714,0.99273396,0.0000760577,0.00012022738,0.0047016055],"study_design_scores_gemma":[0.00005560451,0.0026209399,0.0018115349,0.000011822094,0.000026067646,0.00009485185,0.000031732176,0.00053578574,0.9933861,0.00001961609,0.0013990722,0.000006788761],"about_ca_topic_score_codex":0.0025746236,"about_ca_topic_score_gemma":0.0025883252,"teacher_disagreement_score":0.0025746236,"about_ca_system_score_codex":0.0001773485,"about_ca_system_score_gemma":0.00031634973,"threshold_uncertainty_score":0.0055124164},"labels":[],"label_agreement":null},{"id":"W2003698226","doi":"10.1016/j.antiviral.2013.08.001","title":"Overexpression of microRNA gga-miR-21 in chicken fibroblasts suppresses replication of infectious bursal disease virus through inhibiting VP1 translation","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Agriculture","funders":"State Key Laboratory of Veterinary Biotechnology; National Natural Science Foundation of China","keywords":"Infectious bursal disease; Biology; Virology; Molecular biology; Virus; microRNA; Viral replication; Luciferase; Cell culture; Gene; Gene expression; Reporter gene; Fibroblast; Transfection; Genetics; Virulence","score_opus":0.06339650058971748,"score_gpt":0.389819341118367,"score_spread":0.32642284052864956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003698226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916733,0.0017925013,0.002820887,0.00023035154,0.00028036602,0.000046919235,0.00035261855,0.00015893295,0.0026440858],"genre_scores_gemma":[0.99206275,0.00065180013,0.0032806138,0.00009824741,0.00002806309,0.000044929748,0.00032334798,0.0000485149,0.003461843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996599,0.000062746454,0.000055813645,0.00007981208,0.00007527075,0.00006650005],"domain_scores_gemma":[0.9998253,0.000051148923,0.000040323528,0.00002383369,0.000019620227,0.000039832925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002741398,0.00049911195,0.00035805532,0.00032027691,0.0003771756,0.00055500574,0.0002781813,0.00046232648,0.0010597646],"category_scores_gemma":[0.00022482779,0.00033561673,0.0004537868,0.00012656326,0.0004817491,0.00025948536,0.00024833236,0.00068646285,0.00049757597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014920272,0.0000168721,0.000113171496,0.000024627288,0.0000051841835,0.00005358711,0.000019452511,0.0000488541,0.99890375,0.00011762027,0.00004571212,0.00050184404],"study_design_scores_gemma":[0.000023596232,0.0002469128,0.0011142703,0.0000037437524,0.00002683805,0.00015307087,0.000043828943,0.0011731136,0.99501073,0.000043295273,0.0021540448,0.0000065709096],"about_ca_topic_score_codex":0.0014156792,"about_ca_topic_score_gemma":0.0020379897,"teacher_disagreement_score":0.0014156792,"about_ca_system_score_codex":0.000503336,"about_ca_system_score_gemma":0.000434801,"threshold_uncertainty_score":0.003651917},"labels":[],"label_agreement":null},{"id":"W2004584518","doi":"10.1016/j.antiviral.2004.02.007","title":"Isolation and characterization of herpes simplex virus type 1 resistant to aminothiazolylphenyl-based inhibitors of the viral helicase-primase","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Primase; Helicase; Biology; Herpes simplex virus; Virology; Virus; In vitro; DNA; Molecular biology; Gene; Biochemistry; Polymerase chain reaction; RNA; Reverse transcriptase","score_opus":0.04945904907619818,"score_gpt":0.36482395878672674,"score_spread":0.31536490971052855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004584518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99015874,0.0028433495,0.004604551,0.00009156474,0.000041399813,0.00007580435,0.00036915674,0.00008468645,0.0017307969],"genre_scores_gemma":[0.99105483,0.0014093419,0.00355293,0.000046121517,0.00001705273,0.000033352935,0.0013206509,0.00004526237,0.002520408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997955,0.000041697785,0.000022693577,0.00003302778,0.00006448826,0.00004265073],"domain_scores_gemma":[0.99975544,0.0000811573,0.00005049803,0.000038492424,0.000044823846,0.000029572557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018990274,0.00031840242,0.0004519409,0.00030309416,0.00018631494,0.0004199298,0.000259566,0.00026225558,0.0009016422],"category_scores_gemma":[0.00043324643,0.00024729417,0.00024142377,0.0002075759,0.00016952434,0.00022440031,0.00014252709,0.00046368322,0.00039252682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067648114,0.000028513898,0.00016490849,0.000018584453,0.0000063521006,0.000034545643,0.00001374031,0.00006230057,0.9983139,0.000035103076,0.00003308361,0.0012214896],"study_design_scores_gemma":[0.000013464676,0.00031968206,0.0019475087,0.0000028263223,0.000018846902,0.00037831342,0.000014693683,0.0007413501,0.99529797,0.00002009162,0.0012414117,0.000003864086],"about_ca_topic_score_codex":0.0011179828,"about_ca_topic_score_gemma":0.0011621037,"teacher_disagreement_score":0.0011179828,"about_ca_system_score_codex":0.0002619035,"about_ca_system_score_gemma":0.00020820921,"threshold_uncertainty_score":0.003016293},"labels":[],"label_agreement":null},{"id":"W2006110359","doi":"10.1016/j.antiviral.2007.08.009","title":"Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cidofovir; Thymidine kinase; Foscarnet; Virology; Herpes simplex virus; Ribonucleotide reductase; Recombinant DNA; DNA polymerase; Biology; Molecular biology; Nucleoside; Thymidine; Gene; Virus; DNA; Herpesviridae; Protein subunit; Biochemistry; Viral disease","score_opus":0.08441485098573778,"score_gpt":0.40943498478703716,"score_spread":0.32502013380129935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006110359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918147,0.005189677,0.00039292022,0.000051513183,0.000053265903,0.0000223182,0.00012261227,0.000038208913,0.0023147573],"genre_scores_gemma":[0.9963877,0.0015513755,0.00043275073,0.000024862316,0.000035865054,0.000006483181,0.00021412176,0.0000066504967,0.0013401621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983907,0.000039466613,0.000015155604,0.000015386431,0.00003919393,0.000051676714],"domain_scores_gemma":[0.9997446,0.00010412495,0.00004312512,0.00002840405,0.000025333535,0.00005430174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022908323,0.00028016823,0.0003247066,0.00044053403,0.00014097622,0.00036700163,0.0002755023,0.00022899325,0.0018422559],"category_scores_gemma":[0.00033549592,0.00015550952,0.00028762472,0.00019308903,0.0001742123,0.00026344295,0.00012598588,0.00044886957,0.00021958417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026230898,0.00040815867,0.0010013082,0.00011300051,0.00004119081,0.00009242284,0.00006149546,0.00051017036,0.9756084,0.00019535987,0.00024073783,0.019104728],"study_design_scores_gemma":[0.00025739285,0.0065245125,0.015399458,0.000017760207,0.00008724665,0.0003325306,0.000048874794,0.0010603587,0.9726175,0.00006758043,0.0035718645,0.000014928775],"about_ca_topic_score_codex":0.0015922975,"about_ca_topic_score_gemma":0.0027908296,"teacher_disagreement_score":0.0018422559,"about_ca_system_score_codex":0.00020875507,"about_ca_system_score_gemma":0.0002060414,"threshold_uncertainty_score":0.006163001},"labels":[],"label_agreement":null},{"id":"W2009729050","doi":"10.1016/j.antiviral.2014.12.017","title":"SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research; Agence Nationale de Recherches sur le Sida et les Hépatites Virales; Canada Research Chairs","keywords":"Hepatitis C virus; Virology; Hepatocellular carcinoma; Biology; Viral load; Cirrhosis; Viral replication; Virus; Hepatitis C; Regulator; Immunology; Medicine; Cancer research; Internal medicine; Genetics; Gene","score_opus":0.21696002062450206,"score_gpt":0.47724900180064167,"score_spread":0.26028898117613963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009729050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414897,0.0014492706,0.00062009547,0.00029867826,0.000185828,0.0000340382,0.00078557705,0.00024333558,0.0022341744],"genre_scores_gemma":[0.99490297,0.0009218988,0.00046990972,0.000107461536,0.000039926897,0.000045349807,0.0007004693,0.000030424157,0.0027815436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997317,0.000047985395,0.000025139563,0.00002971303,0.000040759216,0.00012462903],"domain_scores_gemma":[0.9996809,0.000035418154,0.000048791222,0.000033273354,0.000014304088,0.00018737026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022516245,0.00048725135,0.0006732604,0.000325193,0.00022158999,0.0004833116,0.0003930293,0.00051469554,0.0036522108],"category_scores_gemma":[0.0003295694,0.00032901278,0.00041941975,0.00018493508,0.00038525366,0.00039730113,0.00026339898,0.0016755124,0.0010914977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009770422,0.0012596007,0.0007249103,0.000105122395,0.000043261753,0.00020714512,0.000023377213,0.00038013436,0.9782894,0.00038975905,0.0008414778,0.007965367],"study_design_scores_gemma":[0.00085520674,0.011635254,0.029349945,0.000041294144,0.000113124544,0.00075229566,0.00016156076,0.0043543335,0.9466815,0.0005175734,0.005491369,0.00004665266],"about_ca_topic_score_codex":0.0009823715,"about_ca_topic_score_gemma":0.0012034366,"teacher_disagreement_score":0.0036522108,"about_ca_system_score_codex":0.00032266343,"about_ca_system_score_gemma":0.0007725496,"threshold_uncertainty_score":0.012217879},"labels":[],"label_agreement":null},{"id":"W2010436800","doi":"10.1016/j.antiviral.2007.10.009","title":"Treatment of yellow fever","year":2007,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International","keywords":"Ribavirin; Cytokine storm; Medicine; Immunology; Immune system; Cytokine; Virology; Virus; Hepatitis C virus; Disease; Infectious disease (medical specialty); Internal medicine","score_opus":0.3535669420986561,"score_gpt":0.5642778286320669,"score_spread":0.2107108865334108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010436800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022870062,0.99773383,0.00018694095,0.00016342485,0.0002123855,0.000013185912,0.00002992667,0.000009161391,0.001422361],"genre_scores_gemma":[0.0024767194,0.9954755,0.00036193852,0.00038723298,0.00020683615,0.00001932856,0.00008643883,0.000002118308,0.0009838814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984884,0.000034011064,0.000023009043,0.000028811543,0.000044007124,0.000021345742],"domain_scores_gemma":[0.999871,0.000053453783,0.00003445566,0.0000061342453,0.00002298499,0.000011881773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038320027,0.000886613,0.0014351917,0.0016616613,0.00020287027,0.0005918533,0.0007290856,0.00072980236,0.005594088],"category_scores_gemma":[0.0005025388,0.00022654775,0.00082186656,0.0009216768,0.00035217378,0.0005851003,0.0004470665,0.0014752377,0.0020332208],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018612365,0.00013255917,0.00018242208,0.014601257,0.0001297656,0.00018921522,0.00003696574,0.0001711358,0.0028758282,0.0014237075,0.019809501,0.9602616],"study_design_scores_gemma":[0.0002898312,0.00058865483,0.0027767927,0.0069323233,0.00047059503,0.0029957548,0.00006485958,0.00015175811,0.0017766813,0.0013214827,0.9826015,0.00002958582],"about_ca_topic_score_codex":0.00116453,"about_ca_topic_score_gemma":0.0020742025,"teacher_disagreement_score":0.005594088,"about_ca_system_score_codex":0.00035862054,"about_ca_system_score_gemma":0.0005907011,"threshold_uncertainty_score":0.01871407},"labels":[],"label_agreement":null},{"id":"W2010598858","doi":"10.1016/j.antiviral.2010.03.010","title":"Dengue virus replicons: Production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Agence Nationale de la Recherche","keywords":"Replicon; Dengue virus; Virology; Dengue fever; Biology; Flavivirus; Subgenomic mRNA; Green fluorescent protein; Ribavirin; Virus; Molecular biology; Hepatitis C virus; Gene; RNA; Genetics; Plasmid","score_opus":0.048485389364271866,"score_gpt":0.3572641395959428,"score_spread":0.3087787502316709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010598858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93252903,0.00095486303,0.054951787,0.0004197979,0.00021939263,0.00066532975,0.005582499,0.0005362977,0.0041409363],"genre_scores_gemma":[0.8964045,0.00082775037,0.07426423,0.00012385607,0.000037427573,0.0006412129,0.019164927,0.00037517972,0.00816087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999522,0.00010549837,0.00008215658,0.00009748531,0.0001335959,0.000059232356],"domain_scores_gemma":[0.99962246,0.000101060716,0.000063882966,0.0001256733,0.000031789066,0.00005513672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007408582,0.0007490641,0.00042138426,0.0004686773,0.00037043198,0.0004676121,0.0005530295,0.00039071892,0.0013908526],"category_scores_gemma":[0.00051625335,0.00036794785,0.0005183709,0.00035338165,0.0003754549,0.00035521845,0.00044707846,0.0015665552,0.0006721446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012281048,0.00005946922,0.00013814408,0.000021940436,0.000012478522,0.000034534012,0.000037037753,0.00011531598,0.9976714,0.0003959123,0.000097952376,0.0012929097],"study_design_scores_gemma":[0.000028292636,0.00022460593,0.0008219544,0.000003733184,0.00002896366,0.00015700836,0.000020282505,0.0010510009,0.9940327,0.00007091061,0.0035518608,0.00000864135],"about_ca_topic_score_codex":0.00092999387,"about_ca_topic_score_gemma":0.0016465058,"teacher_disagreement_score":0.0013908526,"about_ca_system_score_codex":0.00060066086,"about_ca_system_score_gemma":0.00044103342,"threshold_uncertainty_score":0.004652858},"labels":[],"label_agreement":null},{"id":"W2010807197","doi":"10.1016/j.antiviral.2006.11.011","title":"Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide☆","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; St. Michael's Hospital; AIDS Vancouver; Dalhousie University; University of Toronto; University Health Network; Hôpital Notre-Dame; Maple Leaf Medical Clinic","funders":"","keywords":"Enfuvirtide; Clade; Biology; Mutation; Virology; Gp41; Virus; Genetics; Genotype; Gene; Phylogenetics","score_opus":0.028212271865364583,"score_gpt":0.32589654145777236,"score_spread":0.2976842695924078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010807197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853694,0.00020485772,0.0001381196,0.00003089328,0.000010644213,0.00001125227,0.000118161486,0.000013010258,0.00093616394],"genre_scores_gemma":[0.99917954,0.00007870303,0.00019849422,0.0000487165,0.0000068179093,0.000008465764,0.00015236333,0.0000039514125,0.00032288555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975544,0.000057365578,0.000019062983,0.000056661356,0.00005382053,0.00005760015],"domain_scores_gemma":[0.9994289,0.00021660808,0.00009343665,0.00004184875,0.0000877325,0.00013144738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027636942,0.0003508078,0.00037937352,0.0006729891,0.00030338904,0.0004473536,0.00016665754,0.0004740271,0.0013731126],"category_scores_gemma":[0.0011833136,0.00013601326,0.00022093115,0.00054937525,0.00020997477,0.00028404174,0.00010062923,0.00055354025,0.00032539055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032008593,0.00052705273,0.8393258,0.000055024684,0.00009095132,0.0014289214,0.0004940985,0.0004011738,0.13177076,0.00015629026,0.00047680223,0.022072418],"study_design_scores_gemma":[0.00006758013,0.0057341717,0.9535019,0.000019355864,0.00007069151,0.0056414395,0.00029575665,0.0016623483,0.031695936,0.00014337269,0.0011495061,0.000017972048],"about_ca_topic_score_codex":0.0010625371,"about_ca_topic_score_gemma":0.0008067871,"teacher_disagreement_score":0.0013731126,"about_ca_system_score_codex":0.0002851882,"about_ca_system_score_gemma":0.00017671176,"threshold_uncertainty_score":0.0045934916},"labels":[],"label_agreement":null},{"id":"W2011966733","doi":"10.1016/j.antiviral.2008.10.005","title":"Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women","year":2008,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"Canadian Institutes of Health Research; Health Canada; Ontario HIV Treatment Network; Hamilton Health Sciences; Canadian Foundation for AIDS Research; amfAR, The Foundation for AIDS Research","keywords":"TLR3; Innate immune system; Herpes simplex virus; Interferon; Biology; TLR4; Viral replication; Immunology; Virus; Microbicides for sexually transmitted diseases; Virology; Immune system; Toll-like receptor; Microbiology; Medicine","score_opus":0.0553254321926722,"score_gpt":0.35779364521489493,"score_spread":0.3024682130222227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011966733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750584,0.00097589154,0.00015436149,0.000053197557,0.000025112266,0.000017223481,0.00017129479,0.0000059287922,0.001091149],"genre_scores_gemma":[0.99676347,0.0009395556,0.00020919323,0.00007696442,0.000019272396,0.00003903202,0.00027391457,0.0000041391154,0.001674511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997713,0.000056808887,0.000015573816,0.000032126758,0.00003155992,0.0000925266],"domain_scores_gemma":[0.99988246,0.00003192635,0.000015381409,0.000014335873,0.00002783357,0.000028039436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001784594,0.0001663627,0.0002684035,0.0002612536,0.0003254405,0.00042309813,0.00013135895,0.00025204514,0.0033851957],"category_scores_gemma":[0.0004345203,0.00018226108,0.00026220558,0.00018115845,0.00019890946,0.00020724999,0.00033091055,0.0002919362,0.00045287996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015066755,0.00006999512,0.014730738,0.00015025387,0.000014088759,0.00046333118,0.000429363,0.000029302288,0.9768018,0.00011315655,0.00015179146,0.0055395258],"study_design_scores_gemma":[0.000117296186,0.0042410903,0.4603768,0.000099713405,0.00010177718,0.0041056853,0.004285668,0.00042232126,0.5180371,0.0003350847,0.007851987,0.000025554726],"about_ca_topic_score_codex":0.00055636506,"about_ca_topic_score_gemma":0.00063017436,"teacher_disagreement_score":0.0033851957,"about_ca_system_score_codex":0.00019441177,"about_ca_system_score_gemma":0.0002684918,"threshold_uncertainty_score":0.0113245845},"labels":[],"label_agreement":null},{"id":"W2012849897","doi":"10.1016/j.antiviral.2005.12.006","title":"Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Institut National de la Recherche Scientifique; Armand Frappier Museum","funders":"","keywords":"Protease; Protease inhibitor (pharmacology); Virology; Virus; Drug resistance; In vitro; Biology; Enzyme inhibitor; Microbiology; Enzyme; Viral load; Antiretroviral therapy; Biochemistry","score_opus":0.04953128474737692,"score_gpt":0.3854512389809993,"score_spread":0.3359199542336224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012849897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956208,0.0024923498,0.00034420087,0.00004973128,0.0000313537,0.000030081672,0.00030131472,0.000020918438,0.0011091931],"genre_scores_gemma":[0.99626833,0.0012795392,0.0004768086,0.000048706348,0.000026527641,0.000013424004,0.0007607599,0.0000072011976,0.0011187213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998356,0.000056696117,0.00001639278,0.00002330986,0.00003281241,0.000035119956],"domain_scores_gemma":[0.9998919,0.00003380286,0.00001687063,0.000014113331,0.00001272702,0.00003054498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024268476,0.00026204163,0.00032821606,0.00038266767,0.00016371068,0.00017796695,0.00025408177,0.00028458305,0.0011989533],"category_scores_gemma":[0.0003282959,0.00012897588,0.0003622249,0.00019435152,0.00017665348,0.00025032705,0.0001074779,0.0005719663,0.0003153058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047631823,0.0016182081,0.002552601,0.000107419626,0.00008605134,0.00036924108,0.00006502673,0.0010177655,0.95824075,0.00022713772,0.00040076234,0.030551827],"study_design_scores_gemma":[0.0007115677,0.02928797,0.027237538,0.000012997362,0.00027325895,0.003098769,0.00004499844,0.0021933615,0.9318322,0.00011209317,0.00516566,0.000029455054],"about_ca_topic_score_codex":0.0006068138,"about_ca_topic_score_gemma":0.0004631386,"teacher_disagreement_score":0.0011989533,"about_ca_system_score_codex":0.00021198882,"about_ca_system_score_gemma":0.00014138695,"threshold_uncertainty_score":0.004010856},"labels":[],"label_agreement":null},{"id":"W2013130286","doi":"10.1016/j.antiviral.2006.06.011","title":"Resveratrol suppresses nuclear factor-κB in herpes simplex virus infected cells","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Herpes simplex virus; Resveratrol; Vero cell; Viral replication; Virology; Biology; Virus; NF-κB; IκBα; Molecular biology; Cell biology; Signal transduction; Biochemistry","score_opus":0.05431705798884728,"score_gpt":0.3811911008338261,"score_spread":0.32687404284497884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013130286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98625165,0.0046853665,0.0020651182,0.0005596283,0.0005458467,0.00006388447,0.0010409965,0.00043513463,0.0043523195],"genre_scores_gemma":[0.9884731,0.0026180313,0.0010662831,0.00016942102,0.00008033171,0.000046308032,0.0013287492,0.000050531053,0.006167239],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997117,0.00008989586,0.000032067175,0.000034681118,0.00005228249,0.00007937216],"domain_scores_gemma":[0.99971026,0.00007394565,0.000044699907,0.000072198396,0.000029343557,0.000069542926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002575967,0.00079521333,0.0007147337,0.0006293104,0.00043352114,0.0006035365,0.00052845245,0.00056542736,0.004629002],"category_scores_gemma":[0.0002795015,0.00035105066,0.0007985952,0.00033575785,0.00055721396,0.00042143607,0.00028489417,0.0015702045,0.0011344752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022773575,0.0002429633,0.00015281152,0.00013639395,0.000050809696,0.00010475404,0.00006640157,0.00010434366,0.99373055,0.00018738722,0.00027786393,0.002668458],"study_design_scores_gemma":[0.00023150803,0.0021565086,0.0037387384,0.000015671916,0.00010950338,0.00030202404,0.00025776614,0.0005298662,0.98832744,0.00013965376,0.0041720197,0.000019331574],"about_ca_topic_score_codex":0.0013041042,"about_ca_topic_score_gemma":0.0018436857,"teacher_disagreement_score":0.004629002,"about_ca_system_score_codex":0.000307524,"about_ca_system_score_gemma":0.00046346203,"threshold_uncertainty_score":0.015485585},"labels":[],"label_agreement":null},{"id":"W2014016939","doi":"10.1016/j.antiviral.2011.06.003","title":"Minigenomes, transcription and replication competent virus-like particles and beyond: Reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses","year":2011,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Biology; Virology; Reverse genetics; Viral replication; Virus; Transcription (linguistics); Viral life cycle; Marburg virus; Reverse transcriptase; Genome; Genetics; RNA; Computational biology; Ebola virus; Gene","score_opus":0.3154312292024623,"score_gpt":0.45617233691124487,"score_spread":0.14074110770878256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014016939","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011165049,0.9985759,0.00032355887,0.00012238738,0.00023095237,0.000003940756,0.000012075342,0.0000074469262,0.0006120548],"genre_scores_gemma":[0.0005744463,0.99790037,0.00047274234,0.00014937301,0.00015347938,0.0000070606775,0.000042818334,0.0000024872254,0.0006972671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997949,0.00003184292,0.000024647403,0.000036352856,0.0000897654,0.000022486274],"domain_scores_gemma":[0.99971,0.00015214416,0.00004303969,0.0000114921295,0.000059800816,0.000023429728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008227822,0.0012489823,0.0014975251,0.0019090598,0.0002706422,0.0012480089,0.0011842749,0.0015780502,0.0021820487],"category_scores_gemma":[0.0006864092,0.00045823402,0.0005310795,0.0020408866,0.0008605222,0.0021252048,0.0007044805,0.0023077894,0.0022299646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099999714,0.000073189825,0.00008551552,0.013349193,0.00006017819,0.00016607635,0.00008808187,0.0005128765,0.015927883,0.010540809,0.026685063,0.9324112],"study_design_scores_gemma":[0.000019502186,0.0000726989,0.0002167784,0.0010512313,0.000044461063,0.000535252,0.000038002298,0.00009431384,0.0022329406,0.0023946431,0.9932766,0.00002361935],"about_ca_topic_score_codex":0.00097584125,"about_ca_topic_score_gemma":0.0013300691,"teacher_disagreement_score":0.0021820487,"about_ca_system_score_codex":0.000884038,"about_ca_system_score_gemma":0.001015169,"threshold_uncertainty_score":0.0072996616},"labels":[],"label_agreement":null},{"id":"W2015128810","doi":"10.1016/j.antiviral.2007.08.012","title":"Yin Chen Hao Tang, a Chinese prescription, inhibits both herpes simplex virus type-1 and type-2 infections in vitro","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Kaohsiung Medical University","keywords":"Traditional medicine; Herpes simplex virus; Virus; Houttuynia cordata; In vitro; Medicine; Virology; Pharmacology; Biology; Chemistry; Biochemistry; Chromatography","score_opus":0.056148839739850576,"score_gpt":0.41364932108400554,"score_spread":0.35750048134415496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015128810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8937572,0.07026333,0.0022342477,0.0016154912,0.0006598103,0.0002558305,0.00092146033,0.00023330183,0.030059218],"genre_scores_gemma":[0.9606578,0.023283267,0.0017360451,0.00054039236,0.00012202335,0.00009704181,0.0006476698,0.000019664576,0.012896019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999948,0.000011126647,0.0000046719633,0.0000064738892,0.000013313768,0.000016332482],"domain_scores_gemma":[0.99995315,0.00001327147,0.000008523374,0.0000032530459,0.000006003775,0.000015803396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000847004,0.00037236072,0.0003472132,0.0004399094,0.00038343907,0.00023803914,0.00014818495,0.00019673655,0.004811828],"category_scores_gemma":[0.00016191111,0.00013954051,0.00038588533,0.00031664755,0.00018311045,0.0001616811,0.000216025,0.00043001157,0.00045789214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032713441,0.0013245099,0.00464296,0.0023008147,0.0002005221,0.0010457659,0.00034916057,0.00035000072,0.7315874,0.0009603185,0.007605654,0.24636155],"study_design_scores_gemma":[0.0027856405,0.022819197,0.12074306,0.00039635153,0.0011331564,0.004532906,0.0011257855,0.0027678728,0.7143448,0.0011213531,0.12807544,0.00015443726],"about_ca_topic_score_codex":0.002482247,"about_ca_topic_score_gemma":0.008939724,"teacher_disagreement_score":0.004811828,"about_ca_system_score_codex":0.00018370118,"about_ca_system_score_gemma":0.00058598013,"threshold_uncertainty_score":0.016097128},"labels":[],"label_agreement":null},{"id":"W2016436352","doi":"10.1016/j.antiviral.2007.09.005","title":"Genistein treatment of cells inhibits arenavirus infection","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Arenavirus; Biology; Virology; Genistein; Viral envelope; Tyrosine kinase; Signal transduction; Virus; Lymphocytic choriomeningitis; Cell biology; In vitro; Biochemistry; Cytotoxic T cell","score_opus":0.15465793012101997,"score_gpt":0.4753572917764967,"score_spread":0.32069936165547674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016436352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98884684,0.0023210002,0.0010648973,0.0004230225,0.00017624802,0.000048459744,0.00086532277,0.00018447009,0.0060698385],"genre_scores_gemma":[0.9899136,0.0015357008,0.0011474553,0.00010094299,0.00006422271,0.000045742472,0.0014957762,0.000023839899,0.005672745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982053,0.00003224621,0.0000119634005,0.00002051411,0.000033645818,0.000081171864],"domain_scores_gemma":[0.9998474,0.000063259606,0.000015456257,0.000023744422,0.0000127892945,0.000037280835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015505627,0.00043745906,0.00063133996,0.0003930263,0.00045193208,0.00049326324,0.00032997306,0.000494336,0.0034466868],"category_scores_gemma":[0.00019472325,0.00016704955,0.00031442178,0.0002982131,0.00039262543,0.00025387085,0.00024632184,0.0011050069,0.00091461453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001096576,0.00024130309,0.00042917454,0.00008046548,0.000016496333,0.00013140784,0.000083716586,0.00016171086,0.9931946,0.00033365184,0.0004119215,0.0038189727],"study_design_scores_gemma":[0.00011492632,0.001160671,0.0066889245,0.000011269575,0.000014516518,0.00024933415,0.0001438021,0.0006480442,0.98599434,0.00012863186,0.0048395065,0.000005976876],"about_ca_topic_score_codex":0.0016781067,"about_ca_topic_score_gemma":0.0035233584,"teacher_disagreement_score":0.0034466868,"about_ca_system_score_codex":0.0004707313,"about_ca_system_score_gemma":0.0005766621,"threshold_uncertainty_score":0.01153034},"labels":[],"label_agreement":null},{"id":"W2016760300","doi":"10.1016/j.antiviral.2011.03.029","title":"Rigid Amphipathic Fusion Inhibitors (RAFIs) Inhibit Infectivity of Enveloped Viruses by Targeting Envelope Lipids to Prevent Fusion With Cellular Membranes","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Infectivity; Lipid bilayer fusion; Membrane; Viral envelope; Fusion; Amphiphile; Envelope (radar); Chemistry; Virology; Cell fusion; Cell biology; Biology; Virus; Biochemistry; Cell; Copolymer; Computer science","score_opus":0.0741322587692607,"score_gpt":0.35651485776092035,"score_spread":0.28238259899165963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016760300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861415,0.0035598592,0.00600783,0.0002471831,0.00006197891,0.00009167894,0.00022311187,0.00017260802,0.003494223],"genre_scores_gemma":[0.98968667,0.0027055994,0.0044519654,0.00012234722,0.000027467717,0.00004657619,0.00039663058,0.000026135449,0.0025365527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999105,0.000014162335,0.00000649731,0.000009949445,0.00002816291,0.00003066445],"domain_scores_gemma":[0.99991107,0.000015828311,0.00003097163,0.00000972357,0.000009915803,0.00002248923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023360645,0.00042383405,0.00029483368,0.00019812713,0.00022568816,0.00029974346,0.00016917313,0.00026700558,0.00089676754],"category_scores_gemma":[0.00019305572,0.00015520789,0.0002702451,0.000105558334,0.00025884906,0.00024367597,0.00025951455,0.00077975605,0.00039222906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023656254,0.00005559183,0.00013946227,0.00003565404,0.000010520064,0.00003732291,0.000015809861,0.00026370282,0.99259055,0.0003703852,0.000146514,0.0060979663],"study_design_scores_gemma":[0.00007712468,0.00066323095,0.0014745271,0.0000049777836,0.000019975516,0.00023442031,0.000016074951,0.0012906705,0.9924487,0.00012841032,0.0036324663,0.000009455457],"about_ca_topic_score_codex":0.00033745528,"about_ca_topic_score_gemma":0.000513575,"teacher_disagreement_score":0.00089676754,"about_ca_system_score_codex":0.00020967907,"about_ca_system_score_gemma":0.0001835156,"threshold_uncertainty_score":0.003000021},"labels":[],"label_agreement":null},{"id":"W2020887516","doi":"10.1016/j.antiviral.2014.02.005","title":"The beginning of the end: What is the future of interferon therapy for chronic hepatitis C?","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"","keywords":"Simeprevir; Ribavirin; Sofosbuvir; Medicine; Interferon; Hepatitis C; Pegylated interferon; Virology; Daclatasvir; Hepatitis C virus; Internal medicine; Pharmacology; Virus","score_opus":0.05609946185193702,"score_gpt":0.4059276083611312,"score_spread":0.34982814650919414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020887516","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092639273,0.72736925,0.0005170079,0.25997657,0.00817807,0.000011493623,0.00009755427,0.00003209727,0.002891545],"genre_scores_gemma":[0.032144118,0.75676817,0.0027332103,0.1427405,0.061463844,0.000098417484,0.00021955774,0.000056604113,0.0037756253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931049,0.0042618667,0.0004809612,0.00040023666,0.0011926244,0.00055932696],"domain_scores_gemma":[0.9605665,0.024323534,0.0027431191,0.001042747,0.0065073785,0.0048166085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019157894,0.00076149526,0.0032249035,0.0012216083,0.0018384571,0.00598573,0.0019648355,0.008713555,0.009571099],"category_scores_gemma":[0.026686033,0.00041527502,0.0015740509,0.0010480079,0.005558,0.016316952,0.0021697609,0.010678669,0.0025496024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003998344,0.0005970127,0.0030700502,0.0070032263,0.00034311603,0.00066588307,0.00082385284,0.0007875606,0.0015347931,0.050003856,0.27924737,0.6519249],"study_design_scores_gemma":[0.000667403,0.001404702,0.0051322477,0.014609425,0.00049473194,0.0009268443,0.0030112665,0.0012079091,0.0005526476,0.109125376,0.8625923,0.00027517314],"about_ca_topic_score_codex":0.0025995343,"about_ca_topic_score_gemma":0.0067174225,"teacher_disagreement_score":0.019157894,"about_ca_system_score_codex":0.0022989025,"about_ca_system_score_gemma":0.008993951,"threshold_uncertainty_score":0.10131788},"labels":[],"label_agreement":null},{"id":"W2021712772","doi":"10.1016/j.antiviral.2012.05.006","title":"SKI-1/S1P inhibition: A promising surrogate to statins to block Hepatitis C virus replication","year":2012,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Hepatitis C virus; Viral replication; Virology; Hepatocellular carcinoma; In vivo; Viral load; Steatosis; Replicon; Pharmacology; Virus; In vitro; Medicine; Biology; Chemistry; Cancer research; Internal medicine; Biochemistry","score_opus":0.3412660151930021,"score_gpt":0.532633570903136,"score_spread":0.19136755571013392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021712772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013383093,0.9950035,0.00036431634,0.0004934569,0.00032478097,0.000030431205,0.0001446813,0.000035771744,0.0022646291],"genre_scores_gemma":[0.006215981,0.9901536,0.0005030661,0.00048249942,0.00018875336,0.000034516448,0.00024526313,0.0000047829008,0.0021716822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999076,0.000012956191,0.000014212573,0.000015707597,0.00002954906,0.000019913306],"domain_scores_gemma":[0.99989223,0.000034178825,0.000030333858,0.000004083878,0.000020903182,0.000018414688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038051445,0.00087904616,0.0015386605,0.0013782451,0.0002028755,0.00070996705,0.0006127841,0.0007779192,0.0042834585],"category_scores_gemma":[0.0002948025,0.00022386521,0.00065462827,0.001056472,0.00031894626,0.0006438528,0.0004628122,0.0016510985,0.0018681572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008242712,0.00026580523,0.00020494773,0.016232744,0.00028558268,0.00027860826,0.00003899484,0.00040407726,0.012572717,0.0022397127,0.030269554,0.936383],"study_design_scores_gemma":[0.00071602035,0.0015310956,0.001869189,0.0026374084,0.0009179414,0.0015050211,0.00006689732,0.00034887143,0.010433372,0.0016136614,0.97830415,0.00005624467],"about_ca_topic_score_codex":0.0008710216,"about_ca_topic_score_gemma":0.0022166364,"teacher_disagreement_score":0.0042834585,"about_ca_system_score_codex":0.0004532138,"about_ca_system_score_gemma":0.00083539635,"threshold_uncertainty_score":0.014329612},"labels":[],"label_agreement":null},{"id":"W2025220076","doi":"10.1016/s0166-3542(00)00071-1","title":"An in vitro system for the enzymological analysis of avian hepatitis B virus replication and inhibition in core particles","year":2000,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Duck hepatitis B virus; Polymerase; Viral replication; Biology; Virology; Reverse transcriptase; Context (archaeology); Nucleic acid; Hepatitis B virus; Virus; Enzyme; Molecular biology; RNA; Hepadnaviridae; Biochemistry; Gene","score_opus":0.12555117207709154,"score_gpt":0.4187944444722624,"score_spread":0.29324327239517084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025220076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76464295,0.0065237265,0.21771272,0.00029214914,0.00055022317,0.00060475135,0.0017047864,0.0010102019,0.0069585084],"genre_scores_gemma":[0.7890634,0.0045857304,0.18005136,0.00026977572,0.00019737522,0.0005465697,0.009898788,0.00041917223,0.014967861],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934024,0.00028841675,0.00006405567,0.00009278947,0.00012799965,0.00008648188],"domain_scores_gemma":[0.99916315,0.00034835903,0.00007818078,0.00019721453,0.000121209494,0.00009194736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007583173,0.0013587757,0.0008133464,0.00060790876,0.0007175249,0.00070534943,0.00086334744,0.0006143706,0.0012626108],"category_scores_gemma":[0.0005508211,0.00057309936,0.0007063834,0.00050424534,0.00056076824,0.0005533825,0.0006689111,0.0020742074,0.0014425246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010104461,0.000053293403,0.00011206795,0.000050118546,0.000008035441,0.000027050675,0.000036756508,0.0000629256,0.99868757,0.00016265332,0.00003120026,0.0006673417],"study_design_scores_gemma":[0.000011688551,0.00032160382,0.00079978927,0.000008586888,0.000031533425,0.00014122791,0.000018679073,0.0005477115,0.996367,0.00007598937,0.0016667277,0.000009613254],"about_ca_topic_score_codex":0.0030547483,"about_ca_topic_score_gemma":0.0048500127,"teacher_disagreement_score":0.0030547483,"about_ca_system_score_codex":0.00064234843,"about_ca_system_score_gemma":0.0006959567,"threshold_uncertainty_score":0.006073892},"labels":[],"label_agreement":null},{"id":"W2025612185","doi":"10.1016/j.antiviral.2013.04.001","title":"Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Integrase; DNA; High-throughput screening; HIV Long Terminal Repeat; Ligand binding assay; Biology; Binding site; Small molecule; Virology; Biochemistry; Long terminal repeat; Chemistry; Molecular biology; Gene; Genome","score_opus":0.07631490118335602,"score_gpt":0.36356287961036593,"score_spread":0.2872479784270099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025612185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62706494,0.0046048453,0.35582414,0.0010381317,0.00014618009,0.0008253569,0.0015052232,0.0014333869,0.0075576263],"genre_scores_gemma":[0.68305165,0.0025406692,0.3011968,0.0005857334,0.000042392952,0.0007575704,0.0021873496,0.000106626794,0.009531118],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893135,0.00025428666,0.000034730638,0.00022842636,0.00041395306,0.0001372246],"domain_scores_gemma":[0.999524,0.00017968485,0.00006853522,0.000035496247,0.00011007729,0.00008220228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011160079,0.0011242202,0.00089002703,0.0008856429,0.0005552346,0.0007244912,0.0015109292,0.0017932337,0.0017189329],"category_scores_gemma":[0.0008976078,0.0008196762,0.0005596768,0.0004907636,0.0004719952,0.00065485947,0.00054017786,0.0020511604,0.0008549356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058541613,0.000060986906,0.000095851115,0.000034803914,0.000009019148,0.000012767528,0.000012331418,0.00013306302,0.9969042,0.000102016835,0.00006909344,0.0025071665],"study_design_scores_gemma":[0.000027527363,0.00025783287,0.0006447605,0.000008032661,0.000015018755,0.00015695878,0.00001213518,0.005631352,0.9916825,0.000056927704,0.0014905817,0.000016303466],"about_ca_topic_score_codex":0.0013816133,"about_ca_topic_score_gemma":0.0036264395,"teacher_disagreement_score":0.0017932337,"about_ca_system_score_codex":0.0009873671,"about_ca_system_score_gemma":0.00062179513,"threshold_uncertainty_score":0.0071638823},"labels":[],"label_agreement":null},{"id":"W2026540826","doi":"10.1016/j.antiviral.2008.03.004","title":"Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin","year":2008,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lactoferrin; Heparan sulfate; Biology; Cell; Herpes simplex virus; Chondroitin sulfate; Virology; Cell culture; Biochemistry; Virus; Glycosaminoglycan; Genetics","score_opus":0.0687695916473367,"score_gpt":0.37244540710001567,"score_spread":0.30367581545267897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026540826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98308116,0.009595572,0.0029557361,0.00025476477,0.00007035317,0.000056322217,0.00018997386,0.000108266046,0.0036879568],"genre_scores_gemma":[0.9942648,0.0017516246,0.0016217284,0.000037984926,0.000015633126,0.00002205463,0.00014215586,0.000013054258,0.0021309627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998591,0.00003068423,0.000008829199,0.000017155853,0.00002645777,0.00005770807],"domain_scores_gemma":[0.9999132,0.00003151826,0.000015255295,0.000011469301,0.0000066890084,0.000021822734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021545686,0.00042856188,0.00039717753,0.00024768893,0.00019222805,0.0004202462,0.00028807067,0.0003686768,0.001286377],"category_scores_gemma":[0.00015757007,0.00014606216,0.00029827765,0.00015181818,0.00032727278,0.00041072204,0.00027567835,0.00095246756,0.00023645302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007723567,0.000084973864,0.00009389304,0.000047961723,0.000009419847,0.000058204456,0.000025927304,0.0001394505,0.9940253,0.0002882403,0.00007109175,0.004383312],"study_design_scores_gemma":[0.000038930015,0.0003429242,0.0006763132,0.0000038286867,0.000009187259,0.00010529634,0.000017432294,0.00047594335,0.99696016,0.00004638019,0.0013205622,0.0000029794821],"about_ca_topic_score_codex":0.0016915905,"about_ca_topic_score_gemma":0.0011275643,"teacher_disagreement_score":0.0016915905,"about_ca_system_score_codex":0.000492663,"about_ca_system_score_gemma":0.00029787948,"threshold_uncertainty_score":0.0043033957},"labels":[],"label_agreement":null},{"id":"W2029796174","doi":"10.1016/j.antiviral.2003.07.001","title":"Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Resveratrol; Hairless; Lesion; Herpes simplex virus; Erythema; In vivo; Pharmacology; Medicine; Virus; In vitro; Dermatology; Chemistry; Immunology; Biology; Surgery; Biochemistry","score_opus":0.03585109773665064,"score_gpt":0.40037928020784286,"score_spread":0.36452818247119223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029796174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947476,0.0019281962,0.0006232333,0.00022702386,0.00019086867,0.000040352577,0.00043327315,0.00012873123,0.001680629],"genre_scores_gemma":[0.99329656,0.0012781257,0.00072828506,0.00009774865,0.00004775219,0.000032095184,0.0003774814,0.00002703985,0.0041149873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997646,0.000056497734,0.000017218186,0.00004502717,0.000035173234,0.000081552804],"domain_scores_gemma":[0.99965334,0.000092335256,0.000054588007,0.00004492214,0.00003402625,0.00012068806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019694075,0.0006281608,0.00058867584,0.00054196664,0.00029328305,0.00026509303,0.00036597918,0.0006818618,0.0026491524],"category_scores_gemma":[0.00023295412,0.0002837762,0.000683935,0.00020427053,0.000592445,0.00034660634,0.00017207008,0.0013652712,0.00048607466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005613428,0.00043882287,0.00019155565,0.000087757464,0.000035144134,0.00007675533,0.00004686946,0.00011274193,0.9905702,0.0000817977,0.000117102994,0.0026277849],"study_design_scores_gemma":[0.0002685136,0.0065873885,0.003189893,0.000015123816,0.00011815775,0.00012695979,0.00011057103,0.0004644838,0.98781025,0.000094176175,0.0011962383,0.00001833612],"about_ca_topic_score_codex":0.0014480107,"about_ca_topic_score_gemma":0.0020074702,"teacher_disagreement_score":0.0026491524,"about_ca_system_score_codex":0.00023556665,"about_ca_system_score_gemma":0.00032233846,"threshold_uncertainty_score":0.008862317},"labels":[],"label_agreement":null},{"id":"W2030885831","doi":"10.1016/j.antiviral.2011.11.009","title":"Inhibition or deficiency of cathepsin B leads defects in HIV-1 Gag pseudoparticle release in macrophages and HEK293T cells","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Ontario HIV Treatment Network","keywords":"Cathepsin B; Endosome; Cell biology; Intracellular; Virology; Virus; Biology; HEK 293 cells; Viral envelope; Endocytosis; Extracellular; Pinocytosis; Cell culture; Cell","score_opus":0.06858855620436495,"score_gpt":0.33198507517379383,"score_spread":0.2633965189694289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030885831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773383,0.0015601778,0.011540237,0.0006441862,0.00021116926,0.000092702096,0.0049330676,0.00038166624,0.0032985134],"genre_scores_gemma":[0.97696996,0.0010130247,0.007692268,0.00016730305,0.000027534157,0.00013395646,0.00451595,0.00016714961,0.009312888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895394,0.00018285541,0.00020005586,0.00015644479,0.00030720886,0.00019947461],"domain_scores_gemma":[0.99942636,0.00018329777,0.00010356453,0.0001372697,0.00007400986,0.000075593394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006190408,0.0004944863,0.00069383817,0.00042127483,0.00039960106,0.0011336673,0.0007004891,0.0009489328,0.0021911063],"category_scores_gemma":[0.00044470877,0.00051347906,0.0008005831,0.00038281668,0.00062321307,0.0005835988,0.0005753433,0.0016477243,0.0024071878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002919814,0.00004513608,0.00016030602,0.00004252883,0.000011757989,0.0001579047,0.000055395416,0.000068611575,0.99832326,0.00028404122,0.000102486505,0.00045650496],"study_design_scores_gemma":[0.00003393858,0.000089485184,0.0011690573,0.00000617506,0.000012168086,0.0006347114,0.000059455615,0.0009831104,0.99490935,0.00007906429,0.002013346,0.0000100550415],"about_ca_topic_score_codex":0.0013389233,"about_ca_topic_score_gemma":0.00093633,"teacher_disagreement_score":0.0021911063,"about_ca_system_score_codex":0.00054231856,"about_ca_system_score_gemma":0.00043567334,"threshold_uncertainty_score":0.007329941},"labels":[],"label_agreement":null},{"id":"W2030941371","doi":"10.1016/j.antiviral.2011.07.011","title":"Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Influenza A virus subtype H5N1; Viral replication; Biology; Virology; Virus; In vitro; Cyclooxygenase; Enzyme; Genetics","score_opus":0.1347770368377143,"score_gpt":0.448703199644244,"score_spread":0.3139261628065297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030941371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910589,0.004946825,0.0006001449,0.0001559752,0.00021335982,0.000049880393,0.00065585616,0.000027866734,0.0022911483],"genre_scores_gemma":[0.98926616,0.0040408787,0.0016450974,0.000078146775,0.00010107005,0.000057032412,0.0013708485,0.000008057749,0.0034327344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998235,0.000055506396,0.000017142354,0.00001439488,0.000023844925,0.00006565974],"domain_scores_gemma":[0.99986005,0.000065160726,0.000012072297,0.000015723635,0.000017780143,0.000029279798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004259983,0.00043284617,0.00047378882,0.0002093305,0.00032611354,0.00022452787,0.00031150403,0.00024027102,0.0027167804],"category_scores_gemma":[0.00021315098,0.00018848934,0.0004615709,0.00019542541,0.00021428743,0.00022537271,0.0001734133,0.0006729682,0.00040197486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045339414,0.00067581306,0.0005500421,0.00028594912,0.00004557553,0.00017416754,0.00007571826,0.00041743,0.9865754,0.0001961575,0.00055040495,0.0059192395],"study_design_scores_gemma":[0.00036891288,0.0060913255,0.0050966935,0.000020385616,0.00007516329,0.00023138546,0.000088742054,0.0012550331,0.98435956,0.00005240982,0.0023473843,0.000012893553],"about_ca_topic_score_codex":0.0022929278,"about_ca_topic_score_gemma":0.004361958,"teacher_disagreement_score":0.0027167804,"about_ca_system_score_codex":0.0002900552,"about_ca_system_score_gemma":0.0005978363,"threshold_uncertainty_score":0.009088516},"labels":[],"label_agreement":null},{"id":"W2031242404","doi":"10.1016/j.antiviral.2007.03.010","title":"Chemical properties, mode of action, and in vivo anti-herpes activities of a lignin–carbohydrate complex from Prunella vulgaris","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Innovation and Technology Fund; Chinese University of Hong Kong; University of Hong Kong; Dalhousie University","keywords":"Prunella vulgaris; In vivo; Rhamnose; Vero cell; Biochemistry; Galactose; Polysaccharide; Microbiology; Chemistry; Biology; In vitro; Pharmacology; Medicine","score_opus":0.06156448742838446,"score_gpt":0.3458857927590903,"score_spread":0.2843213053307059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031242404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998083,0.00074372947,0.00062041054,0.000031636093,0.0000056567947,0.000007858715,0.00008427856,0.000010595137,0.00041272913],"genre_scores_gemma":[0.9982363,0.0002237915,0.00035099158,0.000022569011,0.0000051440907,0.0000038691273,0.00035698674,0.000008039481,0.0007924543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999131,0.000022953316,0.000007460825,0.000012453692,0.00001957823,0.000024385074],"domain_scores_gemma":[0.99987185,0.00003438587,0.000025212505,0.000014131756,0.00001488341,0.000039434533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016589256,0.00032470166,0.00018807912,0.00024402703,0.00014746973,0.00023677743,0.00023529325,0.0002467294,0.0008920982],"category_scores_gemma":[0.00015932687,0.00011917723,0.00018103707,0.00020182015,0.00019870604,0.00015356166,0.000103043734,0.00033598533,0.00015929755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018318549,0.000019339288,0.000103465274,0.000012244606,0.0000036596189,0.000022651788,0.000008891777,0.00007230338,0.9990571,0.000021185755,0.0000070633228,0.00048890203],"study_design_scores_gemma":[0.000018163963,0.00028501824,0.0019454109,0.0000024765363,0.000017360875,0.000096515694,0.000015724321,0.0003219777,0.9967085,0.00001986253,0.00056559267,0.0000033690274],"about_ca_topic_score_codex":0.0013329547,"about_ca_topic_score_gemma":0.00078995025,"teacher_disagreement_score":0.0013329547,"about_ca_system_score_codex":0.00023049486,"about_ca_system_score_gemma":0.000107870226,"threshold_uncertainty_score":0.0029844046},"labels":[],"label_agreement":null},{"id":"W2031618987","doi":"10.1016/j.antiviral.2012.12.023","title":"Hepatitis B e antigen levels and response to peginterferon: Influence of precore and basal core promoter mutants","year":2012,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"HBeAg; Hepatitis B virus; Medicine; Gastroenterology; Antigen; Basal (medicine); Hepatitis B; Mutant; Lamivudine; Chronic hepatitis; Virology; Internal medicine; Immunology; Virus; Biology; HBsAg","score_opus":0.15386927165674616,"score_gpt":0.4300484610500494,"score_spread":0.2761791893933032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031618987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892837,0.00015792057,0.00029148796,0.000034779787,0.000019805137,0.000010270744,0.00020817008,0.000017264367,0.00033200005],"genre_scores_gemma":[0.9978587,0.00009305828,0.00046652844,0.000033616292,0.000008798755,0.000015445667,0.00037437328,0.000027381846,0.0011221366],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99954516,0.0001540332,0.000048272555,0.00006780437,0.00005996546,0.0001248226],"domain_scores_gemma":[0.9991567,0.00043832356,0.00008379629,0.00009539357,0.000062889696,0.00016285003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004251054,0.00037327394,0.00032696122,0.00025071017,0.00018453051,0.0005137143,0.0003630103,0.0005171625,0.0016755443],"category_scores_gemma":[0.0010784935,0.00026752288,0.0002839586,0.0002511887,0.0005050318,0.00044864544,0.0002390727,0.00073496153,0.00030945538],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066945893,0.00037146325,0.0010273546,0.000019494677,0.000017849512,0.00007283347,0.00005931962,0.00022161653,0.98998004,0.00010557333,0.00009354884,0.0013362906],"study_design_scores_gemma":[0.00014721777,0.0014756673,0.008099601,0.0000038131056,0.00003636168,0.00016715418,0.00006366926,0.0021215011,0.9873147,0.000060565795,0.00049699104,0.000012688163],"about_ca_topic_score_codex":0.0023243565,"about_ca_topic_score_gemma":0.0013908327,"teacher_disagreement_score":0.0023243565,"about_ca_system_score_codex":0.00044560226,"about_ca_system_score_gemma":0.0002948992,"threshold_uncertainty_score":0.0056052804},"labels":[],"label_agreement":null},{"id":"W2034970205","doi":"10.1016/j.antiviral.2008.04.003","title":"Retinoids inhibit measles virus in vitro via nuclear retinoid receptor signaling pathways","year":2008,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"","keywords":"Retinoid; Measles virus; Retinoid X receptor beta; Biology; Cell culture; Retinoic acid; Retinoid X receptor gamma; Retinol; Retinoid X receptor alpha; Signal transduction; Cancer research; Cell biology; Virology; Vitamin; Measles; Endocrinology; Genetics","score_opus":0.04906167600686478,"score_gpt":0.2991390698049771,"score_spread":0.25007739379811234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034970205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606579,0.014383931,0.008241238,0.0005368276,0.00036369363,0.00018635538,0.0023843255,0.00059139414,0.012654244],"genre_scores_gemma":[0.97751266,0.00585656,0.002936769,0.000098230084,0.000087775035,0.000105973064,0.0027212426,0.00012027944,0.0105605535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931073,0.00024363541,0.00007713359,0.00006365879,0.000115800285,0.00018908358],"domain_scores_gemma":[0.9992343,0.000411052,0.00006632995,0.00015105189,0.00006765484,0.000069631235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064086216,0.001066063,0.00093186094,0.0007712179,0.0005373112,0.0007807457,0.00087808346,0.00045087116,0.003940914],"category_scores_gemma":[0.00070020615,0.00043481842,0.0007704866,0.00045456694,0.00054629677,0.00051857106,0.00046560148,0.0014526498,0.0018600125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014276609,0.00021417774,0.00022896718,0.00012158396,0.00003633707,0.00007716128,0.00008491182,0.00032992946,0.99403495,0.00039201506,0.00026237825,0.0027899444],"study_design_scores_gemma":[0.000034403824,0.0002808345,0.00037700834,0.0000041364133,0.000015448299,0.000043037886,0.000023344997,0.00028411564,0.99774134,0.00004627117,0.001146284,0.0000037009183],"about_ca_topic_score_codex":0.008132713,"about_ca_topic_score_gemma":0.008832674,"teacher_disagreement_score":0.008132713,"about_ca_system_score_codex":0.0011375498,"about_ca_system_score_gemma":0.0008658923,"threshold_uncertainty_score":0.0161708},"labels":[],"label_agreement":null},{"id":"W2037465112","doi":"10.1016/j.antiviral.2013.01.003","title":"Current and future approaches to the therapy of human rabies","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Rabies epidemiology and control","field":"Immunology and Microbiology","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Rabies; Rabies virus; Medicine; Regimen; Coma (optics); Rabies vaccine; Intensive care medicine; Disease; Immunology; Virology; Surgery; Internal medicine","score_opus":0.4699903491001967,"score_gpt":0.4608586767891744,"score_spread":0.009131672311022299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037465112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004478484,0.9986091,0.00015412983,0.0003887573,0.00030128215,0.0000027422213,0.00000725724,0.0000064481032,0.0004855355],"genre_scores_gemma":[0.0004125064,0.99831235,0.0002167432,0.00025147904,0.00038856355,0.000004816905,0.000017803108,0.0000013009683,0.00039445114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977785,0.000047927693,0.000027753293,0.00003503604,0.00007694991,0.000034384964],"domain_scores_gemma":[0.9995277,0.0002283834,0.00005499984,0.000015288451,0.00011640168,0.00005721113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010049308,0.0011180168,0.0016442905,0.0018342824,0.0003495384,0.001161499,0.0012862466,0.0014612129,0.004919533],"category_scores_gemma":[0.0009998465,0.00026208535,0.00046609904,0.0016386549,0.00096619397,0.0018505722,0.00095447066,0.0029129372,0.0022788793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008616218,0.00008357387,0.00010539127,0.006836154,0.00004413599,0.000120414,0.000030387526,0.0002983665,0.0014320184,0.0038708553,0.032520402,0.95457214],"study_design_scores_gemma":[0.00003478306,0.00010732754,0.0004970576,0.0025501146,0.00009901205,0.00083456864,0.00006001343,0.0001356645,0.00040021547,0.0034921747,0.9917727,0.000016292064],"about_ca_topic_score_codex":0.0010198851,"about_ca_topic_score_gemma":0.00255476,"teacher_disagreement_score":0.004919533,"about_ca_system_score_codex":0.0007943976,"about_ca_system_score_gemma":0.0013637481,"threshold_uncertainty_score":0.016457438},"labels":[],"label_agreement":null},{"id":"W2045993180","doi":"10.1016/j.antiviral.2014.02.017","title":"Oseltamivir–zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Zanamivir; Oseltamivir; Virology; Combination therapy; Medicine; Neuraminidase inhibitor; Virus; Influenza A virus; Titer; Pharmacology; Coronavirus disease 2019 (COVID-19); Internal medicine","score_opus":0.14426044425505627,"score_gpt":0.4450199786447343,"score_spread":0.30075953438967806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045993180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562246,0.0011794369,0.00032345587,0.00042324155,0.00022663099,0.000038993516,0.0007691555,0.00008682307,0.001329874],"genre_scores_gemma":[0.99371004,0.000948603,0.00091777585,0.0001899324,0.000069865164,0.000093370254,0.00085488905,0.000026929203,0.003188625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992638,0.00014652239,0.00007227387,0.000109286615,0.00013485113,0.00027325554],"domain_scores_gemma":[0.99941087,0.00007915585,0.00013900806,0.00006611783,0.000052121264,0.00025280594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005729931,0.0009972109,0.002018211,0.00098714,0.00046778753,0.00089128973,0.0007512659,0.001343552,0.0024096682],"category_scores_gemma":[0.00037944442,0.00063574535,0.0010703253,0.00039333256,0.0009080877,0.0016038173,0.00022929563,0.0035616322,0.0004874109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01555805,0.00115289,0.000557544,0.0001347311,0.00010072078,0.000104363244,0.000044467073,0.00029676498,0.9772954,0.0002192603,0.00039539562,0.0041404436],"study_design_scores_gemma":[0.0023688835,0.0300752,0.017389216,0.000049628597,0.00046582357,0.0005866281,0.00023663588,0.0041272617,0.9413257,0.00040934226,0.002888228,0.00007746988],"about_ca_topic_score_codex":0.002306829,"about_ca_topic_score_gemma":0.004459207,"teacher_disagreement_score":0.0024096682,"about_ca_system_score_codex":0.0007989392,"about_ca_system_score_gemma":0.0008642734,"threshold_uncertainty_score":0.008061111},"labels":[],"label_agreement":null},{"id":"W2047767458","doi":"10.1016/j.antiviral.2010.06.001","title":"Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypes","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; Centre Hospitalier de l’Université de Montréal; Jewish General Hospital","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Drug resistance; Virology; Biology; Mutation; Virus; Protease; Protease inhibitor (pharmacology); Recombinant DNA; Resistance mutation; Human immunodeficiency virus (HIV); Lentivirus; Genetics; Viral disease; Enzyme; Viral load; Gene; Reverse transcriptase; Polymerase chain reaction; Antiretroviral therapy","score_opus":0.025592750565193487,"score_gpt":0.35780198163759624,"score_spread":0.33220923107240274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047767458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931253,0.0013082961,0.0029292416,0.00007398714,0.000019850722,0.00005134205,0.00069588824,0.00004844677,0.0017475127],"genre_scores_gemma":[0.9886657,0.0010185186,0.004580815,0.000068340494,0.000009372122,0.00004250924,0.0020032579,0.000030869232,0.0035806666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998591,0.000036056692,0.000012221931,0.000026750302,0.00003880282,0.000026909374],"domain_scores_gemma":[0.9998487,0.000066804656,0.000016087917,0.000018331079,0.000031669584,0.000018358513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002180896,0.0001993931,0.00022330029,0.0002833985,0.00015209363,0.0003378921,0.0004941275,0.00025337105,0.0018048048],"category_scores_gemma":[0.00031047285,0.00014018145,0.00024235711,0.0002106897,0.00015868206,0.0002131583,0.000112162204,0.0007619449,0.00051089475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001981816,0.00011025661,0.0002705184,0.000017071072,0.000005301981,0.000027330068,0.000009823289,0.0002017055,0.99711597,0.00005478985,0.00006174522,0.0019272459],"study_design_scores_gemma":[0.00003831531,0.0010052326,0.0037681307,0.00000400794,0.000028036196,0.00027836554,0.000039653074,0.0034955041,0.98976225,0.000034855988,0.0015413293,0.000004263298],"about_ca_topic_score_codex":0.0021781083,"about_ca_topic_score_gemma":0.002286542,"teacher_disagreement_score":0.0021781083,"about_ca_system_score_codex":0.00037456272,"about_ca_system_score_gemma":0.0002258789,"threshold_uncertainty_score":0.0060376525},"labels":[],"label_agreement":null},{"id":"W2050801792","doi":"10.1016/j.antiviral.2005.08.004","title":"Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health","keywords":"Vero cell; Herpes simplex virus; Dendrimer; Microbicide; HSL and HSV; Chemistry; Cytotoxicity; IC50; Virology; Cytotoxic T cell; In vitro; Virus; Biology; Biochemistry","score_opus":0.13400769923431005,"score_gpt":0.42914197169751717,"score_spread":0.2951342724632071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050801792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593854,0.001303286,0.00083212374,0.00006958893,0.000019738722,0.0000779994,0.00012173039,0.000027472435,0.0016095251],"genre_scores_gemma":[0.9953792,0.001160549,0.0010679709,0.00003775569,0.0000048704223,0.000026804319,0.0002015236,0.000006066283,0.0021152096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993384,0.0000138353,0.0000026054086,0.0000070855585,0.000018900859,0.00002367055],"domain_scores_gemma":[0.99995744,0.000006134272,0.0000064761734,0.0000028803422,0.000011440357,0.000015637159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019299242,0.00023078623,0.00021504085,0.0001339245,0.00016040458,0.0002344973,0.00015817402,0.00018001342,0.00086570624],"category_scores_gemma":[0.000099216566,0.00006208127,0.00014599127,0.00008797286,0.000120649405,0.000108912485,0.00009909885,0.00023076092,0.00016038501],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014245241,0.0004268379,0.00036913398,0.00010234149,0.000016359123,0.00013957586,0.00003409677,0.0011149269,0.9790197,0.00027515367,0.00026712925,0.01681022],"study_design_scores_gemma":[0.00035583018,0.014807705,0.0016016428,0.0000144158785,0.000042565753,0.00039090644,0.000041251496,0.0022802013,0.97749513,0.00006892703,0.002893708,0.000007700436],"about_ca_topic_score_codex":0.00058309117,"about_ca_topic_score_gemma":0.0010848127,"teacher_disagreement_score":0.00086570624,"about_ca_system_score_codex":0.00024401472,"about_ca_system_score_gemma":0.00030562503,"threshold_uncertainty_score":0.0028960705},"labels":[],"label_agreement":null},{"id":"W2051824837","doi":"10.1016/j.antiviral.2007.12.006","title":"Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970–2007)","year":2008,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Provincial Laboratory of Public Health","funders":"","keywords":"Adamantane; Virology; Virus; Amino acid; Amino acid substitution; Influenza A virus; Drug resistance; Biology; Mutation; Microbiology; Chemistry; Genetics; Gene","score_opus":0.24203572411408283,"score_gpt":0.4491608887736014,"score_spread":0.20712516465951855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051824837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072886,0.0020853367,0.00017363105,0.00034907906,0.000034190278,0.000048695314,0.0035255635,0.000012266009,0.0030424765],"genre_scores_gemma":[0.99118173,0.001872138,0.00033167304,0.00026157327,0.000022699181,0.000015683785,0.0022767105,0.000007413443,0.004030387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994979,0.000027520366,0.000026723555,0.000068262605,0.00020410607,0.00017552875],"domain_scores_gemma":[0.99870956,0.00005556635,0.00015626993,0.000026094765,0.0007989557,0.00025349736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005663578,0.00037903409,0.00035103696,0.0016469721,0.002021073,0.0010500441,0.0008859302,0.00045241893,0.00087402784],"category_scores_gemma":[0.00087857555,0.00032695092,0.0003553021,0.0031478058,0.0005941585,0.00028841113,0.00041608477,0.00078367174,0.0001952198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005106758,0.00005824416,0.9722348,0.00008783232,0.00008675781,0.00071843824,0.002064419,0.0004148428,0.0023837907,0.00019455756,0.003154273,0.018091286],"study_design_scores_gemma":[0.000011658845,0.00005347696,0.9952329,0.000026542764,0.000040106977,0.00032996747,0.0013458033,0.00016748847,0.00036256033,0.000012177593,0.0024041364,0.00001324879],"about_ca_topic_score_codex":0.9938624,"about_ca_topic_score_gemma":0.9951599,"teacher_disagreement_score":0.018380372,"about_ca_system_score_codex":0.018380372,"about_ca_system_score_gemma":0.02325368,"threshold_uncertainty_score":0.13335955},"labels":[],"label_agreement":null},{"id":"W2054452932","doi":"10.1016/j.antiviral.2015.01.001","title":"Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Virology; Immunization; Nasal administration; Transmission (telecommunications); Virus; Ebola virus; Medicine; Biology; Antibody; Immunology","score_opus":0.08187384616496686,"score_gpt":0.39539693342040827,"score_spread":0.3135230872554414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054452932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777275,0.0005870023,0.0008209916,0.000066309854,0.000051431805,0.00007112584,0.00006951851,0.000037829228,0.0005230463],"genre_scores_gemma":[0.9939241,0.0009996766,0.0027125247,0.000086839194,0.000036187193,0.00009970549,0.00025035234,0.000014546026,0.0018762089],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998161,0.000033700835,0.000018087647,0.00004277422,0.00002458665,0.000064749154],"domain_scores_gemma":[0.9997124,0.0000733251,0.00007068822,0.00003969351,0.0000287731,0.00007520073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039437725,0.0004906852,0.0003644757,0.00042130574,0.00013258703,0.00028616763,0.0003140449,0.0006803948,0.0009453961],"category_scores_gemma":[0.00031738685,0.00022593899,0.00025387568,0.000093027076,0.00038784955,0.0003829724,0.00019077386,0.0008846195,0.00025981982],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078668166,0.00081365,0.0006387731,0.00006969975,0.000014791963,0.000056116904,0.00003825304,0.000108820626,0.99459887,0.000075050615,0.00003810009,0.002761232],"study_design_scores_gemma":[0.0003573721,0.039108854,0.0121201845,0.00007964025,0.00007300844,0.00035007377,0.00012335982,0.0010119113,0.94510424,0.00011755998,0.0015391366,0.0000146798775],"about_ca_topic_score_codex":0.0005370987,"about_ca_topic_score_gemma":0.0007320232,"teacher_disagreement_score":0.0009453961,"about_ca_system_score_codex":0.00020699148,"about_ca_system_score_gemma":0.0002615327,"threshold_uncertainty_score":0.0031626225},"labels":[],"label_agreement":null},{"id":"W2055698455","doi":"10.1016/j.antiviral.2006.02.008","title":"Increasing prevalence of HIV-1 protease inhibitor-associated mutations correlates with long-term non-suppressive protease inhibitor treatment","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver","funders":"Quest Diagnostics; University of Washington","keywords":"Protease inhibitor (pharmacology); Protease; Virology; HIV-1 protease; Human immunodeficiency virus (HIV); Term (time); Medicine; Biology; Enzyme; Viral load; Antiretroviral therapy; Biochemistry","score_opus":0.025661647620190287,"score_gpt":0.32368918038969136,"score_spread":0.29802753276950106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055698455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946233,0.0022760266,0.00023902266,0.00037039234,0.000026064592,0.000009721939,0.0003297635,0.000022996395,0.0021026945],"genre_scores_gemma":[0.9989942,0.00029985158,0.00010776451,0.000081641636,0.000045122542,0.000004434165,0.00018006071,0.0000040983828,0.00028286842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990676,0.00021975093,0.00013446972,0.00016541431,0.00020820704,0.00020462733],"domain_scores_gemma":[0.9828607,0.004402794,0.008816353,0.000737433,0.0012877622,0.0018948881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000935286,0.00021799374,0.000562423,0.0007765723,0.0006941563,0.0011943517,0.0005765672,0.00089792267,0.004193529],"category_scores_gemma":[0.008217121,0.00025241694,0.00045112998,0.0013488798,0.00047300477,0.0010809839,0.00034537155,0.001875831,0.0004787224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003680393,0.00007144508,0.994626,0.000013633243,0.00004738191,0.00015467498,0.000042895485,0.000044195516,0.0007934005,0.000030814597,0.00011604989,0.0036914765],"study_design_scores_gemma":[0.000003792477,0.00014375728,0.99843854,0.0000054004977,0.000035582834,0.00078274065,0.00008259696,0.00013084433,0.00014998,0.000039571845,0.0001837194,0.0000033957792],"about_ca_topic_score_codex":0.0012726997,"about_ca_topic_score_gemma":0.001832949,"teacher_disagreement_score":0.004193529,"about_ca_system_score_codex":0.0003227542,"about_ca_system_score_gemma":0.00055001996,"threshold_uncertainty_score":0.014028728},"labels":[],"label_agreement":null},{"id":"W2055770088","doi":"10.1016/j.antiviral.2013.05.003","title":"The lung microvascular endothelium as a therapeutic target in severe influenza","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"ARDS; Lung; Hypoxemia; Endothelium; Sepsis; Medicine; Immunology; Endothelial stem cell; Biology; Internal medicine","score_opus":0.25162348157591524,"score_gpt":0.5184449099430837,"score_spread":0.26682142836716843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055770088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035564637,0.9996082,0.000023187751,0.0000883156,0.00007844561,0.0000017923069,0.0000051854504,0.0000011133465,0.00015827164],"genre_scores_gemma":[0.0003336007,0.9992888,0.00005586891,0.000093056755,0.000100177895,0.0000024043943,0.000008007299,3.449568e-7,0.000117695796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980766,0.000039131748,0.000038350357,0.000030356787,0.00006349535,0.000021020114],"domain_scores_gemma":[0.9995945,0.00022906595,0.00006642623,0.000007946627,0.00007912526,0.000022962817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083032984,0.0008966569,0.0019956022,0.0022312403,0.00024502978,0.0011945628,0.0007440105,0.0013617442,0.0025484508],"category_scores_gemma":[0.0009865129,0.0003446862,0.0006474677,0.0021760685,0.0004621258,0.0012581509,0.000710558,0.001687508,0.00086040614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001953715,0.00007481063,0.00023081983,0.046837375,0.00025987535,0.0002409019,0.000046467063,0.0002398339,0.0018332251,0.0019645852,0.023755372,0.92432135],"study_design_scores_gemma":[0.0001270935,0.0002607685,0.0016892441,0.021013942,0.001134688,0.0016370342,0.00015662375,0.00018739188,0.0009985882,0.0022620445,0.970485,0.00004766197],"about_ca_topic_score_codex":0.0013799197,"about_ca_topic_score_gemma":0.003172063,"teacher_disagreement_score":0.0025484508,"about_ca_system_score_codex":0.0005297245,"about_ca_system_score_gemma":0.0012482799,"threshold_uncertainty_score":0.008525431},"labels":[],"label_agreement":null},{"id":"W2061934699","doi":"10.1016/j.antiviral.2008.02.001","title":"Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules","year":2008,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University; Public Health Agency of Canada; University of Manitoba","funders":"Canadian Institutes of Health Research; Manitoba Medical Service Foundation","keywords":"Influenza A virus subtype H5N1; Virology; Neuraminidase; Biology; Transduction (biophysics); Influenza A virus; Hemagglutinin (influenza); Viral vector; Oseltamivir; Neuraminidase inhibitor; Virus; Recombinant DNA; Medicine; Biochemistry; Gene","score_opus":0.16225901549436017,"score_gpt":0.4067390509268816,"score_spread":0.24448003543252145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061934699","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958878,0.0017355394,0.03345504,0.00023945702,0.00006299975,0.0005141098,0.003356715,0.0003520331,0.0014062522],"genre_scores_gemma":[0.9374522,0.0013423816,0.042654455,0.0001383716,0.000018790926,0.00023888685,0.0128322635,0.00013009003,0.0051926235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975747,0.00004267661,0.000029396175,0.00003672588,0.000101607846,0.000032049076],"domain_scores_gemma":[0.9998635,0.000045198994,0.000024629191,0.00001704952,0.000022216567,0.000027371001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032654006,0.00054712873,0.0005494129,0.00040217055,0.0001998259,0.00063898193,0.00063617784,0.0003142986,0.0009221766],"category_scores_gemma":[0.00022664844,0.0002713993,0.00037602833,0.0003563588,0.00017862779,0.00029330654,0.00021298215,0.0007850025,0.00048606843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048568683,0.000042099407,0.00008596506,0.000018341108,0.000008131324,0.00001621599,0.0000050654635,0.00007527992,0.9986475,0.000050182633,0.000042682765,0.0009599878],"study_design_scores_gemma":[0.00002274606,0.00029896753,0.00094234815,0.0000026139553,0.000028870465,0.00014451955,0.000010999811,0.0016762747,0.99538225,0.000018834573,0.0014641568,0.0000073486517],"about_ca_topic_score_codex":0.0013256625,"about_ca_topic_score_gemma":0.0017094283,"teacher_disagreement_score":0.0013256625,"about_ca_system_score_codex":0.0004193904,"about_ca_system_score_gemma":0.0002720511,"threshold_uncertainty_score":0.0030849576},"labels":[],"label_agreement":null},{"id":"W2065172397","doi":"10.1016/s0166-3542(00)00080-2","title":"Topical effects of cidofovir on cutaneous rabbit warts: treatment regimen and inoculum dependence","year":2000,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Cidofovir; Titer; Inoculation; Regimen; Erythema; Medicine; Virology; Surgery; Immunology; Virus","score_opus":0.04584998312997246,"score_gpt":0.39394726894424786,"score_spread":0.3480972858142754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065172397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990602,0.0055703553,0.000583246,0.000089211186,0.00013113447,0.00010895872,0.00011152707,0.000025425696,0.002778246],"genre_scores_gemma":[0.997589,0.0013029351,0.00031694325,0.000035180637,0.00007567523,0.000016617854,0.00005087271,0.0000106671805,0.00060219906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995011,0.00021824049,0.000045133518,0.000059150283,0.00005614172,0.00012024096],"domain_scores_gemma":[0.998774,0.0007759202,0.000104663304,0.00016733429,0.00007437696,0.000103718856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065978593,0.00028334392,0.0007802779,0.00037511374,0.00029733303,0.0003239577,0.00032143624,0.00040633808,0.002444668],"category_scores_gemma":[0.001756233,0.0001934945,0.00034421484,0.00024120795,0.0003724269,0.0005372871,0.0001890172,0.00064315455,0.0002439647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06633698,0.005347711,0.0045759897,0.0004929347,0.00014432686,0.0006008537,0.0002951369,0.0010334944,0.7876314,0.00038924036,0.00057216344,0.13257988],"study_design_scores_gemma":[0.002634665,0.14706168,0.08899915,0.00011734478,0.0006699678,0.0018632662,0.0004890793,0.003633758,0.74732226,0.0003861784,0.006740125,0.00008255977],"about_ca_topic_score_codex":0.0009894345,"about_ca_topic_score_gemma":0.0017819258,"teacher_disagreement_score":0.002444668,"about_ca_system_score_codex":0.00025314986,"about_ca_system_score_gemma":0.00025057205,"threshold_uncertainty_score":0.0081781745},"labels":[],"label_agreement":null},{"id":"W2065243148","doi":"10.1016/j.antiviral.2007.08.001","title":"Porcine plasma ficolin binds and reduces infectivity of porcine reproductive and respiratory syndrome virus (PRRSV) in vitro","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Canadian Institutes of Health Research","keywords":"Ficolin; Porcine reproductive and respiratory syndrome virus; Recombinant DNA; Collectin; Lectin pathway; Biology; Lectin; Complement system; Arterivirus; In vitro; Innate immune system; Virus; Glycoprotein; Virology; Molecular biology; Immune system; Mannan-binding lectin; Biochemistry; Classical complement pathway; Immunology","score_opus":0.08025344957853148,"score_gpt":0.3493860978206842,"score_spread":0.2691326482421527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065243148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950275,0.0016908738,0.00097483816,0.00009188589,0.000045860543,0.000021619127,0.00018107811,0.000037485937,0.0019288234],"genre_scores_gemma":[0.9919681,0.0007277051,0.0011102443,0.00020301383,0.000045306668,0.000021602724,0.0016137178,0.000030149911,0.00428028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935013,0.00018865603,0.00003051175,0.00006985362,0.00013810598,0.00022278818],"domain_scores_gemma":[0.99959034,0.00023233965,0.000035397486,0.000039123162,0.000046778994,0.000055972552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003365587,0.00048753657,0.00033892985,0.00047916913,0.0003756729,0.0005723376,0.000535513,0.0006593626,0.0016799466],"category_scores_gemma":[0.00060512853,0.00032923868,0.0004356266,0.00021597084,0.00031929003,0.0002724072,0.00035318028,0.0005525187,0.0006078766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002879671,0.000067263885,0.00024986966,0.000043478263,0.0000101625365,0.00006101297,0.0000403781,0.00006843204,0.9984799,0.000044291508,0.00008581671,0.0005615935],"study_design_scores_gemma":[0.000022187132,0.0006490991,0.012034434,0.000009769123,0.000025610108,0.00036098086,0.00007367644,0.0009257092,0.9836009,0.000035725283,0.0022498146,0.000012186346],"about_ca_topic_score_codex":0.006158459,"about_ca_topic_score_gemma":0.0030956857,"teacher_disagreement_score":0.006158459,"about_ca_system_score_codex":0.00062082126,"about_ca_system_score_gemma":0.0003540716,"threshold_uncertainty_score":0.012245238},"labels":[],"label_agreement":null},{"id":"W2065462956","doi":"10.1016/j.antiviral.2004.08.004","title":"A novel model of HPV infection in meshed human foreskin grafts","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Foreskin; In situ hybridization; Papilloma; Histology; Medicine; HPV infection; Pathology; Virology; Biology; Cell culture; Cervical cancer; Gene expression; Internal medicine; Cancer; Gene","score_opus":0.2000282829938549,"score_gpt":0.47451939844230784,"score_spread":0.27449111544845295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065462956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727936,0.001442935,0.018966688,0.00034326554,0.0004107935,0.0001752072,0.0006267247,0.00014560041,0.0050953203],"genre_scores_gemma":[0.9875587,0.00065371406,0.0074184667,0.0000878434,0.000032991167,0.00008048358,0.00024416612,0.000017984965,0.0039056572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977475,0.000053941094,0.000018004534,0.000047587146,0.000054192926,0.00005149712],"domain_scores_gemma":[0.9997714,0.000071828035,0.00003786331,0.00007023524,0.000007226381,0.000041332776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039800984,0.0003615487,0.00025797248,0.00048210679,0.0003610551,0.00054295914,0.00061643875,0.00068872655,0.0021468634],"category_scores_gemma":[0.00022869346,0.00022965053,0.00058683194,0.00018706844,0.00049909955,0.0005537204,0.000340407,0.0007305977,0.00028007582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012790086,0.00036588268,0.0005133063,0.00015826122,0.000025875432,0.000855294,0.00010880382,0.00231706,0.98250914,0.008064598,0.00017981538,0.0036228916],"study_design_scores_gemma":[0.0003652047,0.008472255,0.0063590715,0.00008361656,0.00012710752,0.005084075,0.00034779363,0.01777763,0.9416024,0.004857675,0.014872682,0.00005042572],"about_ca_topic_score_codex":0.00059871015,"about_ca_topic_score_gemma":0.00064944255,"teacher_disagreement_score":0.0021468634,"about_ca_system_score_codex":0.00039136386,"about_ca_system_score_gemma":0.00031368193,"threshold_uncertainty_score":0.007182002},"labels":[],"label_agreement":null},{"id":"W2066743245","doi":"10.1016/j.antiviral.2005.10.007","title":"Treatment of intravaginal HSV-2 infection in mice: A comparison of CpG oligodeoxynucleotides and resiquimod (R-848)","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Terry Fox Research Institute","funders":"","keywords":"TLR9; CpG Oligodeoxynucleotide; Innate immune system; Immune system; Agonist; TLR7; Immunology; Biology; CpG site; Chemokine; Receptor; Toll-like receptor","score_opus":0.10050744449403827,"score_gpt":0.4613525181820126,"score_spread":0.36084507368797436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066743245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98803073,0.0044780783,0.0025833475,0.00028168497,0.00031454212,0.00030398325,0.0005252848,0.00022303229,0.00325929],"genre_scores_gemma":[0.9843785,0.0036447698,0.005387504,0.00017047083,0.00012069518,0.0003076844,0.0005951657,0.000053813084,0.0053413357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962664,0.00010975273,0.000026819172,0.000066432294,0.00006115048,0.00010917772],"domain_scores_gemma":[0.9997409,0.000057075034,0.000056251778,0.000026196254,0.000024335972,0.000095262105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045866758,0.0005802385,0.0011492743,0.00063530204,0.00021798813,0.00033373153,0.00056491804,0.00093305594,0.0018066955],"category_scores_gemma":[0.00031560054,0.00028952005,0.00043739716,0.00026734642,0.00039401388,0.00045636247,0.00017983723,0.0010614914,0.00039744092],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0145370765,0.0019684343,0.0002016935,0.0003867158,0.00006463126,0.000073899115,0.000070446804,0.00066161074,0.9542323,0.00029127797,0.0003489532,0.027162999],"study_design_scores_gemma":[0.0019927383,0.046765633,0.0016424236,0.00004049836,0.00016251428,0.00025598265,0.00006427292,0.0018673206,0.9427897,0.000105482635,0.0042787073,0.00003471439],"about_ca_topic_score_codex":0.0017238363,"about_ca_topic_score_gemma":0.0025142136,"teacher_disagreement_score":0.0018066955,"about_ca_system_score_codex":0.00029062846,"about_ca_system_score_gemma":0.00069779035,"threshold_uncertainty_score":0.00604403},"labels":[],"label_agreement":null},{"id":"W2067082178","doi":"10.1016/s0166-3542(03)00112-8","title":"HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Boehringer Ingelheim (Canada)","funders":"","keywords":"Electroretinography; Retinal; Erg; Retinitis; Medicine; Cidofovir; Ophthalmology; Cytomegalovirus retinitis; Retinal degeneration; Retina; Virology; Virus; Biology; Human cytomegalovirus","score_opus":0.07454354648736128,"score_gpt":0.3840748088871355,"score_spread":0.30953126239977424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067082178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874281,0.0029466646,0.004149606,0.00024614693,0.00014703262,0.0001663372,0.00067240256,0.00025897508,0.003984777],"genre_scores_gemma":[0.9899596,0.001189968,0.0031527313,0.000079156955,0.00004337005,0.00016843567,0.00038642314,0.000027178798,0.0049929833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996141,0.00008310469,0.000029493436,0.00005970009,0.00010411116,0.00010937279],"domain_scores_gemma":[0.99976474,0.000054642533,0.000054344906,0.000050617593,0.000022312019,0.00005336854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003123194,0.0004865772,0.00036455237,0.00069090223,0.000253989,0.00026923724,0.00031400597,0.0007134624,0.0013679685],"category_scores_gemma":[0.00023615967,0.00012601555,0.00032409024,0.00023480025,0.0005179328,0.0004356989,0.00019890147,0.0015667127,0.0002510599],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047742666,0.00023668719,0.00015371742,0.000048187147,0.000010029888,0.00011602458,0.000028258899,0.0000778013,0.9956436,0.00019731496,0.000114897804,0.002896036],"study_design_scores_gemma":[0.000050587645,0.0019327017,0.0028583033,0.00000946048,0.000018842493,0.00017681104,0.000025104346,0.0006415457,0.9932411,0.000060322902,0.0009796497,0.0000056955405],"about_ca_topic_score_codex":0.0011266522,"about_ca_topic_score_gemma":0.0013225607,"teacher_disagreement_score":0.0013679685,"about_ca_system_score_codex":0.00035435744,"about_ca_system_score_gemma":0.00024939535,"threshold_uncertainty_score":0.004576266},"labels":[],"label_agreement":null},{"id":"W2067685971","doi":"10.1016/j.antiviral.2014.08.015","title":"Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Dosing; Ribavirin; Internal medicine; Gastroenterology; Placebo; Hepatitis C virus; MiR-122; Chronic hepatitis; Hepatitis C; Virus; Immunology; Pathology","score_opus":0.017970550729739267,"score_gpt":0.32018224973390513,"score_spread":0.3022116990041659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067685971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894805,0.008233439,0.00033191658,0.00019619869,0.000043961634,0.00003368586,0.00019860742,0.000020168049,0.0014614424],"genre_scores_gemma":[0.9983853,0.0007320796,0.00010174582,0.00014837824,0.000036955225,0.000025404019,0.00018908079,0.0000036401461,0.00037733532],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99950266,0.00020742905,0.000052840533,0.000062768355,0.00009397788,0.000080316255],"domain_scores_gemma":[0.9989312,0.00037519445,0.00036248457,0.000088110806,0.00011196056,0.0001310783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014095589,0.00019375961,0.0006731947,0.00017563083,0.00026888298,0.0005129466,0.00016387593,0.0004217558,0.0011318986],"category_scores_gemma":[0.0020599235,0.000084883286,0.0005699883,0.00026601308,0.00027952818,0.00044460577,0.00016111307,0.00066378433,0.00022935096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19431642,0.0038825215,0.23947537,0.0008052148,0.001603924,0.0006301057,0.00040042558,0.0018422869,0.05743206,0.000577885,0.0015120378,0.4975217],"study_design_scores_gemma":[0.0078466125,0.16843958,0.77476096,0.00024963022,0.0027332625,0.0017718062,0.0004277838,0.0038535588,0.02909889,0.00093742803,0.009780911,0.000099560406],"about_ca_topic_score_codex":0.0003002331,"about_ca_topic_score_gemma":0.00036841555,"teacher_disagreement_score":0.0014095589,"about_ca_system_score_codex":0.00041225425,"about_ca_system_score_gemma":0.00034481884,"threshold_uncertainty_score":0.007454574},"labels":[],"label_agreement":null},{"id":"W2070125035","doi":"10.1016/j.antiviral.2013.10.007","title":"The combination of valacyclovir with an anti-TNF alpha antibody increases survival rate compared to antiviral therapy alone in a murine model of herpes simplex virus encephalitis","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Herpes simplex virus; Etanercept; Tumor necrosis factor alpha; Immune system; Virus; Medicine; Antibody; Encephalitis; Viral encephalitis; Pathogenesis; Immunology; Viral load; Virology; Combination therapy; Pharmacology","score_opus":0.08247525602762802,"score_gpt":0.4055634919178162,"score_spread":0.3230882358901882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070125035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955694,0.0023960716,0.0005232258,0.00013358612,0.00018551425,0.00002469408,0.00016000382,0.000057405876,0.0009499987],"genre_scores_gemma":[0.9956524,0.0014043584,0.0008547415,0.000041137566,0.0000722194,0.000037167494,0.00021319077,0.000013814187,0.0017110064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997805,0.000052243027,0.000015693024,0.000038766888,0.000038888385,0.00007399507],"domain_scores_gemma":[0.9996203,0.00008472944,0.00008334721,0.000037517086,0.000020888592,0.0001532728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028411945,0.00054792693,0.00086406263,0.00063269923,0.00020622811,0.00050306646,0.00040079176,0.00058911106,0.0012307626],"category_scores_gemma":[0.00027223324,0.00019362831,0.0004004973,0.00025472188,0.00043025432,0.0006282209,0.00017183284,0.0015455052,0.00020885302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019673545,0.002169179,0.0009153904,0.0001453924,0.000065072265,0.00015334957,0.00007320368,0.00078823883,0.95771635,0.00022946672,0.00041958896,0.017651206],"study_design_scores_gemma":[0.0006770862,0.05041089,0.0065155244,0.000039278217,0.00020692078,0.00060200103,0.00009709204,0.0029080356,0.93621916,0.0001952294,0.0020927375,0.000036001842],"about_ca_topic_score_codex":0.00048031236,"about_ca_topic_score_gemma":0.00070115936,"teacher_disagreement_score":0.0012307626,"about_ca_system_score_codex":0.0002859249,"about_ca_system_score_gemma":0.00034745393,"threshold_uncertainty_score":0.0041173697},"labels":[],"label_agreement":null},{"id":"W2070528933","doi":"10.1016/j.antiviral.2009.05.004","title":"Translational insensitivity to potent activation of PKR by HCV IRES RNA","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Internal ribosome entry site; Protein kinase R; RNA; Biology; Translation (biology); EIF-2 kinase; Virology; Eukaryotic translation; Protein biosynthesis; Picornavirus; Interferon; Molecular biology; Ribosome; RNA silencing; Initiation factor; Messenger RNA; Phosphorylation; Cell biology; RNA interference; Biochemistry; Protein kinase A; Gene","score_opus":0.03611876428698934,"score_gpt":0.3623040886127023,"score_spread":0.32618532432571296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070528933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932473,0.0011336592,0.00137427,0.00026294854,0.00014278594,0.0000387325,0.00057715335,0.00016902713,0.0030541457],"genre_scores_gemma":[0.99664056,0.00048719833,0.0005861682,0.000116915995,0.000057795543,0.000028290731,0.0006941404,0.00004690032,0.0013420064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995871,0.00010978178,0.000064937136,0.000043241907,0.000077692894,0.00011724958],"domain_scores_gemma":[0.9993585,0.00021800863,0.000076953,0.0001454668,0.000036156132,0.00016494052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006169504,0.0005581963,0.0004909699,0.00047364883,0.00023474493,0.00050781295,0.00024105598,0.00030916787,0.00467458],"category_scores_gemma":[0.0006649953,0.0003005708,0.00045975184,0.0002755958,0.00065418606,0.00036550392,0.00044131227,0.0011147785,0.00061254646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010773183,0.00010520231,0.00016375355,0.00004867951,0.000010973429,0.00012884151,0.000020778602,0.0002041486,0.9964898,0.00040350616,0.00015908331,0.0011878388],"study_design_scores_gemma":[0.000043717806,0.000903114,0.002185108,0.0000064097558,0.000010986091,0.00037642257,0.000028845401,0.0007132442,0.9946926,0.00010842407,0.0009224756,0.000008453135],"about_ca_topic_score_codex":0.000659378,"about_ca_topic_score_gemma":0.0007679507,"teacher_disagreement_score":0.00467458,"about_ca_system_score_codex":0.00046586207,"about_ca_system_score_gemma":0.00036114993,"threshold_uncertainty_score":0.015638053},"labels":[],"label_agreement":null},{"id":"W2070756649","doi":"10.1016/j.antiviral.2013.02.016","title":"Capripoxvirus-vectored vaccines against livestock diseases in Africa","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta; University of Saskatchewan; Canadian Food Inspection Agency","funders":"University of Alberta; University of Saskatchewan","keywords":"Livestock; Rift Valley fever; Vaccination; Virology; Monkeypox; Veterinary medicine; Biology; Environmental health; Medicine; Virus; Recombinant DNA","score_opus":0.14490181865148902,"score_gpt":0.405438003530366,"score_spread":0.260536184878877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070756649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022116725,0.9986557,0.00012858429,0.0001372985,0.00021504512,0.0000067553106,0.000016447837,0.000004960423,0.00061396224],"genre_scores_gemma":[0.0010045184,0.99796873,0.00016219419,0.00012450575,0.00014529376,0.0000066004636,0.000036409372,8.958751e-7,0.0005509203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998841,0.000015384192,0.000015585649,0.000019078389,0.000042452048,0.000023365521],"domain_scores_gemma":[0.99981695,0.000073299416,0.000038583,0.000004640744,0.00004401218,0.000022516344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006236926,0.0009176247,0.0010068129,0.0013815351,0.00016788694,0.0006977205,0.00070548896,0.0008695725,0.002774746],"category_scores_gemma":[0.000503714,0.00025077688,0.00028601623,0.0012122708,0.00034417183,0.0010371183,0.00048309122,0.0012691765,0.0010059068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012328934,0.00008208378,0.00012211694,0.008810038,0.00004688926,0.00015433406,0.00003182729,0.00024802642,0.004623075,0.0016472564,0.018971262,0.9651398],"study_design_scores_gemma":[0.0000584612,0.00024928118,0.0008295944,0.003083477,0.00013283831,0.0009813526,0.00005489461,0.00010578084,0.002151173,0.0009345571,0.99140394,0.000014810007],"about_ca_topic_score_codex":0.0009005248,"about_ca_topic_score_gemma":0.0015811529,"teacher_disagreement_score":0.002774746,"about_ca_system_score_codex":0.00052531535,"about_ca_system_score_gemma":0.0008341594,"threshold_uncertainty_score":0.00928247},"labels":[],"label_agreement":null},{"id":"W2072181122","doi":"10.1016/j.antiviral.2005.06.008","title":"Effect of resveratrol on herpes simplex virus vaginal infection in the mouse","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Resveratrol; Herpes simplex virus; Placebo; Virus; Vagina; Viral shedding; Viral replication; Medicine; Biology; Immunology; Virology; Pharmacology; Internal medicine; Surgery; Pathology","score_opus":0.055579206244588134,"score_gpt":0.4385959232346391,"score_spread":0.38301671699005096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072181122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914534,0.0035424354,0.00056610466,0.00043600277,0.00024352618,0.000041729138,0.00068330916,0.00013428977,0.002899184],"genre_scores_gemma":[0.9892727,0.0027987477,0.0008161736,0.00020864572,0.00006467484,0.00003545653,0.0006321494,0.000032350512,0.006139218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997588,0.00006610206,0.000017343731,0.00004587441,0.00003171914,0.00008012933],"domain_scores_gemma":[0.99958426,0.00010605181,0.00007059529,0.000054165033,0.00003891172,0.00014607275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023760424,0.0006371074,0.0006259108,0.0009061452,0.0003361962,0.00036559682,0.00040559968,0.00097034016,0.0023515632],"category_scores_gemma":[0.00031820577,0.00032584905,0.0007237673,0.00023665716,0.00063643197,0.00045340284,0.00023111013,0.0014230866,0.00051229086],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016197268,0.0011499869,0.0005525193,0.00021757612,0.00008882923,0.0001448876,0.00011531216,0.0003122054,0.9715688,0.00029646474,0.00028753182,0.009068522],"study_design_scores_gemma":[0.00069332984,0.019410254,0.007831218,0.000056725203,0.00031079515,0.0002527901,0.00029831124,0.0008894487,0.9656934,0.00043202954,0.004073102,0.000058471567],"about_ca_topic_score_codex":0.0013324027,"about_ca_topic_score_gemma":0.0017710566,"teacher_disagreement_score":0.0023515632,"about_ca_system_score_codex":0.00029376327,"about_ca_system_score_gemma":0.00034351344,"threshold_uncertainty_score":0.00786674},"labels":[],"label_agreement":null},{"id":"W2073165330","doi":"10.1016/j.antiviral.2010.07.001","title":"Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canadian Institutes of Health Research; Centre Hospitalier Universitaire de Québec; Amylin Pharmaceuticals","keywords":"Human metapneumovirus; Medicine; Monoclonal antibody; Titer; Immunology; Virology; Antibody titer; Antibody; Respiratory system; Respiratory tract infections; Internal medicine","score_opus":0.12414931626722309,"score_gpt":0.43937494630224727,"score_spread":0.3152256300350242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073165330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041474,0.003909118,0.0021215493,0.0005385938,0.00021172897,0.000085727945,0.00031520127,0.00023393474,0.002169366],"genre_scores_gemma":[0.99248224,0.0023033805,0.0016149452,0.000156646,0.00010400725,0.00009649014,0.0004075067,0.000022583099,0.0028121998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997652,0.00004774534,0.00001546078,0.00005074638,0.00004881051,0.00007187898],"domain_scores_gemma":[0.9997367,0.000053805976,0.000057194506,0.000045441244,0.000014812429,0.00009207545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043397743,0.0009478638,0.0006188812,0.0010459865,0.00029931456,0.00041664302,0.0005664388,0.0010687521,0.0012340753],"category_scores_gemma":[0.00024501578,0.00024715063,0.0004856345,0.00024929622,0.0007385658,0.0005680881,0.00019366117,0.0015491311,0.00022965993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005576738,0.0018893185,0.00041680102,0.00009442592,0.00004320191,0.00033923253,0.000025553165,0.00040769074,0.9833551,0.0009138996,0.0003307423,0.0066072172],"study_design_scores_gemma":[0.0014147302,0.022709275,0.004157709,0.000051905183,0.00030461542,0.0015955563,0.000055027293,0.0036008386,0.9608627,0.00088589196,0.0043325354,0.000029290903],"about_ca_topic_score_codex":0.0005572243,"about_ca_topic_score_gemma":0.00050477503,"teacher_disagreement_score":0.0012340753,"about_ca_system_score_codex":0.00040334676,"about_ca_system_score_gemma":0.00036244647,"threshold_uncertainty_score":0.0041283965},"labels":[],"label_agreement":null},{"id":"W2073480716","doi":"10.1016/j.antiviral.2014.03.017","title":"Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Hepatitis D virus; Virology; Hepatitis D; Viral entry; Medicine; Entry inhibitor; Hepatitis B virus; In vitro; Viral replication; Virus; Pharmacology; Biology; HBsAg","score_opus":0.22382249421954814,"score_gpt":0.379732559637433,"score_spread":0.15591006541788488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073480716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625765,0.007942918,0.0043810965,0.00081286347,0.00037310558,0.0006984863,0.0010727951,0.00017468145,0.021967454],"genre_scores_gemma":[0.9766908,0.0043268735,0.0058871517,0.00032528545,0.00010671198,0.00032899555,0.00091317354,0.00002613038,0.011394721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978584,0.000086567896,0.000013757945,0.000025727088,0.000046262012,0.000041876872],"domain_scores_gemma":[0.9998271,0.00004584365,0.000038276266,0.000026428424,0.00003086368,0.000031569896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005338127,0.0002871433,0.0002629812,0.00028212066,0.00032934072,0.00034796976,0.00021414281,0.00044096907,0.0059261792],"category_scores_gemma":[0.00031392873,0.00011235917,0.00033142423,0.00017057652,0.0003126933,0.00024298136,0.00015179996,0.0006272063,0.00038864271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006407449,0.0023670492,0.0019281447,0.00046337256,0.000104713756,0.00022711245,0.0001362526,0.0005123589,0.8989119,0.0025547424,0.0025386144,0.08384835],"study_design_scores_gemma":[0.0011593987,0.02629156,0.005665372,0.000070906724,0.00017325881,0.0006379908,0.0001375002,0.0007778158,0.91569394,0.00027754012,0.04909085,0.000023827097],"about_ca_topic_score_codex":0.0009844097,"about_ca_topic_score_gemma":0.002610444,"teacher_disagreement_score":0.0059261792,"about_ca_system_score_codex":0.0003765092,"about_ca_system_score_gemma":0.00068609166,"threshold_uncertainty_score":0.0198251},"labels":[],"label_agreement":null},{"id":"W2073526348","doi":"10.1016/j.antiviral.2011.04.001","title":"Interferon-γ influences immunity elicited by vaccines against very virulent Marek’s disease virus","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Marek's disease; Virulence; Virology; Biology; Vaccination; Virus; Immunity; Interferon; Plasmid; Immune system; Microbiology; Immunology; Gene","score_opus":0.11537763320337872,"score_gpt":0.3926820829303194,"score_spread":0.2773044497269407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073526348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700004,0.0006847236,0.00040854074,0.00009223872,0.000101616366,0.000022519554,0.000083568935,0.000014279368,0.0015923954],"genre_scores_gemma":[0.9984427,0.00035529557,0.0002741035,0.00008803967,0.000038114908,0.000017240347,0.0000890631,0.000009257339,0.00068626954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996159,0.00014664239,0.000031869236,0.000045431683,0.000040946168,0.0001191543],"domain_scores_gemma":[0.99969304,0.00015328675,0.000043957403,0.000029408888,0.000026764968,0.000053458287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004149252,0.00038633126,0.00030242105,0.0003412752,0.00020740318,0.0005487033,0.00024224649,0.0004590352,0.0016335828],"category_scores_gemma":[0.00055437896,0.00018804506,0.00029740052,0.00012159231,0.00041826884,0.0003286535,0.00024877005,0.0011120156,0.00036768278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025005562,0.00011764681,0.0008604734,0.00005156743,0.000014253351,0.0000822748,0.000048457674,0.00024341996,0.9925297,0.00021482885,0.000061159924,0.0032757334],"study_design_scores_gemma":[0.0005877841,0.0036213088,0.020973826,0.000050235267,0.00018341052,0.00036505968,0.00033190392,0.0021341948,0.96788377,0.00074141345,0.0031063547,0.000020768739],"about_ca_topic_score_codex":0.00025021087,"about_ca_topic_score_gemma":0.00024302423,"teacher_disagreement_score":0.0016335828,"about_ca_system_score_codex":0.00037018926,"about_ca_system_score_gemma":0.00020709769,"threshold_uncertainty_score":0.0054649115},"labels":[],"label_agreement":null},{"id":"W2073739863","doi":"10.1016/j.antiviral.2014.06.020","title":"Analysis of the transcriptome and immune function of monocytes during IFNα-based therapy in chronic HCV revealed induction of TLR7 responsiveness","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Sociale en Geesteswetenschappen, NWO; Virgo Consortium; Bristol-Myers Squibb","keywords":"TLR7; Immunology; Immune system; Cytokine; Monocyte; In vivo; Interferon; Biology; Ex vivo; Transcriptome; Medicine; Toll-like receptor; Innate immune system; Gene expression; Gene","score_opus":0.033448616487475644,"score_gpt":0.31304291380127547,"score_spread":0.2795942973137998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073739863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977951,0.0005655872,0.0004776056,0.000045603636,0.000019189933,0.000014559445,0.000526741,0.000008012855,0.00054768537],"genre_scores_gemma":[0.99691534,0.00038867607,0.00038413415,0.00008090823,0.000017401746,0.00005284336,0.0006540003,0.000007517991,0.0014993632],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998116,0.00003617211,0.000010713574,0.000029979497,0.00003273636,0.00007879766],"domain_scores_gemma":[0.9999045,0.0000199556,0.00001891879,0.000011147162,0.000018565433,0.000026852838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001931988,0.000149348,0.00038443092,0.00018163238,0.0002801586,0.00044895604,0.00007015071,0.00026102675,0.0015575382],"category_scores_gemma":[0.0001842239,0.00011544027,0.00027119907,0.00018865835,0.00022000792,0.0001574247,0.00018516483,0.00049654284,0.0003788634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034243162,0.00006255578,0.0070271417,0.000073294046,0.000018371682,0.00014172545,0.00016131296,0.00009144812,0.9843136,0.00009619814,0.000109642344,0.004480298],"study_design_scores_gemma":[0.00011335456,0.0028872958,0.56941706,0.000078251614,0.00021021857,0.0008955149,0.0019687891,0.0024210075,0.41739243,0.0005269335,0.0040551634,0.000034016422],"about_ca_topic_score_codex":0.00048199645,"about_ca_topic_score_gemma":0.00090841175,"teacher_disagreement_score":0.0015575382,"about_ca_system_score_codex":0.00023761713,"about_ca_system_score_gemma":0.00022942838,"threshold_uncertainty_score":0.005210459},"labels":[],"label_agreement":null},{"id":"W2074366047","doi":"10.1016/j.antiviral.2006.10.012","title":"Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"","keywords":"Zanamivir; Neuraminidase; Virology; Neuraminidase inhibitor; Oseltamivir; Virus; Influenza A virus; Mutation; Recombinant DNA; Hemagglutinin (influenza); Recombinant virus; Biology; Influenzavirus B; Orthomyxoviridae; Gene; Genetics; Medicine","score_opus":0.0685784773872101,"score_gpt":0.38464928073487814,"score_spread":0.316070803347668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074366047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461645,0.0007636664,0.0024612036,0.000043298183,0.00003578973,0.00007887851,0.0007617011,0.000031227493,0.001207695],"genre_scores_gemma":[0.9843321,0.0008176426,0.0075640855,0.00006863976,0.000023372262,0.00010284669,0.0035075485,0.000088824585,0.0034949654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996494,0.00008198694,0.000050055896,0.00004723522,0.0001017524,0.000069579684],"domain_scores_gemma":[0.9996289,0.00017481783,0.00003971602,0.00004885778,0.000068969675,0.00003876493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003322769,0.00052398065,0.00064013916,0.00038379437,0.00026158182,0.00047950013,0.00051382225,0.00035271153,0.0010784345],"category_scores_gemma":[0.000564204,0.00035176525,0.0005608281,0.00037016155,0.00021554789,0.000277532,0.00020379468,0.00067406875,0.0005312184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117203126,0.000029267716,0.00030008404,0.000017527125,0.000010035939,0.00003885523,0.000027017868,0.00011329694,0.99872714,0.00003719619,0.000016445218,0.00056590635],"study_design_scores_gemma":[0.000017162529,0.00042736807,0.005111403,0.000003393467,0.000033829023,0.00030024198,0.00005800651,0.0011225876,0.9921234,0.000026381626,0.0007684219,0.00000770382],"about_ca_topic_score_codex":0.0026581667,"about_ca_topic_score_gemma":0.0019515454,"teacher_disagreement_score":0.0026581667,"about_ca_system_score_codex":0.00033852182,"about_ca_system_score_gemma":0.00020921657,"threshold_uncertainty_score":0.005285442},"labels":[],"label_agreement":null},{"id":"W2074806701","doi":"10.1016/j.antiviral.2008.01.152","title":"Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions","year":2008,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Outbreak; Case fatality rate; Medicine; Ebola virus; Ebolavirus; Marburg virus; Ebola vaccine; Infectious disease (medical specialty); Ebola Hemorrhagic Fever; Virology; Intensive care medicine; Disease; Clinical trial; Environmental health; Pathology; Population","score_opus":0.3371074663774374,"score_gpt":0.5050210633326645,"score_spread":0.16791359695522712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074806701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008201708,0.9987074,0.00014496542,0.00037106546,0.00015113286,0.000008026855,0.000013320489,0.0000074387854,0.00051468646],"genre_scores_gemma":[0.0005808907,0.99826473,0.00036827705,0.00031553578,0.00014960123,0.000010288763,0.000027330518,0.0000012859733,0.00028222013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971837,0.000060349714,0.000041449908,0.000046259815,0.00010125623,0.000032174423],"domain_scores_gemma":[0.99927384,0.00038111053,0.0001171822,0.000017358447,0.00016487372,0.000045569977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012907431,0.0013318913,0.0031009822,0.002820595,0.0002961736,0.0012206836,0.0014092334,0.0018764051,0.0043842676],"category_scores_gemma":[0.0012361913,0.00037942905,0.0010216711,0.0021306116,0.0006348566,0.0018810075,0.0005995153,0.0023836235,0.0018731199],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013326532,0.00014083841,0.00016820212,0.014827163,0.00014580341,0.0002240586,0.000041499596,0.00035802517,0.0017023988,0.0027485387,0.027861034,0.9516491],"study_design_scores_gemma":[0.00016981011,0.00033529804,0.0011082313,0.0077047604,0.00045191712,0.0014944801,0.0001222328,0.00018601926,0.000830904,0.0023135717,0.98525107,0.000031604897],"about_ca_topic_score_codex":0.0021015652,"about_ca_topic_score_gemma":0.0037442215,"teacher_disagreement_score":0.0043842676,"about_ca_system_score_codex":0.0010443671,"about_ca_system_score_gemma":0.002087255,"threshold_uncertainty_score":0.014666855},"labels":[],"label_agreement":null},{"id":"W2075138163","doi":"10.1016/j.antiviral.2011.09.004","title":"FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"TLR4; Innate immune system; TLR2; Lung; Immunology; Influenza A virus; Biology; Virus; Inflammation; Immune system; Virology; Microbiology; Medicine","score_opus":0.2980825734765801,"score_gpt":0.46947228715747213,"score_spread":0.171389713680892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075138163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280167,0.0016632125,0.002059982,0.00054103456,0.00009340231,0.000058527323,0.0004769871,0.00021487153,0.0020903118],"genre_scores_gemma":[0.9904473,0.00091411447,0.0025727414,0.00042340258,0.00008803726,0.00010324017,0.0007898122,0.000052543586,0.0046087336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995152,0.000093756156,0.000035575067,0.00007810614,0.00007894766,0.00019829276],"domain_scores_gemma":[0.9995289,0.00005499377,0.0001211398,0.000071438946,0.000035428307,0.0001881358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061387516,0.0009498897,0.0005557717,0.0009968536,0.0004018722,0.00052566273,0.0003969451,0.0011218175,0.0015791466],"category_scores_gemma":[0.0003174425,0.0005229204,0.00068555406,0.0001823501,0.0007704227,0.0006595845,0.00037241858,0.0026043146,0.0006879262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014062033,0.00020071473,0.00025666686,0.00005057725,0.000009942047,0.00008259167,0.000026294945,0.0000967247,0.9959705,0.00016024776,0.00013195783,0.0016075112],"study_design_scores_gemma":[0.0003347631,0.0031610078,0.0060960944,0.000028304543,0.000056161774,0.00043362938,0.00010027714,0.0011808241,0.9863236,0.00032104173,0.0019466847,0.00001760537],"about_ca_topic_score_codex":0.00047288666,"about_ca_topic_score_gemma":0.0007030161,"teacher_disagreement_score":0.0015791466,"about_ca_system_score_codex":0.0006962081,"about_ca_system_score_gemma":0.00039700375,"threshold_uncertainty_score":0.0052827597},"labels":[],"label_agreement":null},{"id":"W2075666829","doi":"10.1016/j.antiviral.2013.04.013","title":"Viral envelope glycoprotein processing by proprotein convertases","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal","funders":"Université de Lausanne; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Viral envelope; Glycoprotein; Biology; Viral pathogenesis; Furin; Viral entry; Virology; Virus; Computational biology; Cell biology; Viral replication; Genetics; Enzyme","score_opus":0.11346925902047274,"score_gpt":0.4158452883780427,"score_spread":0.30237602935756996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075666829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014899511,0.9975358,0.00036048103,0.00021378887,0.00053294195,0.000006925702,0.000018432169,0.000009968352,0.0011725735],"genre_scores_gemma":[0.0008389766,0.9969207,0.00034773388,0.00016945433,0.00054880173,0.000008135592,0.00005292661,0.0000021476978,0.001111243],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983203,0.000020561116,0.00002355629,0.000033341952,0.00006443534,0.000025981873],"domain_scores_gemma":[0.99980253,0.00006410266,0.000036174886,0.000008267901,0.00006247129,0.000026461421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005428334,0.0015479206,0.001275828,0.0015141583,0.00022970614,0.0012087321,0.0008289211,0.0010649866,0.001979716],"category_scores_gemma":[0.0005377836,0.00039622525,0.00032210958,0.0017817171,0.00065095763,0.0015480297,0.0007380275,0.0019483856,0.002056659],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012357146,0.00006186448,0.00010454012,0.0067512663,0.00004020323,0.00023237274,0.000021104064,0.000341417,0.0058147735,0.0021987364,0.03279534,0.95151484],"study_design_scores_gemma":[0.000035640292,0.00007369067,0.0005663747,0.0012223698,0.000074735086,0.0012810925,0.000038269467,0.0001780676,0.0022902775,0.002283631,0.9919344,0.000021283375],"about_ca_topic_score_codex":0.0007802039,"about_ca_topic_score_gemma":0.0012376403,"teacher_disagreement_score":0.001979716,"about_ca_system_score_codex":0.00079095736,"about_ca_system_score_gemma":0.0011321176,"threshold_uncertainty_score":0.0066227913},"labels":[],"label_agreement":null},{"id":"W2077581494","doi":"10.1016/j.antiviral.2012.08.012","title":"WFDC1/ps20: A host factor that influences the neutrophil response to murine hepatitis virus (MHV) 1 infection","year":2012,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs; University Health Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"CXCL1; Biology; Immunology; Immune system; Microbiology; Virology; Chemokine","score_opus":0.07389450539630842,"score_gpt":0.36413159282337065,"score_spread":0.2902370874270622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077581494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979108,0.0005149225,0.00062641443,0.00007489681,0.000018357876,0.000012165841,0.00018908088,0.00002949987,0.00062391633],"genre_scores_gemma":[0.9975172,0.00032828012,0.0007419017,0.00003414346,0.000012601495,0.000011275146,0.00030504086,0.000019057037,0.0010305169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998808,0.000023311804,0.000008133062,0.00001812878,0.000025230021,0.000044334327],"domain_scores_gemma":[0.99987936,0.00002373402,0.000025523545,0.000011531758,0.0000074863747,0.000052333966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001498677,0.00032635612,0.00016966632,0.0002791947,0.00024904322,0.00031695623,0.00019594746,0.000221252,0.0011483447],"category_scores_gemma":[0.00018130415,0.00011774729,0.00012820156,0.0001277325,0.00029510338,0.00022061351,0.00016680222,0.00050951965,0.00028210398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028463334,0.000038957733,0.00021400246,0.000010901408,0.0000012822238,0.000040180203,0.0000057127595,0.00006153157,0.9986305,0.000070895185,0.000034489334,0.00060690666],"study_design_scores_gemma":[0.00005090784,0.00034843484,0.00746903,0.000005845723,0.000012028288,0.00031718484,0.000039539074,0.0014873855,0.98892736,0.00010031774,0.0012359893,0.000005987827],"about_ca_topic_score_codex":0.0007949148,"about_ca_topic_score_gemma":0.0013349641,"teacher_disagreement_score":0.0011483447,"about_ca_system_score_codex":0.000510544,"about_ca_system_score_gemma":0.00023707065,"threshold_uncertainty_score":0.003841579},"labels":[],"label_agreement":null},{"id":"W2080095545","doi":"10.1016/j.antiviral.2015.03.001","title":"Down-regulation of suppressor of cytokine signaling 3 by miR-122 enhances interferon-mediated suppression of hepatitis B virus","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity; National Natural Science Foundation of China","keywords":"Interferon; Suppressor of cytokine signaling 1; Virology; Cytokine; Suppressor; Virus; Hepatitis B virus; MiR-122; Immunology; Medicine; Biology; Hepatitis C virus; Gene; Genetics","score_opus":0.08123459829342115,"score_gpt":0.3823441300280892,"score_spread":0.30110953173466803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080095545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98972017,0.0019178914,0.002780868,0.00027093964,0.00028995343,0.00004407956,0.00015680918,0.00019942067,0.0046197386],"genre_scores_gemma":[0.9959734,0.0005197589,0.0013595254,0.0001172448,0.00004097938,0.000031235137,0.00019110115,0.000028594279,0.0017381483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997632,0.00005107035,0.000029111414,0.00003229751,0.00006745582,0.000056922636],"domain_scores_gemma":[0.9998679,0.000029949268,0.000027557924,0.00001512465,0.000019581454,0.000039933555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026168211,0.00034554364,0.0003587527,0.0002369502,0.0002264875,0.00044921975,0.00019907262,0.00030566205,0.0021047106],"category_scores_gemma":[0.00039559443,0.00017486118,0.00032320252,0.00012720656,0.0002690789,0.00031378452,0.0002318044,0.0009202938,0.000601213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073849823,0.00015866848,0.00025052944,0.00004603762,0.000010250011,0.00005772638,0.000017563158,0.000111905196,0.9938923,0.00017021604,0.00016692998,0.004379246],"study_design_scores_gemma":[0.00014826558,0.001365961,0.004830077,0.000009182779,0.000071278984,0.00033326496,0.000066590095,0.0040987856,0.98497367,0.00018083896,0.0039070323,0.000015035812],"about_ca_topic_score_codex":0.00022291465,"about_ca_topic_score_gemma":0.00041717914,"teacher_disagreement_score":0.0021047106,"about_ca_system_score_codex":0.00020436599,"about_ca_system_score_gemma":0.00027308747,"threshold_uncertainty_score":0.007040918},"labels":[],"label_agreement":null},{"id":"W2081116136","doi":"10.1016/j.antiviral.2013.09.018","title":"Universal anti-neuraminidase antibody inhibiting all influenza A subtypes","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Ottawa; Health Canada","funders":"","keywords":"Epitope; Neuraminidase; Monoclonal antibody; Virology; Antibody; Biology; Influenza A virus; Virus; Viral replication; Amino acid; Peptide sequence; Immunology; Biochemistry; Gene","score_opus":0.18397769633088198,"score_gpt":0.4747452553409837,"score_spread":0.29076755901010176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081116136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815062,0.0070648086,0.0011928626,0.00035129543,0.0002026597,0.00023700867,0.00037079945,0.00004434859,0.009029955],"genre_scores_gemma":[0.9872765,0.0033947937,0.0022908773,0.00033894074,0.00008782441,0.0000665398,0.00039865365,0.000006099438,0.006139827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951446,0.00013575255,0.000048046575,0.00006405193,0.000084270505,0.00015353893],"domain_scores_gemma":[0.9995745,0.000097553675,0.000059876074,0.000059825845,0.00010205458,0.00010627594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011771792,0.0002875737,0.00036854643,0.0003271143,0.00023826235,0.00026047908,0.00044327127,0.0003330301,0.0034763734],"category_scores_gemma":[0.00058039534,0.00013536683,0.00021812183,0.00027311742,0.00026447957,0.0003204568,0.00030595067,0.00039370038,0.00042326516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014455116,0.0027467893,0.024150832,0.0005995522,0.00029798917,0.00026741362,0.000247035,0.0002260194,0.7450161,0.0017821344,0.0023407638,0.20787032],"study_design_scores_gemma":[0.0030540237,0.06450197,0.13059594,0.0002048758,0.00074950175,0.0028938488,0.00066706777,0.00059535756,0.7296266,0.0007180479,0.06636165,0.000031205393],"about_ca_topic_score_codex":0.0015239554,"about_ca_topic_score_gemma":0.002742886,"teacher_disagreement_score":0.0034763734,"about_ca_system_score_codex":0.000252987,"about_ca_system_score_gemma":0.00084947504,"threshold_uncertainty_score":0.011629641},"labels":[],"label_agreement":null},{"id":"W2086230721","doi":"10.1016/j.antiviral.2006.05.013","title":"Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?","year":2006,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Microbicides for sexually transmitted diseases; Microbicide; Drug; Human immunodeficiency virus (HIV); Potency; Vaginal microbicide; Drug resistance; Pharmacology; HIV drug resistance; Virology; Limiting; Medicine; Population; Biology; Antiretroviral therapy; Viral load; In vitro; Microbiology; Health services","score_opus":0.13677041303927173,"score_gpt":0.42541701983054114,"score_spread":0.2886466067912694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086230721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009756118,0.9980938,0.00017888664,0.0005180015,0.00035444865,0.0000035120665,0.00000793096,0.000007104732,0.0007387841],"genre_scores_gemma":[0.00065382436,0.9976172,0.0003205306,0.0004177267,0.0003542978,0.00000563181,0.000015457324,0.0000015364492,0.00061382994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996799,0.000055915352,0.000040281542,0.000053039148,0.00012784342,0.000042998887],"domain_scores_gemma":[0.99908817,0.0005017802,0.00010645343,0.000024832105,0.00020165548,0.00007713127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016278614,0.0010039194,0.0026443126,0.0010516975,0.00036537816,0.0014874033,0.0015010294,0.0020038607,0.0037776646],"category_scores_gemma":[0.0016152374,0.0003613869,0.000459722,0.0010965128,0.0008607239,0.0021424112,0.0005717823,0.0026403617,0.0027493355],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017652434,0.00006908416,0.00018132868,0.006753518,0.00006752799,0.000308499,0.00003584453,0.000269349,0.0020149525,0.004038496,0.030621577,0.95546323],"study_design_scores_gemma":[0.000062914914,0.00022529172,0.0005915859,0.0024798878,0.00013475538,0.0017959966,0.00007256845,0.00012628577,0.00087222434,0.0027520026,0.99086654,0.000019914878],"about_ca_topic_score_codex":0.001366803,"about_ca_topic_score_gemma":0.0033447011,"teacher_disagreement_score":0.0037776646,"about_ca_system_score_codex":0.0008004576,"about_ca_system_score_gemma":0.0016428917,"threshold_uncertainty_score":0.012637496},"labels":[],"label_agreement":null},{"id":"W2086933325","doi":"10.1016/j.antiviral.2007.08.008","title":"Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Oseltamivir; Neuraminidase; Neuraminidase inhibitor; Virology; Influenza A virus; Recombinant DNA; Microbiology; Mutant; Biology; Influenza A virus subtype H5N1; Zanamivir; Virus; Medicine; Gene; Genetics; Coronavirus disease 2019 (COVID-19); Internal medicine; Infectious disease (medical specialty)","score_opus":0.1371009898528008,"score_gpt":0.4384835129207547,"score_spread":0.3013825230679539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086933325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546885,0.0025621487,0.00021850753,0.000025646237,0.000035369907,0.000013549656,0.00013262015,0.00001325317,0.0015300207],"genre_scores_gemma":[0.99801576,0.00067518716,0.00023589248,0.000023576818,0.00000910946,0.0000035900214,0.0003544899,0.0000028785296,0.00067950663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999025,0.000021476983,0.000008398621,0.000011302937,0.000025174473,0.00003126543],"domain_scores_gemma":[0.99994123,0.000016984306,0.000009745531,0.0000036686156,0.000008188321,0.000020163496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017946225,0.000332003,0.00028768147,0.00018288169,0.00012713768,0.00023796223,0.00026869564,0.00020739507,0.0013449801],"category_scores_gemma":[0.00019442789,0.00013252585,0.00022909525,0.00012282125,0.0001311548,0.0001366703,0.00010524044,0.00034113272,0.00033169106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004834227,0.0004960495,0.0017621195,0.00013980977,0.00009617575,0.00011708043,0.000031452386,0.00091290224,0.97639465,0.00026989623,0.00031642485,0.014629173],"study_design_scores_gemma":[0.0006416833,0.012704894,0.0101503,0.000029721019,0.00017460086,0.000545984,0.000037453658,0.0058064293,0.9674394,0.0000755063,0.0023758921,0.000018141864],"about_ca_topic_score_codex":0.0024702144,"about_ca_topic_score_gemma":0.0020566443,"teacher_disagreement_score":0.0024702144,"about_ca_system_score_codex":0.00021689327,"about_ca_system_score_gemma":0.0003048556,"threshold_uncertainty_score":0.004911661},"labels":[],"label_agreement":null},{"id":"W2089734387","doi":"10.1016/j.antiviral.2004.12.009","title":"Development of a cotton rat–human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Université Laval","keywords":"Virus; Virology; Biology; Human metapneumovirus; Titer; Inoculation; Metapneumovirus; Respiratory tract; Respiratory system; Immunology; Respiratory tract infections; Anatomy","score_opus":0.38593757445326443,"score_gpt":0.5472659183829395,"score_spread":0.16132834392967504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089734387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97133464,0.0019025985,0.019292545,0.00056426437,0.00046836495,0.000644763,0.0009811809,0.00027332775,0.004538398],"genre_scores_gemma":[0.956965,0.0017392782,0.031330172,0.00014182436,0.000106953514,0.00065599085,0.0014323336,0.000056290228,0.007572158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999635,0.000095518175,0.00002519848,0.00007808362,0.000076909935,0.000089367895],"domain_scores_gemma":[0.999642,0.0000921088,0.00005687661,0.0000695809,0.000038382415,0.00010108968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007807472,0.00108578,0.00041018697,0.0009425401,0.0006046915,0.00045523822,0.0007299407,0.0006100653,0.002279606],"category_scores_gemma":[0.0003185682,0.000331946,0.00064290204,0.00020857542,0.00049760606,0.0007202313,0.000440947,0.0018823972,0.0005136543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006847621,0.00048227806,0.00054518605,0.00005775603,0.000024232153,0.00016725447,0.000048497986,0.00033447356,0.9927408,0.0011913739,0.00021275006,0.0035107327],"study_design_scores_gemma":[0.00021628868,0.0059865285,0.003413413,0.000028723154,0.00009237579,0.00090383575,0.000092833354,0.0049173725,0.97655994,0.00043025461,0.00733468,0.000023716306],"about_ca_topic_score_codex":0.0044985204,"about_ca_topic_score_gemma":0.005996415,"teacher_disagreement_score":0.0044985204,"about_ca_system_score_codex":0.0007589477,"about_ca_system_score_gemma":0.0007974314,"threshold_uncertainty_score":0.008944631},"labels":[],"label_agreement":null},{"id":"W2090894089","doi":"10.1016/j.antiviral.2015.03.016","title":"The Herpes Simplex Virus-1 genome contains multiple clusters of repeated G-quadruplex: Implications for the antiviral activity of a G-quadruplex ligand","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"European Research Council; Bill and Melinda Gates Foundation","keywords":"Biology; Genome; G-quadruplex; Herpes simplex virus; Nucleic acid; DNA; Viral replication; Virology; Virus; Guanine; Genetics; Gene; Nucleotide","score_opus":0.1761714675678894,"score_gpt":0.43790408665086966,"score_spread":0.2617326190829803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090894089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803381,0.0038293467,0.01156602,0.0008137245,0.00013494375,0.000071144,0.00023897404,0.0002211169,0.0027864815],"genre_scores_gemma":[0.993189,0.00054732704,0.0047335983,0.0003109245,0.000046301528,0.000023305016,0.00018253535,0.000017332351,0.00094977475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984384,0.000039070812,0.000010113974,0.00004856555,0.00003314923,0.000025232699],"domain_scores_gemma":[0.99974006,0.00006619993,0.00006670973,0.000028192128,0.00003215162,0.00006658179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002622736,0.00023376953,0.00035504778,0.00027453736,0.00040393393,0.0006578734,0.00034815905,0.00058094796,0.0023816763],"category_scores_gemma":[0.00040683054,0.00020020407,0.00024363182,0.00013089567,0.00035063777,0.0004754306,0.0003054721,0.0006583294,0.00060498837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039268204,0.000064018415,0.00079561054,0.00009848446,0.000026753945,0.00015680605,0.00005284979,0.00047408167,0.98752624,0.0020127823,0.00027238866,0.008127286],"study_design_scores_gemma":[0.00017041233,0.0040925024,0.013318347,0.000056352408,0.000103369566,0.0022915208,0.00025422184,0.008326845,0.95165884,0.006840807,0.012814618,0.00007213366],"about_ca_topic_score_codex":0.00026578238,"about_ca_topic_score_gemma":0.00030775773,"teacher_disagreement_score":0.0023816763,"about_ca_system_score_codex":0.00037226046,"about_ca_system_score_gemma":0.0002981366,"threshold_uncertainty_score":0.007967532},"labels":[],"label_agreement":null},{"id":"W2091134244","doi":"10.1016/j.antiviral.2010.10.001","title":"Nigericin is a potent inhibitor of the early stage of vaccinia virus replication","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Public Health Agency; Gilead Sciences","keywords":"Vaccinia; Nigericin; Virology; Orthopoxvirus; Biology; Virus; Viral replication; Poxviridae; Gene; Genetics; Recombinant DNA","score_opus":0.04046852519623202,"score_gpt":0.35574083595253747,"score_spread":0.31527231075630546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091134244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97185093,0.013121681,0.0064842906,0.00047968104,0.00023898463,0.00015316007,0.0006993966,0.0003136616,0.0066580796],"genre_scores_gemma":[0.99275416,0.0025504178,0.0021886535,0.0000859534,0.0000357859,0.00002464448,0.0003961157,0.000014723428,0.001949457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999076,0.00002273659,0.000012108962,0.000012035073,0.000016808199,0.00002868435],"domain_scores_gemma":[0.99982315,0.0000753474,0.00002062602,0.000018156246,0.000012423664,0.000050351075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018768912,0.0003274332,0.0003113324,0.00020218204,0.00018611074,0.00032348675,0.00020039582,0.00030687056,0.0010549698],"category_scores_gemma":[0.00023161442,0.0001737955,0.00017509492,0.000091519825,0.00020046099,0.00021157165,0.00018196051,0.00081952865,0.00025488756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050807133,0.00004515298,0.0001342437,0.00004759718,0.000005340271,0.00006844731,0.0000067945325,0.00008231116,0.9968016,0.00010614428,0.00007804816,0.0021161586],"study_design_scores_gemma":[0.000084087966,0.00062543666,0.0024026365,0.000008707787,0.00000981215,0.00029083467,0.000010901697,0.0004495092,0.99385625,0.00006887675,0.0021870807,0.000005841851],"about_ca_topic_score_codex":0.0005550436,"about_ca_topic_score_gemma":0.0007703831,"teacher_disagreement_score":0.0010549698,"about_ca_system_score_codex":0.0002782561,"about_ca_system_score_gemma":0.0002552823,"threshold_uncertainty_score":0.0035292506},"labels":[],"label_agreement":null},{"id":"W2092528857","doi":"10.1016/j.antiviral.2013.03.014","title":"Influenza virus resistance to neuraminidase inhibitors","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"","keywords":"Zanamivir; Neuraminidase; Neuraminidase inhibitor; Oseltamivir; Medicine; Antiviral drug; Drug resistance; Pandemic; Virus; Virology; Drug; Intensive care medicine; Pharmacology; Biology; Coronavirus disease 2019 (COVID-19); Microbiology; Infectious disease (medical specialty); Disease; Internal medicine","score_opus":0.41699606212396134,"score_gpt":0.5538126083726812,"score_spread":0.13681654624871986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092528857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009034811,0.9992656,0.00003220401,0.00011510154,0.00007719736,0.000006774092,0.00001918507,0.0000025447923,0.00039102492],"genre_scores_gemma":[0.00063435,0.99888974,0.000080727004,0.00015431773,0.000058956124,0.0000073601427,0.00002017792,5.452586e-7,0.00015377198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995932,0.00009430314,0.00011640132,0.000048818776,0.00011181584,0.00003548168],"domain_scores_gemma":[0.9990422,0.00057210424,0.00020828676,0.000019193078,0.00012402511,0.000034132187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011890975,0.0009797072,0.0023928632,0.0026478926,0.00017091971,0.00091844465,0.000770353,0.0010362846,0.0040330985],"category_scores_gemma":[0.0023522368,0.00035860736,0.0010709168,0.0024627668,0.0004154898,0.0009319835,0.0006802603,0.001147378,0.00077869237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032669632,0.000064842905,0.00025838678,0.10523114,0.0008102222,0.00026191247,0.00006040831,0.0002432849,0.0018154227,0.0010447246,0.01975589,0.8701271],"study_design_scores_gemma":[0.00030893998,0.00044359875,0.0022406445,0.04162679,0.004360915,0.0017842838,0.00012429786,0.0001179327,0.001286697,0.0010908688,0.94657207,0.000042830365],"about_ca_topic_score_codex":0.0015806658,"about_ca_topic_score_gemma":0.0033998145,"teacher_disagreement_score":0.0040330985,"about_ca_system_score_codex":0.0008103132,"about_ca_system_score_gemma":0.0015769777,"threshold_uncertainty_score":0.013492048},"labels":[],"label_agreement":null},{"id":"W2093922965","doi":"10.1016/j.antiviral.2009.08.009","title":"Human H1 promoter expressed short hairpin RNAs (shRNAs) suppress avian influenza virus replication in chicken CH-SAH and canine MDCK cells","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Krell Institute; Ontario Ministry of Agriculture, Food and Rural Affairs; Poultry Industry Council; Agriculture and Agri-Food Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Poultry Research Council","keywords":"Virology; Biology; Viral replication; Replication (statistics); Small hairpin RNA; Influenza A virus; Avian influenza virus; Virus; Cell biology; Gene; Influenza A virus subtype H5N1; RNA; Genetics","score_opus":0.06178441009399893,"score_gpt":0.3820911159581269,"score_spread":0.32030670586412796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093922965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996747,0.0005814491,0.0010554425,0.000074497984,0.00004323059,0.00003241767,0.00041087763,0.00004042116,0.0010145595],"genre_scores_gemma":[0.9938373,0.0003006273,0.0019506516,0.000042067066,0.0000135536475,0.000040786836,0.0008488029,0.000018701734,0.0029475894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997483,0.000050250164,0.00003362635,0.00004892759,0.00005023086,0.00006875422],"domain_scores_gemma":[0.99970716,0.00013208194,0.000039969498,0.00005119676,0.00002790539,0.000041734005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000324047,0.00026827736,0.0002783665,0.00027716628,0.0002556145,0.0003590877,0.00021468417,0.00025900188,0.001196497],"category_scores_gemma":[0.00019162489,0.00021808523,0.00026573325,0.00014768926,0.00036470706,0.00021256485,0.0001823054,0.00067618943,0.0003619634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017396014,0.000023937286,0.00019874016,0.000019104518,0.0000037786256,0.000018058821,0.000029076316,0.000055500343,0.99884737,0.00012243104,0.00006417274,0.0004438076],"study_design_scores_gemma":[0.000022223614,0.00032043704,0.0028192024,0.0000034761226,0.000010848985,0.00007629776,0.000063935586,0.0012872325,0.9941127,0.000023042881,0.0012577268,0.0000028208226],"about_ca_topic_score_codex":0.00238124,"about_ca_topic_score_gemma":0.004362179,"teacher_disagreement_score":0.00238124,"about_ca_system_score_codex":0.0004931013,"about_ca_system_score_gemma":0.00025769518,"threshold_uncertainty_score":0.004734814},"labels":[],"label_agreement":null},{"id":"W2094644660","doi":"10.1016/j.antiviral.2014.12.009","title":"Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Virology; Epitope; Virus; Neutralizing antibody; Paramyxoviridae; Mononegavirales; Antibody; Hemagglutinin (influenza); Influenza A virus; Biology; Immunology; Viral disease","score_opus":0.125006831271783,"score_gpt":0.4234490907906369,"score_spread":0.29844225951885395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094644660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938399,0.0007372272,0.0031456226,0.00008607399,0.00008949348,0.00003857346,0.00037229044,0.00008756079,0.0016032687],"genre_scores_gemma":[0.99542505,0.00033823325,0.0015283157,0.000055972043,0.000021540036,0.00001427997,0.00090412295,0.000020775926,0.0016916211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997291,0.00005325667,0.000023491568,0.000047049474,0.00006845887,0.00007868333],"domain_scores_gemma":[0.99971646,0.00010876227,0.000044208617,0.000046268993,0.0000293816,0.000054866723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042045876,0.0006155575,0.00033371878,0.00030291706,0.00016251374,0.00030554782,0.0003271767,0.0005423695,0.0011081853],"category_scores_gemma":[0.00024403563,0.00020480917,0.00043063506,0.00016914733,0.00035838896,0.00033195614,0.0002489328,0.0010826617,0.000528629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014842935,0.00003848384,0.00013620265,0.000015870586,0.000007683259,0.00002166296,0.000010161962,0.000039113063,0.99901783,0.00009667346,0.00002659598,0.00044131198],"study_design_scores_gemma":[0.00004443872,0.0009525428,0.0037896438,0.00000693134,0.00003314041,0.00044626393,0.000027496304,0.0013327999,0.9918908,0.00008263651,0.0013872178,0.00000617616],"about_ca_topic_score_codex":0.0008735941,"about_ca_topic_score_gemma":0.0006694883,"teacher_disagreement_score":0.0011081853,"about_ca_system_score_codex":0.00034238075,"about_ca_system_score_gemma":0.00030800753,"threshold_uncertainty_score":0.0037072897},"labels":[],"label_agreement":null},{"id":"W2095227056","doi":"10.1016/j.antiviral.2011.09.006","title":"Camelpox: Target for eradication?","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Insect and Pesticide Research","field":"Agricultural and Biological Sciences","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency","funders":"National Institutes of Health","keywords":"Virology; Medicine","score_opus":0.3008840712665263,"score_gpt":0.3864906124540429,"score_spread":0.08560654118751665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095227056","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17256613,0.40379092,0.022263156,0.28470096,0.008556589,0.000368263,0.0030727491,0.0009362627,0.103744864],"genre_scores_gemma":[0.67679024,0.16953148,0.012218326,0.056050945,0.0063774455,0.00031345832,0.0030381465,0.00015058107,0.07552952],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9996315,0.00007033781,0.000024680725,0.00006903013,0.00007580205,0.00012867448],"domain_scores_gemma":[0.99960274,0.00007761028,0.00009074011,0.000034964083,0.00008214911,0.00011189103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002051291,0.00056507235,0.00073180004,0.00038142913,0.0003411228,0.001807388,0.0006899645,0.0020921663,0.0131329475],"category_scores_gemma":[0.0009968451,0.00015877438,0.00048011413,0.00031172,0.00093391695,0.0024690093,0.00062399794,0.0019683037,0.0023989584],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004241746,0.00058190414,0.012649825,0.0023094488,0.00037096033,0.0016713821,0.0003772994,0.00073660666,0.2909829,0.056313716,0.13537632,0.49438798],"study_design_scores_gemma":[0.000572621,0.0038883314,0.014121759,0.0009415902,0.00038877988,0.0033456401,0.0012548305,0.0013526693,0.067400366,0.025721118,0.88094294,0.000069357724],"about_ca_topic_score_codex":0.0006157215,"about_ca_topic_score_gemma":0.0007862508,"teacher_disagreement_score":0.0131329475,"about_ca_system_score_codex":0.0011563435,"about_ca_system_score_gemma":0.0010327401,"threshold_uncertainty_score":0.043934107},"labels":[],"label_agreement":null},{"id":"W2095491985","doi":"10.1016/j.antiviral.2012.08.010","title":"The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides","year":2012,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Polymerase; Biology; DNA polymerase; Nucleic acid; Reverse transcriptase; DNA; Virology; RNA; Primer (cosmetics); Virus; Viral replication; Genetics; Chemistry; Gene","score_opus":0.2695881361853387,"score_gpt":0.486886444217496,"score_spread":0.21729830803215727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095491985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009782988,0.9976804,0.00013211457,0.0000538415,0.00004950995,0.000004013744,0.000020919773,0.000005210682,0.0010755472],"genre_scores_gemma":[0.004093481,0.9946403,0.00023936982,0.00006192267,0.00006318412,0.0000062211857,0.000035966525,0.0000010303397,0.00085863424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999361,0.0000080324235,0.000008789258,0.000013407899,0.000023287184,0.000010372803],"domain_scores_gemma":[0.99994206,0.000022615664,0.000017117824,0.0000018857254,0.000010843025,0.000005437717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019355689,0.000630075,0.0007756341,0.00091273285,0.00013658106,0.0004819689,0.0005765109,0.00045967908,0.0018607926],"category_scores_gemma":[0.00017368403,0.00020879967,0.0002711657,0.0008131914,0.0002452937,0.00058420043,0.0002837156,0.0006809277,0.0009189695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022610663,0.00008423499,0.00017322364,0.014622913,0.00006111237,0.00028923285,0.00006139235,0.000579351,0.033213805,0.0023928916,0.005821018,0.94247466],"study_design_scores_gemma":[0.000057855978,0.0004861401,0.0019353154,0.0020634509,0.00021703992,0.0027762172,0.00008330276,0.00021515321,0.023403887,0.0016733593,0.96704817,0.000040142604],"about_ca_topic_score_codex":0.0006810523,"about_ca_topic_score_gemma":0.0010998186,"teacher_disagreement_score":0.0018607926,"about_ca_system_score_codex":0.00030782993,"about_ca_system_score_gemma":0.00035140594,"threshold_uncertainty_score":0.00622499},"labels":[],"label_agreement":null},{"id":"W2107333674","doi":"10.1016/s0166-3542(00)00114-5","title":"A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus","year":2000,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Heritage Medical Research Clinic","funders":"","keywords":"cccDNA; Circular DNA; Virology; Virus; Biology; DNA; Hepatitis B virus; Genome; DNA virus; Polymerase chain reaction; Viral replication; Duck hepatitis B virus; Hepadnaviridae; Gene; Genetics","score_opus":0.11831721330333456,"score_gpt":0.35728792592048025,"score_spread":0.2389707126171457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107333674","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26180735,0.0037906328,0.70905566,0.00089480693,0.0018220665,0.0037942766,0.0022332305,0.0037397544,0.012862157],"genre_scores_gemma":[0.26899868,0.0019102824,0.68619204,0.0017500572,0.0005567043,0.007334456,0.007580657,0.00050169823,0.025175367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9922375,0.002767979,0.00035042193,0.002147219,0.0017404247,0.00075637153],"domain_scores_gemma":[0.9924159,0.0044450783,0.0003566261,0.0006835428,0.0015321712,0.0005666818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004145517,0.0033102464,0.001991991,0.0024800838,0.0012019388,0.0011465689,0.0027109305,0.002465098,0.006039891],"category_scores_gemma":[0.004649921,0.0018751044,0.0016013187,0.0012505541,0.0023261153,0.0009400267,0.0011144477,0.0039473674,0.0034173783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006596648,0.0005246912,0.0011235914,0.0003057967,0.00005830747,0.00006998685,0.00021878934,0.00031975086,0.9864385,0.0012253375,0.00067918474,0.00837633],"study_design_scores_gemma":[0.00042185176,0.0051816404,0.0051505673,0.000138554,0.00020420265,0.00079339946,0.00026605904,0.01755157,0.9575416,0.0011720922,0.011444145,0.0001342508],"about_ca_topic_score_codex":0.0019897977,"about_ca_topic_score_gemma":0.0038262391,"teacher_disagreement_score":0.006039891,"about_ca_system_score_codex":0.0017700924,"about_ca_system_score_gemma":0.0021258257,"threshold_uncertainty_score":0.02192384},"labels":[],"label_agreement":null},{"id":"W2108231926","doi":"10.1016/j.antiviral.2011.05.016","title":"Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions","year":2011,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; Thunder Bay Regional Research Institute","funders":"Cancer Prevention Research Trust","keywords":"Lopinavir; HeLa; Foreskin; Toxicity; Cancer research; Chemistry; Human papillomavirus; Cell culture; Virology; Medicine; Pharmacology; Cell; Biology; Virus; Internal medicine; Biochemistry; Viral load","score_opus":0.30516797746407687,"score_gpt":0.4535937317886897,"score_spread":0.14842575432461286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108231926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96259874,0.012916992,0.004299042,0.0005872729,0.0002170315,0.00015647689,0.00069619244,0.000472801,0.018055577],"genre_scores_gemma":[0.98908895,0.0019549408,0.0013045088,0.00033110724,0.000041616997,0.000036094152,0.000472151,0.00002716378,0.006743404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998894,0.00003571851,0.000005364016,0.000025188408,0.000014790932,0.000029511151],"domain_scores_gemma":[0.99991524,0.000036745478,0.000011055449,0.0000093596345,0.000008479968,0.000019146386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016840898,0.00029803487,0.0003466992,0.00021322965,0.00018438592,0.00034597117,0.00018878323,0.00034796394,0.007871811],"category_scores_gemma":[0.00023012793,0.00011730898,0.0002194046,0.00010850531,0.00019261315,0.00022176649,0.0001489184,0.00051174324,0.00081722037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001483649,0.00019219007,0.0006200857,0.00020373614,0.000023657809,0.00018766153,0.000024188163,0.0001717585,0.95344365,0.00022018292,0.00067893916,0.042750377],"study_design_scores_gemma":[0.00030094458,0.006710836,0.011365549,0.00003095888,0.00007583904,0.002103823,0.00005894083,0.0006608212,0.96222186,0.00012446208,0.016321797,0.000024070849],"about_ca_topic_score_codex":0.00044311097,"about_ca_topic_score_gemma":0.0012791783,"teacher_disagreement_score":0.007871811,"about_ca_system_score_codex":0.00012279383,"about_ca_system_score_gemma":0.00014638942,"threshold_uncertainty_score":0.026333809},"labels":[],"label_agreement":null},{"id":"W2114506463","doi":"10.1016/j.antiviral.2009.04.009","title":"Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herbal Medicine Research Studies","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Virus; Common cold; Chemokine; Proinflammatory cytokine; Virology; Echinacea (animal); Interleukin 8; Respiratory system; Secretion; Herb; Biology; Immunology; Medicine; Cytokine; Microbiology; Inflammation; Traditional medicine","score_opus":0.07492421491050086,"score_gpt":0.40564794554532757,"score_spread":0.33072373063482674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114506463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633044,0.0014918147,0.0010679791,0.00007684358,0.00003988859,0.000053640655,0.0001767553,0.000027122855,0.0007355024],"genre_scores_gemma":[0.99539447,0.0012101119,0.0013015793,0.00005101587,0.000026730137,0.000042805088,0.00047148933,0.000008673827,0.0014932039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998828,0.00002447368,0.000018375622,0.000014902975,0.000020460719,0.000038949114],"domain_scores_gemma":[0.99985814,0.000041161467,0.000028610151,0.00002531868,0.000018479204,0.00002821843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002559969,0.00050186843,0.0004053498,0.0003188836,0.00020180861,0.00019666116,0.00018844008,0.00025032109,0.0020189928],"category_scores_gemma":[0.00023329596,0.00014940981,0.0004113931,0.0002243569,0.000343644,0.0003446435,0.0001992348,0.0006331248,0.00021477282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001381113,0.0003008259,0.00023379264,0.000088033434,0.000016417702,0.00008213267,0.000037969996,0.00006276448,0.99410325,0.00008250502,0.000034234366,0.0035769234],"study_design_scores_gemma":[0.00019733675,0.0032865158,0.0032580616,0.000010305978,0.00003764058,0.00012686783,0.000044181146,0.00011282546,0.9921468,0.000044823006,0.00073030096,0.0000044866306],"about_ca_topic_score_codex":0.0003860242,"about_ca_topic_score_gemma":0.0007702179,"teacher_disagreement_score":0.0020189928,"about_ca_system_score_codex":0.000103170765,"about_ca_system_score_gemma":0.0003457156,"threshold_uncertainty_score":0.00675416},"labels":[],"label_agreement":null},{"id":"W2119169700","doi":"10.1016/j.antiviral.2010.08.015","title":"Cholera toxin inhibits HIV-1 replication in human colorectal epithelial HT-29 cells through adenylate cyclase activation","year":2010,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Vibrio bacteria research studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Université Laval","keywords":"Cholera toxin; Vibrio cholerae; Biology; Cholera; Microbiology; Virology; Enterotoxin; Receptor; Viral replication; Toxin; Clostridium difficile toxin A; Virus; Clostridium difficile; Bacteria","score_opus":0.03564670251154885,"score_gpt":0.3734541258528648,"score_spread":0.33780742334131597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119169700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925052,0.0035706523,0.0004722782,0.00031998512,0.00013902748,0.00004004755,0.00071803364,0.00005890388,0.0021759162],"genre_scores_gemma":[0.9926036,0.0023449233,0.0005249613,0.00009457047,0.000033999782,0.000031123396,0.0010910457,0.000012339531,0.0032635212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975044,0.000056060908,0.000017402837,0.000022770293,0.000042536492,0.000110810426],"domain_scores_gemma":[0.9998111,0.00009526742,0.000013689371,0.00003068001,0.00001889189,0.000030284544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016868106,0.00033566024,0.00037214442,0.00024884028,0.00028396674,0.0005515758,0.00023489763,0.0004423332,0.0022496597],"category_scores_gemma":[0.00036095412,0.00022708927,0.0004628872,0.00027166877,0.000365269,0.00021027029,0.00021763134,0.0009944632,0.0004937339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077446114,0.000120606426,0.00024490405,0.00007543731,0.000012888225,0.0000984422,0.0000419035,0.0000869356,0.99715155,0.0001273724,0.00015266713,0.0011129301],"study_design_scores_gemma":[0.00032266707,0.0026146043,0.012757745,0.000024337947,0.00004169261,0.00031479207,0.00014475222,0.0011204268,0.97992665,0.00010306216,0.0026110222,0.000018241133],"about_ca_topic_score_codex":0.0073488317,"about_ca_topic_score_gemma":0.008573006,"teacher_disagreement_score":0.0073488317,"about_ca_system_score_codex":0.0006932502,"about_ca_system_score_gemma":0.0007002922,"threshold_uncertainty_score":0.014612138},"labels":[],"label_agreement":null},{"id":"W2121716762","doi":"10.1016/j.antiviral.2013.08.019","title":"Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medicinska Forskningsrådet; Vetenskapsrådet; Canadian Institutes of Health Research; IngaBritt och Arne Lundbergs Forskningsstiftelse; Canada Research Chairs; Västra Götalandsregionen","keywords":"Vero cell; Herpes simplex virus; Infectivity; Virology; Genital herpes; Virus; Biology; In vivo; Viral replication; In vitro; HSL and HSV; Viral shedding","score_opus":0.04922621266507007,"score_gpt":0.33401577345602834,"score_spread":0.2847895607909583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121716762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721307,0.0008612374,0.00063951395,0.000043625205,0.000037587553,0.000024654988,0.00009839402,0.000020770296,0.0010612573],"genre_scores_gemma":[0.99637336,0.00065491983,0.00090255804,0.000048777867,0.00002270812,0.000023058838,0.00023324008,0.000011318735,0.0017300679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998586,0.000028900022,0.000009617649,0.000021920114,0.00003409135,0.000046814268],"domain_scores_gemma":[0.9997018,0.000070050206,0.00007920306,0.000020336645,0.000021180635,0.00010734063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018027348,0.00031245136,0.00022981633,0.00028372696,0.000105888,0.00032076062,0.00026705474,0.00038725362,0.0012373062],"category_scores_gemma":[0.00024197684,0.00013791029,0.00013663825,0.00010749513,0.00028754683,0.00021865092,0.000110792535,0.00073311443,0.00021269644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010322586,0.000112480164,0.00010956306,0.000030299158,0.000005724653,0.000033052554,0.000012385467,0.00016462647,0.99695265,0.00009993455,0.000023168157,0.0014237992],"study_design_scores_gemma":[0.00016032966,0.0042233225,0.0015482916,0.000007452229,0.000018882814,0.00014492827,0.000027359261,0.0004727669,0.99193794,0.00005782882,0.0013953822,0.0000055301734],"about_ca_topic_score_codex":0.00046711828,"about_ca_topic_score_gemma":0.0004206606,"teacher_disagreement_score":0.0012373062,"about_ca_system_score_codex":0.00024017,"about_ca_system_score_gemma":0.00017741276,"threshold_uncertainty_score":0.004139185},"labels":[],"label_agreement":null},{"id":"W2149363016","doi":"10.1016/j.antiviral.2009.07.005","title":"Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"Michael Smith Health Research BC; Canadian Institutes of Health Research; Heart and Stroke Foundation of British Columbia and Yukon; National Institute of General Medical Sciences; Heart and Stroke Foundation of Canada","keywords":"Small interfering RNA; HeLa; Folate receptor; RNA; Biology; Ligand (biochemistry); Coxsackievirus; Gene silencing; Viral replication; Chemistry; In vitro; Molecular biology; Cell biology; Virology; Receptor; Virus; Biochemistry; Cancer cell; Gene; Enterovirus; Cancer; Genetics","score_opus":0.06344989725394086,"score_gpt":0.3639606113438208,"score_spread":0.30051071408987995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149363016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688806,0.0014391004,0.025557742,0.00019444946,0.0000891761,0.00013472524,0.00030038413,0.00031022393,0.0030934943],"genre_scores_gemma":[0.97757316,0.0008078225,0.015043686,0.00011039734,0.0000205723,0.00011440011,0.0004941083,0.00007122101,0.0057645217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997367,0.000051773528,0.000029725197,0.00006152928,0.00005705036,0.00006314472],"domain_scores_gemma":[0.9998486,0.00005235412,0.000036110338,0.000018823574,0.000018500275,0.00002561928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006117352,0.0004811383,0.0003275384,0.00029405946,0.00033579898,0.00058896624,0.00032952474,0.0005130718,0.0012473084],"category_scores_gemma":[0.00021723082,0.0003020381,0.000298452,0.00020268526,0.00032487878,0.00030564834,0.00025682762,0.0005906356,0.0004732747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063717576,0.0000151392605,0.00003468744,0.00002789879,0.0000037528769,0.000027926553,0.000019623541,0.00006954237,0.9984571,0.00037243485,0.000042791056,0.0008653578],"study_design_scores_gemma":[0.00001095095,0.0000665434,0.00014715786,0.0000017874565,0.000006630619,0.00003676183,0.0000055665273,0.0005550675,0.9983216,0.000027382195,0.0008181782,0.0000022986158],"about_ca_topic_score_codex":0.00048271558,"about_ca_topic_score_gemma":0.0011893893,"teacher_disagreement_score":0.0012473084,"about_ca_system_score_codex":0.0006722381,"about_ca_system_score_gemma":0.00039635692,"threshold_uncertainty_score":0.004877448},"labels":[],"label_agreement":null},{"id":"W2176296348","doi":"10.1016/j.antiviral.2015.11.001","title":"Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Deutsche Forschungsgemeinschaft; Wilhelm Sander-Stiftung","keywords":"Woodchuck hepatitis virus; Entecavir; CpG Oligodeoxynucleotide; Peripheral blood mononuclear cell; Immune system; Immunology; TLR9; Hepatitis B virus; CpG site; In vivo; Virology; Biology; Viral replication; Viral load; Virus; Medicine; Hepadnaviridae; In vitro; Lamivudine; Gene expression","score_opus":0.15894257964627648,"score_gpt":0.4176381085681958,"score_spread":0.25869552892191927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176296348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975038,0.00047428932,0.00079154177,0.00006252263,0.00007086702,0.000077024815,0.00010674824,0.00005024649,0.0008629201],"genre_scores_gemma":[0.99356985,0.00053014513,0.0016808707,0.00004844415,0.000035381338,0.000112161586,0.00023954861,0.000016913531,0.003766597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997874,0.00005335932,0.000015804997,0.000039678096,0.000034617817,0.00006917528],"domain_scores_gemma":[0.9998518,0.000026400512,0.0000241568,0.000018511206,0.000014068542,0.000065034845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002407475,0.00058125204,0.0005497875,0.00041234898,0.00026308076,0.00027486737,0.00026202187,0.00040831201,0.0013874249],"category_scores_gemma":[0.00013619779,0.00021423493,0.00025347614,0.00016812852,0.00035715633,0.00034212932,0.00015124487,0.0011194834,0.0002889484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027802123,0.0010248,0.00021478497,0.000044685676,0.000012675039,0.000052488605,0.000027904096,0.0001474655,0.9926299,0.00007822606,0.00008658969,0.0029002724],"study_design_scores_gemma":[0.00039952225,0.0217797,0.0026432674,0.000012342739,0.00005765739,0.00018144876,0.000056385823,0.0011733208,0.9724572,0.000058094534,0.0011665077,0.0000147401415],"about_ca_topic_score_codex":0.0012502075,"about_ca_topic_score_gemma":0.0032415988,"teacher_disagreement_score":0.0013874249,"about_ca_system_score_codex":0.00025192645,"about_ca_system_score_gemma":0.0004789561,"threshold_uncertainty_score":0.004641354},"labels":[],"label_agreement":null},{"id":"W2223974350","doi":"10.1016/j.antiviral.2015.11.012","title":"Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"National Institute of Allergy and Infectious Diseases; U.S. Public Health Service; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Ebola virus; Virology; Serology; Ebolavirus; Antibody; Filoviridae; VP40; Nucleoprotein; Biology; Viral matrix protein; Glycoprotein; Virus; Marburg virus; Immunology; Viral disease; Molecular biology; Paramyxoviridae","score_opus":0.16506675775502133,"score_gpt":0.519286898507329,"score_spread":0.3542201407523077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223974350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96317774,0.002826039,0.019748002,0.000099586396,0.00007450778,0.00042574946,0.0010873387,0.00020788153,0.012353082],"genre_scores_gemma":[0.9760399,0.0012893527,0.016490137,0.00023870493,0.000055157445,0.0006821908,0.001163209,0.000030771615,0.004010617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991628,0.00039652304,0.000040212122,0.00016732998,0.0001799795,0.000053140782],"domain_scores_gemma":[0.9991979,0.00028299761,0.00017701113,0.00010966224,0.00018364373,0.00004873864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013166335,0.0006936874,0.00026509908,0.0012368419,0.00041926742,0.0005155445,0.0004677621,0.0004827963,0.0011548982],"category_scores_gemma":[0.0014082246,0.00034153444,0.00019607511,0.00047869363,0.0007342541,0.00032259026,0.00022124166,0.0006772117,0.0003479689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002093639,0.0010363947,0.15054959,0.00042466618,0.00021104788,0.00032324172,0.0018418523,0.00051466585,0.79032713,0.00179251,0.0012183716,0.04966689],"study_design_scores_gemma":[0.0001995904,0.009746844,0.62839806,0.0002077166,0.00030101748,0.0046664784,0.001972035,0.0049754097,0.33052614,0.002716132,0.016214764,0.00007574781],"about_ca_topic_score_codex":0.0013362373,"about_ca_topic_score_gemma":0.0014559217,"teacher_disagreement_score":0.0013362373,"about_ca_system_score_codex":0.00031061168,"about_ca_system_score_gemma":0.00016913735,"threshold_uncertainty_score":0.006963134},"labels":[],"label_agreement":null},{"id":"W2224426314","doi":"10.1016/j.antiviral.2015.10.007","title":"Agonistic 4-1BB antibody fails to reduce disease burden during acute respiratory syncytial virus (RSV) infection","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"National Institutes of Health; Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Virus; Antibody; Immunology; CD8; Virology; Immune system; Agonistic behaviour; Medicine; Respiratory system; Biology; Internal medicine","score_opus":0.1589316779338063,"score_gpt":0.4936297213999463,"score_spread":0.33469804346614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224426314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824774,0.0007734433,0.0001666602,0.00010802753,0.00005060981,0.000011648285,0.0000460396,0.000023676474,0.00057229],"genre_scores_gemma":[0.99860877,0.00026540444,0.00015410478,0.00010392525,0.000021180247,0.000011394807,0.00013283257,0.000004354075,0.00069802895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972385,0.00009053932,0.00001766904,0.000024020703,0.000047981724,0.000095862146],"domain_scores_gemma":[0.9996494,0.000078818404,0.000046764675,0.00003984947,0.000040510145,0.00014473798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030197966,0.00026050615,0.00071722857,0.00009481764,0.00021017987,0.00032059156,0.00030821728,0.00041859533,0.00086242036],"category_scores_gemma":[0.0005337582,0.000121218145,0.00023706906,0.00005376796,0.0002020283,0.00025582465,0.00015065458,0.00089104095,0.00029319865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00986031,0.0023085496,0.010474884,0.00014365632,0.00014297268,0.00026918048,0.00009948639,0.00078119116,0.94168127,0.00014490003,0.001129331,0.032964155],"study_design_scores_gemma":[0.0015506024,0.073490456,0.37179092,0.00009114416,0.0005440985,0.002679153,0.0006194919,0.0076848534,0.5336453,0.00044177307,0.0074159885,0.00004625684],"about_ca_topic_score_codex":0.001004291,"about_ca_topic_score_gemma":0.0019962178,"teacher_disagreement_score":0.001004291,"about_ca_system_score_codex":0.00020975745,"about_ca_system_score_gemma":0.00039120513,"threshold_uncertainty_score":0.0028851032},"labels":[],"label_agreement":null},{"id":"W2238087249","doi":"10.1016/j.antiviral.2016.01.001","title":"Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"National Natural Science Foundation of China; Manitoba Health Research Council; Canadian Institutes of Health Research; Canadian Foundation for AIDS Research","keywords":"Ebola virus; Virology; Prunella vulgaris; Vero cell; Ebolavirus; Virus; Filoviridae; Biology; Medicine; Viral disease; Paramyxoviridae","score_opus":0.028903295284684893,"score_gpt":0.3544381305793759,"score_spread":0.325534835294691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2238087249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942899,0.002883628,0.00089377287,0.00006403205,0.000028100916,0.000032286265,0.0002264546,0.000013437345,0.001568416],"genre_scores_gemma":[0.994616,0.001345155,0.0011670943,0.00009476617,0.000032352676,0.00002340432,0.0008476294,0.000011340247,0.0018623658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999523,0.000008659441,0.0000040980203,0.000008054262,0.000009926327,0.000016962254],"domain_scores_gemma":[0.9999201,0.000025727672,0.000009733937,0.000006433838,0.0000145180275,0.000023337545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007459136,0.0003421122,0.0003077155,0.0002782906,0.00020140494,0.00018824956,0.00015083727,0.00020790412,0.0010048059],"category_scores_gemma":[0.00013484071,0.000094724564,0.00035164956,0.00021509333,0.00016889414,0.00019505309,0.000103089245,0.00041508523,0.00021125941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020066382,0.000042888187,0.00010994065,0.00004080136,0.00000577043,0.000054196258,0.000011375266,0.00002629447,0.99866223,0.000017963826,0.00000868702,0.0008192332],"study_design_scores_gemma":[0.00004896051,0.0012400922,0.016669808,0.000018040377,0.00008563787,0.0004513285,0.000068877154,0.00052509486,0.97829616,0.000073587784,0.002513204,0.000009265743],"about_ca_topic_score_codex":0.00072766823,"about_ca_topic_score_gemma":0.0005573175,"teacher_disagreement_score":0.0010048059,"about_ca_system_score_codex":0.00008754423,"about_ca_system_score_gemma":0.00012932328,"threshold_uncertainty_score":0.0033614635},"labels":[],"label_agreement":null},{"id":"W2260339506","doi":"10.1016/j.antiviral.2016.02.006","title":"Statins can exert dual, concentration dependent effects on HCV entry in vitro","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Pravastatin; Downregulation and upregulation; Atorvastatin; In vitro; In vivo; Pharmacology; Medicine; Statin; Ribavirin; HMG-CoA reductase; Viral entry; Reductase; Hepatitis C virus; Immunology; Cholesterol; Chemistry; Virus; Biology; Internal medicine; Enzyme; Biochemistry; Viral replication","score_opus":0.06674329022386635,"score_gpt":0.4132207350815794,"score_spread":0.34647744485771304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260339506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96912307,0.014882136,0.0025301003,0.0011418606,0.00042789488,0.00017798535,0.0026766686,0.0001928754,0.008847423],"genre_scores_gemma":[0.97608757,0.0077298824,0.0036786548,0.00036263347,0.00013414037,0.00014862619,0.0029199491,0.000056686913,0.008881845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999348,0.00019042543,0.000119930424,0.000049826845,0.00012104108,0.00017079542],"domain_scores_gemma":[0.99958795,0.00015675473,0.000044346707,0.00006596093,0.00007596873,0.00006898882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043278182,0.0003858281,0.0008559052,0.00039542626,0.0003752139,0.0008126136,0.00034867722,0.00047122734,0.0039919484],"category_scores_gemma":[0.0006871141,0.00028471494,0.0007361794,0.00042106622,0.0002971562,0.0004489654,0.00067555986,0.00082354347,0.0014033134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050606234,0.0004528483,0.0008211989,0.00054086285,0.0001057713,0.00014915178,0.00014939051,0.00015629064,0.98263997,0.00037925874,0.00143372,0.008110862],"study_design_scores_gemma":[0.0005566342,0.0028728975,0.008579138,0.000055582976,0.00015042037,0.00035674733,0.00015954864,0.00085233484,0.97689337,0.00018036213,0.009305828,0.0000370225],"about_ca_topic_score_codex":0.0029465843,"about_ca_topic_score_gemma":0.0075631225,"teacher_disagreement_score":0.0039919484,"about_ca_system_score_codex":0.00042259408,"about_ca_system_score_gemma":0.0009860712,"threshold_uncertainty_score":0.013354421},"labels":[],"label_agreement":null},{"id":"W2304592771","doi":"10.1016/j.antiviral.2016.03.012","title":"Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"Taipei Medical University; Ministry of Science and Technology, Taiwan","keywords":"Hepatitis C virus; Virology; Hepatocellular carcinoma; Ribavirin; Hepatitis C; Medicine; Entry inhibitor; Viral entry; Virus; Viral replication; Cancer research","score_opus":0.07069911098754443,"score_gpt":0.41576671697176837,"score_spread":0.3450676059842239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304592771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99131143,0.002317307,0.003657525,0.00012257473,0.000011824201,0.00005113726,0.0011848455,0.00007112473,0.0012722523],"genre_scores_gemma":[0.99038786,0.001430417,0.00390528,0.00006858782,0.00001034324,0.000025167283,0.0024717427,0.000025508765,0.0016750003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99997187,0.000005103633,0.000002029721,0.0000063399543,0.0000065783097,0.0000080840155],"domain_scores_gemma":[0.9999442,0.000014682904,0.000014140032,0.0000051658863,0.000012832552,0.000008881052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069207046,0.00035409085,0.00023317343,0.0005182521,0.000169127,0.00020334551,0.0001408675,0.00013467828,0.0008933248],"category_scores_gemma":[0.00009192856,0.00008550249,0.00032750622,0.00028449326,0.00015996057,0.00017703575,0.00012041276,0.0003357161,0.00021170967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002279864,0.00002591947,0.0004650359,0.00005162529,0.000010118046,0.00002630854,0.000010979683,0.00020216436,0.9955793,0.00003216551,0.0000229671,0.0033454625],"study_design_scores_gemma":[0.000032637487,0.0009791222,0.01949411,0.000011344089,0.0000867106,0.00023628969,0.00006444676,0.0021406065,0.9735247,0.000079103585,0.0033418075,0.000009283099],"about_ca_topic_score_codex":0.0008427439,"about_ca_topic_score_gemma":0.0012362819,"teacher_disagreement_score":0.0008933248,"about_ca_system_score_codex":0.00015738612,"about_ca_system_score_gemma":0.00015043652,"threshold_uncertainty_score":0.0029884577},"labels":[],"label_agreement":null},{"id":"W2350561728","doi":"10.1016/j.antiviral.2016.05.006","title":"The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research; GlaxoSmithKline","keywords":"Zanamivir; Oseltamivir; Neuraminidase; Virology; Titer; Biology; Virus; Microbiology; Resistance mutation; Medicine; RNA; Reverse transcriptase; Coronavirus disease 2019 (COVID-19)","score_opus":0.14260972703069322,"score_gpt":0.43415358660680564,"score_spread":0.2915438595761124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2350561728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967704,0.00015432847,0.0012338614,0.00011409557,0.00006360121,0.00002962253,0.00040850195,0.00003156741,0.0011940373],"genre_scores_gemma":[0.99760723,0.00010707866,0.001176015,0.00006685103,0.000007578982,0.000013630749,0.00030319934,0.00002386292,0.0006945675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972206,0.00007588369,0.000037920272,0.000046989193,0.000065749955,0.00005131371],"domain_scores_gemma":[0.999843,0.00004642629,0.000037180438,0.0000211107,0.000012930742,0.000039434635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016125155,0.0003480852,0.000324076,0.00020034805,0.00026078348,0.00026365102,0.0002929265,0.0006155789,0.0015178329],"category_scores_gemma":[0.00030296273,0.00017818515,0.00039703085,0.00014019963,0.00035813384,0.00021956743,0.00026090335,0.0008718735,0.00047289883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001603183,0.000078756144,0.000535421,0.000015318914,0.000017160331,0.00027522695,0.00001936734,0.000088717985,0.9974833,0.0001163604,0.00009022309,0.0011199875],"study_design_scores_gemma":[0.0000539419,0.0011006809,0.009757814,0.00001159373,0.000041784962,0.0029249915,0.0001175784,0.0021261459,0.9816459,0.000105362014,0.0020959827,0.000018158411],"about_ca_topic_score_codex":0.0018409963,"about_ca_topic_score_gemma":0.0019435124,"teacher_disagreement_score":0.0018409963,"about_ca_system_score_codex":0.00032474377,"about_ca_system_score_gemma":0.00020194161,"threshold_uncertainty_score":0.00507766},"labels":[],"label_agreement":null},{"id":"W2413117341","doi":"10.1016/j.antiviral.2016.10.008","title":"Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Immunology; Virus; Pneumonia; Innate immune system; Nasal administration; Chemokine; Immune system; Context (archaeology); Respiratory tract; Lower respiratory tract infection; Medicine; Viral pneumonia; Respiratory system; Disease; Biology; Respiratory tract infections; Internal medicine; Infectious disease (medical specialty); Coronavirus disease 2019 (COVID-19)","score_opus":0.08884647766459165,"score_gpt":0.3814603324629072,"score_spread":0.2926138547983156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413117341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496835,0.0016545238,0.0017302615,0.00018327196,0.00012277455,0.00006607998,0.00019039848,0.0000943342,0.0009900099],"genre_scores_gemma":[0.99432594,0.000937464,0.0026159347,0.0001157301,0.00009536509,0.00011666027,0.0003188528,0.000017705117,0.0014563119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978787,0.00003189053,0.000014205775,0.000042764037,0.000033002118,0.0000902959],"domain_scores_gemma":[0.9998834,0.000018404378,0.000027683787,0.000018914134,0.000008555761,0.000043040713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023166124,0.0006024009,0.00054728414,0.0003519167,0.0002478354,0.00032946287,0.000441389,0.00073149917,0.0011994833],"category_scores_gemma":[0.00013566727,0.00017738213,0.00045711893,0.00011814543,0.0004550009,0.00039931302,0.00023106452,0.0015363552,0.00034204486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013682537,0.0004127962,0.00018853229,0.000063744956,0.000013785827,0.00007338329,0.000020751757,0.00008619948,0.994158,0.00014385162,0.000086759144,0.0033839555],"study_design_scores_gemma":[0.00043400537,0.0046154517,0.0034701477,0.000016701644,0.00006599269,0.0002541789,0.00004759235,0.00090241275,0.98817295,0.00013270637,0.0018765659,0.000011340466],"about_ca_topic_score_codex":0.00019659742,"about_ca_topic_score_gemma":0.00039314208,"teacher_disagreement_score":0.0011994833,"about_ca_system_score_codex":0.00022109489,"about_ca_system_score_gemma":0.00030912983,"threshold_uncertainty_score":0.0040126443},"labels":[],"label_agreement":null},{"id":"W2462974575","doi":"10.1016/j.antiviral.2016.07.004","title":"Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Nucleic acid; Virology; Broad spectrum; Antiviral treatment; Antiviral therapy; Hepatitis; Medicine; Biology; Chemistry; Chronic hepatitis; Virus; Combinatorial chemistry; Biochemistry","score_opus":0.08977392654334417,"score_gpt":0.4036727077382293,"score_spread":0.3138987811948851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462974575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022865247,0.9982346,0.00008289319,0.00012769438,0.000119697914,0.000005142899,0.000011599378,0.0000058878672,0.0011837083],"genre_scores_gemma":[0.0010199843,0.997938,0.00017594878,0.00011367303,0.00009686745,0.0000056319554,0.000017578132,9.973013e-7,0.00063135463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998504,0.000021451482,0.000022409897,0.000022349112,0.00006746209,0.000015886706],"domain_scores_gemma":[0.9998752,0.000045598445,0.000025253425,0.0000039104525,0.00003502909,0.000014928621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036560534,0.0006423732,0.0009460643,0.002534986,0.00025284302,0.0007042895,0.00044747323,0.0007407325,0.0031972528],"category_scores_gemma":[0.00034042253,0.00021322905,0.00042221014,0.0020133147,0.000399082,0.001143216,0.00050063286,0.0013702074,0.0014753141],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063125655,0.00009898986,0.00014863328,0.020646038,0.000049500573,0.0001734267,0.00008831082,0.00027899083,0.0059632156,0.0041787885,0.017807772,0.9505032],"study_design_scores_gemma":[0.000016140484,0.00015021084,0.00094408495,0.0031122286,0.00006821754,0.0013125777,0.00007584554,0.000076486554,0.0013077393,0.0014144395,0.9915057,0.00001639865],"about_ca_topic_score_codex":0.0006895156,"about_ca_topic_score_gemma":0.0012819683,"teacher_disagreement_score":0.0031972528,"about_ca_system_score_codex":0.00043589622,"about_ca_system_score_gemma":0.00073914876,"threshold_uncertainty_score":0.010695875},"labels":[],"label_agreement":null},{"id":"W2487753465","doi":"10.1016/j.antiviral.2016.07.015","title":"MERS-CoV spike protein: Targets for vaccines and therapeutics","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Chinese Academy of Sciences; National Natural Science Foundation of China","keywords":"Middle East respiratory syndrome coronavirus; Spike Protein; Virology; Middle East respiratory syndrome; Outbreak; Coronavirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Biology; Medicine; Disease; Immunology; Infectious disease (medical specialty)","score_opus":0.2381780743804344,"score_gpt":0.5081083494068118,"score_spread":0.26993027502637745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487753465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000086407825,0.99879503,0.00007614534,0.0002491831,0.00016267593,0.000004000822,0.000027049458,0.000005759865,0.0005937155],"genre_scores_gemma":[0.0005355168,0.9985843,0.00013034852,0.00016833784,0.00012777456,0.000004130132,0.00003752262,8.1893563e-7,0.0004112963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997944,0.000031231473,0.000030659605,0.000033894266,0.000079726815,0.000030148974],"domain_scores_gemma":[0.99967,0.00014045321,0.00006307448,0.000008900312,0.00008354737,0.000034020908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000755959,0.0010400862,0.001872897,0.0022344093,0.00024009812,0.0013926638,0.0007223447,0.0013131909,0.0048395405],"category_scores_gemma":[0.00079651695,0.00029618913,0.0005667917,0.0020986353,0.0004847391,0.0016842481,0.00087543804,0.0017468976,0.0023584003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014626642,0.00007132006,0.00014861683,0.015322021,0.00010013647,0.00015104491,0.0000402484,0.00027560955,0.0024423522,0.0025893268,0.030613603,0.9480995],"study_design_scores_gemma":[0.000035333982,0.00013453251,0.00051416253,0.0035253156,0.00018316902,0.0005832663,0.00006540142,0.00008296303,0.0005416054,0.0016688285,0.9926461,0.000019362458],"about_ca_topic_score_codex":0.0008999166,"about_ca_topic_score_gemma":0.0019513625,"teacher_disagreement_score":0.0048395405,"about_ca_system_score_codex":0.0007214002,"about_ca_system_score_gemma":0.001682393,"threshold_uncertainty_score":0.016189873},"labels":[],"label_agreement":null},{"id":"W2528330764","doi":"10.1016/j.antiviral.2016.09.013","title":"A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Oak Ridge Institute for Science and Education; National Institutes of Health","keywords":"Enzootic; Tick; Crimean–Congo hemorrhagic fever; Livestock; Transmission (telecommunications); Outbreak; Viremia; Tick-borne disease; Virology; Biology; Disease; Hyalomma; Veterinary medicine; Virus; Ecology; Medicine; Ixodidae; Pathology","score_opus":0.1717682286979072,"score_gpt":0.47781609131887426,"score_spread":0.30604786262096706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528330764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119258155,0.99919707,0.000060519564,0.00009807092,0.00012929445,0.000008825095,0.000039651226,0.0000026262562,0.00034471863],"genre_scores_gemma":[0.0003863545,0.99912304,0.00015274929,0.00010645785,0.0000676297,0.0000065932422,0.000032192784,6.4775946e-7,0.0001244273],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997037,0.000060729177,0.000094050585,0.000045008284,0.00007343412,0.000023103721],"domain_scores_gemma":[0.9989274,0.0006723117,0.00017339105,0.000018484392,0.00016355781,0.00004487291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010080712,0.0009639335,0.0016648109,0.004460352,0.00028618265,0.001147542,0.000933164,0.0008158696,0.0035572029],"category_scores_gemma":[0.0016365695,0.0003715556,0.0007921619,0.0037464849,0.00043361683,0.0013242111,0.00068231625,0.001112468,0.0005851396],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019834198,0.00011695772,0.00040060218,0.14215662,0.00031190066,0.00033019832,0.00018487117,0.0002500689,0.0033097658,0.0024569868,0.024226189,0.8260575],"study_design_scores_gemma":[0.00003998751,0.00026295308,0.002798626,0.034642994,0.0009589266,0.0016270844,0.0002074961,0.000085035055,0.00089295104,0.00093153864,0.9575049,0.000047594334],"about_ca_topic_score_codex":0.0020704977,"about_ca_topic_score_gemma":0.0041382755,"teacher_disagreement_score":0.004460352,"about_ca_system_score_codex":0.0006348478,"about_ca_system_score_gemma":0.002076555,"threshold_uncertainty_score":0.011900008},"labels":[],"label_agreement":null},{"id":"W2553822584","doi":"10.1016/j.antiviral.2016.11.007","title":"The I427T neuraminidase (NA) substitution, located outside the NA active site of an influenza A(H1N1)pdm09 variant with reduced susceptibility to NA inhibitors, alters NA properties and impairs viral fitness","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Zanamivir; Neuraminidase; Oseltamivir; Titer; Virology; Recombinant DNA; Influenza A virus; Virus; Biology; Mutant; Viral replication; Enzyme; Neuraminidase inhibitor; Chemistry; Molecular biology; Gene; Biochemistry; Coronavirus disease 2019 (COVID-19); Medicine","score_opus":0.10680784441848729,"score_gpt":0.386721984593594,"score_spread":0.27991414017510674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553822584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930286,0.0003445639,0.0024885896,0.0003006879,0.00027676584,0.0000905926,0.0007261944,0.00006712748,0.002676851],"genre_scores_gemma":[0.9946854,0.00018170805,0.002517947,0.0002782524,0.0000504483,0.00004840405,0.0007235895,0.00006503285,0.0014492549],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950075,0.00015763432,0.00007321127,0.00008677213,0.0001131967,0.00006845556],"domain_scores_gemma":[0.9996711,0.000059848804,0.00008350691,0.000032761272,0.00004321153,0.00010949551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004025261,0.0010395428,0.0006667052,0.00032310918,0.0006050752,0.0004521932,0.00062020443,0.0011601648,0.0032969052],"category_scores_gemma":[0.0005530132,0.00026863802,0.0009374642,0.00041701095,0.00081197656,0.00028746843,0.00046288897,0.0009587114,0.0010723196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026492872,0.00041570034,0.0047220406,0.00011335432,0.00025859097,0.004049667,0.00017377309,0.0007217526,0.9745632,0.0013099379,0.00079694553,0.010225734],"study_design_scores_gemma":[0.0016995424,0.0075560687,0.043986734,0.00016014805,0.00074939354,0.022598537,0.0007440537,0.009267121,0.88943326,0.0010568753,0.02254117,0.0002070897],"about_ca_topic_score_codex":0.0032845656,"about_ca_topic_score_gemma":0.0031243167,"teacher_disagreement_score":0.0032969052,"about_ca_system_score_codex":0.00048626514,"about_ca_system_score_gemma":0.0005801559,"threshold_uncertainty_score":0.0110292435},"labels":[],"label_agreement":null},{"id":"W2555716205","doi":"10.1016/j.antiviral.2016.11.002","title":"Amending Koch's postulates for viral disease: When “growth in pure culture” leads to a loss of virulence","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"National Institutes of Health","keywords":"Biology; Virulence; Context (archaeology); Hantavirus; Virology; Disease; Bunyaviridae; Virus; Adaptation (eye); Genetics; Medicine; Neuroscience; Gene","score_opus":0.13791039506663785,"score_gpt":0.48508237251174513,"score_spread":0.3471719774451073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555716205","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030393354,0.9947525,0.0012300591,0.0016106268,0.00054408447,0.000006442071,0.000019199228,0.000010903311,0.0015222155],"genre_scores_gemma":[0.0036943548,0.9928692,0.0011449194,0.0008990164,0.0005187104,0.000013527938,0.000037630896,0.0000047773838,0.0008179371],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994747,0.00013432786,0.00007364871,0.000066022185,0.00020669262,0.000044671906],"domain_scores_gemma":[0.99916995,0.00052473065,0.00010866426,0.000040622683,0.00012621611,0.00002981512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001482827,0.00065776525,0.0015338813,0.0015504579,0.00023939452,0.001589166,0.0011124066,0.0017682414,0.0015092274],"category_scores_gemma":[0.001393085,0.00024391912,0.00057449343,0.0012413746,0.0019964266,0.0032805123,0.0011206906,0.0037782663,0.001082358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010746468,0.000069919544,0.0002857538,0.018898686,0.0001205867,0.00036504085,0.00023585944,0.00044980404,0.011500766,0.06613387,0.02537973,0.87645257],"study_design_scores_gemma":[0.000014782066,0.000083347164,0.00041326886,0.0026551879,0.00008424411,0.0015113453,0.00013752612,0.00012354089,0.0037816905,0.021498103,0.96966153,0.00003546405],"about_ca_topic_score_codex":0.000425299,"about_ca_topic_score_gemma":0.0005976412,"teacher_disagreement_score":0.0017682414,"about_ca_system_score_codex":0.00071381946,"about_ca_system_score_gemma":0.0011571738,"threshold_uncertainty_score":0.007842064},"labels":[],"label_agreement":null},{"id":"W2556090342","doi":"10.1016/j.antiviral.2016.11.017","title":"Synergistic drug combination effectively blocks Ebola virus infection","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"National Institute of Allergy and Infectious Diseases; National Center for GM Crops; National Institutes of Health","keywords":"Ebola virus; Drug; Posaconazole; Ebolavirus; Virology; Pharmacology; Toremifene; Mefloquine; Medicine; Antiviral drug; Biology; Virus; Immunology; Microbiology; Malaria; Internal medicine; Chloroquine; Amphotericin B","score_opus":0.05798860668639612,"score_gpt":0.40582580550168074,"score_spread":0.34783719881528463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556090342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98507845,0.007944919,0.001692034,0.00024874028,0.000089478555,0.00021642569,0.00043235382,0.00010425895,0.0041933474],"genre_scores_gemma":[0.9929172,0.003087275,0.0023296296,0.000093797215,0.00003273665,0.0000695551,0.00038207325,0.000013066311,0.0010746164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999711,0.00008083144,0.000032040312,0.000043130578,0.00007280302,0.00006013038],"domain_scores_gemma":[0.99987745,0.000032070384,0.000023199327,0.000013215503,0.000016863278,0.000037157686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021612326,0.00037341187,0.00088941073,0.00054836896,0.00018892334,0.0003422812,0.000299306,0.0002628669,0.0021228145],"category_scores_gemma":[0.0003461866,0.00015145642,0.00029371819,0.00033052402,0.00020796101,0.00025022303,0.0003164689,0.0005041408,0.00043923667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027683412,0.0014957805,0.0020270909,0.00042878254,0.00021196599,0.00026450458,0.00007847052,0.0011513374,0.91750973,0.00031440277,0.0013997403,0.072349936],"study_design_scores_gemma":[0.0009914524,0.027777879,0.018304443,0.00006438348,0.0006173105,0.0026583704,0.0001074406,0.0032543496,0.91772896,0.0003110092,0.028127758,0.000056678862],"about_ca_topic_score_codex":0.00029004828,"about_ca_topic_score_gemma":0.001143375,"teacher_disagreement_score":0.0021228145,"about_ca_system_score_codex":0.00023076532,"about_ca_system_score_gemma":0.00031881218,"threshold_uncertainty_score":0.007101536},"labels":[],"label_agreement":null},{"id":"W2557367716","doi":"10.1016/j.antiviral.2016.11.019","title":"Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"National Institutes of Health; Public Health Agency of Canada; Emergent BioSolutions","keywords":"In vivo; In vitro; Host (biology); Virology; Microbiology; Biology; Chemistry; Biochemistry; Biotechnology; Genetics","score_opus":0.04746248677001807,"score_gpt":0.4019827718104963,"score_spread":0.3545202850404782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557367716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952295,0.0011338291,0.0014954845,0.000037687347,0.000020012792,0.000030276222,0.00020240735,0.000049234917,0.001801557],"genre_scores_gemma":[0.9967068,0.0005391676,0.0012338592,0.0000123016225,0.000006846544,0.000022394022,0.00024231627,0.000008120646,0.0012281889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998692,0.000046001318,0.000008763812,0.000018037255,0.00002481829,0.000033079017],"domain_scores_gemma":[0.9998816,0.0000519555,0.000020767407,0.000017775608,0.0000134491975,0.0000143802945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029686565,0.0004108311,0.0002088323,0.00015359008,0.00015424051,0.00023383509,0.00027388768,0.00027616002,0.001713147],"category_scores_gemma":[0.00020317051,0.00009969912,0.00019853334,0.000117003096,0.00017996175,0.0001890821,0.00009383382,0.00040824097,0.00019900089],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038591714,0.0000681194,0.000112931666,0.000044353455,0.000009084847,0.000020570425,0.000019963205,0.00026229816,0.9973308,0.00011571488,0.00003095945,0.001599384],"study_design_scores_gemma":[0.000011388819,0.0007405403,0.00033802993,0.0000020677933,0.000011299274,0.000024401777,0.000009900431,0.0003270974,0.9981029,0.000011063567,0.00041967165,0.0000015993014],"about_ca_topic_score_codex":0.0006563231,"about_ca_topic_score_gemma":0.00065085065,"teacher_disagreement_score":0.001713147,"about_ca_system_score_codex":0.00016801266,"about_ca_system_score_gemma":0.0001734505,"threshold_uncertainty_score":0.005731106},"labels":[],"label_agreement":null},{"id":"W2586346865","doi":"10.1016/j.antiviral.2017.01.025","title":"Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05–2013/14, Toronto, Canada","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Public Health Ontario; William Osler Health System; Sunnybrook Health Science Centre; St. Michael's Hospital; Izaak Walton Killam Health Centre; Sinai Health System; North York General Hospital; Toronto Public Health; University of Toronto; Toronto East General Hospital; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pandemic; Guideline; Retrospective cohort study; Antiviral treatment; Odds ratio; Medical prescription; Observational study; Internal medicine; Disease; Young adult; Pediatrics; Coronavirus disease 2019 (COVID-19); Virus; Immunology; Infectious disease (medical specialty); Pathology; Pharmacology","score_opus":0.06871343138177273,"score_gpt":0.4055487070867197,"score_spread":0.336835275704947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586346865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638906,0.002710266,0.00013464941,0.0010573779,0.000087331406,0.00007135099,0.027985401,0.000030959913,0.004032031],"genre_scores_gemma":[0.9877558,0.00152419,0.00016369918,0.0002752364,0.00003466898,0.000034738852,0.007809972,0.000014370449,0.002387391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988122,0.000066939625,0.00013496127,0.00015841261,0.00034128613,0.00048627565],"domain_scores_gemma":[0.9963096,0.00013286766,0.00067187677,0.00007352997,0.0017108098,0.0011013363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059981877,0.00042734802,0.00061738683,0.0014719694,0.0018987708,0.0016048462,0.0018645924,0.0008055937,0.0032268385],"category_scores_gemma":[0.0021328807,0.0005836599,0.00092881796,0.004834654,0.00069017505,0.0007275465,0.0009650256,0.0014106997,0.0004557758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002832154,0.000041854506,0.99354666,0.000071614966,0.00010201007,0.00009727957,0.0005953526,0.00017318754,0.00019664025,0.00009109907,0.002604244,0.0021967213],"study_design_scores_gemma":[0.00000526697,0.000015085755,0.99867564,0.000023814075,0.000016264448,0.000025615254,0.00066775363,0.00007761347,0.000028679133,0.000003532736,0.00045413474,0.000006461842],"about_ca_topic_score_codex":0.9943334,"about_ca_topic_score_gemma":0.9963935,"teacher_disagreement_score":0.03913625,"about_ca_system_score_codex":0.03913625,"about_ca_system_score_gemma":0.040538568,"threshold_uncertainty_score":0.28395468},"labels":[],"label_agreement":null},{"id":"W2602370702","doi":"10.1016/j.antiviral.2017.03.016","title":"Comparison of three cell-based drug screening platforms for HSV-1 infection","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institutes of Health; Pittsburgh Center for Kidney Research, University of Pittsburgh; National Institute of Diabetes and Digestive and Kidney Diseases; Fogarty International Center; Scioto Foundation","keywords":"Vero cell; Herpes simplex virus; Virology; Antiviral drug; Neurotropic virus; Encephalitis; Drug; Neurotoxicity; Lytic cycle; Induced pluripotent stem cell; Progenitor cell; HSL and HSV; Biology; Virus; Neural stem cell; Cell culture; Pharmacology; Immunology; Medicine; Stem cell; Toxicity; Internal medicine","score_opus":0.28122368428302413,"score_gpt":0.5167682611950645,"score_spread":0.23554457691204034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602370702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756329,0.007871749,0.007702688,0.00052414794,0.00024729775,0.0004129106,0.002207583,0.0003171395,0.0050835167],"genre_scores_gemma":[0.9649909,0.009740207,0.015074977,0.00034934538,0.000052305964,0.00045463265,0.0034240568,0.000052494514,0.005861087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929297,0.00014663501,0.000055564833,0.000089704256,0.0003014781,0.000113683964],"domain_scores_gemma":[0.9994149,0.000270629,0.000057477115,0.000057805566,0.00013204623,0.0000672541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006314074,0.00076223724,0.0010424034,0.001149196,0.00045195874,0.0016689299,0.0006990963,0.0008904231,0.0027108404],"category_scores_gemma":[0.0010209127,0.00036034966,0.0008673647,0.00068104616,0.00032840416,0.0006477652,0.0006480279,0.0006859782,0.00093485526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003468521,0.0012781362,0.0020741557,0.0007118796,0.00023842203,0.00016093993,0.00011671873,0.0030719882,0.938427,0.00053370325,0.0011730548,0.048745584],"study_design_scores_gemma":[0.00018441536,0.006302778,0.0044399174,0.00003691509,0.00039412465,0.00023433387,0.00015029739,0.006517359,0.97583514,0.00015392619,0.0056853057,0.00006552445],"about_ca_topic_score_codex":0.0011935954,"about_ca_topic_score_gemma":0.002266341,"teacher_disagreement_score":0.0027108404,"about_ca_system_score_codex":0.00046274182,"about_ca_system_score_gemma":0.00053622987,"threshold_uncertainty_score":0.009068668},"labels":[],"label_agreement":null},{"id":"W2604663227","doi":"10.1016/j.antiviral.2017.04.004","title":"Herpes simplex virus type 1 abrogates the antiviral activity of Ch25h via its virion host shutoff protein","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Natural Science Foundation of China; National Science Foundation","keywords":"Ectopic expression; Herpes simplex virus; Gene knockdown; Viral replication; Biology; Endonuclease; Mutant; Virology; Virus; Molecular biology; Gene; Genetics","score_opus":0.08766925390711647,"score_gpt":0.39740966022177643,"score_spread":0.30974040631465993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604663227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704,0.00069969613,0.0005179828,0.000077695084,0.00004819691,0.000009991696,0.0001611316,0.000066228684,0.0013789559],"genre_scores_gemma":[0.9976332,0.00022458799,0.0002871842,0.000023107952,0.000011576702,0.000010860112,0.00023860595,0.000016260181,0.0015545951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998472,0.000021419402,0.000008213195,0.000018310155,0.00003269269,0.000072224124],"domain_scores_gemma":[0.99988675,0.000032264772,0.00002105733,0.000019055487,0.0000052553387,0.000035621535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014839054,0.00039740567,0.00021541165,0.00024148962,0.00021339886,0.000308656,0.00026737267,0.00024413853,0.0019625889],"category_scores_gemma":[0.00011951,0.00011778502,0.00023419812,0.00013564256,0.0004123228,0.00017877073,0.0001581698,0.00071314804,0.0003817045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041779157,0.000079456244,0.00012316662,0.000016414417,0.0000066191847,0.000051919284,0.000010221203,0.000106940555,0.9975509,0.00025863788,0.000093121445,0.0012847465],"study_design_scores_gemma":[0.00004270383,0.00037508353,0.0019265112,0.000003083779,0.000008121933,0.000074293064,0.000017097886,0.0005321298,0.9957302,0.00007490297,0.001211556,0.0000043136492],"about_ca_topic_score_codex":0.0009733527,"about_ca_topic_score_gemma":0.0011138258,"teacher_disagreement_score":0.0019625889,"about_ca_system_score_codex":0.00045594134,"about_ca_system_score_gemma":0.00030670504,"threshold_uncertainty_score":0.006565571},"labels":[],"label_agreement":null},{"id":"W2751541811","doi":"10.1016/j.antiviral.2017.09.005","title":"Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"Natural Sciences and Engineering Research Council of Canada; Defense Advanced Research Projects Agency","keywords":"Polyclonal antibodies; Zika virus; Microcephaly; Antibody; Virology; Biology; Atrophy; Immunology; Virus; Medicine; Pathology","score_opus":0.05516204557119253,"score_gpt":0.40785991560548907,"score_spread":0.35269787003429653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751541811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841935,0.003889621,0.0052584154,0.0003922839,0.0002692474,0.00013209936,0.00077449094,0.0004694052,0.0046209646],"genre_scores_gemma":[0.98528415,0.0027126723,0.0028824946,0.00023724756,0.00014870847,0.0001270046,0.0016621982,0.00009761471,0.0068478547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993593,0.00009716578,0.000049516137,0.00012211308,0.000091863025,0.000279974],"domain_scores_gemma":[0.99943405,0.00014543784,0.00014457271,0.000077854995,0.000067452325,0.00013069778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007075907,0.000851394,0.00046909568,0.000984383,0.0003075463,0.0006299948,0.0006426711,0.0008629313,0.0030674534],"category_scores_gemma":[0.00037648997,0.00057820306,0.0004835782,0.00031682933,0.0005197327,0.00047230822,0.00022223828,0.0023294087,0.0009969923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005052773,0.00019572578,0.00026775512,0.000078077246,0.000028712277,0.00006817276,0.00003837096,0.00008269029,0.9966102,0.00024462244,0.00023311627,0.0016471462],"study_design_scores_gemma":[0.00028708042,0.0015177887,0.0036239682,0.0000257171,0.00014765588,0.00037649952,0.00005922629,0.0008065602,0.98834896,0.000117501586,0.004679528,0.000009407152],"about_ca_topic_score_codex":0.0013192728,"about_ca_topic_score_gemma":0.0019020829,"teacher_disagreement_score":0.0030674534,"about_ca_system_score_codex":0.0006600551,"about_ca_system_score_gemma":0.0003435847,"threshold_uncertainty_score":0.010261714},"labels":[],"label_agreement":null},{"id":"W2756406013","doi":"10.1016/j.antiviral.2017.09.006","title":"Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Universiteit Gent; Belgian Federal Science Policy Office; Bundesministerium für Bildung und Forschung; Helmholtz-Alberta Initiative; Deutsches Zentrum für Infektionsforschung","keywords":"Bioavailability; Hepatitis C virus; Flavivirus; Virology; Pharmacology; Viral quasispecies; Virus; Medicine; Hepatitis C; Hepatocellular carcinoma; Entry inhibitor; Viral entry; Viral replication; Internal medicine","score_opus":0.08325274644832413,"score_gpt":0.4054551226464054,"score_spread":0.32220237619808123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756406013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996951,0.00064850156,0.0011953731,0.000053654003,0.00002482158,0.00002019792,0.00012835868,0.000059320282,0.0009187622],"genre_scores_gemma":[0.99717486,0.00039992263,0.00096857507,0.000023731596,0.00000632248,0.000011995087,0.00018631665,0.000017189283,0.0012112276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999959,0.000008613589,0.0000021552892,0.000007013545,0.000004938496,0.00001834015],"domain_scores_gemma":[0.99994695,0.00001276969,0.000010351857,0.000008909802,0.000004598733,0.000016337699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004853934,0.00033354323,0.0002459799,0.00014498108,0.00012359346,0.00017319419,0.0001669693,0.00015869552,0.0011118874],"category_scores_gemma":[0.00006287925,0.00010282662,0.00013920746,0.00012323183,0.00022169502,0.0002077143,0.00012689279,0.0004059432,0.00019784547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006553228,0.000055969802,0.00007892729,0.00002828211,0.000004879536,0.000026455464,0.000010642813,0.00003698637,0.99729604,0.00008907032,0.000031201005,0.001686248],"study_design_scores_gemma":[0.000045540783,0.0008989201,0.00110136,0.0000026848606,0.000015483643,0.000060846753,0.00001561546,0.00020464946,0.9965758,0.0000371664,0.0010386967,0.0000033414653],"about_ca_topic_score_codex":0.0014947932,"about_ca_topic_score_gemma":0.0025833468,"teacher_disagreement_score":0.0014947932,"about_ca_system_score_codex":0.00016230297,"about_ca_system_score_gemma":0.00030552802,"threshold_uncertainty_score":0.0037196875},"labels":[],"label_agreement":null},{"id":"W2758559651","doi":"10.1016/j.antiviral.2017.09.014","title":"Recombinant hemagglutinin proteins formulated in a novel PELC/CpG adjuvant for H7N9 subunit vaccine development","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Ministry of Science and Technology, Taiwan","keywords":"Adjuvant; Virology; Hemagglutinin (influenza); Protein subunit; CpG Oligodeoxynucleotide; Antibody; Virus; Biology; Recombinant DNA; Vaccination; Immunology; Microbiology; Gene; Gene expression","score_opus":0.3827855380291485,"score_gpt":0.5173536423773502,"score_spread":0.13456810434820166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758559651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97305083,0.0014844143,0.023286708,0.0001303149,0.00008020279,0.00012570445,0.00016240795,0.00006258901,0.0016169196],"genre_scores_gemma":[0.9760879,0.00091479876,0.019652374,0.000082359846,0.000014510366,0.00003976108,0.00030440712,0.000016938502,0.0028868844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992347,0.000013403127,0.0000061719415,0.000011558736,0.000028208595,0.000017075636],"domain_scores_gemma":[0.99995804,0.000005596199,0.000008786752,0.000003857286,0.000012684674,0.000010999803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023211891,0.0002533587,0.0001485855,0.00013711413,0.000102753795,0.00015906335,0.0001601709,0.00025398587,0.0006871491],"category_scores_gemma":[0.00012890334,0.000104197534,0.00016622095,0.00012876623,0.00013530282,0.0002201059,0.00019621575,0.00048484004,0.0003480784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052886277,0.000022272632,0.00005195678,0.000018435523,0.000002245313,0.000012224,0.000003991706,0.00010346042,0.9980609,0.000066502675,0.000017289378,0.0015877191],"study_design_scores_gemma":[0.00001672775,0.00026722543,0.00040283037,0.0000042050447,0.00001315548,0.00006594076,0.0000073188253,0.0013417214,0.99600464,0.00003234975,0.0018413287,0.000002502644],"about_ca_topic_score_codex":0.0005373742,"about_ca_topic_score_gemma":0.00091770507,"teacher_disagreement_score":0.0006871491,"about_ca_system_score_codex":0.0002233874,"about_ca_system_score_gemma":0.00030764335,"threshold_uncertainty_score":0.0022987723},"labels":[],"label_agreement":null},{"id":"W2765633725","doi":"10.1016/j.antiviral.2017.10.018","title":"Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; Animal and Plant Quarantine Agency","keywords":"Virology; Immunogenicity; Hemagglutinin (influenza); Virus; Epitope; Biology; Recombinant DNA; Influenza A virus; Recombinant virus; Antigenic drift; Immune system; Antibody; Microbiology; Immunology; Gene; Genetics","score_opus":0.1900535117901409,"score_gpt":0.46990630097941666,"score_spread":0.27985278918927575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765633725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892324,0.00025726706,0.00036874198,0.000019574261,0.000019593574,0.000013607648,0.00004723215,0.000009121083,0.0003415605],"genre_scores_gemma":[0.9991423,0.00009427184,0.0001542686,0.000020549638,0.00001326406,0.000008690202,0.00019444701,0.000004780411,0.00036742978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967647,0.00010295137,0.000028621873,0.000045635057,0.00006158675,0.00008469607],"domain_scores_gemma":[0.99962354,0.00013594552,0.000059846072,0.000054298427,0.00005907894,0.000067320885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000681934,0.0004894746,0.00025653298,0.00023498341,0.00019610635,0.0004148615,0.0003244668,0.000570794,0.0007368076],"category_scores_gemma":[0.00061258493,0.00018380332,0.00035308563,0.000122040445,0.000386362,0.00054686464,0.00019140045,0.0009143449,0.00023140074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029732657,0.0006860744,0.0007234754,0.00004535431,0.000026929365,0.00007195293,0.00005446775,0.0004321464,0.9931144,0.00017421604,0.00005097815,0.0016468046],"study_design_scores_gemma":[0.00028938294,0.010931733,0.0046940343,0.000008007427,0.000078267076,0.0003166324,0.00004363191,0.0023968746,0.9804944,0.00008765095,0.000648661,0.000010681391],"about_ca_topic_score_codex":0.0006151898,"about_ca_topic_score_gemma":0.00023083069,"teacher_disagreement_score":0.0007368076,"about_ca_system_score_codex":0.00038657716,"about_ca_system_score_gemma":0.00026926163,"threshold_uncertainty_score":0.0036064982},"labels":[],"label_agreement":null},{"id":"W2767690638","doi":"10.1016/j.antiviral.2017.10.022","title":"Activity of nucleic acid polymers in rodent models of HBV infection","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec Rehabilitation Research Network","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Natural Science Foundation of China; Deutsche Forschungsgemeinschaft","keywords":"HBsAg; Virology; Hepatitis B virus; HBeAg; Woodchuck hepatitis virus; Biology; Hepadnaviridae; Duck hepatitis B virus; Immunology; Virus; Medicine","score_opus":0.17204380165233993,"score_gpt":0.44494416236965606,"score_spread":0.27290036071731616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767690638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98562247,0.0070080506,0.0025908283,0.00020978577,0.000112116344,0.0004432123,0.00078855234,0.00031273524,0.002912187],"genre_scores_gemma":[0.9834119,0.0053317696,0.0027850617,0.00011533675,0.000040668034,0.0005638081,0.0014376235,0.000036730733,0.0062770094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997384,0.00006846199,0.00002221618,0.00005298219,0.00005113253,0.00006685088],"domain_scores_gemma":[0.9996929,0.000038176357,0.000090009285,0.000046560934,0.0000307082,0.000101702884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039099168,0.0008134445,0.00050977786,0.0009210667,0.00024774254,0.00032488158,0.00030663368,0.0004751092,0.0019948531],"category_scores_gemma":[0.00020691275,0.00030889327,0.0004345698,0.00025446166,0.00043365484,0.00036703594,0.00022421191,0.0011610896,0.0005334083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042690304,0.0036248155,0.0011192291,0.00037660392,0.000057956462,0.0002836651,0.00008810671,0.00036091622,0.9734397,0.00026342188,0.0003341482,0.015782487],"study_design_scores_gemma":[0.0007058269,0.0996761,0.010412337,0.00008658853,0.00019990686,0.0012804354,0.00015439828,0.0014425807,0.87759745,0.00017593162,0.008234489,0.000033839744],"about_ca_topic_score_codex":0.0008670445,"about_ca_topic_score_gemma":0.0012375944,"teacher_disagreement_score":0.0019948531,"about_ca_system_score_codex":0.0003410828,"about_ca_system_score_gemma":0.0003579782,"threshold_uncertainty_score":0.0066734552},"labels":[],"label_agreement":null},{"id":"W2767733689","doi":"10.1016/j.antiviral.2017.11.009","title":"HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"Commonwealth of Pennsylvania","keywords":"HBsAg; RNA; Hepatitis B virus; Messenger RNA; Virology; Biology; Molecular biology; Hepatitis B virus PRE beta; Virus; Chemistry; Gene; Biochemistry; Hepatitis B virus DNA polymerase","score_opus":0.19693320588716903,"score_gpt":0.4180343848270063,"score_spread":0.22110117893983725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767733689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955829,0.0011137058,0.0014711472,0.00008956848,0.000029654586,0.00002200904,0.00011713559,0.000044373748,0.0015294687],"genre_scores_gemma":[0.9967272,0.00030305848,0.00097080256,0.000040962237,0.000011759998,0.000011741956,0.00021795303,0.000010400664,0.0017059838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999219,0.000022405793,0.0000053263866,0.000015718957,0.000012855464,0.000021724434],"domain_scores_gemma":[0.99986255,0.000056961748,0.000023777207,0.000019914516,0.000019039042,0.000017814556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001717349,0.00015512001,0.00018465018,0.00012338975,0.00014868756,0.00016891863,0.00012242193,0.00021274835,0.0019584564],"category_scores_gemma":[0.00017316992,0.00010270726,0.00019520213,0.00005849903,0.0002554868,0.00012529259,0.00008642355,0.00027070954,0.00028851896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039594845,0.00001787484,0.00009648865,0.00001467324,0.0000022704687,0.000026555519,0.0000091764405,0.000021914686,0.9986173,0.00008684397,0.0000126304885,0.0006983219],"study_design_scores_gemma":[0.00002525323,0.0003454714,0.002765216,0.0000022137267,0.000005478295,0.0000618803,0.000010988847,0.00024965912,0.9960396,0.0000307697,0.00046072516,0.000002700553],"about_ca_topic_score_codex":0.000860571,"about_ca_topic_score_gemma":0.0010526764,"teacher_disagreement_score":0.0019584564,"about_ca_system_score_codex":0.00027266913,"about_ca_system_score_gemma":0.00026320168,"threshold_uncertainty_score":0.006551683},"labels":[],"label_agreement":null},{"id":"W2770489650","doi":"10.1016/j.antiviral.2017.11.013","title":"Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of Allergy and Infectious Diseases; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; North Carolina Department of Health and Human Services; Foundation for the National Institutes of Health","keywords":"Favipiravir; Human metapneumovirus; Medicine; Nitazoxanide; Virology; Clinical trial; Respiratory tract infections; Immunology; Intensive care medicine; Respiratory system; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty)","score_opus":0.3514624045679613,"score_gpt":0.4963894126311662,"score_spread":0.1449270080632049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770489650","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029456136,0.3784419,0.00076751906,0.3734676,0.21773817,0.00028011587,0.00022187177,0.000037974947,0.026099216],"genre_scores_gemma":[0.019306319,0.37659124,0.002316682,0.106383026,0.4233855,0.00041703036,0.0003825762,0.00008319785,0.07113454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964653,0.0010317969,0.00022307449,0.0003065219,0.0012857242,0.000687538],"domain_scores_gemma":[0.9943779,0.0013286723,0.000389201,0.000094057126,0.0015324196,0.0022776756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013160513,0.0018760489,0.0015665046,0.0022571632,0.0022685651,0.0048628347,0.001738122,0.010488997,0.014488267],"category_scores_gemma":[0.006548407,0.00055858295,0.0015026246,0.001331958,0.0014526581,0.0035611128,0.0049460656,0.011906419,0.0026315225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074230717,0.0005010102,0.0008340911,0.0013802258,0.00006178776,0.00024325807,0.000415505,0.00029755113,0.0015560099,0.0038221483,0.7899491,0.20019704],"study_design_scores_gemma":[0.00017920972,0.00047234952,0.0036241135,0.0024283454,0.00006876638,0.0003024734,0.0006813282,0.0002161414,0.0006257907,0.002879038,0.9884697,0.000052746032],"about_ca_topic_score_codex":0.002145096,"about_ca_topic_score_gemma":0.010413423,"teacher_disagreement_score":0.014488267,"about_ca_system_score_codex":0.003692702,"about_ca_system_score_gemma":0.006782929,"threshold_uncertainty_score":0.069600284},"labels":[],"label_agreement":null},{"id":"W2770934051","doi":"10.1016/j.antiviral.2017.11.018","title":"Antivirals acting on viral envelopes via biophysical mechanisms of action","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Russian Science Foundation","keywords":"Action (physics); Virology; Biology; Chemistry; Physics","score_opus":0.11041747323040241,"score_gpt":0.39991653348823236,"score_spread":0.28949906025782995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770934051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8561293,0.021164564,0.08393089,0.0057946495,0.0011254522,0.0001441641,0.00016105446,0.00031616975,0.031233741],"genre_scores_gemma":[0.98751557,0.004111292,0.0041072182,0.0004432267,0.0001715237,0.000059737245,0.000055330864,0.000023828688,0.0035123646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996871,0.00010122592,0.000014243737,0.000043553715,0.00009035674,0.00006355463],"domain_scores_gemma":[0.9996209,0.00018326109,0.000064225016,0.00004799875,0.000041129377,0.000042488457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084198185,0.00053963414,0.0002875789,0.00027562026,0.00038488916,0.0014371065,0.00049645314,0.0007812652,0.002587946],"category_scores_gemma":[0.0012101284,0.00021209112,0.0003209959,0.000114061564,0.0013684931,0.0020591277,0.0006658162,0.0013425562,0.00058890786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022156876,0.00008030269,0.00042575697,0.0001285465,0.000015608102,0.00016548176,0.00012460235,0.00057251286,0.9522342,0.036840577,0.00028160537,0.008909269],"study_design_scores_gemma":[0.00014213589,0.0006670481,0.0033010524,0.00006288455,0.000035370635,0.0013655269,0.00035348782,0.008473,0.93296826,0.03728981,0.015286812,0.000054557302],"about_ca_topic_score_codex":0.000072119554,"about_ca_topic_score_gemma":0.00004791909,"teacher_disagreement_score":0.002587946,"about_ca_system_score_codex":0.00046882362,"about_ca_system_score_gemma":0.00028122452,"threshold_uncertainty_score":0.008657515},"labels":[],"label_agreement":null},{"id":"W2774265441","doi":"10.1016/j.antiviral.2017.12.006","title":"Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Chronic hepatitis; Hepatology; Medicine; Viral hepatitis; Selection (genetic algorithm); Hepatitis B; Family medicine; Immunology; Internal medicine; Computer science; Virus","score_opus":0.2496520602574766,"score_gpt":0.5155969837215653,"score_spread":0.26594492346408866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774265441","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08472509,0.023686573,0.014994718,0.75679255,0.083021455,0.0038395524,0.0023749212,0.00044066695,0.030124476],"genre_scores_gemma":[0.41049096,0.055238087,0.05487584,0.3155325,0.034308344,0.011411783,0.0053140447,0.0008966667,0.11193184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9787467,0.009924341,0.0013466958,0.0011120676,0.004221557,0.0046486934],"domain_scores_gemma":[0.94514924,0.014205583,0.002485308,0.0009489999,0.0106842145,0.026526632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07345702,0.0017156621,0.0008846994,0.0017037515,0.007535667,0.010705846,0.003565227,0.011146053,0.0059997556],"category_scores_gemma":[0.040957954,0.0011826014,0.0031224682,0.0010270963,0.0024830715,0.0052664024,0.018261658,0.019204993,0.0029414713],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016522575,0.0014284601,0.0073241508,0.010271686,0.00042426604,0.010502868,0.092495665,0.0017136324,0.014340746,0.015066062,0.69538474,0.14939554],"study_design_scores_gemma":[0.00031404998,0.0007676745,0.0060004494,0.0037278521,0.00020185552,0.0011680012,0.08139032,0.00047771208,0.0039664255,0.0078967605,0.89376783,0.0003210887],"about_ca_topic_score_codex":0.005471895,"about_ca_topic_score_gemma":0.007931677,"teacher_disagreement_score":0.07345702,"about_ca_system_score_codex":0.008449908,"about_ca_system_score_gemma":0.040798087,"threshold_uncertainty_score":0.3884825},"labels":[],"label_agreement":null},{"id":"W2783963160","doi":"10.1016/j.antiviral.2018.01.002","title":"The role of adjuvant immunomodulatory agents for treatment of severe influenza","year":2018,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Immunology; Internal medicine; Pharmacology","score_opus":0.3956414398444933,"score_gpt":0.5558238068627308,"score_spread":0.16018236701823751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783963160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035709258,0.99969137,0.000018708233,0.000063724896,0.000055956538,0.0000029297325,0.0000071756035,9.341217e-7,0.0001233696],"genre_scores_gemma":[0.0003883271,0.99926454,0.00007717564,0.000108910994,0.000072079136,0.000003400336,0.0000115185585,3.4807852e-7,0.000073718315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970883,0.00006727003,0.00007552345,0.000039546765,0.00008470059,0.000024052846],"domain_scores_gemma":[0.99911207,0.000620518,0.00011968619,0.0000138306295,0.00010728089,0.000026524322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010508527,0.0007489966,0.0019589625,0.0021669546,0.00019857271,0.0010432389,0.00089112925,0.00112979,0.0034621796],"category_scores_gemma":[0.0017132383,0.00026899067,0.0009935772,0.0017650594,0.00042012442,0.0011144531,0.00063597446,0.0017699653,0.0006206175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025251397,0.00008713202,0.00019610017,0.08816166,0.00046665888,0.00016711847,0.000052951058,0.00023244537,0.0013190879,0.0020746924,0.013776373,0.8932133],"study_design_scores_gemma":[0.00024862654,0.00035697865,0.0017302146,0.04455311,0.0021183672,0.001409562,0.00013440425,0.000154379,0.00084356783,0.0022985046,0.94611055,0.00004170636],"about_ca_topic_score_codex":0.0012622994,"about_ca_topic_score_gemma":0.0023990634,"teacher_disagreement_score":0.0034621796,"about_ca_system_score_codex":0.00045959625,"about_ca_system_score_gemma":0.0012410153,"threshold_uncertainty_score":0.011582077},"labels":[],"label_agreement":null},{"id":"W2789201597","doi":"10.1016/j.antiviral.2018.01.011","title":"Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health; Public Health Agency of Canada","keywords":"Favipiravir; Marburg virus; Virology; Virus; Ebola virus; Medicine; In vivo; Case fatality rate; Outbreak; Antiviral drug; Immunology; Infectious disease (medical specialty); Disease; Biology; Internal medicine; Coronavirus disease 2019 (COVID-19); Epidemiology","score_opus":0.12762008774026137,"score_gpt":0.44807911248727067,"score_spread":0.32045902474700927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789201597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97479904,0.0038368718,0.012564504,0.0006472178,0.0007209688,0.00045091976,0.0016695779,0.0009033059,0.0044076145],"genre_scores_gemma":[0.9834995,0.0020438293,0.006330012,0.00018799123,0.00008859268,0.00027545198,0.00092204515,0.000112011396,0.006540463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994143,0.000093884475,0.000038791295,0.00016654925,0.000101237114,0.00018517698],"domain_scores_gemma":[0.9997559,0.00004146479,0.000054370703,0.00004367134,0.00001919701,0.00008542976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004627103,0.00155643,0.0008269768,0.00096969557,0.0004897374,0.00058488204,0.0007611154,0.0016586825,0.0011384626],"category_scores_gemma":[0.00026226407,0.00038320664,0.0011772257,0.00021182356,0.0007252804,0.00075071986,0.000265696,0.0029561764,0.00058989937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007398376,0.00041983405,0.00014984212,0.00006617813,0.000025957655,0.0002697572,0.000050539293,0.00015385,0.99547076,0.00033071966,0.00020702659,0.002115726],"study_design_scores_gemma":[0.00011386144,0.0030681505,0.0006132849,0.000012572453,0.00006476631,0.0005166175,0.00002765208,0.00090449094,0.9927859,0.00011717111,0.0017641175,0.000011472136],"about_ca_topic_score_codex":0.0014914782,"about_ca_topic_score_gemma":0.0013207243,"teacher_disagreement_score":0.0016586825,"about_ca_system_score_codex":0.0005048294,"about_ca_system_score_gemma":0.00046842318,"threshold_uncertainty_score":0.0038084984},"labels":[],"label_agreement":null},{"id":"W2791665254","doi":"10.1016/j.antiviral.2018.02.010","title":"Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Darunavir; Therapeutic drug monitoring; Medicine; Pharmacodynamics; Pharmacokinetics; Internal medicine; Viral load; Salvage therapy; Human immunodeficiency virus (HIV); Enfuvirtide; Drug; Antiretroviral therapy; Oncology; Pharmacology; Virology; Immunology; Chemotherapy","score_opus":0.06808064592542144,"score_gpt":0.3891810107672819,"score_spread":0.32110036484186044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791665254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810712,0.005094185,0.0028667885,0.0017851004,0.00032449793,0.00016626877,0.00014138299,0.00008084166,0.008469751],"genre_scores_gemma":[0.99507,0.001900017,0.0009311989,0.00059841824,0.0005901362,0.000021362526,0.000088858375,0.000026788886,0.0007733501],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99917525,0.00011829025,0.00012508236,0.00016797146,0.00013399289,0.00027935652],"domain_scores_gemma":[0.9976659,0.00070973596,0.00055629143,0.00016548671,0.00015441011,0.0007483121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040580874,0.002176109,0.0012636827,0.0023907323,0.0028413842,0.00210316,0.0015365573,0.004697422,0.0019382309],"category_scores_gemma":[0.004361958,0.0011811637,0.0014280969,0.0015711623,0.0020469928,0.0023209122,0.0015876611,0.0034175715,0.0007419278],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002571878,0.00006088863,0.013827489,0.000014924346,0.000008589732,0.98438454,0.00015102394,0.000050822564,0.0002587198,0.00005805708,0.00014454892,0.0010146586],"study_design_scores_gemma":[0.0000066072585,0.00006400473,0.0049846745,0.000014084693,0.000017637107,0.9939243,0.00020899341,0.00021207091,0.0002416421,0.00007343757,0.00024088145,0.000011669095],"about_ca_topic_score_codex":0.002249316,"about_ca_topic_score_gemma":0.0025139565,"teacher_disagreement_score":0.004697422,"about_ca_system_score_codex":0.0012973252,"about_ca_system_score_gemma":0.0011615914,"threshold_uncertainty_score":0.0094127655},"labels":[],"label_agreement":null},{"id":"W2793449736","doi":"10.1016/j.antiviral.2018.02.017","title":"Inhibition of NF-κB-dependent HIV-1 replication by the marine natural product bengamide A","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver; Jewish General Hospital; McGill University; University of British Columbia; Université de Sherbrooke; Simon Fraser University","funders":"Canadian Institutes of Health Research","keywords":"Biology; Viral replication; Long terminal repeat; Peripheral blood mononuclear cell; NF-κB; Reporter gene; HIV Long Terminal Repeat; Gene; Virology; Cell culture; Gene expression; Molecular biology; Cell biology; Signal transduction; In vitro; Genetics; Virus","score_opus":0.035733694594546506,"score_gpt":0.3503164268284042,"score_spread":0.3145827322338577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793449736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880741,0.0042356662,0.0014873996,0.00021166213,0.00008143812,0.000033532448,0.00021522099,0.00007967795,0.005581327],"genre_scores_gemma":[0.9952807,0.001763789,0.0004647643,0.00003422654,0.000019091622,0.0000116135625,0.00011845427,0.000006400622,0.0023009577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999542,0.000007921396,0.0000029998519,0.0000052460687,0.000008070101,0.000021568077],"domain_scores_gemma":[0.9999546,0.000010569537,0.000009712945,0.0000063796565,0.0000050496797,0.000013807024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010333371,0.00031472795,0.000117149684,0.00013158911,0.00015011312,0.00020291419,0.00022900703,0.0001478613,0.0022848218],"category_scores_gemma":[0.00012352537,0.00009418818,0.0002160697,0.00006779087,0.00023410613,0.00020030241,0.00020005427,0.00042180443,0.00029558234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007266711,0.000075986674,0.00016269932,0.000066758425,0.0000093825065,0.000095039526,0.000018757024,0.00014805722,0.99304104,0.00024292374,0.00011636993,0.0052964273],"study_design_scores_gemma":[0.00007797644,0.0012011979,0.001989327,0.000008943876,0.000013862536,0.00017616004,0.000032583503,0.00044490586,0.993137,0.00010685442,0.002805003,0.000006184226],"about_ca_topic_score_codex":0.0011395334,"about_ca_topic_score_gemma":0.0011611101,"teacher_disagreement_score":0.0022848218,"about_ca_system_score_codex":0.0002510405,"about_ca_system_score_gemma":0.00027749865,"threshold_uncertainty_score":0.007643521},"labels":[],"label_agreement":null},{"id":"W2800533296","doi":"10.1016/j.antiviral.2018.04.009","title":"Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Zanamivir; Neuraminidase; Recombinant DNA; Titer; In vitro; Mutant; Enzyme; Oseltamivir; Virus; Biology; Virulence; Chemistry; Virology; IC50; Wild type; Molecular biology; Biochemistry; Gene; Coronavirus disease 2019 (COVID-19)","score_opus":0.26098232952606143,"score_gpt":0.4754012148655624,"score_spread":0.214418885339501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800533296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984939,0.00025981062,0.00030057528,0.000045048404,0.00003378007,0.000011227239,0.00022987147,0.0000109091825,0.00061487546],"genre_scores_gemma":[0.99806696,0.0001325543,0.0005961016,0.000038272563,0.0000074513764,0.000007859497,0.00046046957,0.000024225652,0.0006661045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991831,0.00026933747,0.00015862068,0.00009188135,0.00017105983,0.00012595058],"domain_scores_gemma":[0.99939275,0.00024336534,0.00012654872,0.00007306498,0.000084509804,0.00007986156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006330497,0.00061128027,0.0003358068,0.00021934102,0.0002737556,0.00058007595,0.00059129286,0.00052006944,0.001875299],"category_scores_gemma":[0.0010974512,0.00021865363,0.00048644474,0.00024256333,0.0004223458,0.00038792152,0.00032955993,0.0006969114,0.0008010879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011752668,0.00030650012,0.0017630775,0.000061105944,0.00005984153,0.00029150464,0.00007173344,0.0012445532,0.9921078,0.00024559535,0.000140212,0.0025328475],"study_design_scores_gemma":[0.000039090868,0.0007814301,0.0037050184,0.0000143508605,0.00006721832,0.00040608298,0.000092230344,0.0024763914,0.99114203,0.0000692808,0.0011877193,0.000019118163],"about_ca_topic_score_codex":0.003117967,"about_ca_topic_score_gemma":0.0027014178,"teacher_disagreement_score":0.003117967,"about_ca_system_score_codex":0.00067115756,"about_ca_system_score_gemma":0.0005101611,"threshold_uncertainty_score":0.0062735677},"labels":[],"label_agreement":null},{"id":"W2884966105","doi":"10.1016/j.antiviral.2018.07.016","title":"Natural product-derived compounds in HIV suppression, remission, and eradication strategies","year":2018,"lang":"en","type":"review","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"Alliance for Accelerating Excellence in Science in Africa; Government of the United Kingdom; Wellcome Trust; Natural Sciences and Engineering Research Council of Canada; African Academy of Sciences; Canadian Institutes of Health Research; New Partnership for Africa's Development; American Astronautical Society","keywords":"Human immunodeficiency virus (HIV); Antiretroviral therapy; Natural product; Cart; Medicine; Virology; Immunology; Intensive care medicine; Viral load; Biology","score_opus":0.08715928368583975,"score_gpt":0.42213936358265247,"score_spread":0.3349800798968127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884966105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012699184,0.9986174,0.0001047021,0.0001768022,0.00023602229,0.000005236983,0.00001627734,0.000005413832,0.00071111217],"genre_scores_gemma":[0.0009713031,0.9978376,0.0001737031,0.00017881463,0.00023045347,0.0000074671552,0.00002783289,0.0000011495633,0.0005716193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998658,0.000022397677,0.000017264523,0.00002251482,0.000051826555,0.00002021473],"domain_scores_gemma":[0.99981886,0.00008840164,0.000029207307,0.000006599294,0.000037234226,0.000019722213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005480202,0.00065487664,0.0011863715,0.001240477,0.00023415302,0.00105489,0.0008047819,0.00090892,0.0035236378],"category_scores_gemma":[0.00056545995,0.00022227538,0.00037395564,0.0011025035,0.0004760546,0.0011362275,0.00062355265,0.0021045723,0.0013358868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015679943,0.00012848985,0.00012916693,0.012031762,0.00006724619,0.00018532171,0.00004621538,0.00028520968,0.003003585,0.0064977035,0.027396088,0.95007235],"study_design_scores_gemma":[0.000041682102,0.00015266408,0.00044634155,0.0024493425,0.00009912692,0.0008295459,0.00004522582,0.00008635307,0.0008799991,0.0026592265,0.99229467,0.00001590816],"about_ca_topic_score_codex":0.0005222156,"about_ca_topic_score_gemma":0.0013677373,"teacher_disagreement_score":0.0035236378,"about_ca_system_score_codex":0.00041616568,"about_ca_system_score_gemma":0.000812703,"threshold_uncertainty_score":0.011787772},"labels":[],"label_agreement":null},{"id":"W2886392601","doi":"10.1016/j.antiviral.2018.07.021","title":"A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research; Krembil Foundation","keywords":"Virology; Ectodomain; Cotton rat; Virus; Mononegavirales; Biology; Vaccination; Paramyxoviridae; Antibody; Immunology; Viral disease","score_opus":0.11584064219681708,"score_gpt":0.43261317176213293,"score_spread":0.3167725295653159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886392601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970898,0.00056615606,0.0014061446,0.000044820874,0.000046009092,0.00003142602,0.00004429574,0.000027802804,0.00074352307],"genre_scores_gemma":[0.9972337,0.0003180534,0.0012320033,0.000052881613,0.000021590806,0.000014092762,0.0001519463,0.0000088123925,0.00096687913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983823,0.000032242973,0.000007255426,0.000023129118,0.000036454872,0.00006260814],"domain_scores_gemma":[0.99990475,0.000025236306,0.000021274138,0.000011362708,0.000011993334,0.000025345133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020871186,0.00060563686,0.00027369845,0.00026999402,0.00012001248,0.00026323606,0.00018974293,0.00043230725,0.0006209334],"category_scores_gemma":[0.00014231863,0.0001508134,0.00026361705,0.00014014203,0.00025189668,0.00024114632,0.00024316955,0.00092069636,0.00023312408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034381653,0.00013245635,0.00015518951,0.000023750585,0.000008368745,0.000047041987,0.000013052019,0.00019099689,0.9970547,0.00010508962,0.00004720823,0.0018783592],"study_design_scores_gemma":[0.0002460763,0.0046039154,0.0035821272,0.000015733141,0.000104048384,0.0004998983,0.000043651726,0.002795984,0.98527306,0.000109609886,0.0027156419,0.000010206048],"about_ca_topic_score_codex":0.00040503018,"about_ca_topic_score_gemma":0.0005404459,"teacher_disagreement_score":0.0006209334,"about_ca_system_score_codex":0.0002447706,"about_ca_system_score_gemma":0.00028596062,"threshold_uncertainty_score":0.0020772219},"labels":[],"label_agreement":null},{"id":"W2890762658","doi":"10.1016/j.antiviral.2018.09.008","title":"Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of British Columbia; University of Ottawa; AIDS Vancouver; University of Toronto; University Health Network; Toronto General Hospital; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Dosing; Medicine; Pharmacokinetics; Pregnancy; Pharmacology; Toxicity; Regimen; Drug; Amniotic fluid; Adverse effect; Therapeutic index; Developmental toxicity; Fetus; Internal medicine; Biology","score_opus":0.1500829631765242,"score_gpt":0.4705371755160908,"score_spread":0.3204542123395666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890762658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.943568,0.0068104407,0.037549008,0.0026032613,0.00061686215,0.0008468455,0.0012513405,0.00038843803,0.0063657677],"genre_scores_gemma":[0.96876234,0.004523298,0.017495487,0.00074073736,0.00016044902,0.00066811574,0.00082019524,0.00019852209,0.006630979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984225,0.00076643704,0.000093663926,0.00019488538,0.00036413374,0.00015846049],"domain_scores_gemma":[0.99883646,0.0003570954,0.00029346457,0.00026348577,0.000110814646,0.00013863356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022940582,0.00095369073,0.0007894221,0.00090039865,0.00047372628,0.0013926148,0.00091948046,0.0010350508,0.0021374312],"category_scores_gemma":[0.0019679966,0.0005933526,0.00079596235,0.00046410062,0.0010078086,0.0011636785,0.0004471445,0.0034696301,0.00054904964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063609104,0.0046504145,0.0016465323,0.0001850855,0.00009704795,0.0002926955,0.0002083057,0.0024504478,0.95015275,0.0026376848,0.0012139895,0.030104006],"study_design_scores_gemma":[0.0010306155,0.035361778,0.0041721985,0.00006186607,0.00044574038,0.0009464687,0.00016735824,0.01030311,0.9296167,0.0011743236,0.016655007,0.00006489967],"about_ca_topic_score_codex":0.0013804527,"about_ca_topic_score_gemma":0.0017184117,"teacher_disagreement_score":0.0022940582,"about_ca_system_score_codex":0.00097310514,"about_ca_system_score_gemma":0.001056786,"threshold_uncertainty_score":0.012132287},"labels":[],"label_agreement":null},{"id":"W2891172236","doi":"10.1016/j.antiviral.2018.09.007","title":"Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation, in vitro and in animal models","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Zanamivir; Neuraminidase; Titer; Virology; Microbiology; Inoculation; Biology; Virus; Medicine; Coronavirus disease 2019 (COVID-19); Immunology","score_opus":0.3656101780992341,"score_gpt":0.5224849922897125,"score_spread":0.15687481419047838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891172236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938501,0.0022026584,0.0009619821,0.0000630966,0.00008993666,0.00003265015,0.00081228727,0.0000221375,0.001964994],"genre_scores_gemma":[0.9909972,0.0020010225,0.0018469371,0.00007067856,0.00003853325,0.000043303608,0.0024318025,0.00001252314,0.0025580316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997774,0.000055870805,0.000023336528,0.000042268362,0.00004216714,0.000058958787],"domain_scores_gemma":[0.9996394,0.0001357852,0.000039647563,0.000041153166,0.000078910874,0.00006503214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038457353,0.0003214197,0.00034792096,0.00037435087,0.0002529631,0.000444886,0.00025893128,0.00038524924,0.00093545753],"category_scores_gemma":[0.00034240537,0.00019759737,0.00040560472,0.0002064081,0.00021639938,0.00044602636,0.0001661945,0.0007117338,0.00033761602],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023709114,0.00057576044,0.0030363223,0.00014647312,0.000035135818,0.00018655395,0.00007707337,0.00025903515,0.9894286,0.00021821371,0.00023009989,0.0034358674],"study_design_scores_gemma":[0.00013189,0.01278879,0.05027817,0.000039033595,0.0002050632,0.001426515,0.00043487316,0.0032761586,0.9258134,0.00021533789,0.005357128,0.00003367359],"about_ca_topic_score_codex":0.0023243532,"about_ca_topic_score_gemma":0.0035244531,"teacher_disagreement_score":0.0023243532,"about_ca_system_score_codex":0.00029708396,"about_ca_system_score_gemma":0.0002024971,"threshold_uncertainty_score":0.004621625},"labels":[],"label_agreement":null},{"id":"W2897426627","doi":"10.1016/j.antiviral.2018.10.011","title":"Tangeretin, an extract from Citrus peels, blocks cellular entry of arenaviruses that cause viral hemorrhagic fever","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"Canadian Institutes of Health Research; National Science and Technology Major Project; National Natural Science Foundation of China","keywords":"Arenavirus; Lassa virus; Virology; Lassa fever; Ribavirin; Viral hemorrhagic fever; Biology; Virus; Ebola virus; Immunology; Hepatitis C virus","score_opus":0.15191302837352458,"score_gpt":0.4262649843675219,"score_spread":0.2743519559939973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897426627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948802,0.0026056115,0.00035750653,0.00007729328,0.000046641628,0.000022257154,0.000106538966,0.000044479657,0.0018595039],"genre_scores_gemma":[0.9946832,0.0016943582,0.0006166031,0.00007418692,0.000037335456,0.000016089325,0.000353159,0.000013269523,0.0025118028],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999372,0.000014257276,0.0000068657737,0.000009453025,0.000009751786,0.000022369304],"domain_scores_gemma":[0.9999106,0.00003633474,0.000013802849,0.000007974227,0.000007662408,0.00002361861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009263342,0.0003850442,0.00033462804,0.00028510258,0.00015762057,0.00023196028,0.00019053082,0.00033279235,0.002241876],"category_scores_gemma":[0.00020069028,0.00010086229,0.00022060488,0.000090472575,0.00021325548,0.00040880684,0.000109995344,0.00048711523,0.00024978444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015734565,0.00026619027,0.00024447922,0.00014798237,0.000020826263,0.00014557951,0.000035971756,0.000060980765,0.99094725,0.00007150291,0.00013665225,0.0063491417],"study_design_scores_gemma":[0.00071657693,0.00880932,0.015289141,0.00003838088,0.000095163705,0.0009780364,0.00008865479,0.0006308307,0.9693318,0.00018250785,0.0038212277,0.000018286473],"about_ca_topic_score_codex":0.0004890884,"about_ca_topic_score_gemma":0.0009078852,"teacher_disagreement_score":0.002241876,"about_ca_system_score_codex":0.00014278364,"about_ca_system_score_gemma":0.00016083158,"threshold_uncertainty_score":0.007499814},"labels":[],"label_agreement":null},{"id":"W2899793329","doi":"10.1016/j.antiviral.2018.11.002","title":"HBV antigen and DNA loss from mouse serum is associated with novel vaccine-induced HBV surface antigen-specific cell-mediated immunity and cytokine production","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"National Natural Science Foundation of China","keywords":"Antigen; Virology; Immunology; Immunity; Cytokine; DNA vaccination; Biology; Medicine; Immune system; Immunization","score_opus":0.08113860884448572,"score_gpt":0.33944982225560627,"score_spread":0.25831121341112057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899793329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954621,0.0013616593,0.0020609244,0.000056854555,0.000030752624,0.000031452942,0.00017731376,0.00009302009,0.0007259437],"genre_scores_gemma":[0.99601126,0.00041460546,0.0010515741,0.000054519365,0.000024838942,0.000049380946,0.00046510456,0.000024080307,0.0019046459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996855,0.000050486025,0.000034170524,0.00006111199,0.00006235012,0.000106394225],"domain_scores_gemma":[0.99959856,0.00008112212,0.0001296203,0.00006909003,0.000035735306,0.00008590548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039635602,0.0007279141,0.00039651676,0.0007225392,0.00014162294,0.0003885951,0.00020412664,0.00052747794,0.0014946508],"category_scores_gemma":[0.0003363839,0.00027738968,0.0005216112,0.00020656188,0.0005140077,0.0003716146,0.0002562372,0.0011567181,0.00044327904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005766273,0.00006032106,0.0005597449,0.000028602852,0.00000574112,0.00007337912,0.000011971035,0.000017629201,0.99797994,0.00006227338,0.0000116265055,0.0006122545],"study_design_scores_gemma":[0.00004541598,0.0009236933,0.009003263,0.0000060146235,0.00002417003,0.00049745117,0.000025376203,0.00032553516,0.9886634,0.000088415945,0.00039325142,0.000004123773],"about_ca_topic_score_codex":0.00015891038,"about_ca_topic_score_gemma":0.0002173369,"teacher_disagreement_score":0.0014946508,"about_ca_system_score_codex":0.00028374942,"about_ca_system_score_gemma":0.00022535144,"threshold_uncertainty_score":0.0050001144},"labels":[],"label_agreement":null},{"id":"W2901227506","doi":"10.1016/j.antiviral.2018.11.011","title":"Tomatidine, a novel antiviral compound towards dengue virus","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Wageningen University and Research; Centers for Disease Control and Prevention; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; Universiteit Leiden; Leids Universitair Medisch Centrum; European Commission; Ministère de l'Économie, de la Science et de l'Innovation - Québec; University of South Carolina; Universitair Medisch Centrum Groningen; Universidad de Antioquia; Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS); Rijksuniversiteit Groningen; Purdue University","keywords":"Dengue virus; Dengue fever; Virology; Virus; Antiviral drug; Biology; Serotype","score_opus":0.09638298681734651,"score_gpt":0.42689965675007807,"score_spread":0.33051666993273154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901227506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87011397,0.080040164,0.02413536,0.0008138776,0.00037140294,0.0004069759,0.0012049882,0.00040434522,0.022508819],"genre_scores_gemma":[0.95629865,0.024272496,0.011487156,0.00027406053,0.00006742621,0.00007606287,0.00073808874,0.000018355027,0.006767798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999641,0.000007892278,0.0000040667746,0.000010354078,0.0000070957335,0.0000063956772],"domain_scores_gemma":[0.9999825,0.0000027418712,0.000004107441,0.0000015744941,0.0000032365795,0.000005896338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068601556,0.00029935339,0.0002367508,0.00027683907,0.00017097742,0.0001676876,0.0001603665,0.00026619853,0.00077746226],"category_scores_gemma":[0.00007884434,0.0000775061,0.00019170839,0.0001533011,0.00016874139,0.00025348293,0.00022001863,0.00028311953,0.00022376749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041467894,0.00013033702,0.00036910106,0.00075510546,0.000029734243,0.0006548437,0.00007508704,0.0007742444,0.95218855,0.0010511231,0.00066080317,0.042896405],"study_design_scores_gemma":[0.00025947895,0.0041580684,0.0029117425,0.000061258856,0.00009795132,0.0036931876,0.000053924807,0.0022800693,0.9203028,0.0003711054,0.065774836,0.000035540426],"about_ca_topic_score_codex":0.00032849124,"about_ca_topic_score_gemma":0.000576049,"teacher_disagreement_score":0.00077746226,"about_ca_system_score_codex":0.00011160115,"about_ca_system_score_gemma":0.00014811812,"threshold_uncertainty_score":0.0026008487},"labels":[],"label_agreement":null},{"id":"W2905300319","doi":"10.1016/j.antiviral.2018.12.010","title":"Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research; Krembil Foundation","keywords":"Cotton rat; Virology; Vaccination; Virus; Antibody; Mononegavirales; Medicine; Immunology; Paramyxoviridae; Neutralization; Biology; Viral disease","score_opus":0.10821387608094216,"score_gpt":0.4117631069643261,"score_spread":0.3035492308833839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905300319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860746,0.00032994497,0.0007729204,0.000032799966,0.000014775351,0.000010270549,0.00001912572,0.000017323116,0.00019549506],"genre_scores_gemma":[0.9982299,0.0002958557,0.00067709835,0.000027943695,0.000007570171,0.000008899535,0.000059021786,0.0000065398763,0.0006870836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993825,0.000010963152,0.0000034091183,0.000013506156,0.000011162899,0.00002264644],"domain_scores_gemma":[0.9999254,0.000015620248,0.00002278964,0.0000060591724,0.000008962284,0.000021245094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016865677,0.0002602075,0.00019228543,0.00013584385,0.000087024186,0.0001770773,0.0001774647,0.0003486104,0.0004961007],"category_scores_gemma":[0.00015819726,0.00009545586,0.00015377955,0.000041984385,0.00018935958,0.00016757299,0.0001307925,0.00045279472,0.00013739956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046397772,0.00008732182,0.0002451553,0.000032177835,0.000005185469,0.00005891745,0.00002150564,0.000060574148,0.997009,0.00004978875,0.00002660652,0.0019398448],"study_design_scores_gemma":[0.00012886862,0.0077808057,0.005976883,0.000027528084,0.000093307215,0.0005613932,0.000075096315,0.0015004189,0.98195297,0.0000710934,0.0018230152,0.000008722635],"about_ca_topic_score_codex":0.0004560791,"about_ca_topic_score_gemma":0.00047692552,"teacher_disagreement_score":0.0004961007,"about_ca_system_score_codex":0.00021172583,"about_ca_system_score_gemma":0.00015823632,"threshold_uncertainty_score":0.0016595721},"labels":[],"label_agreement":null},{"id":"W2907851514","doi":"10.1016/j.antiviral.2019.01.001","title":"VER-155008 induced Hsp70 proteins expression in fish cell cultures while impeding replication of two RNA viruses","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Aquaculture disease management and microbiota","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Huntsman Marine Science Centre; University of Guelph; University of the Fraser Valley; University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada; Elanco Animal Health","keywords":"Virology; Biology; Infectious pancreatic necrosis virus; Virus; Viral replication; Hsp70; RNA; Cell culture; Cytopathic effect; Embryo; Gene; Heat shock protein; Cell biology; Genetics","score_opus":0.05979420935482495,"score_gpt":0.368471086363464,"score_spread":0.30867687700863905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907851514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608743,0.00039725716,0.0009511953,0.00008470217,0.000064795364,0.000032219334,0.00045786332,0.000045939174,0.0018785899],"genre_scores_gemma":[0.98955625,0.0002920666,0.002211642,0.000082583254,0.000017763703,0.000052064046,0.001431156,0.000019583991,0.0063367803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998375,0.000023274455,0.000019825316,0.000035274497,0.00003481662,0.00004933573],"domain_scores_gemma":[0.9999275,0.000021305645,0.000011474455,0.000012503104,0.000011743338,0.000015479061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014699099,0.00033723318,0.0003472915,0.00012274046,0.00014624193,0.00030469202,0.00016141815,0.00029668232,0.0017134545],"category_scores_gemma":[0.000107362364,0.00010569028,0.00033997578,0.00013947146,0.00024275838,0.00017410202,0.000187403,0.0006795883,0.00034690564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011539626,0.000030855397,0.000099197096,0.00001977874,0.000002151985,0.00002322232,0.000015468853,0.000023829132,0.9992261,0.000037345606,0.000026410224,0.00038026803],"study_design_scores_gemma":[0.000015594187,0.0005102032,0.002811511,0.0000031803722,0.000008968159,0.00005234487,0.00004456072,0.00029616978,0.99500656,0.000015445557,0.0012318366,0.000003576856],"about_ca_topic_score_codex":0.0013912858,"about_ca_topic_score_gemma":0.00196777,"teacher_disagreement_score":0.0017134545,"about_ca_system_score_codex":0.00035679678,"about_ca_system_score_gemma":0.000306565,"threshold_uncertainty_score":0.0057320595},"labels":[],"label_agreement":null},{"id":"W2912166467","doi":"10.1016/j.antiviral.2019.02.005","title":"Inhibition of HBV replication by N-hydroxyisoquinolinedione and N-hydroxypyridinedione ribonuclease H inhibitors","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Hepatitis B virus; RNase H; Virology; DNA; Biology; Molecular biology; Cytotoxicity; Viral replication; DNA replication; Ribonuclease; RNA; RNase P; Chemistry; Virus; In vitro; Gene; Genetics","score_opus":0.0396463608960163,"score_gpt":0.3570163981326019,"score_spread":0.3173700372365856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912166467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821145,0.011075329,0.0017995234,0.00014027998,0.000101065525,0.000081307546,0.00014826811,0.00007511125,0.0044646286],"genre_scores_gemma":[0.99447036,0.0021427055,0.0009703597,0.000045325978,0.000042754622,0.000032800086,0.0001685594,0.000007149779,0.0021199598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998192,0.00008508594,0.000015343969,0.000015259462,0.000026012407,0.000039133913],"domain_scores_gemma":[0.99984276,0.000067857814,0.000029520923,0.00001641771,0.000016242508,0.000027117734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041561123,0.00023798402,0.00024106471,0.00019718727,0.000113909606,0.00019418297,0.00023237488,0.00019480978,0.0016080651],"category_scores_gemma":[0.00027773395,0.000121895544,0.00020471487,0.0000969227,0.00018493473,0.00018584989,0.00011320252,0.0003135776,0.00025105895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059377137,0.00052664056,0.00063865056,0.00018043419,0.000034733745,0.000103538376,0.00006767986,0.0004505805,0.9708554,0.00044491675,0.00021449274,0.020545328],"study_design_scores_gemma":[0.0005605142,0.012453312,0.003936126,0.000015592253,0.00003472196,0.00021071154,0.00003468989,0.0009995177,0.97759444,0.00006900369,0.004079936,0.000011402958],"about_ca_topic_score_codex":0.0005519715,"about_ca_topic_score_gemma":0.0007738147,"teacher_disagreement_score":0.0016080651,"about_ca_system_score_codex":0.00017514001,"about_ca_system_score_gemma":0.0001738053,"threshold_uncertainty_score":0.0053795576},"labels":[],"label_agreement":null},{"id":"W2912481674","doi":"10.1016/j.antiviral.2019.01.011","title":"Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Merck Sharp and Dohme; Canada Research Chairs","keywords":"Human cytomegalovirus; Virology; Biology; Drug resistance; Ganciclovir; Virus; Microbiology","score_opus":0.42709707190366647,"score_gpt":0.5536105815723571,"score_spread":0.12651350966869063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912481674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006607777,0.9993104,0.00006271147,0.00015305603,0.000083139596,0.0000040912673,0.000014083335,0.0000039761394,0.00030256118],"genre_scores_gemma":[0.0006360607,0.9985663,0.00016877573,0.00025957686,0.00011199067,0.0000056359536,0.00002576724,0.000001258643,0.00022469817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963796,0.00007961435,0.00007400364,0.00006213199,0.00011111636,0.0000352018],"domain_scores_gemma":[0.999198,0.0004554645,0.00013479133,0.000017495398,0.00014880579,0.000045364122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012770741,0.0009413362,0.0023054641,0.003341541,0.00020475352,0.0015027977,0.0010655234,0.0014792623,0.004447121],"category_scores_gemma":[0.0015557582,0.0004154001,0.0014377306,0.0021895533,0.0004323775,0.0014185983,0.00066921936,0.0024186578,0.0012100443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021612852,0.00009192017,0.00018175218,0.026421204,0.00023535939,0.00016903723,0.000045910125,0.00034907367,0.0014686378,0.0023562023,0.017597353,0.95086735],"study_design_scores_gemma":[0.00020265524,0.00060092454,0.0014433562,0.01383223,0.0009671502,0.001730237,0.000059353177,0.00030312221,0.0009349751,0.0015795402,0.97830176,0.00004471735],"about_ca_topic_score_codex":0.0011125983,"about_ca_topic_score_gemma":0.0028095224,"teacher_disagreement_score":0.004447121,"about_ca_system_score_codex":0.0008299047,"about_ca_system_score_gemma":0.001624043,"threshold_uncertainty_score":0.0148771405},"labels":[],"label_agreement":null},{"id":"W2915009094","doi":"10.1016/j.antiviral.2019.02.009","title":"Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"HBsAg; In vitro; Secretion; Nucleic acid; Immune system; Hepatitis B virus; Hepatocellular carcinoma; Cirrhosis; Chemistry; Virology; Biology; Medicine; Immunology; Cancer research; Biochemistry; Virus; Internal medicine","score_opus":0.04038057639909725,"score_gpt":0.3535649606924945,"score_spread":0.31318438429339723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915009094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918641,0.001702421,0.00232038,0.00014503708,0.00013794456,0.00005358354,0.0005276374,0.00013499205,0.003113848],"genre_scores_gemma":[0.9868068,0.0011768888,0.0020853423,0.0000818929,0.000045251745,0.000061818304,0.001427345,0.000035431687,0.008279109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996964,0.00009606405,0.000037379792,0.000034756904,0.00006437477,0.00007106662],"domain_scores_gemma":[0.99986136,0.000051963216,0.00001655275,0.000027954738,0.000021190399,0.000020918073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031045568,0.0004919303,0.00036848919,0.00022501929,0.00023332087,0.00037324228,0.00016277986,0.00028588457,0.0015843275],"category_scores_gemma":[0.00015872836,0.0001807997,0.00055635476,0.00036218984,0.00028872312,0.00024378567,0.00021262505,0.0006830078,0.00083176355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055707764,0.000100973004,0.00019220004,0.000073569354,0.000009899721,0.00008172873,0.00005987401,0.00007929158,0.9973149,0.00008421972,0.000070729104,0.0013755482],"study_design_scores_gemma":[0.000030749776,0.00089140283,0.0016843815,0.000004253251,0.000012474633,0.0000585812,0.000031316213,0.00040910277,0.99584454,0.000017004651,0.0010125879,0.0000036176205],"about_ca_topic_score_codex":0.0015279541,"about_ca_topic_score_gemma":0.00096204795,"teacher_disagreement_score":0.0015843275,"about_ca_system_score_codex":0.0002404814,"about_ca_system_score_gemma":0.00030204473,"threshold_uncertainty_score":0.0053001046},"labels":[],"label_agreement":null},{"id":"W2918933655","doi":"10.1016/j.antiviral.2019.03.001","title":"Characterization of Reston virus infection in ferrets","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Food Inspection Agency; University of Manitoba; Public Health Agency of Canada","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; Public Health Agency; Public Health Agency of Canada","keywords":"Virology; Biology; Virus; Viremia; Ebolavirus; Viral replication; Pathogenicity; Immunology; Microbiology; Ebola virus","score_opus":0.08145172780756879,"score_gpt":0.42790763926845854,"score_spread":0.3464559114608897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918933655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609333,0.0005000114,0.0009798692,0.000028313163,0.000022975037,0.00008285812,0.00037063356,0.000029438728,0.0018926887],"genre_scores_gemma":[0.99503976,0.00032241034,0.001123677,0.000059902926,0.000018617933,0.00007593904,0.0010753768,0.000017100214,0.002267283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975044,0.000033171968,0.000024540223,0.00007865628,0.000042545664,0.00007066065],"domain_scores_gemma":[0.99979717,0.00004811529,0.00005043872,0.000024399647,0.00003756185,0.0000423899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028033575,0.000489188,0.0002667201,0.0009310964,0.00043483998,0.00055435626,0.00025721407,0.0004305768,0.00083561003],"category_scores_gemma":[0.0003380932,0.00012442263,0.00039881637,0.00015148026,0.00047736306,0.0004596784,0.00022977317,0.0004602401,0.0002646935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006617179,0.00010581207,0.02385982,0.00006746291,0.000023128889,0.000651637,0.00031319555,0.000081228725,0.9714106,0.00017732072,0.00006566627,0.0025824397],"study_design_scores_gemma":[0.000034347195,0.0023172072,0.4117913,0.000049965485,0.00014554904,0.0054004584,0.0020101517,0.001507841,0.5721546,0.00035797464,0.0041941996,0.00003637893],"about_ca_topic_score_codex":0.0022835082,"about_ca_topic_score_gemma":0.0016005893,"teacher_disagreement_score":0.0022835082,"about_ca_system_score_codex":0.00050207414,"about_ca_system_score_gemma":0.00017941726,"threshold_uncertainty_score":0.0045404434},"labels":[],"label_agreement":null},{"id":"W2924181747","doi":"10.1016/j.antiviral.2019.03.009","title":"GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"Medical Research Council","keywords":"Chikungunya; Virology; Epidemiology; Outbreak; Disease; Biology; Medicine; Pathology","score_opus":0.3143008299577493,"score_gpt":0.5086522754351819,"score_spread":0.1943514454774326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924181747","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.088602245,0.24551985,0.027956923,0.11104274,0.07075242,0.011667139,0.083485626,0.0031828056,0.35779023],"genre_scores_gemma":[0.2586151,0.1797799,0.041267186,0.05681305,0.02583528,0.0049215434,0.19439368,0.001622074,0.23675215],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968491,0.00065621716,0.00047427556,0.00023112801,0.0013781576,0.00041111922],"domain_scores_gemma":[0.9954933,0.00077938405,0.0006782403,0.0003160016,0.0019433447,0.000789752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006716595,0.0015256192,0.0005500197,0.0020999857,0.00065632,0.0014361023,0.0018313358,0.0033582507,0.0046561374],"category_scores_gemma":[0.0033935567,0.00046139027,0.0012498582,0.0010632601,0.0007898253,0.0009989367,0.0014553734,0.002260041,0.00415979],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089227624,0.0003927032,0.028551184,0.005157833,0.00023221738,0.0044958447,0.00077874196,0.0010836706,0.038108118,0.0034452071,0.74394065,0.17292152],"study_design_scores_gemma":[0.000054821154,0.00042703617,0.04341983,0.00093044154,0.00009154884,0.0018539276,0.00025688438,0.00018831453,0.006628561,0.00045024414,0.9456579,0.000040539715],"about_ca_topic_score_codex":0.01891905,"about_ca_topic_score_gemma":0.0077563105,"teacher_disagreement_score":0.01891905,"about_ca_system_score_codex":0.0017555819,"about_ca_system_score_gemma":0.0069149463,"threshold_uncertainty_score":0.037617862},"labels":[],"label_agreement":null},{"id":"W2930758931","doi":"10.1016/j.antiviral.2019.03.014","title":"Identification of a clinical compound losmapimod that blocks Lassa virus entry","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China; Public Health Agency; Public Health Agency of Canada","keywords":"Lassa virus; Lassa fever; Virology; Arenavirus; Biology; Virus; Immunology; Antigen","score_opus":0.1868226214171019,"score_gpt":0.5032365179607636,"score_spread":0.3164138965436617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930758931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9523129,0.01246438,0.010459688,0.002748987,0.000544685,0.0010921574,0.002870179,0.00043893093,0.017068239],"genre_scores_gemma":[0.97946197,0.0048678457,0.00492033,0.0007220821,0.00011511904,0.00026120723,0.0031942218,0.000030124165,0.006427165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998877,0.000022274746,0.000008152034,0.00001941245,0.000026988171,0.000035501103],"domain_scores_gemma":[0.99991274,0.000011987792,0.000019139583,0.0000060734315,0.000015468799,0.00003449244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023582578,0.000509912,0.0004695668,0.00031486904,0.00021871598,0.0005253419,0.0004174815,0.00043704166,0.0043001533],"category_scores_gemma":[0.00026977246,0.00017261106,0.0002808893,0.00017131669,0.0003595717,0.0002887446,0.00023330396,0.0011379605,0.0007836161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033871322,0.001309413,0.0008438185,0.00043192235,0.00007436633,0.00065268605,0.00007127915,0.0012042286,0.94269305,0.0016320895,0.00380425,0.04389574],"study_design_scores_gemma":[0.008000705,0.041096687,0.008987391,0.0001726477,0.00027548612,0.0044628307,0.0001771013,0.0056862873,0.83473694,0.0013374698,0.09497242,0.00009409978],"about_ca_topic_score_codex":0.0004578474,"about_ca_topic_score_gemma":0.0009803239,"teacher_disagreement_score":0.0043001533,"about_ca_system_score_codex":0.0003693644,"about_ca_system_score_gemma":0.00070360384,"threshold_uncertainty_score":0.014385402},"labels":[],"label_agreement":null},{"id":"W2949120013","doi":"10.1016/j.antiviral.2019.104542","title":"Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Genome British Columbia","keywords":"Neuraminidase; Sialic acid; Virus; Biology; Wild type; Mutant; Virology; Influenza A virus; Hemagglutinin (influenza); Titer; Orthomyxoviridae; Neuraminidase inhibitor; Molecular biology; Biochemistry; Gene","score_opus":0.16928875617667422,"score_gpt":0.46163906468421,"score_spread":0.2923503085075358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949120013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529904,0.00015816344,0.0024549933,0.00009637608,0.00007752119,0.000050261384,0.00044300922,0.00005450013,0.0013662827],"genre_scores_gemma":[0.98900247,0.00014900597,0.005596487,0.00006710508,0.000018327846,0.00003770563,0.0012523526,0.00008497517,0.0037915532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970573,0.000050412757,0.00003984161,0.00006114143,0.000079595615,0.000063226944],"domain_scores_gemma":[0.9997801,0.00007630467,0.000039196886,0.000039447314,0.000018520313,0.000046470945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000245084,0.00051999086,0.00042638424,0.00018943037,0.00027016396,0.00038159537,0.0005816591,0.0005604564,0.0010327051],"category_scores_gemma":[0.00024017434,0.00023483335,0.00045896647,0.00019199157,0.00024474284,0.00020861898,0.00031230482,0.0007513143,0.0005592278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008450956,0.000042761283,0.00018794772,0.000008791354,0.000007742982,0.00006131764,0.000018264034,0.00009461932,0.99898106,0.000093767194,0.000041220068,0.00037795407],"study_design_scores_gemma":[0.000018054965,0.00033366284,0.0022259215,0.000003360587,0.0000148318195,0.00033335545,0.0000380146,0.0021299943,0.99374515,0.000021976397,0.0011264483,0.000009246626],"about_ca_topic_score_codex":0.0036708047,"about_ca_topic_score_gemma":0.0032396305,"teacher_disagreement_score":0.0036708047,"about_ca_system_score_codex":0.00053759065,"about_ca_system_score_gemma":0.0002346928,"threshold_uncertainty_score":0.007298887},"labels":[],"label_agreement":null},{"id":"W2955217622","doi":"10.1016/j.antiviral.2019.104543","title":"Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto; Vancouver Infectious Diseases Centre; Canada Research Chairs; McGill University; Maple Leaf Medical Clinic","funders":"Janssen Pharmaceuticals; Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University; Arthur Foundation; Johnson and Johnson; Gilead Sciences; Merck; Yale University","keywords":"Darunavir; Emtricitabine; Tenofovir alafenamide; Medicine; Internal medicine; Adverse effect; Cobicistat; Gastroenterology; Viral load; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy","score_opus":0.03428119433678359,"score_gpt":0.3278131052699593,"score_spread":0.29353191093317577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955217622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909168,0.0010145872,0.00048333965,0.00034600656,0.00015869693,0.0023837266,0.0020859065,0.00010391552,0.002507124],"genre_scores_gemma":[0.99034786,0.0004957248,0.0010149272,0.0006170683,0.00013728415,0.0022763545,0.0014050156,0.000027897644,0.0036777235],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990325,0.0005322457,0.000053420925,0.00017787168,0.00006665114,0.00013727855],"domain_scores_gemma":[0.9989643,0.00023661258,0.0002879774,0.00012689877,0.00006863371,0.00031561177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026052175,0.0017509727,0.0017026738,0.00036323915,0.00041412798,0.001117436,0.001022208,0.0018658441,0.0063988864],"category_scores_gemma":[0.0021640407,0.00067341415,0.0016747015,0.00024544622,0.0010704966,0.0013705792,0.00038911166,0.0038126067,0.0014045982],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96693176,0.013291457,0.0010766459,0.00021209424,0.00044127915,0.000052331554,0.00006934167,0.00055486587,0.0038833402,0.00008430832,0.00086160103,0.012540992],"study_design_scores_gemma":[0.8424467,0.14916119,0.0050302027,0.000030835654,0.00025922369,0.00006588103,0.000028932545,0.00058865134,0.0013730376,0.00021084947,0.0007797545,0.000024825702],"about_ca_topic_score_codex":0.00039208925,"about_ca_topic_score_gemma":0.0009925634,"teacher_disagreement_score":0.0063988864,"about_ca_system_score_codex":0.0007324751,"about_ca_system_score_gemma":0.00069538254,"threshold_uncertainty_score":0.021406412},"labels":[],"label_agreement":null},{"id":"W2962367258","doi":"10.1016/j.antiviral.2019.104561","title":"The Val430Ile neuraminidase (NA) substitution, identified in influenza B virus isolates, impacts the catalytic 116Arg residue causing reduced susceptibility to NA inhibitors","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Shionogi; Canadian Institutes of Health Research; BioCryst","keywords":"Neuraminidase; Virology; Residue (chemistry); Influenzavirus B; Virus; Chemistry; Substitution (logic); Orthomyxoviridae; Influenza A virus; Microbiology; Biology; Biochemistry","score_opus":0.11997820566410337,"score_gpt":0.4380638959558294,"score_spread":0.318085690291726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962367258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949024,0.0005138551,0.0017659474,0.00017161638,0.00011303194,0.00004256351,0.0006059938,0.00004448714,0.0018400821],"genre_scores_gemma":[0.9971117,0.0001674405,0.0012277237,0.00009429062,0.000015283882,0.00000850668,0.00039357322,0.000024143703,0.0009572704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996251,0.0001131335,0.000055532808,0.000059706956,0.00008151514,0.000064983455],"domain_scores_gemma":[0.99968314,0.000058536643,0.000098768294,0.000030153009,0.000047802696,0.000081592836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003264912,0.00072406465,0.0004980483,0.00029615045,0.00034224155,0.0004196947,0.00038048945,0.00079354533,0.004295948],"category_scores_gemma":[0.00057364395,0.00019729504,0.00066301867,0.0003275128,0.00053540483,0.00021133716,0.000364238,0.0006390272,0.0011325054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012397479,0.00014057646,0.0048987106,0.000103912505,0.0001311638,0.0021124247,0.000091605005,0.0004275937,0.98391694,0.00038342926,0.00025539703,0.006298427],"study_design_scores_gemma":[0.00024990094,0.0026732422,0.05075489,0.00008618162,0.00030575204,0.014994293,0.00043884694,0.002747701,0.9193958,0.00038554703,0.007897227,0.00007046414],"about_ca_topic_score_codex":0.0028135998,"about_ca_topic_score_gemma":0.0017946161,"teacher_disagreement_score":0.004295948,"about_ca_system_score_codex":0.00026408798,"about_ca_system_score_gemma":0.0003613533,"threshold_uncertainty_score":0.014371395},"labels":[],"label_agreement":null},{"id":"W2963915114","doi":"10.1016/j.antiviral.2019.104566","title":"Responses of human mast cells and epithelial cells following exposure to influenza A virus","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; University of Alberta; Lung Association, Alberta and NWT; American Academy of Allergy Asthma and Immunology","keywords":"Innate immune system; Mast cell; Biology; Prostaglandin D2; Chemokine; Virus; Influenza A virus; Immune system; Cell culture; Virology; Histamine; Immunology; Interleukin 8; Receptor; Cytokine","score_opus":0.0467525850937612,"score_gpt":0.3536596534192745,"score_spread":0.30690706832551334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963915114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965553,0.0010863743,0.00027740625,0.00008194578,0.00006186359,0.00006627924,0.00022624662,0.000009602838,0.0016349388],"genre_scores_gemma":[0.9967168,0.00057280005,0.00024265863,0.00016783997,0.00007279218,0.00009491907,0.00038720202,0.000003512818,0.001741375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999516,0.00018819513,0.000020945135,0.000048759546,0.00005698753,0.000169061],"domain_scores_gemma":[0.99977165,0.0001042294,0.000021682117,0.00003088205,0.00003417653,0.000037299706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058258814,0.00035154953,0.00039064707,0.00032439193,0.0004344648,0.00040401038,0.0002400411,0.0009549492,0.0034129284],"category_scores_gemma":[0.0005209985,0.00025096152,0.0005703149,0.00026564408,0.00043746055,0.0003799885,0.0003228459,0.0006820611,0.00059671566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008041167,0.00027980335,0.0036796068,0.0001543084,0.000031194366,0.0012228081,0.0004334861,0.00008936087,0.9830776,0.00012530813,0.00021030278,0.002655018],"study_design_scores_gemma":[0.00060292747,0.012012356,0.23124716,0.00006056224,0.00015066002,0.002527566,0.0027798878,0.0010095431,0.7432991,0.00048408593,0.0057879686,0.000038165395],"about_ca_topic_score_codex":0.0007483153,"about_ca_topic_score_gemma":0.0007911567,"teacher_disagreement_score":0.0034129284,"about_ca_system_score_codex":0.0002360604,"about_ca_system_score_gemma":0.00018095801,"threshold_uncertainty_score":0.011417389},"labels":[],"label_agreement":null},{"id":"W2970630414","doi":"10.1016/j.antiviral.2019.104594","title":"Innate immune protection from pneumonia virus of mice induced by a novel immunomodulator is prolonged by dual treatment and mediated by macrophages","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Innate immune system; Nasal administration; Immunology; Immune system; Respiratory tract; Virus; Pneumonia; Lung; Lower respiratory tract infection; Medicine; Respiratory system; Biology; Respiratory tract infections; Internal medicine","score_opus":0.06255313066928946,"score_gpt":0.37170194956335884,"score_spread":0.30914881889406937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970630414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955134,0.0018275365,0.0014837058,0.00012767779,0.00011140376,0.000034735043,0.000119910386,0.00005384093,0.00072773383],"genre_scores_gemma":[0.99521154,0.00080830755,0.0017308716,0.000105486426,0.00009947255,0.00010045792,0.00019988924,0.000016086116,0.0017279194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997546,0.000052322845,0.00001866789,0.0000444822,0.00003186527,0.00009805885],"domain_scores_gemma":[0.9998733,0.000013141247,0.000032527692,0.000020304433,0.00001052628,0.000050262202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022488652,0.0006499069,0.00056205085,0.00028527115,0.00018925923,0.00028910133,0.00025361296,0.00045063312,0.0011921466],"category_scores_gemma":[0.00011609225,0.00015035665,0.00040345752,0.00009653795,0.00036521885,0.00036524062,0.00034000364,0.0012988583,0.00026675037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021593294,0.00023875167,0.00029830783,0.00006256398,0.00001123765,0.000061025687,0.000021886373,0.000044716122,0.9938018,0.0001462214,0.000054522763,0.0030996208],"study_design_scores_gemma":[0.0003688433,0.0057792286,0.0053062323,0.000023305298,0.0001015898,0.00038684165,0.000059900325,0.00066114444,0.9834542,0.00019159642,0.0036509968,0.000016025597],"about_ca_topic_score_codex":0.00006344367,"about_ca_topic_score_gemma":0.0001450473,"teacher_disagreement_score":0.0011921466,"about_ca_system_score_codex":0.00011975663,"about_ca_system_score_gemma":0.00020519346,"threshold_uncertainty_score":0.003988147},"labels":[],"label_agreement":null},{"id":"W2974084556","doi":"10.1016/j.antiviral.2019.104611","title":"GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Chikungunya; Epidemiology; Virology; Outbreak; Medicine; Disease; Natural history; Environmental health; Pathology","score_opus":0.23129628375727188,"score_gpt":0.4956612875635213,"score_spread":0.2643650038062494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974084556","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8880595,0.024218103,0.0037248596,0.0028753167,0.0018019427,0.0022255774,0.042039093,0.0002638749,0.03479175],"genre_scores_gemma":[0.914243,0.019061105,0.0038761443,0.001796625,0.00068606547,0.0004695783,0.04760499,0.00011011216,0.0121524185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995788,0.000076413366,0.000096014,0.000070228336,0.00009139955,0.00008717481],"domain_scores_gemma":[0.9992281,0.00015390903,0.00018328991,0.00007257374,0.00015980353,0.00020227737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008020439,0.00070368976,0.0002795852,0.0014888686,0.00040478003,0.0005382983,0.0003844421,0.0006625263,0.0019150914],"category_scores_gemma":[0.00096424524,0.00033016686,0.00047359444,0.0010520638,0.0004717143,0.00047974108,0.00089864293,0.00054872525,0.00063828926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008770222,0.00022337974,0.8102217,0.0024667485,0.00036367268,0.017684832,0.003449139,0.00090701185,0.044540275,0.00068942294,0.052690163,0.06588669],"study_design_scores_gemma":[0.000025013887,0.0002563795,0.93233854,0.0002806644,0.000067705805,0.007928872,0.00090789725,0.00014805552,0.0017000142,0.00011000863,0.05620368,0.00003315809],"about_ca_topic_score_codex":0.023667622,"about_ca_topic_score_gemma":0.012939223,"teacher_disagreement_score":0.023667622,"about_ca_system_score_codex":0.00072294386,"about_ca_system_score_gemma":0.0013100734,"threshold_uncertainty_score":0.047059774},"labels":[],"label_agreement":null},{"id":"W2982098704","doi":"10.1016/j.antiviral.2019.104640","title":"The Biosafety Level 4 Zoonotic Laboratory Network (BSL4ZNet): Report of a workshop on live animal handling","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Animal Disease Management and Epidemiology","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Canadian Food Inspection Agency","funders":"National Institutes of Health; Commonwealth Scientific and Industrial Research Organisation; U.S. Department of Agriculture","keywords":"Biosafety; Animal welfare; Excellence; Animal health; Library science; Political science; Medicine; Environmental health; Medical education; Veterinary medicine; Law; Biology; Pathology; Computer science","score_opus":0.3675134541537822,"score_gpt":0.43602542996875276,"score_spread":0.06851197581497054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982098704","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035994253,0.9844334,0.0006519958,0.0055688927,0.002959418,0.00012504717,0.0006523361,0.000046634563,0.00520234],"genre_scores_gemma":[0.0020550664,0.985005,0.0014983605,0.0037536295,0.00053573475,0.0001008604,0.0013484538,0.000011687983,0.005691191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907196,0.00017863419,0.000129532,0.00006633252,0.0003901893,0.00016332332],"domain_scores_gemma":[0.99780613,0.00056475727,0.00042977044,0.000036197598,0.0009298827,0.0002332329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004587673,0.0014592807,0.0012191039,0.0026193473,0.00035620882,0.0013182146,0.0015944571,0.0025323047,0.0060557313],"category_scores_gemma":[0.0022570963,0.00040515646,0.00088992104,0.002534612,0.00044575328,0.0013745303,0.001404439,0.0026916487,0.001994518],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027900733,0.00014262238,0.00033134964,0.019586127,0.00009223615,0.00012481217,0.000053883334,0.0004825819,0.0015512172,0.0015827478,0.2106317,0.7651418],"study_design_scores_gemma":[0.00005816744,0.00012726692,0.0014358716,0.008113221,0.00016511412,0.00014581557,0.000061994666,0.000092653056,0.00070932665,0.00033206827,0.98874295,0.000015562326],"about_ca_topic_score_codex":0.017286368,"about_ca_topic_score_gemma":0.02641953,"teacher_disagreement_score":0.017286368,"about_ca_system_score_codex":0.002639041,"about_ca_system_score_gemma":0.009942599,"threshold_uncertainty_score":0.034371495},"labels":[],"label_agreement":null},{"id":"W2993785019","doi":"10.1016/j.antiviral.2019.104670","title":"GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 5: Entomological aspects","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"Medical Research Council","keywords":"Alphavirus; Virology; Chikungunya; Biology; Virus","score_opus":0.24054939034977815,"score_gpt":0.5018523121365485,"score_spread":0.2613029217867703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993785019","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5021545,0.09309372,0.007897998,0.016999489,0.02009407,0.011600922,0.09198471,0.0009341795,0.2552404],"genre_scores_gemma":[0.6441803,0.067045175,0.009025804,0.012599014,0.010075939,0.0013816726,0.13512014,0.0003055282,0.12026643],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995383,0.00008386139,0.00008066687,0.00004878789,0.00016304341,0.00008542844],"domain_scores_gemma":[0.9991903,0.00012020094,0.00015480511,0.00006267303,0.00025687632,0.00021507448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011147233,0.0007511342,0.00024701917,0.0013900952,0.00048907375,0.00065247883,0.0005047606,0.0011860038,0.004216669],"category_scores_gemma":[0.00067781727,0.00028293522,0.0004894632,0.00093857513,0.0003855796,0.0005315401,0.00096714584,0.0007948557,0.0016495766],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014258246,0.0008128328,0.3509137,0.00494301,0.00038021334,0.021194585,0.0021745127,0.0015393907,0.08145946,0.0017191251,0.35744938,0.17598796],"study_design_scores_gemma":[0.00004519032,0.0008034123,0.51566476,0.0004966603,0.00007549531,0.005190372,0.00076435204,0.000273414,0.0037583478,0.00017936077,0.47270623,0.000042481824],"about_ca_topic_score_codex":0.018203774,"about_ca_topic_score_gemma":0.01448587,"teacher_disagreement_score":0.018203774,"about_ca_system_score_codex":0.00072739716,"about_ca_system_score_gemma":0.0014363006,"threshold_uncertainty_score":0.036195636},"labels":[],"label_agreement":null},{"id":"W2999137482","doi":"10.1016/j.antiviral.2019.104703","title":"The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: Potential effects on adaptive immunity and response to vaccination","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Diabetes Canada","keywords":"Lassa fever; Immunology; Immune system; Interferon; Acquired immune system; Disease; Virology; Biology; Immunity; Dengue fever; Virus; Medicine; Internal medicine","score_opus":0.4794942360077474,"score_gpt":0.5268524292306945,"score_spread":0.047358193222947154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999137482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011518422,0.99897975,0.00011151577,0.00015816353,0.00018981287,0.0000057437046,0.000019263372,0.000004207927,0.00041640108],"genre_scores_gemma":[0.00040043553,0.9988556,0.00014838159,0.00016654521,0.00008580202,0.000008969633,0.00003389268,0.0000013490085,0.00029912454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981993,0.000042903397,0.000031221905,0.000033511842,0.000053043692,0.000019405175],"domain_scores_gemma":[0.9995254,0.00029215045,0.00005771027,0.000017631668,0.000076038275,0.0000311669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009351238,0.00082579954,0.0012441813,0.0017474947,0.00015003298,0.0006377089,0.0007296146,0.00092162454,0.0023577744],"category_scores_gemma":[0.0008055906,0.00023032744,0.00072741066,0.0013254283,0.0006519666,0.0011063277,0.00059116184,0.0022608472,0.0010321853],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021600397,0.00009311494,0.00012737127,0.024706675,0.00016504459,0.0001077841,0.00004986822,0.00022473565,0.009519728,0.005465276,0.02419867,0.9351257],"study_design_scores_gemma":[0.00009834486,0.00031427408,0.0012654036,0.0067593087,0.00033172188,0.0009172784,0.0000388843,0.00006619042,0.0031380241,0.0029600624,0.9840784,0.00003214127],"about_ca_topic_score_codex":0.0006281108,"about_ca_topic_score_gemma":0.0010395398,"teacher_disagreement_score":0.0023577744,"about_ca_system_score_codex":0.00046710932,"about_ca_system_score_gemma":0.00073644257,"threshold_uncertainty_score":0.007887542},"labels":[],"label_agreement":null},{"id":"W3005409321","doi":"10.1016/j.antiviral.2020.104742","title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1837,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Horizon 2020; Canadian Institutes of Health Research","keywords":"Furin; Virology; Coronavirus; Biology; Genome; Cleavage (geology); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Glycoprotein; Coronavirus disease 2019 (COVID-19); Betacoronavirus; Pandemic; Genetics; Clade; Computational biology; Gene; Phylogenetic tree; Infectious disease (medical specialty); Medicine","score_opus":0.11049972145780963,"score_gpt":0.41003661453462376,"score_spread":0.29953689307681414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005409321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963961,0.00023691577,0.001705535,0.00008577027,0.00004892247,0.000015195535,0.000425676,0.000016295884,0.0010694346],"genre_scores_gemma":[0.99279517,0.00013110331,0.0026924524,0.00018570507,0.000020387844,0.000008420258,0.0029844937,0.000014020608,0.00116832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987245,0.000015456659,0.00001168944,0.000021292855,0.0000523355,0.000026834594],"domain_scores_gemma":[0.99969053,0.00004964628,0.00007979893,0.00003899938,0.00005272451,0.000088360626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016256362,0.00023044474,0.00027413171,0.00017871875,0.00030505503,0.00043476332,0.0001702577,0.00044138922,0.0007656964],"category_scores_gemma":[0.00035640007,0.00010455973,0.00047937012,0.00021375563,0.00035044295,0.00029804907,0.00022325454,0.000560262,0.00044992403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020909974,0.000022368875,0.0017872929,0.00002026984,0.000015192707,0.00035730485,0.00003835426,0.000077280485,0.9954917,0.00034440146,0.00008593835,0.0015508289],"study_design_scores_gemma":[0.0000843282,0.0009714308,0.1607852,0.000031817195,0.00009115653,0.007967878,0.0003269753,0.003497446,0.8107956,0.00086932705,0.014525135,0.00005370988],"about_ca_topic_score_codex":0.0023927086,"about_ca_topic_score_gemma":0.0027633498,"teacher_disagreement_score":0.0023927086,"about_ca_system_score_codex":0.0006218428,"about_ca_system_score_gemma":0.0005348481,"threshold_uncertainty_score":0.004757583},"labels":[],"label_agreement":null},{"id":"W3007824046","doi":"10.1016/j.antiviral.2020.104753","title":"Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Oseltamivir; Virus; Pandemic; Virology; Placebo; Medicine; Influenza A virus; Antibody; Immunology; Biology; Internal medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.18570863436949855,"score_gpt":0.44838690740384346,"score_spread":0.2626782730343449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007824046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972097,0.0010758336,0.00023030999,0.000130064,0.000114705996,0.000060453363,0.00018337782,0.00005890212,0.0009366724],"genre_scores_gemma":[0.99566144,0.0006456073,0.0003970377,0.00012833932,0.0001161192,0.000101596044,0.00038292687,0.000018923389,0.0025481004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994523,0.0001665681,0.000038366426,0.00009227708,0.00005484877,0.0001956778],"domain_scores_gemma":[0.99901974,0.00031875435,0.00015570578,0.00012260127,0.00008057789,0.00030262378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011587202,0.0010997384,0.0010790188,0.00096007204,0.00040973615,0.0005975042,0.00093353476,0.0016015527,0.0011459029],"category_scores_gemma":[0.00082165905,0.0003802942,0.0008219962,0.00018722976,0.0015774702,0.0011845846,0.00033940838,0.0025091923,0.00027629483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050555952,0.0057632076,0.00172279,0.00025204744,0.00013264614,0.0002575774,0.00033932758,0.00065343594,0.92959946,0.0003908891,0.0004102097,0.009922404],"study_design_scores_gemma":[0.0016077787,0.08742795,0.009467621,0.00005088566,0.00026429349,0.00027916976,0.00021834667,0.0014410015,0.89747006,0.0002184056,0.0015125248,0.000041969404],"about_ca_topic_score_codex":0.0012071254,"about_ca_topic_score_gemma":0.0010258885,"teacher_disagreement_score":0.0016015527,"about_ca_system_score_codex":0.00054953626,"about_ca_system_score_gemma":0.0004070022,"threshold_uncertainty_score":0.0061279535},"labels":[],"label_agreement":null},{"id":"W3011607905","doi":"10.1016/j.antiviral.2020.104774","title":"Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Helmholtz-Alberta Initiative; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Medizinischen Hochschule Hannover; Deutsche Forschungsgemeinschaft; Helmholtz Association; Deutsches Zentrum für Infektionsforschung; National Science Foundation","keywords":"Virus; In vivo; Viral entry; Virology; Biology; Ex vivo; Pneumovirinae; Microbiology; Viral replication; Paramyxoviridae; Viral disease","score_opus":0.12217450116967979,"score_gpt":0.42640825407755867,"score_spread":0.3042337529078789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011607905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842398,0.009503868,0.0031587095,0.00006625718,0.000022117269,0.00012551909,0.00045127014,0.00007680897,0.0023555232],"genre_scores_gemma":[0.9890615,0.0042839935,0.003862237,0.000057819438,0.000011405721,0.00008728385,0.00057319005,0.000012581388,0.0020499171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999362,0.000016267033,0.0000051809916,0.000010344196,0.000017038017,0.000015005271],"domain_scores_gemma":[0.99996567,0.000005883381,0.000009182182,0.000002726472,0.0000053498547,0.000011137865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011784377,0.0003378459,0.00026422928,0.00021453868,0.000081574304,0.00021839049,0.00016154996,0.00020336646,0.0006224856],"category_scores_gemma":[0.00009773972,0.00008308787,0.00017685353,0.00016020465,0.00010338231,0.00014357317,0.00018620712,0.00037555958,0.00019765203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019971405,0.000038249884,0.00014432146,0.000078234734,0.000007400757,0.000068630565,0.000013155696,0.00021915542,0.99437535,0.00005591179,0.000033686483,0.0047661643],"study_design_scores_gemma":[0.00008637333,0.0020555016,0.0032903603,0.000016663851,0.000026116726,0.00038501094,0.000025290732,0.0010361138,0.9875216,0.000050530674,0.0054971054,0.000009238812],"about_ca_topic_score_codex":0.00033718065,"about_ca_topic_score_gemma":0.0006479371,"teacher_disagreement_score":0.0006224856,"about_ca_system_score_codex":0.00018047763,"about_ca_system_score_gemma":0.00013929416,"threshold_uncertainty_score":0.0020824075},"labels":[],"label_agreement":null},{"id":"W3013944367","doi":"10.1016/j.antiviral.2020.104780","title":"Put a cork in it: Plugging the M2 viral ion channel to sink influenza","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health; Health Research","keywords":"Virology; Virus; Adamantane; Influenza A virus; Pandemic; Biology; Chemistry; Coronavirus disease 2019 (COVID-19); Medicine; Infectious disease (medical specialty)","score_opus":0.4645564701714462,"score_gpt":0.5617031123935495,"score_spread":0.09714664222210334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013944367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030789952,0.9922059,0.00057792524,0.0018048165,0.0022340082,0.000018571656,0.000067345296,0.000072765084,0.0027107992],"genre_scores_gemma":[0.0027164493,0.98519725,0.0011773477,0.0036188858,0.0008366743,0.000024606235,0.0001377671,0.000019087825,0.006271806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998215,0.00003888942,0.000023336022,0.000028017572,0.000058691712,0.000029650535],"domain_scores_gemma":[0.99978906,0.00010338113,0.000026554346,0.000008659604,0.00004788981,0.000024426385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005895796,0.0008397459,0.0011315834,0.0012316105,0.00024308586,0.0014463733,0.0008780892,0.0018172546,0.007865826],"category_scores_gemma":[0.00088458776,0.0002394178,0.0009503641,0.00079050596,0.00046058898,0.002254094,0.0009179588,0.0025624158,0.004924592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024243529,0.00007853483,0.00011245466,0.020010449,0.00019595148,0.00019298198,0.000086444605,0.00019533707,0.005391876,0.006422842,0.089132756,0.8779379],"study_design_scores_gemma":[0.00008009076,0.000118714874,0.00031288512,0.0033291383,0.00019272286,0.0003670445,0.000056017023,0.000106207786,0.0012835343,0.0031311244,0.9909972,0.000025285814],"about_ca_topic_score_codex":0.0012641377,"about_ca_topic_score_gemma":0.0024867402,"teacher_disagreement_score":0.007865826,"about_ca_system_score_codex":0.0005267783,"about_ca_system_score_gemma":0.0009508006,"threshold_uncertainty_score":0.026313782},"labels":[],"label_agreement":null},{"id":"W3019419026","doi":"10.1016/j.antiviral.2020.104807","title":"Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Virology; Recombinant DNA; In vitro; Biology; Mutation; Virus; Genetics; Gene","score_opus":0.2550754146358055,"score_gpt":0.45181588539935874,"score_spread":0.19674047076355322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019419026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967969,0.00040542227,0.0013509921,0.000028422905,0.000012410334,0.000032833086,0.0006754715,0.000021027927,0.00067661493],"genre_scores_gemma":[0.99223197,0.00035194715,0.002868998,0.00004729641,0.000010586783,0.00004438796,0.0030123005,0.000030062196,0.0014024152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998246,0.00003484766,0.00002057238,0.00004064147,0.000040826493,0.000038438553],"domain_scores_gemma":[0.9998455,0.00004669509,0.000035614492,0.000026824122,0.000022732058,0.000022590222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020017124,0.00031331042,0.00016250784,0.00025454245,0.00015533982,0.00033469824,0.00029284833,0.00024562018,0.0007876558],"category_scores_gemma":[0.00024928837,0.0001266974,0.00030913574,0.00017328603,0.00020025561,0.0001955542,0.00013608317,0.0005741576,0.0003656897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000731077,0.000024997611,0.0002753762,0.000009822666,0.000004524391,0.00002429761,0.00001649475,0.000053196778,0.9990478,0.00004504684,0.000012680249,0.00041260108],"study_design_scores_gemma":[0.000033298846,0.0014799339,0.014994253,0.000008966888,0.00005134645,0.0009698774,0.00014403654,0.0013888917,0.9779203,0.000071826325,0.0029275082,0.000009767722],"about_ca_topic_score_codex":0.0012001238,"about_ca_topic_score_gemma":0.00080696243,"teacher_disagreement_score":0.0012001238,"about_ca_system_score_codex":0.0002047176,"about_ca_system_score_gemma":0.000118956756,"threshold_uncertainty_score":0.0026349425},"labels":[],"label_agreement":null},{"id":"W3022455442","doi":"10.1016/j.antiviral.2020.104816","title":"Mechanisms of HBV immune evasion","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Innate immune system; Acquired immune system; Immunology; Immunity; Immune system; Biology; Context (archaeology); Hepatitis B virus; Evasion (ethics); Virology; Virus","score_opus":0.3115883086993262,"score_gpt":0.5095569659367478,"score_spread":0.19796865723742163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022455442","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028322038,0.99947387,0.000025803794,0.000117465046,0.00007802541,0.0000025156712,0.00000832129,0.0000017604002,0.00026391304],"genre_scores_gemma":[0.00032218252,0.9992742,0.000059807244,0.00010917046,0.00009202206,0.0000041106896,0.000011100227,3.5154403e-7,0.00012711925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976116,0.00006933686,0.00004328158,0.00003397644,0.000065230815,0.000027086911],"domain_scores_gemma":[0.99954647,0.00028292846,0.00007279577,0.000010646138,0.00006133983,0.000025788151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009001168,0.0010644905,0.0019781317,0.0025485768,0.00021887576,0.0013508211,0.0006329821,0.001188763,0.0046614553],"category_scores_gemma":[0.0012768838,0.00030739294,0.0006735027,0.0020818312,0.0005250709,0.0011626951,0.0007935234,0.0014290683,0.0012677562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021523373,0.000051711937,0.00025282466,0.055062503,0.0002459819,0.0001693546,0.000049384835,0.00024158681,0.0009456792,0.0030653595,0.021359148,0.9183412],"study_design_scores_gemma":[0.00016817919,0.00022496987,0.001742353,0.035673726,0.0011308707,0.0013877655,0.00014730672,0.00015615803,0.0005807223,0.0048521324,0.9538962,0.000039717117],"about_ca_topic_score_codex":0.001214258,"about_ca_topic_score_gemma":0.0023923977,"teacher_disagreement_score":0.0046614553,"about_ca_system_score_codex":0.0007565402,"about_ca_system_score_gemma":0.0015918328,"threshold_uncertainty_score":0.015594065},"labels":[],"label_agreement":null},{"id":"W3037030278","doi":"10.1016/j.antiviral.2020.104853","title":"Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"HBsAg; Hepatitis B virus; Virology; Biology; Immune system; Virus; Antibody; HBeAg; Immunology","score_opus":0.07151390067108727,"score_gpt":0.3604882220197021,"score_spread":0.28897432134861484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037030278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865281,0.004029996,0.0036927476,0.000104494466,0.000047805108,0.00007299844,0.000862164,0.000057382218,0.0046044523],"genre_scores_gemma":[0.9844716,0.0023977144,0.004341242,0.0000831871,0.000032134092,0.000086036314,0.0026806185,0.000038859787,0.005868448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998136,0.00006695972,0.000020451713,0.000019399466,0.000045089324,0.000034510475],"domain_scores_gemma":[0.9997912,0.000096415984,0.000018220087,0.00003650026,0.0000420495,0.00001555471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003372906,0.00028792652,0.00021386266,0.00022607886,0.00018037217,0.00022977404,0.00017261994,0.00021534922,0.0028279622],"category_scores_gemma":[0.0003248212,0.00014023171,0.00041288018,0.00018688498,0.00016611812,0.00027892838,0.0001387623,0.0004445725,0.0010193969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018281171,0.000056044264,0.00012892991,0.000059884598,0.000004699636,0.000043608623,0.00003091716,0.0000480602,0.9978375,0.00007449944,0.00003094654,0.0015020518],"study_design_scores_gemma":[0.00001089411,0.0005870602,0.0023744274,0.000006800762,0.000015503083,0.000117799995,0.00002980357,0.00026069998,0.9948927,0.000026226315,0.001674095,0.0000039346396],"about_ca_topic_score_codex":0.00051844923,"about_ca_topic_score_gemma":0.0004346916,"teacher_disagreement_score":0.0028279622,"about_ca_system_score_codex":0.00012365854,"about_ca_system_score_gemma":0.00018101135,"threshold_uncertainty_score":0.009460509},"labels":[],"label_agreement":null},{"id":"W3041182781","doi":"10.1016/j.antiviral.2020.104859","title":"Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico; International Development Research Centre; University of Alberta","keywords":"Zika virus; Virology; Sofosbuvir; Transmission (telecommunications); Medicine; Biology; Virus; Computer science","score_opus":0.031691202223836104,"score_gpt":0.3313672773429618,"score_spread":0.2996760751191257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041182781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987192,0.0005204587,0.00007200813,0.000039932933,0.00001269593,0.0000040149653,0.00004030997,0.000012600182,0.0005788516],"genre_scores_gemma":[0.9989268,0.0003421296,0.00012525904,0.000027431137,0.000014633957,0.000005684191,0.00007659014,0.000003885442,0.00047751865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999335,0.000021166801,0.000004259708,0.000008249245,0.0000061603014,0.000026658669],"domain_scores_gemma":[0.999897,0.00002680663,0.000015772834,0.000013957986,0.000008234277,0.000038262377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013094874,0.0002203022,0.00017785413,0.0001747775,0.00015462264,0.00014845764,0.00015285182,0.0002110784,0.000819301],"category_scores_gemma":[0.00024866028,0.00009232177,0.00015869114,0.00006040822,0.0002672809,0.00012350688,0.000068366586,0.00031803502,0.00013889243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039610714,0.00025179485,0.0025674303,0.000080349164,0.000046979752,0.00025363563,0.000070131995,0.00016647956,0.9826878,0.00025424786,0.00026898217,0.009391208],"study_design_scores_gemma":[0.0005447438,0.02342704,0.08633722,0.0000304677,0.00021472482,0.0017560638,0.00021475657,0.0022160653,0.8797906,0.00042264911,0.0050227838,0.000022890921],"about_ca_topic_score_codex":0.0009832802,"about_ca_topic_score_gemma":0.00088885834,"teacher_disagreement_score":0.0009832802,"about_ca_system_score_codex":0.00011780704,"about_ca_system_score_gemma":0.00016880655,"threshold_uncertainty_score":0.0027408004},"labels":[],"label_agreement":null},{"id":"W3048772446","doi":"10.1016/j.antiviral.2020.104903","title":"Viperin protein inhibits the replication of caprine parainfluenza virus type 3 (CPIV 3) by interaction with viral N protein","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Agriculture","funders":"Postdoctoral Science Foundation of Jiangsu Province; National Natural Science Foundation of China; China Postdoctoral Science Foundation; Jiangsu Agricultural Science and Technology Innovation Fund","keywords":"Virology; Replication (statistics); Viral replication; Biology; Virus","score_opus":0.10710064305604855,"score_gpt":0.40899579909448636,"score_spread":0.3018951560384378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048772446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957669,0.0019691114,0.00047392608,0.000053970325,0.00003505217,0.000012430979,0.0000447207,0.000020755231,0.0016231806],"genre_scores_gemma":[0.9973145,0.00050751364,0.00046819806,0.00005204642,0.000019261237,0.000013300592,0.00015060965,0.000006399069,0.0014682048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998313,0.000048293557,0.000008772912,0.000019428173,0.000032052027,0.000060023027],"domain_scores_gemma":[0.9999174,0.000029052995,0.000014514443,0.000008189415,0.000006538517,0.000024232451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015692205,0.00021044859,0.0002790973,0.00008198458,0.00019399586,0.00022368047,0.0002872961,0.00032518743,0.0011959011],"category_scores_gemma":[0.00023205209,0.00010393763,0.00025378275,0.00005748136,0.00024579235,0.00013183679,0.00019953668,0.00043424495,0.00023553544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064938277,0.00007925985,0.00041749366,0.000064556094,0.000020665328,0.00012079899,0.000016891048,0.00010366606,0.99655825,0.00008646883,0.0001049566,0.0017776348],"study_design_scores_gemma":[0.0001089727,0.0020154635,0.018379133,0.000014849691,0.000038674487,0.0006433986,0.00004711173,0.0020395345,0.9731598,0.000088575594,0.0034555225,0.000009075634],"about_ca_topic_score_codex":0.0008656436,"about_ca_topic_score_gemma":0.0009863484,"teacher_disagreement_score":0.0011959011,"about_ca_system_score_codex":0.00025683155,"about_ca_system_score_gemma":0.00021698324,"threshold_uncertainty_score":0.0040007234},"labels":[],"label_agreement":null},{"id":"W3095531782","doi":"10.1016/j.antiviral.2020.104970","title":"Burden of influenza B virus infection and considerations for clinical management","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Department of Health and Aged Care, Australian Government; Roche","keywords":"Medicine; Epidemiology; Pandemic; Neuraminidase; Disease; Intensive care medicine; Disease burden; Virology; Virus; Clinical trial; Neuraminidase inhibitor; Disease management; Immunology; Infectious disease (medical specialty); Coronavirus disease 2019 (COVID-19); Internal medicine","score_opus":0.6702519866143979,"score_gpt":0.6349529966941866,"score_spread":0.0352989899202113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095531782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027593915,0.9977919,0.000043070533,0.0016391451,0.00022530014,0.000005202048,0.000014336465,0.0000029559756,0.0002504702],"genre_scores_gemma":[0.0003476095,0.99817634,0.00019637877,0.0008762343,0.00023124139,0.000011608715,0.000020185558,9.978943e-7,0.000139405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824345,0.00071065297,0.00042778335,0.00012119336,0.00042519247,0.00007172961],"domain_scores_gemma":[0.9957824,0.002960267,0.00052685564,0.00005808379,0.0005740094,0.00009844945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037958708,0.0008495059,0.0026792127,0.0027218666,0.00043862368,0.0020297088,0.0012682666,0.0020223612,0.005293166],"category_scores_gemma":[0.0071351067,0.00039384037,0.0014776462,0.0022071966,0.0007075466,0.0027276354,0.0010707781,0.002526287,0.0013948659],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001601028,0.000043631262,0.00027923982,0.11341354,0.0005143545,0.00027855212,0.00020288439,0.00036197042,0.0004892329,0.0050129923,0.06549282,0.81375074],"study_design_scores_gemma":[0.000060039434,0.00012898864,0.001292677,0.122780725,0.0009067738,0.0012229433,0.00041573768,0.00010456703,0.00013288965,0.0053819953,0.8675331,0.000039450068],"about_ca_topic_score_codex":0.0033643031,"about_ca_topic_score_gemma":0.0059523354,"teacher_disagreement_score":0.005293166,"about_ca_system_score_codex":0.00145595,"about_ca_system_score_gemma":0.004352481,"threshold_uncertainty_score":0.020074785},"labels":[],"label_agreement":null},{"id":"W3107388860","doi":"10.1016/j.antiviral.2020.104972","title":"Host RNA quality control as a hepatitis B antiviral target","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Virology; RNA; Medicine; Biology; Genetics; Gene","score_opus":0.19952415320008277,"score_gpt":0.500807972834056,"score_spread":0.3012838196339732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107388860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029899766,0.99947363,0.000027907732,0.00011130426,0.000085087115,0.000003042873,0.000012209659,0.0000023211542,0.00025457176],"genre_scores_gemma":[0.00037930172,0.9990922,0.00009161821,0.00018070787,0.00007921873,0.000004890526,0.00001774979,6.7071574e-7,0.0001536794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996948,0.000079282014,0.000061298175,0.000050082523,0.000083091196,0.00003147041],"domain_scores_gemma":[0.99907047,0.0005927441,0.00013997675,0.0000176911,0.00013243635,0.000046745838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013493141,0.001167311,0.0023830533,0.0033927583,0.00022420165,0.0015490043,0.0006896421,0.0014406033,0.006106455],"category_scores_gemma":[0.0017954978,0.00040991686,0.0010036157,0.0028764012,0.0005323229,0.0012600044,0.0007728802,0.0017865245,0.0014275034],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030529976,0.000066123815,0.00018787138,0.10216373,0.000481948,0.00014830672,0.00004956745,0.00026276105,0.0013154758,0.0024177402,0.02546805,0.8671331],"study_design_scores_gemma":[0.0002811506,0.00031761156,0.0014155766,0.04847566,0.0028887233,0.00080410426,0.00012020918,0.0001781045,0.0007645352,0.0027118833,0.94199544,0.000047040307],"about_ca_topic_score_codex":0.001807616,"about_ca_topic_score_gemma":0.0038781145,"teacher_disagreement_score":0.006106455,"about_ca_system_score_codex":0.0009292331,"about_ca_system_score_gemma":0.0022168453,"threshold_uncertainty_score":0.02042818},"labels":[],"label_agreement":null},{"id":"W3128621058","doi":"10.1016/j.antiviral.2021.105034","title":"Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies","year":2021,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Antiviral therapy; Disease; Limiting; Medicine; Virology; Intensive care medicine; Virus; Outbreak; Immunology; Biology; Internal medicine","score_opus":0.2334401548311417,"score_gpt":0.5003849075069242,"score_spread":0.26694475267578255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128621058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009010985,0.9987664,0.00021560659,0.00014871004,0.00016096035,0.0000046411324,0.000010106217,0.000006243241,0.0005973053],"genre_scores_gemma":[0.00055133784,0.99834883,0.00032959884,0.00016585272,0.00010967622,0.000007487272,0.000025646976,0.000001589505,0.00045991378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998398,0.000028310178,0.000016687642,0.000028100128,0.000058119025,0.000028964761],"domain_scores_gemma":[0.9997414,0.00014208957,0.000026478481,0.000008025101,0.00005265257,0.00002934685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009160955,0.0011446777,0.0015003326,0.0015172014,0.00023460935,0.0012306167,0.0009104051,0.001067679,0.0030685368],"category_scores_gemma":[0.00062213116,0.00029549754,0.00049577,0.0013641332,0.00058938575,0.0014819355,0.0007080677,0.0025788133,0.0017595993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016305414,0.00012380537,0.000113042464,0.010213218,0.00008007751,0.00020179499,0.000043739557,0.0004894751,0.0048568216,0.0058412952,0.02289608,0.95497745],"study_design_scores_gemma":[0.000052839798,0.00018025779,0.00036366086,0.0020038204,0.00011830696,0.000730734,0.000042655054,0.00015628438,0.0015152537,0.0024372984,0.9923768,0.000022058648],"about_ca_topic_score_codex":0.000789463,"about_ca_topic_score_gemma":0.0019294537,"teacher_disagreement_score":0.0030685368,"about_ca_system_score_codex":0.0006846289,"about_ca_system_score_gemma":0.0009030681,"threshold_uncertainty_score":0.010265291},"labels":[],"label_agreement":null},{"id":"W3130514573","doi":"10.1016/j.antiviral.2021.105046","title":"Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Institute of Infection and Immunity","keywords":"Foscarnet; Ganciclovir; DNA polymerase; Virology; Mutant; Biology; Human cytomegalovirus; Recombinant DNA; Herpes simplex virus; Molecular biology; DNA; Mutation; Virus; Genetics; Gene","score_opus":0.08317647964692601,"score_gpt":0.42198399510508827,"score_spread":0.33880751545816223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130514573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779296,0.000674271,0.00042840684,0.00003828209,0.000063569016,0.00001062735,0.00014034119,0.000017352966,0.00083411334],"genre_scores_gemma":[0.99852556,0.00024970408,0.00035463073,0.00004533822,0.000014388209,0.0000061232745,0.00022168258,0.000020594262,0.0005619795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938,0.0001680131,0.00007420799,0.00010297945,0.00011176182,0.00016297438],"domain_scores_gemma":[0.999456,0.00021632429,0.00010383245,0.000043428354,0.000056536228,0.00012384288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040264777,0.0005517648,0.00049842446,0.0004016219,0.00030131848,0.00055537565,0.00035075075,0.0004296123,0.0036980251],"category_scores_gemma":[0.0009047148,0.00023090905,0.0005433314,0.0003274288,0.00059932104,0.0002845942,0.00033363482,0.0006000386,0.0005690327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039849025,0.00014090817,0.0024758382,0.00010984714,0.00013008667,0.00038856862,0.000069769034,0.000784788,0.98729837,0.00039965694,0.000094784504,0.004122577],"study_design_scores_gemma":[0.00011566455,0.0020573176,0.013946228,0.00003462162,0.00033361142,0.0007683776,0.00022710122,0.0025191393,0.97744465,0.0002644479,0.0022567264,0.000032040352],"about_ca_topic_score_codex":0.0017610707,"about_ca_topic_score_gemma":0.0019103413,"teacher_disagreement_score":0.0036980251,"about_ca_system_score_codex":0.0003648312,"about_ca_system_score_gemma":0.00049983844,"threshold_uncertainty_score":0.012371123},"labels":[],"label_agreement":null},{"id":"W3154943564","doi":"10.1016/j.antiviral.2021.105078","title":"A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Exoribonuclease; RNA-dependent RNA polymerase; Virology; Biology; Proofreading; Polymerase; RNA polymerase; Favipiravir; RNA; Genetics; Gene; Coronavirus disease 2019 (COVID-19); Medicine","score_opus":0.08491855043424056,"score_gpt":0.4161720030832382,"score_spread":0.33125345264899764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154943564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82321614,0.027549693,0.10867903,0.0009376597,0.0010353974,0.0012346533,0.0079787625,0.0009710026,0.02839764],"genre_scores_gemma":[0.8692933,0.013641252,0.08452514,0.0005400944,0.00020534697,0.0011106903,0.007410236,0.0000666233,0.023207273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989992,0.000298351,0.000111291534,0.00015224332,0.0003728212,0.0000660303],"domain_scores_gemma":[0.9996755,0.000120485456,0.000051656978,0.00005031124,0.00007643549,0.000025728197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005428691,0.0011695693,0.00077489536,0.00038509705,0.0002836653,0.00053921796,0.0005046173,0.0008958209,0.0023022057],"category_scores_gemma":[0.00035200763,0.00026548078,0.0004994941,0.00045238138,0.0002551881,0.00040712793,0.00033190486,0.0011847448,0.0014134248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006671927,0.00017136113,0.00031551154,0.0001856662,0.000019360023,0.000047967584,0.000031368214,0.00015997462,0.99524903,0.00011307467,0.00017799511,0.0034620273],"study_design_scores_gemma":[0.000019223333,0.0016015567,0.0009864203,0.000013686995,0.00003184559,0.00018282946,0.00002809857,0.00082863524,0.9930622,0.00005812589,0.003173728,0.000013655729],"about_ca_topic_score_codex":0.00033829582,"about_ca_topic_score_gemma":0.0008040074,"teacher_disagreement_score":0.0023022057,"about_ca_system_score_codex":0.00019419742,"about_ca_system_score_gemma":0.000260571,"threshold_uncertainty_score":0.0077016354},"labels":[],"label_agreement":null},{"id":"W3165190372","doi":"10.1016/j.antiviral.2021.105103","title":"Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy","year":2021,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Neurological Disorders and Stroke; National Human Genome Research Institute; National Institutes of Health","keywords":"Lytic cycle; Epigenetics; Chromatin; Biology; Histone; Virus latency; Gene silencing; Epigenetic therapy; Cell biology; Genetics; Viral replication; Computational biology; Virus; DNA methylation; Gene; Gene expression","score_opus":0.1237211014503995,"score_gpt":0.4490785500216084,"score_spread":0.3253574485712089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165190372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019544056,0.991264,0.0015352109,0.0009459197,0.00081812695,0.00001586447,0.000048752663,0.000025490264,0.0033922598],"genre_scores_gemma":[0.017573828,0.9767522,0.0012202616,0.0006256697,0.0008512999,0.000027658545,0.000098016724,0.000007924879,0.0028431641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999194,0.000020558091,0.000009294046,0.000013645805,0.000024077262,0.000012939921],"domain_scores_gemma":[0.9999267,0.000031815973,0.000009885291,0.0000030202305,0.00001850299,0.0000101396345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034801933,0.00029261835,0.0005044208,0.00038943323,0.000121066245,0.0005166383,0.00033431873,0.00056490593,0.0020395594],"category_scores_gemma":[0.00023440296,0.000094313735,0.00026547088,0.0002842769,0.00028133878,0.0005334853,0.00031807992,0.0009172851,0.0007296167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030598845,0.00013186593,0.0006701794,0.014173524,0.00010263982,0.00080930936,0.000255932,0.001463694,0.13725175,0.026520774,0.023111168,0.7952031],"study_design_scores_gemma":[0.000034271554,0.00050501013,0.0017926495,0.0014381353,0.00011743667,0.0019900035,0.00011979759,0.0005888742,0.026678495,0.006632864,0.96006674,0.00003570107],"about_ca_topic_score_codex":0.00023385181,"about_ca_topic_score_gemma":0.00050016394,"teacher_disagreement_score":0.0020395594,"about_ca_system_score_codex":0.00042838973,"about_ca_system_score_gemma":0.0003803625,"threshold_uncertainty_score":0.0068230033},"labels":[],"label_agreement":null},{"id":"W3176968497","doi":"10.1016/j.antiviral.2021.105123","title":"Next-generation sequencing for cytomegalovirus antiviral resistance genotyping in a clinical virology laboratory","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; Public Health Agency of Canada; St. Paul's Hospital; University of British Columbia","funders":"Merck Canada; Faculty of Medicine, Prince of Songkla University; University of British Columbia","keywords":"Minion; Sanger sequencing; Ion semiconductor sequencing; DNA sequencing; Genotyping; Virology; Biology; Nanopore sequencing; Computational biology; Genetics; Genotype; DNA; Gene","score_opus":0.2735702276180468,"score_gpt":0.45701563234995074,"score_spread":0.18344540473190396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176968497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72228295,0.00690118,0.22554913,0.0065558706,0.0015347945,0.001867981,0.01075755,0.0032094829,0.021341119],"genre_scores_gemma":[0.8113633,0.0013508154,0.17089976,0.0048404234,0.00048511237,0.00070521026,0.005553268,0.00038860447,0.004413481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963806,0.0012402147,0.0002749985,0.0008725593,0.0009009195,0.00033071495],"domain_scores_gemma":[0.99633574,0.0017363671,0.00025478206,0.00029746533,0.0010062489,0.00036937319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030313346,0.0006828054,0.00075343,0.0016601591,0.0009049717,0.0017348421,0.0008995647,0.0014465022,0.0028635047],"category_scores_gemma":[0.005836958,0.00041742934,0.0009427803,0.00074917503,0.0005122025,0.0005864953,0.0008492242,0.0013379877,0.0011528499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024162584,0.0012736358,0.20752144,0.00085685414,0.0004911924,0.005233812,0.0026667556,0.0062123365,0.4974427,0.004420306,0.016726451,0.2547384],"study_design_scores_gemma":[0.00044306112,0.004524806,0.2409729,0.0018573591,0.001313182,0.01393438,0.0037364678,0.12347479,0.4304658,0.013608968,0.16534364,0.00032464185],"about_ca_topic_score_codex":0.0050102035,"about_ca_topic_score_gemma":0.006970097,"teacher_disagreement_score":0.0050102035,"about_ca_system_score_codex":0.001056702,"about_ca_system_score_gemma":0.0026049786,"threshold_uncertainty_score":0.016031384},"labels":[],"label_agreement":null},{"id":"W3212269280","doi":"10.1016/j.antiviral.2021.105206","title":"Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Monoclonal antibody; Virology; Antigenicity; Neutralization; Antibody; Neutralizing antibody; Virus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Biology; Vaccination; Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Immunology; Infectious disease (medical specialty)","score_opus":0.16186344511486248,"score_gpt":0.4262860896056333,"score_spread":0.2644226444907708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212269280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481771,0.0047059227,0.035444595,0.0005780418,0.00025885657,0.0013192353,0.0019491122,0.00023143819,0.0073357145],"genre_scores_gemma":[0.9506534,0.003824607,0.027472101,0.0008046881,0.00016611782,0.0008272429,0.00926401,0.00007720961,0.0069106207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943846,0.00009527525,0.0000513674,0.00007854008,0.0001328166,0.00020352329],"domain_scores_gemma":[0.9996599,0.00008107049,0.0000363665,0.000035090787,0.00013578162,0.000051918967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009053581,0.000994791,0.0005134854,0.00065152865,0.00034378716,0.0005296834,0.00073024444,0.0006511146,0.002391607],"category_scores_gemma":[0.0007670116,0.00044936512,0.0006355231,0.00036030207,0.00016670856,0.0003613645,0.00030666232,0.0013571713,0.0009158275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028113343,0.0003883911,0.00052849937,0.00007834104,0.000039307615,0.00010293877,0.00004529429,0.00063431624,0.9853892,0.00032381504,0.00056328333,0.011625472],"study_design_scores_gemma":[0.00066883396,0.0048014303,0.009003926,0.000041695654,0.00016368488,0.0011883852,0.000081303915,0.007379207,0.9477368,0.00034033196,0.02856503,0.000029311166],"about_ca_topic_score_codex":0.0016897662,"about_ca_topic_score_gemma":0.002061607,"teacher_disagreement_score":0.002391607,"about_ca_system_score_codex":0.0008167404,"about_ca_system_score_gemma":0.00043199354,"threshold_uncertainty_score":0.0080007315},"labels":[],"label_agreement":null},{"id":"W3216010712","doi":"10.1016/j.antiviral.2021.105209","title":"2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fundamental Research Funds for the Central Universities; National Key Research and Development Program of China; National Infrastructure for Microbiological Resources; Chinese Academy of Medical Sciences; National Natural Science Foundation of China","keywords":"Virology; RNA polymerase; Exoribonuclease; RNA-dependent RNA polymerase; Thio-; Coronavirus; Biology; Virus; Viral replication; RNA; Medicine; Coronavirus disease 2019 (COVID-19); Gene; Chemistry; Disease; Biochemistry; Infectious disease (medical specialty)","score_opus":0.10424055489291661,"score_gpt":0.4223945402369167,"score_spread":0.3181539853440001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216010712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474947,0.014720259,0.017016487,0.0003805835,0.00023649882,0.00064360164,0.0021293482,0.0004920558,0.016886478],"genre_scores_gemma":[0.9676476,0.008971178,0.013824876,0.00036235544,0.0000497663,0.0005468869,0.001804646,0.000037854825,0.0067549525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978834,0.000039307415,0.000018306495,0.00004748144,0.000058691337,0.00004793807],"domain_scores_gemma":[0.9999201,0.000019087554,0.000021053194,0.000009536403,0.000013458569,0.000016659864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022369581,0.00065239915,0.00039797666,0.00029426673,0.00016219575,0.00015032454,0.00035658188,0.00034950156,0.0019630482],"category_scores_gemma":[0.00015010209,0.00017234497,0.0002837781,0.00034530737,0.00015969935,0.00026857218,0.00017924626,0.000598054,0.0006331031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003169919,0.00043309605,0.00023134344,0.00035036012,0.000025653888,0.00014974737,0.000037155325,0.0008943086,0.9840794,0.00037238226,0.00052192155,0.012587586],"study_design_scores_gemma":[0.00019555744,0.0044654007,0.0020712204,0.000027545042,0.000036481477,0.00047918063,0.000033080665,0.0012985115,0.9823293,0.00008571124,0.008951808,0.00002607977],"about_ca_topic_score_codex":0.000344783,"about_ca_topic_score_gemma":0.001138322,"teacher_disagreement_score":0.0019630482,"about_ca_system_score_codex":0.00017496625,"about_ca_system_score_gemma":0.00023119565,"threshold_uncertainty_score":0.006567061},"labels":[],"label_agreement":null},{"id":"W3217351888","doi":"10.1016/j.antiviral.2021.105211","title":"Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"cccDNA; HBsAg; Virology; HBeAg; In vitro; Hepatitis B virus; In vivo; Viral replication; Biology; Molecular biology; Hepatitis B; Virus; Biochemistry","score_opus":0.18417890910065435,"score_gpt":0.46262113204812266,"score_spread":0.27844222294746834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217351888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772815,0.0050927456,0.005514759,0.00053833454,0.00014624129,0.0014644347,0.0018936414,0.00020511996,0.007863262],"genre_scores_gemma":[0.98362446,0.004329396,0.002906939,0.0002341484,0.00007153978,0.00038519021,0.0026225715,0.000039223527,0.005786511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982977,0.000052941672,0.000009591943,0.0000175895,0.000028487964,0.000061651546],"domain_scores_gemma":[0.9997658,0.000043211217,0.00004336226,0.00002208674,0.000040018873,0.000085509186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064105063,0.0007587673,0.00042997897,0.000457974,0.00028716275,0.00044441613,0.0005458096,0.00052588905,0.004038085],"category_scores_gemma":[0.0004003499,0.00028017678,0.00042194137,0.0002028405,0.00031466348,0.00040811472,0.00011472587,0.001187867,0.00083667814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014071387,0.013902584,0.0007566677,0.00050347863,0.0001648122,0.0002999303,0.00014018813,0.0025655685,0.92845803,0.0009028721,0.002328743,0.03590582],"study_design_scores_gemma":[0.0073976344,0.21693237,0.0060481555,0.00006570891,0.00042327994,0.0008512303,0.00010644494,0.0036583368,0.7464325,0.00036102804,0.017683892,0.000039441577],"about_ca_topic_score_codex":0.0013651762,"about_ca_topic_score_gemma":0.002033453,"teacher_disagreement_score":0.004038085,"about_ca_system_score_codex":0.00038775915,"about_ca_system_score_gemma":0.00092384627,"threshold_uncertainty_score":0.013508797},"labels":[],"label_agreement":null},{"id":"W4200346724","doi":"10.1016/j.antiviral.2021.105229","title":"Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged mice","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Immunogenicity; Adjuvant; Vaccination; Immunology; Immune system; Virology; Influenza vaccine; Virus; Biology; Influenza A virus; Medicine","score_opus":0.09122811490464562,"score_gpt":0.45445366300993256,"score_spread":0.36322554810528696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200346724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709904,0.0020039435,0.00041677538,0.000029479048,0.000044524008,0.000018330493,0.00008083606,0.000011639552,0.0002954698],"genre_scores_gemma":[0.99403447,0.0025528634,0.0012051538,0.00008144467,0.000082388215,0.000040288407,0.00022964607,0.000012945469,0.0017608759],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998708,0.000027895454,0.00001601281,0.000014838268,0.000023273673,0.000047234233],"domain_scores_gemma":[0.9996118,0.00007711401,0.00009191104,0.000018299981,0.00005000363,0.00015091423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003953205,0.00031576667,0.000404941,0.0002747995,0.000082081344,0.00017630734,0.00015739047,0.00022607863,0.000646531],"category_scores_gemma":[0.000367272,0.00013832713,0.0002557561,0.00008864122,0.00015738733,0.00030696305,0.0001418481,0.00042649847,0.00012687888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005678432,0.00041966658,0.00085511326,0.0001324875,0.000026114125,0.00005271139,0.000046859823,0.0002006151,0.9862459,0.0001101218,0.000054645574,0.0061773974],"study_design_scores_gemma":[0.00032636386,0.033230513,0.013955521,0.000039006904,0.00022001239,0.00022188203,0.0000852163,0.000628648,0.94840467,0.00015082215,0.002715621,0.00002172944],"about_ca_topic_score_codex":0.00020688809,"about_ca_topic_score_gemma":0.00037026955,"teacher_disagreement_score":0.000646531,"about_ca_system_score_codex":0.000099293895,"about_ca_system_score_gemma":0.0001828693,"threshold_uncertainty_score":0.0021628737},"labels":[],"label_agreement":null},{"id":"W4210245365","doi":"10.1016/j.antiviral.2022.105254","title":"5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis","year":2022,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Key Research and Development Program of China; Chinese Academy of Meteorological Sciences; Fundamental Research Funds for the Central Universities; Beijing Municipal Commission of Education; National Natural Science Foundation of China","keywords":"Virology; Biology; Coronavirus; RNA-dependent RNA polymerase; RNA polymerase; RNA; Genetics; Disease; Gene; Medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.14213532369573625,"score_gpt":0.42689788046419735,"score_spread":0.2847625567684611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210245365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98869985,0.0039379564,0.0019672685,0.00008169621,0.000037388276,0.00010343504,0.0008471011,0.00013250808,0.004192803],"genre_scores_gemma":[0.9901394,0.0024388244,0.002403331,0.000078439174,0.000012433093,0.000051354422,0.0017785432,0.000016653987,0.0030810304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999928,0.000013637101,0.0000063506286,0.000012239523,0.000020413307,0.00001947751],"domain_scores_gemma":[0.9999664,0.000008702463,0.000006303313,0.0000040736313,0.000006245177,0.000008348033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115051575,0.00039427012,0.0003094657,0.00033182767,0.0001176308,0.00017592614,0.0001597257,0.00019756216,0.0012029427],"category_scores_gemma":[0.00008787947,0.00008369014,0.00022338505,0.00020685674,0.00010819948,0.00009041626,0.00013123649,0.00031647462,0.00028156926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023044311,0.00012497505,0.0002702895,0.00008975145,0.0000097543225,0.00006417894,0.000014477237,0.00045783346,0.98990226,0.00007335541,0.00012943229,0.008633199],"study_design_scores_gemma":[0.00013669708,0.0041085067,0.004306703,0.000014579143,0.00003640355,0.0003050274,0.000029182225,0.0012514187,0.98420274,0.000038727918,0.005559989,0.000010022651],"about_ca_topic_score_codex":0.0009358895,"about_ca_topic_score_gemma":0.002197044,"teacher_disagreement_score":0.0012029427,"about_ca_system_score_codex":0.00019700591,"about_ca_system_score_gemma":0.00023532823,"threshold_uncertainty_score":0.004024267},"labels":[],"label_agreement":null},{"id":"W4225331163","doi":"10.1016/j.antiviral.2022.105328","title":"In vitro activity of letermovir against human cytomegalovirus isolates with different drug susceptibility phenotypes","year":2022,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Institute of Infection and Immunity; Canadian Institutes of Health Research; Merck Canada","keywords":"Human cytomegalovirus; Biology; Virology; Recombinant DNA; Polymerase; Sanger sequencing; DNA polymerase; Mutation; Virus; Genetics; DNA; Gene","score_opus":0.05244458202467387,"score_gpt":0.36691472865145586,"score_spread":0.31447014662678197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225331163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985136,0.0059495065,0.00091815955,0.00006134706,0.0001108642,0.000040491977,0.00095526176,0.000034852314,0.0020780943],"genre_scores_gemma":[0.9921868,0.0021733409,0.0012334668,0.000050478462,0.000042012984,0.000030216752,0.002429877,0.000014873981,0.0018389339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995732,0.00017914631,0.000055103304,0.00004927929,0.00006214088,0.000081258506],"domain_scores_gemma":[0.9995735,0.00023693012,0.000036110116,0.000051148334,0.00005105399,0.00005131181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004520613,0.0006241796,0.00042617356,0.00039167047,0.00024675176,0.00044995986,0.00034510792,0.0003705639,0.0018735372],"category_scores_gemma":[0.00075719407,0.00018318658,0.00047374432,0.00039128587,0.00026093496,0.00023226414,0.00025190198,0.00053515634,0.0005766508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025729362,0.00033124542,0.0011900784,0.0002063892,0.00006373926,0.00015779621,0.00012499266,0.0008129321,0.98969615,0.00012364086,0.00019628207,0.0045239194],"study_design_scores_gemma":[0.00007432626,0.0038309828,0.004922822,0.000017669716,0.00006664819,0.0002550285,0.00006414177,0.0006469829,0.9887782,0.000034201705,0.0012960301,0.00001301728],"about_ca_topic_score_codex":0.0018659525,"about_ca_topic_score_gemma":0.0016321136,"teacher_disagreement_score":0.0018735372,"about_ca_system_score_codex":0.00024608476,"about_ca_system_score_gemma":0.0002602713,"threshold_uncertainty_score":0.0062675476},"labels":[],"label_agreement":null},{"id":"W4251161773","doi":"10.1016/j.antiviral.2019.104610","title":"GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 3: Epidemiological distribution of Mayaro virus","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Epidemiology; Seroprevalence; Virology; Chikungunya; Virus; Natural history; Biology; Serology; Disease; Alphavirus; Medicine; Immunology; Antibody; Ecology; Internal medicine","score_opus":0.2324811269300088,"score_gpt":0.4959641093547184,"score_spread":0.2634829824247096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251161773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048352545,0.99814165,0.000040199422,0.00026389144,0.00018291785,0.000012757253,0.00010333399,0.000003239831,0.00076854863],"genre_scores_gemma":[0.0021595298,0.9967366,0.00008619094,0.00020285581,0.00007659922,0.000007813657,0.00015145805,8.9550144e-7,0.0005780392],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998388,0.000027930659,0.0000358866,0.000023767736,0.000052420055,0.000021080392],"domain_scores_gemma":[0.9995272,0.00015391722,0.00010201239,0.000014846346,0.00015771475,0.000044252847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001038398,0.00049725187,0.00072590687,0.002619989,0.00017232705,0.0006405245,0.00041889332,0.0005258507,0.002355186],"category_scores_gemma":[0.0008023416,0.00022227113,0.00070794753,0.0023701491,0.00030937576,0.00069835683,0.00047444616,0.00074767804,0.00049667066],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003047769,0.00007604273,0.001224666,0.032624904,0.00026839867,0.00023624669,0.00017098327,0.00031935808,0.0040556607,0.002334508,0.03920919,0.9191753],"study_design_scores_gemma":[0.00008072138,0.00042511773,0.015030737,0.012076603,0.00078614394,0.0015383116,0.00020698854,0.00013723536,0.002021254,0.0006531723,0.96701014,0.000033529872],"about_ca_topic_score_codex":0.008500807,"about_ca_topic_score_gemma":0.011241555,"teacher_disagreement_score":0.008500807,"about_ca_system_score_codex":0.0008085045,"about_ca_system_score_gemma":0.0027547062,"threshold_uncertainty_score":0.016902685},"labels":[],"label_agreement":null},{"id":"W4298148582","doi":"10.1016/j.antiviral.2022.105427","title":"Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir","year":2022,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Dolutegravir; Integrase; Elvitegravir; Raltegravir; Virology; Integrase inhibitor; Rilpivirine; Drug resistance; Pharmacology; Human immunodeficiency virus (HIV); Genotype; Medicine; Drug; Biology; Viral load; Genetics; Antiretroviral therapy; Gene","score_opus":0.040519588999534624,"score_gpt":0.33569647352513765,"score_spread":0.29517688452560303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298148582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751955,0.0008678574,0.00009276265,0.000028794275,0.0000034204013,0.000007612477,0.00029727022,0.000005073416,0.0011776383],"genre_scores_gemma":[0.9995128,0.00014984098,0.00006908917,0.000009109501,0.0000031315076,0.000002563363,0.00015185194,0.0000020231244,0.000099564626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997434,0.00007276776,0.000032342738,0.000066599794,0.00005511605,0.000029841452],"domain_scores_gemma":[0.9988531,0.00038266619,0.0004905852,0.00007328611,0.00012104554,0.00007928102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032276742,0.00012357568,0.00020847321,0.00046611304,0.000101545644,0.00029516107,0.00017482448,0.00021411832,0.0013867036],"category_scores_gemma":[0.0024408265,0.0000832649,0.00013044264,0.00041943332,0.00012843942,0.00014121947,0.00011281868,0.0002923459,0.00018405604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005936454,0.000052995063,0.986271,0.000030377698,0.000078990735,0.00035181278,0.000075159005,0.00019092264,0.0021546492,0.00006243832,0.00014743471,0.009990575],"study_design_scores_gemma":[0.0000060630136,0.00020304795,0.9969807,0.000010464914,0.000038459315,0.001646235,0.0000708831,0.00029901133,0.00043824618,0.0000555125,0.00024728512,0.0000039969914],"about_ca_topic_score_codex":0.0007458413,"about_ca_topic_score_gemma":0.00071720843,"teacher_disagreement_score":0.0013867036,"about_ca_system_score_codex":0.000115101175,"about_ca_system_score_gemma":0.000076333534,"threshold_uncertainty_score":0.00463897},"labels":[],"label_agreement":null},{"id":"W4311089805","doi":"10.1016/j.antiviral.2022.105484","title":"Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics","year":2022,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Université de Sherbrooke; Simon Fraser University; University of British Columbia","funders":"Mitacs; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Genome British Columbia","keywords":"Bafilomycin; Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Vero cell; EC50; Monoclonal antibody; Cell culture; Chemistry; Microbiology; In vitro; Coronavirus disease 2019 (COVID-19); Biology; Virus; Medicine; Biochemistry; Antibody; Immunology; Infectious disease (medical specialty); Disease","score_opus":0.21066745483164154,"score_gpt":0.45967938277607084,"score_spread":0.2490119279444293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311089805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94721663,0.0154460445,0.023090746,0.00046035906,0.0000874381,0.00046525197,0.0016446424,0.00027969043,0.011309372],"genre_scores_gemma":[0.9680864,0.007510138,0.018168854,0.00026215965,0.000019894353,0.00013946106,0.0011151853,0.00002619541,0.00467173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999294,0.000013631868,0.000004715947,0.000012400043,0.00002440669,0.000015366706],"domain_scores_gemma":[0.99995697,0.0000082835895,0.0000097906695,0.000003928086,0.000010405469,0.000010711505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016977768,0.00036828528,0.00027677073,0.00030887267,0.00010226152,0.00029942987,0.00015648903,0.00030250667,0.0015365558],"category_scores_gemma":[0.00011086662,0.000139323,0.0003463657,0.00016942222,0.00012489918,0.00022326135,0.00021786451,0.00033169484,0.0005282563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106455,0.00008177475,0.00021963131,0.00020371436,0.000015493359,0.00015936424,0.000025577187,0.0008067881,0.9871674,0.0003584865,0.00015852584,0.010696731],"study_design_scores_gemma":[0.000099868295,0.0026098583,0.0031355908,0.00007018455,0.00006580489,0.0005891008,0.00007916055,0.0017775643,0.96904314,0.0004302352,0.022080023,0.000019457195],"about_ca_topic_score_codex":0.0002431255,"about_ca_topic_score_gemma":0.0008748331,"teacher_disagreement_score":0.0015365558,"about_ca_system_score_codex":0.00021944563,"about_ca_system_score_gemma":0.00019814566,"threshold_uncertainty_score":0.005140245},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4361281962","doi":"10.1016/j.antiviral.2023.105577","title":"Corrigendum to “Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics” “Antiviral Research 209 (2023)/105484”","year":2023,"lang":"en","type":"erratum","venue":"Antiviral Research","topic":"Phytochemistry and Biological Activities","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Université de Sherbrooke; Simon Fraser University; University of British Columbia","funders":"National Institutes of Health; Sealy and Smith Foundation; Gillson Longenbaugh Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; John S. Dunn Foundation; Amon G. Carter Foundation","keywords":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Coronavirus disease 2019 (COVID-19); Lead (geology); 2019-20 coronavirus outbreak; Natural (archaeology); Medicine; Biology; Infectious disease (medical specialty); Internal medicine; Disease","score_opus":0.3318802516409663,"score_gpt":0.4201467638412243,"score_spread":0.088266512200258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361281962","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008155097,0.0015055054,0.000342159,0.03343685,0.94842,0.00006458773,0.0010417084,0.00027552395,0.014832091],"genre_scores_gemma":[0.0035585659,0.007452224,0.0025254968,0.08821385,0.19960462,0.00017112985,0.00383235,0.0006051102,0.6940367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970306,0.00025273906,0.00027786958,0.00040622722,0.001651724,0.0003807209],"domain_scores_gemma":[0.9914272,0.0012862528,0.0003959563,0.00046108165,0.0055590183,0.0008705562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020355831,0.0023922657,0.002283784,0.00344951,0.003263971,0.0037436667,0.0028995106,0.0064922883,0.14215554],"category_scores_gemma":[0.011999744,0.001185128,0.0022483424,0.0017527022,0.0012010621,0.0016865637,0.0014615643,0.0077470243,0.08910829],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022914928,0.00001204685,0.000012546792,0.000052552634,0.0000050699614,0.00005661377,0.0000020792265,0.000020149084,0.000097779535,0.0002269171,0.9961903,0.0033009017],"study_design_scores_gemma":[0.000047964277,0.000035160087,0.00061362924,0.00008382711,0.000030338979,0.00009925102,0.000012860355,0.00015156924,0.00063782796,0.00067064026,0.997593,0.00002386299],"about_ca_topic_score_codex":0.024689002,"about_ca_topic_score_gemma":0.04704583,"teacher_disagreement_score":0.14215554,"about_ca_system_score_codex":0.005081218,"about_ca_system_score_gemma":0.0051764706,"threshold_uncertainty_score":0.47555768},"labels":[],"label_agreement":null},{"id":"W4382396744","doi":"10.1016/j.antiviral.2023.105660","title":"Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Discontinuation; Capsid; Hepatitis B virus; Medicine; Combination therapy; Viral load; Hepatitis B; Virology; Internal medicine; Gastroenterology; Virus","score_opus":0.10915616196660032,"score_gpt":0.4383497965040562,"score_spread":0.32919363453745587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382396744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853766,0.00031497495,0.000095050855,0.000028829327,0.000011083618,0.00004051096,0.0004729953,0.000003927264,0.000494961],"genre_scores_gemma":[0.9966934,0.0002314523,0.00034840353,0.00014517049,0.000012860147,0.000063106854,0.0015227388,0.000009009332,0.00097392616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974483,0.00009850789,0.000023143042,0.00004812241,0.000035451005,0.00005006335],"domain_scores_gemma":[0.9996276,0.0000917545,0.0000790618,0.00003584981,0.000058853566,0.00010694338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048334684,0.00023496214,0.0005044528,0.00030719666,0.00037039738,0.0005249057,0.00017751665,0.00042608252,0.0022222712],"category_scores_gemma":[0.000632405,0.00022031649,0.00037760712,0.0002958499,0.00019765316,0.00019363513,0.00014474778,0.0005235104,0.00040613167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16038898,0.0056492677,0.4616664,0.0003708721,0.001060385,0.0011805696,0.0007209654,0.00090707705,0.29932782,0.0004815029,0.0027798596,0.06546621],"study_design_scores_gemma":[0.010829749,0.057699684,0.89846456,0.00007733069,0.00084420794,0.001973052,0.00068187434,0.0013951214,0.017600488,0.00024123806,0.010132476,0.000060210383],"about_ca_topic_score_codex":0.0009328342,"about_ca_topic_score_gemma":0.0014070402,"teacher_disagreement_score":0.0022222712,"about_ca_system_score_codex":0.0002539033,"about_ca_system_score_gemma":0.00031592627,"threshold_uncertainty_score":0.007434249},"labels":[],"label_agreement":null},{"id":"W4385189431","doi":"10.1016/j.antiviral.2023.105680","title":"The hepatic GABAergic system promotes liver macrophage M2 polarization and mediates HBV replication in mice","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Shandong First Medical University; Natural Science Foundation of Shandong Province; National Natural Science Foundation of China","keywords":"Hepatitis B virus; Viral replication; HBsAg; GABAergic; Transfection; Biology; Virology; Immunology; Cancer research; Chemistry; Virus; Receptor; Medicine; Internal medicine; Cell culture","score_opus":0.03898125543924413,"score_gpt":0.3605482639271823,"score_spread":0.3215670084879382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385189431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905399,0.0021607333,0.0029276542,0.00039154085,0.00008012346,0.00009059837,0.0005013061,0.0002506595,0.003057367],"genre_scores_gemma":[0.9897914,0.0015883934,0.0021609885,0.00020587747,0.0000281306,0.0001708398,0.0003999629,0.00004869198,0.0056058727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997904,0.000044267283,0.000019000687,0.00004102043,0.000033437267,0.00007188428],"domain_scores_gemma":[0.9998684,0.0000069072403,0.00003743739,0.000016526572,0.000011863897,0.000058767335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002216741,0.00042585656,0.0002844081,0.0005871774,0.00023895281,0.00027354714,0.00021758508,0.00039350145,0.0016174152],"category_scores_gemma":[0.000110567,0.00029668654,0.0003474993,0.00012144306,0.00036678687,0.00026665095,0.0003389557,0.001058929,0.00053686224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074369187,0.00013724777,0.00060219795,0.00007156245,0.0000098057135,0.00014137282,0.000050979655,0.000055443437,0.99481875,0.0002817764,0.00012948131,0.0029576614],"study_design_scores_gemma":[0.00029100338,0.0023409151,0.014972694,0.000054823333,0.00007114159,0.0007442819,0.00017267659,0.0015426145,0.9722467,0.0003347474,0.007210259,0.000018063856],"about_ca_topic_score_codex":0.0006777489,"about_ca_topic_score_gemma":0.0012318152,"teacher_disagreement_score":0.0016174152,"about_ca_system_score_codex":0.00036915985,"about_ca_system_score_gemma":0.0002577544,"threshold_uncertainty_score":0.005410731},"labels":[],"label_agreement":null},{"id":"W4387358847","doi":"10.1016/j.antiviral.2023.105730","title":"Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Natural Sciences and Engineering Research Council of Canada; Queen's University; Banting Research Foundation","keywords":"Cyclophilin A; Biology; Virology; Gene; Coronavirus; Cell culture; Cyclophilin; Gene expression; Cell biology; Coronavirus disease 2019 (COVID-19); Molecular biology; Genetics; Medicine; Pathology","score_opus":0.06718686528676804,"score_gpt":0.38283595623790806,"score_spread":0.31564909095114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387358847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949222,0.00081292854,0.0018048651,0.00012954812,0.00004420644,0.000026882306,0.0004670558,0.000085899264,0.0017064066],"genre_scores_gemma":[0.9943984,0.0005566726,0.0017970988,0.000053593645,0.000020092177,0.000038228995,0.0010122356,0.00003553523,0.0020882061],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997303,0.000048264832,0.000030913892,0.000038911803,0.00006728302,0.00008427303],"domain_scores_gemma":[0.99955267,0.0001674614,0.00004395513,0.00010527688,0.000036099238,0.00009448422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022377603,0.00031522737,0.0004800336,0.00038010298,0.00032288962,0.00051028415,0.00020678573,0.00030567017,0.0011756602],"category_scores_gemma":[0.00019447684,0.00020320404,0.00050399976,0.00037057398,0.00034342555,0.00021194597,0.00023091256,0.0010520368,0.00046694197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007023622,0.00003694647,0.0000915488,0.000009563477,0.000002208177,0.000025938945,0.0000116861265,0.000026985075,0.9994155,0.00006338993,0.000018113364,0.00022776728],"study_design_scores_gemma":[0.000013992099,0.0002286063,0.0032584583,0.0000026128955,0.000009151632,0.0001314344,0.000027718708,0.00071824767,0.9946353,0.000025655718,0.00094572455,0.0000030943559],"about_ca_topic_score_codex":0.0013797205,"about_ca_topic_score_gemma":0.0017525193,"teacher_disagreement_score":0.0013797205,"about_ca_system_score_codex":0.00034162367,"about_ca_system_score_gemma":0.00041510558,"threshold_uncertainty_score":0.0039330125},"labels":[],"label_agreement":null},{"id":"W4387747110","doi":"10.1016/j.antiviral.2023.105736","title":"ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; McMaster University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canada Foundation for Innovation","keywords":"Biology; Virology; ASK1; Virus; Viral replication; Protein kinase R; Kinase; Vaccinia; Activator (genetics); Protein kinase A; Interferon; Cell biology; Mitogen-activated protein kinase kinase; Receptor; Biochemistry","score_opus":0.11998237690830317,"score_gpt":0.41046820339299284,"score_spread":0.2904858264846897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387747110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.880336,0.09893787,0.0058978684,0.0008168113,0.00032997533,0.00031036767,0.0012183692,0.00036044573,0.011792301],"genre_scores_gemma":[0.9688742,0.020626519,0.0028262932,0.00029907838,0.00006836744,0.0001326273,0.0012635011,0.000019135548,0.005890197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999205,0.000019842133,0.000008685979,0.000015202295,0.000017977301,0.000017719074],"domain_scores_gemma":[0.99995303,0.000007816312,0.000014730327,0.000004113482,0.000008537325,0.000011666792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019542764,0.00041954013,0.0004031682,0.00036248346,0.0001637071,0.0002483158,0.00015174452,0.0002236088,0.0020628592],"category_scores_gemma":[0.0000863191,0.0000717451,0.00026616707,0.00017453817,0.00014779378,0.00024093123,0.00016384592,0.00068889686,0.00039132766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015588562,0.0007765067,0.0011897848,0.0010044791,0.00009708408,0.00023293192,0.000053257125,0.0005516043,0.890115,0.0008684044,0.0015383743,0.10201357],"study_design_scores_gemma":[0.00041438805,0.00986051,0.010437758,0.00009042211,0.00015727435,0.001442066,0.00007750479,0.0016030262,0.9251294,0.0005517173,0.050207987,0.000027999416],"about_ca_topic_score_codex":0.0001185691,"about_ca_topic_score_gemma":0.00063407107,"teacher_disagreement_score":0.0020628592,"about_ca_system_score_codex":0.00016770118,"about_ca_system_score_gemma":0.00015975814,"threshold_uncertainty_score":0.006900966},"labels":[],"label_agreement":null},{"id":"W4388968728","doi":"10.1016/j.antiviral.2023.105758","title":"A phenothiazine urea derivative broadly inhibits coronavirus replication via viral protease inhibition","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Saint Vincent University; Saint Mary's University; University of Saskatchewan; Dalhousie University","funders":"","keywords":"Proteases; Protease; Polyproteins; Viral replication; Biology; Coronavirus; Biochemistry; Virology; Enzyme; Virus; Coronavirus disease 2019 (COVID-19)","score_opus":0.14375048098441648,"score_gpt":0.4499879883160517,"score_spread":0.30623750733163524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388968728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326456,0.0019695605,0.0018380993,0.0001188809,0.000050641796,0.00007044467,0.00018063253,0.00011021845,0.0023969517],"genre_scores_gemma":[0.9961041,0.0009626024,0.0012049566,0.000053310174,0.000012872355,0.000025126483,0.0002061656,0.0000063986577,0.0014244431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999237,0.000014254406,0.000004655789,0.000011142464,0.000016246302,0.000030027442],"domain_scores_gemma":[0.9999645,0.000007223284,0.000009556346,0.000004043306,0.0000045999536,0.00001008341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012949826,0.0003436792,0.00021544434,0.0001246693,0.00011857103,0.00013503488,0.00024163749,0.00022743683,0.0011719285],"category_scores_gemma":[0.00008771378,0.00011531826,0.0001674516,0.00010566831,0.00017068682,0.00013352031,0.000121806996,0.00042508694,0.00019106679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020488384,0.000039964376,0.000073591946,0.00003642572,0.0000063991374,0.00003257762,0.000008034358,0.000104824816,0.99737084,0.000053300446,0.00008461879,0.0019846123],"study_design_scores_gemma":[0.00012638433,0.0023738025,0.0024467926,0.0000049266278,0.000019894303,0.00025867246,0.000013584174,0.0009033526,0.9920873,0.00003035611,0.0017298767,0.0000050266576],"about_ca_topic_score_codex":0.000664637,"about_ca_topic_score_gemma":0.0015833767,"teacher_disagreement_score":0.0011719285,"about_ca_system_score_codex":0.00021202804,"about_ca_system_score_gemma":0.00018493403,"threshold_uncertainty_score":0.003920436},"labels":[],"label_agreement":null},{"id":"W4390145972","doi":"10.1016/j.antiviral.2023.105787","title":"Pralatrexate inhibited the replication of varicella zoster virus and vesicular stomatitis virus: An old dog with new tricks","year":2023,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Natural Science Foundation of China","keywords":"Varicella zoster virus; Viral replication; Vesicular stomatitis virus; Virus; Virology; In vitro; In vivo; Biology; Antiviral drug; Mechanism of action; Biochemistry","score_opus":0.07582295121733769,"score_gpt":0.40132375678653737,"score_spread":0.3255008055691997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390145972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73058873,0.17555976,0.012443161,0.035606444,0.0050980938,0.00023484889,0.0008195969,0.000932178,0.03871717],"genre_scores_gemma":[0.9278667,0.041763145,0.0045378134,0.004735261,0.0021320758,0.00006273178,0.00031228087,0.00009720258,0.01849278],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979585,0.00007943345,0.000018618875,0.000018348195,0.0000480033,0.00003970606],"domain_scores_gemma":[0.999728,0.00009557681,0.00003229407,0.00005074072,0.000053247975,0.00004008214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005306782,0.00031032073,0.00051082805,0.00022596853,0.00017417227,0.00048269102,0.0003387798,0.00035919074,0.0024904986],"category_scores_gemma":[0.0006526734,0.00013478928,0.00029653526,0.00011344069,0.0007632072,0.0014125461,0.00021528477,0.0019189214,0.00052834867],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065613436,0.0013305672,0.0027966313,0.00095011946,0.00034996236,0.00055193884,0.00045125224,0.00071882707,0.47142082,0.015970854,0.018267397,0.4806303],"study_design_scores_gemma":[0.00427766,0.050213326,0.036648102,0.00039081124,0.00076420495,0.0049702087,0.001008892,0.0049002375,0.40524337,0.020973397,0.4703753,0.00023466625],"about_ca_topic_score_codex":0.00046042746,"about_ca_topic_score_gemma":0.0016372186,"teacher_disagreement_score":0.0024904986,"about_ca_system_score_codex":0.0002110317,"about_ca_system_score_gemma":0.0003188295,"threshold_uncertainty_score":0.008331537},"labels":[],"label_agreement":null},{"id":"W4391022518","doi":"10.1016/j.antiviral.2024.105815","title":"An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity; National Institute of Mental Health; National Health and Medical Research Council; National Institutes of Health","keywords":"Nasal administration; Small interfering RNA; Gene silencing; RNA interference; Virology; Biology; Immunology; Medicine; RNA; Gene; Genetics","score_opus":0.08624937850393366,"score_gpt":0.4367229983958779,"score_spread":0.35047361989194425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391022518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874906,0.0023066693,0.0071535003,0.00012816666,0.00006728604,0.00011601674,0.0002579785,0.000116155905,0.0023635803],"genre_scores_gemma":[0.9870629,0.0011312295,0.0076797046,0.00009303243,0.000014689717,0.00007229553,0.0003675327,0.000017621205,0.0035609433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998857,0.000017583674,0.000009500456,0.000029415649,0.0000344225,0.000023363305],"domain_scores_gemma":[0.99994683,0.000009147817,0.000017518181,0.0000060662637,0.00000941647,0.000010967439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016857478,0.0003528686,0.00023871963,0.00015694794,0.00012629622,0.00021598917,0.00019642054,0.0002667931,0.0008470309],"category_scores_gemma":[0.000082512735,0.00010767805,0.00025511268,0.000062541425,0.0001928756,0.0001612048,0.00014422974,0.00040422962,0.00018730975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025223237,0.000018275094,0.00005696137,0.000021307107,0.0000020316293,0.000011224855,0.000003997497,0.000026334086,0.99889046,0.000025856947,0.000015771644,0.00090266194],"study_design_scores_gemma":[0.000008622469,0.00062432606,0.0011099321,0.0000033294832,0.000013219625,0.00011538749,0.000010482566,0.0004301967,0.9962443,0.000010760483,0.0014271287,0.0000023663652],"about_ca_topic_score_codex":0.00057673483,"about_ca_topic_score_gemma":0.0014806258,"teacher_disagreement_score":0.0008470309,"about_ca_system_score_codex":0.00023793953,"about_ca_system_score_gemma":0.0002885338,"threshold_uncertainty_score":0.0028336644},"labels":[],"label_agreement":null},{"id":"W4391056045","doi":"10.1016/j.antiviral.2024.105811","title":"Activation of cGAS-STING suppresses coxsackievirus replication via interferon-dependent signaling","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Stimulator of interferon genes; Sting; Interferon; Signal transduction; Gene knockdown; Biology; IRF3; Cell biology; Interferon regulatory factors; Interferon type I; TANK-binding kinase 1; Viral replication; Virus; Virology; Receptor; Innate immune system; Gene; MAPK/ERK pathway; Biochemistry","score_opus":0.08233381906551915,"score_gpt":0.39395751064259904,"score_spread":0.3116236915770799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391056045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265176,0.0031984383,0.001618795,0.00016191331,0.000060255497,0.000036560123,0.00030415284,0.000094706644,0.0018734025],"genre_scores_gemma":[0.9967638,0.0009673489,0.00087788724,0.00006069478,0.000011344778,0.00003420919,0.00028794105,0.0000049236132,0.0009919383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999002,0.00001863425,0.000009633222,0.00001562738,0.000020926087,0.000034889104],"domain_scores_gemma":[0.9999585,0.000006189954,0.000013814744,0.000004549736,0.000003934184,0.000013015443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010897066,0.00027846044,0.00023074244,0.0001366432,0.00011024693,0.00022057649,0.00012519263,0.00020782006,0.0008683545],"category_scores_gemma":[0.00008245256,0.00007754003,0.00022763555,0.00009709031,0.0001725436,0.00013962956,0.00013942573,0.00064677047,0.00020803856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002816308,0.000057970392,0.00015986491,0.000062305946,0.0000060172865,0.00003144704,0.000010982655,0.000078809135,0.9968407,0.00010274994,0.00007372193,0.0022937523],"study_design_scores_gemma":[0.00006997136,0.00078875135,0.004129231,0.000011624538,0.000023536828,0.00020920888,0.000030452937,0.0019384887,0.98933625,0.000062616964,0.00339444,0.000005395086],"about_ca_topic_score_codex":0.0004287045,"about_ca_topic_score_gemma":0.00082680857,"teacher_disagreement_score":0.0008683545,"about_ca_system_score_codex":0.00021462176,"about_ca_system_score_gemma":0.00026421619,"threshold_uncertainty_score":0.002904892},"labels":[],"label_agreement":null},{"id":"W4393195508","doi":"10.1016/j.antiviral.2024.105869","title":"Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Simon Fraser University; Université de Sherbrooke; University of British Columbia","funders":"GeneTex; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; University of British Columbia","keywords":"Host (biology); Chemistry; Virology; Mechanism of action; TMPRSS2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Action (physics); Microbiology; Coronavirus disease 2019 (COVID-19); Biology; Biochemistry; Medicine; Genetics; Physics; Pathology","score_opus":0.09663143742622812,"score_gpt":0.40928353614016016,"score_spread":0.31265209871393207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393195508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906337,0.0032733178,0.0012960207,0.00011404493,0.00005078553,0.0000373443,0.0003204123,0.00009066028,0.004183692],"genre_scores_gemma":[0.99648654,0.0009023838,0.0010939847,0.00006823734,0.000015710568,0.000022841306,0.0004934779,0.000006803315,0.0009100044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998547,0.000031498927,0.000016437865,0.000016407013,0.0000487563,0.000032161257],"domain_scores_gemma":[0.9999398,0.000022459142,0.000010284408,0.0000073623587,0.0000071886143,0.00001298381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016009409,0.00034272854,0.00036003822,0.00015040928,0.00011203949,0.00023960212,0.0002069534,0.00027681296,0.0012537147],"category_scores_gemma":[0.00014108985,0.0001413794,0.00021382107,0.00017119928,0.00013992959,0.00012430476,0.00015501607,0.00054123154,0.00031791223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038935157,0.00017879829,0.00032762295,0.00008206241,0.000025417754,0.000055293498,0.000017710758,0.0003436037,0.9943619,0.00007758947,0.00017045245,0.003970199],"study_design_scores_gemma":[0.00014947625,0.0039814636,0.010806254,0.000014363803,0.000058095622,0.0009033213,0.000043294756,0.0027328806,0.97665775,0.00006346607,0.0045775897,0.000012052447],"about_ca_topic_score_codex":0.0007924488,"about_ca_topic_score_gemma":0.0020510177,"teacher_disagreement_score":0.0012537147,"about_ca_system_score_codex":0.00021620364,"about_ca_system_score_gemma":0.00020667062,"threshold_uncertainty_score":0.0041941404},"labels":[],"label_agreement":null},{"id":"W4393346747","doi":"10.1016/j.antiviral.2024.105877","title":"Supplementation of seasonal vaccine with multi-subtype neuraminidase and M2 ectodomain virus-like particle improves protection against homologous and heterologous influenza viruses in aged mice","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute on Aging; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Georgia State University","keywords":"Virology; Vaccination; Heterologous; Influenza vaccine; Ectodomain; Biology; Neuraminidase; Virus; Population; Hemagglutination assay; Immunology; Titer; Medicine; Receptor; Genetics","score_opus":0.12293599411864774,"score_gpt":0.4235850161126214,"score_spread":0.30064902199397364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393346747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975751,0.0011251159,0.000541209,0.00006308894,0.000079515485,0.000019698942,0.00022661727,0.000049307062,0.00032028274],"genre_scores_gemma":[0.9929985,0.0009735928,0.0011753732,0.00010560114,0.000042075277,0.00004275421,0.0004831735,0.000027100241,0.004151865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998154,0.000034202872,0.000018015398,0.00005187705,0.00002349996,0.00005710025],"domain_scores_gemma":[0.999741,0.00001860057,0.00007504949,0.00002553983,0.000025874104,0.00011383889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026758687,0.0005471376,0.00057583326,0.00033082764,0.0001652218,0.0002362196,0.0003952819,0.0004773044,0.0010775421],"category_scores_gemma":[0.00018515563,0.00019226655,0.00040073748,0.000107068634,0.00031255203,0.00058118365,0.0001874979,0.00086947216,0.00031435103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037418378,0.0005549861,0.0003820602,0.00006382724,0.000025978157,0.00004692526,0.000040137566,0.00006217121,0.9926125,0.00004869279,0.00007073552,0.0023501453],"study_design_scores_gemma":[0.00030240326,0.02164251,0.01111929,0.000028064624,0.00021458515,0.0002613438,0.00011843591,0.0005996888,0.96262217,0.00012884181,0.0029432252,0.000019559127],"about_ca_topic_score_codex":0.0006867262,"about_ca_topic_score_gemma":0.0008774453,"teacher_disagreement_score":0.0010775421,"about_ca_system_score_codex":0.00021527511,"about_ca_system_score_gemma":0.00023373477,"threshold_uncertainty_score":0.00360471},"labels":[],"label_agreement":null},{"id":"W4395685088","doi":"10.1016/j.antiviral.2024.105893","title":"Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections","year":2024,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Schwartz/Reisman Emergency Medicine Institute; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Monoclonal antibody; Medicine; Antibody; Immunology; Virology; Hepatitis B virus; Hepatitis B; Antigen; Virus","score_opus":0.20371630802164337,"score_gpt":0.5213370371599079,"score_spread":0.3176207291382645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395685088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000102185455,0.99890244,0.0000620336,0.00019220568,0.00011771988,0.000003895509,0.000010436063,0.0000047697195,0.000604248],"genre_scores_gemma":[0.00048459737,0.9987924,0.00011473214,0.0001804014,0.000102757185,0.0000073043134,0.00001714929,0.0000010955398,0.00029961352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981195,0.00004323209,0.000027478414,0.00003000345,0.000067268236,0.000020128788],"domain_scores_gemma":[0.99974614,0.00014084109,0.000034137123,0.000007947803,0.000051385807,0.000019573505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008035302,0.000591725,0.0012397865,0.0016860571,0.00017573786,0.0007769942,0.0007997494,0.0009993132,0.004196559],"category_scores_gemma":[0.00071729044,0.00024944553,0.0006521039,0.0011691566,0.0004003158,0.001336462,0.0005154703,0.0014362712,0.0014316147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013957646,0.0000908542,0.00010540648,0.03415445,0.00012924874,0.00012559048,0.0000681399,0.00035391754,0.0017120839,0.00452705,0.020334003,0.9382598],"study_design_scores_gemma":[0.0000592454,0.00016946878,0.0007323209,0.008541721,0.00019463332,0.0008086581,0.000061003637,0.000118220865,0.0004120152,0.0024758591,0.9864094,0.000017362408],"about_ca_topic_score_codex":0.0008425845,"about_ca_topic_score_gemma":0.0013376736,"teacher_disagreement_score":0.004196559,"about_ca_system_score_codex":0.000513376,"about_ca_system_score_gemma":0.0009832939,"threshold_uncertainty_score":0.014038861},"labels":[],"label_agreement":null},{"id":"W4401324553","doi":"10.1016/j.antiviral.2024.105979","title":"Orally dissolving film as a potential vaccine delivery carrier to prevent influenza virus infection","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research Foundation of Korea; Ministry of Education; CHEO Research Institute","keywords":"Vaccination; Virology; Virus; Medicine; Antibody; Immunology; Immunization; Antibody titer; Influenza A virus; Antigen; Titer","score_opus":0.09475089796329865,"score_gpt":0.4613536525207302,"score_spread":0.3666027545574315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401324553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768813,0.0133650135,0.0048148083,0.00043914584,0.00026349392,0.00015245088,0.00008681619,0.00006988596,0.003927063],"genre_scores_gemma":[0.97744125,0.007077552,0.0067243185,0.00014789606,0.00007559139,0.0000628978,0.000106280684,0.000019847808,0.008344363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999287,0.000017084472,0.0000031464008,0.000014163025,0.000020659441,0.000016258753],"domain_scores_gemma":[0.99994624,0.000017371834,0.000011152613,0.0000031860786,0.000012420679,0.000009633014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021061179,0.0001852708,0.0002385342,0.00016286789,0.00016667567,0.00022017094,0.00020535378,0.00033546574,0.0015783957],"category_scores_gemma":[0.00019090308,0.00009503082,0.0001709903,0.0000928787,0.00014293798,0.00030303435,0.00013118995,0.0004307061,0.000225509],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045730773,0.00021888674,0.00018997252,0.00029110498,0.000014265464,0.00016841937,0.000061648054,0.00011212367,0.972422,0.00023174277,0.00032564395,0.025506863],"study_design_scores_gemma":[0.00010483008,0.006655816,0.002355367,0.000051610514,0.00014331812,0.0003979123,0.00012475156,0.0017066966,0.9763257,0.00007326748,0.012047598,0.000013154262],"about_ca_topic_score_codex":0.0008473768,"about_ca_topic_score_gemma":0.0008979684,"teacher_disagreement_score":0.0015783957,"about_ca_system_score_codex":0.00010767723,"about_ca_system_score_gemma":0.00017653444,"threshold_uncertainty_score":0.0052802563},"labels":[],"label_agreement":null},{"id":"W4401355252","doi":"10.1016/j.antiviral.2024.105976","title":"Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Diverse Scientific Research Studies","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; Clinical and Translational Science Institute, Boston University; Clinical and Translational Science Institute, University of Pittsburgh; National Cancer Institute; National Institutes of Health; Massachusetts Consortium on Pathogen Readiness; Boston University","keywords":"Coronavirus; Virology; Virus; Viral replication; Biology; eIF4A; Translation (biology); Medicine; Coronavirus disease 2019 (COVID-19); Gene; Biochemistry","score_opus":0.20925698202647447,"score_gpt":0.4840355234944932,"score_spread":0.2747785414680187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401355252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9072617,0.059080075,0.008328426,0.0008521483,0.00030281098,0.00025973594,0.0013659666,0.000646393,0.021902675],"genre_scores_gemma":[0.9797599,0.011033267,0.0041019134,0.00028992663,0.00011765539,0.00005590942,0.0009668322,0.00002229474,0.0036523729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997625,0.00007020929,0.000025996424,0.000038376464,0.00006249387,0.000040533585],"domain_scores_gemma":[0.9997929,0.00004924605,0.000080240876,0.00001636618,0.000026763582,0.00003446187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046362774,0.00042355695,0.0003770007,0.00042386013,0.00017638318,0.00026440492,0.00019508191,0.0004357348,0.0021136506],"category_scores_gemma":[0.00036644106,0.000112997506,0.00027461827,0.0002597034,0.0002494893,0.00024244402,0.00022831111,0.00046410554,0.00072200916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022462225,0.00029533848,0.0011352729,0.00041870156,0.000055601373,0.0004002547,0.000050495244,0.00063038454,0.90712124,0.0013517502,0.0013266002,0.08496817],"study_design_scores_gemma":[0.0006629281,0.008041187,0.007387078,0.000045822548,0.000065815286,0.002366751,0.000048666243,0.0012181434,0.92847383,0.00031085397,0.051337816,0.000041189374],"about_ca_topic_score_codex":0.00030803453,"about_ca_topic_score_gemma":0.00038238303,"teacher_disagreement_score":0.0021136506,"about_ca_system_score_codex":0.00023057662,"about_ca_system_score_gemma":0.0001678194,"threshold_uncertainty_score":0.0070708394},"labels":[],"label_agreement":null},{"id":"W4402314510","doi":"10.1016/j.antiviral.2024.105995","title":"Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada); Public Health Agency of Canada","funders":"Public Health Agency of Canada","keywords":"Monkeypox; Cidofovir; Outbreak; Virology; Clade; Pandemic; Transmission (telecommunications); Smallpox; Disease; Virus; Biology; Medicine; Infectious disease (medical specialty); Vaccination; Vaccinia; Coronavirus disease 2019 (COVID-19); Gene; Phylogenetics","score_opus":0.05016156535997781,"score_gpt":0.3652086948991522,"score_spread":0.3150471295391744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402314510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935928,0.0041565476,0.00031285136,0.00005387242,0.00004757218,0.000042205218,0.0003511717,0.000019889312,0.0014229679],"genre_scores_gemma":[0.9965635,0.0013704059,0.0005729815,0.000052329215,0.000023857605,0.00003058327,0.000490239,0.000005104703,0.0008910456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998609,0.000032339598,0.0000144957785,0.000030030424,0.000022991597,0.000039191866],"domain_scores_gemma":[0.99988663,0.000030502608,0.000020994246,0.000010687162,0.000015243008,0.00003593198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017595784,0.00027437593,0.0003960572,0.00019956732,0.00013581937,0.0002606614,0.00021638595,0.00031532385,0.0013312041],"category_scores_gemma":[0.00027744233,0.00009173389,0.0003086307,0.000102756625,0.00012966408,0.00019108718,0.00010113407,0.0004817923,0.00020881997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038440204,0.0012957569,0.0019590983,0.00026861936,0.00006647768,0.000118637065,0.00010940662,0.0009555492,0.96534824,0.00011185297,0.0005202341,0.025402132],"study_design_scores_gemma":[0.0006111031,0.036657255,0.034692746,0.000055026976,0.00017053889,0.0009335376,0.000119435375,0.0025737518,0.9143817,0.00007670599,0.009691059,0.000037144877],"about_ca_topic_score_codex":0.0010564076,"about_ca_topic_score_gemma":0.0010428141,"teacher_disagreement_score":0.0013312041,"about_ca_system_score_codex":0.00020132237,"about_ca_system_score_gemma":0.00017538098,"threshold_uncertainty_score":0.004453361},"labels":[],"label_agreement":null},{"id":"W4402758970","doi":"10.1016/j.antiviral.2024.106010","title":"Preclinical and clinical antiviral characterization of AB-836, a potent capsid assembly modulator against hepatitis B virus","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Capsid; Virology; Virus; Hepatitis B virus; Medicine; Biology","score_opus":0.1261666485360752,"score_gpt":0.45854313196582813,"score_spread":0.3323764834297529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402758970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99048,0.0038751124,0.0016501882,0.00030428,0.00007819387,0.00035802994,0.00031024677,0.00006370463,0.0028802953],"genre_scores_gemma":[0.9935262,0.0023660464,0.001179339,0.0001739414,0.000059504975,0.00012669408,0.00058082474,0.000013825923,0.0019736488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999788,0.0000839518,0.000010502631,0.000016957849,0.000030819032,0.00006972938],"domain_scores_gemma":[0.9998425,0.000028286102,0.00002588801,0.000016721237,0.000024925715,0.00006172316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008765352,0.00054352044,0.00036992415,0.00029767735,0.00023148878,0.000514438,0.00039294802,0.00036720498,0.0022965698],"category_scores_gemma":[0.00036387806,0.00022499613,0.0002861368,0.00015012786,0.00042452064,0.00036348612,0.0001590312,0.0013366797,0.0004986592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012421786,0.012511627,0.0010200649,0.0003853896,0.00011023154,0.00022953683,0.00019915593,0.0014681239,0.92087334,0.00074423215,0.0015307564,0.04850582],"study_design_scores_gemma":[0.012127865,0.34768146,0.014395406,0.00011413772,0.00037546383,0.0011311705,0.00025169025,0.0038076597,0.59694296,0.00054771214,0.022581605,0.000042932465],"about_ca_topic_score_codex":0.0005331829,"about_ca_topic_score_gemma":0.0008607305,"teacher_disagreement_score":0.0022965698,"about_ca_system_score_codex":0.0002916277,"about_ca_system_score_gemma":0.00059820537,"threshold_uncertainty_score":0.0076828003},"labels":[],"label_agreement":null},{"id":"W4402910425","doi":"10.1016/j.antiviral.2024.106015","title":"Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Health~Holland; Aids Fonds; National Institutes of Health; amfAR, The Foundation for AIDS Research","keywords":"Effector; Human immunodeficiency virus (HIV); Antibody; Virology; Antibody-dependent cell-mediated cytotoxicity; Immunology; Computational biology; Biology; Monoclonal antibody","score_opus":0.07181583889299027,"score_gpt":0.43451503544276354,"score_spread":0.3626991965497733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402910425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947115,0.0012689744,0.0026795897,0.000038062783,0.000018312743,0.000033823053,0.000114599585,0.000028951641,0.001106224],"genre_scores_gemma":[0.99155396,0.0011854264,0.005722245,0.00006664358,0.000007382821,0.00003380445,0.00032264725,0.000019507912,0.0010884522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997998,0.00002833422,0.000024088276,0.000031214135,0.000060688868,0.00005590734],"domain_scores_gemma":[0.9999069,0.000021394959,0.000020869667,0.000009645099,0.000025956575,0.000015150707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002901877,0.0005006648,0.00023040127,0.0002211263,0.00009822979,0.00039212138,0.00034777922,0.00050431286,0.0007961922],"category_scores_gemma":[0.00022054558,0.00012087442,0.00028178035,0.00019551003,0.000116535775,0.00028093322,0.00016579973,0.00042432337,0.00018746627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017093885,0.00008859458,0.0001803533,0.00004979213,0.000013579761,0.000028182312,0.000010372698,0.0005527871,0.9952508,0.000088731314,0.000030550502,0.0035352875],"study_design_scores_gemma":[0.000017415767,0.0006098341,0.0012023288,0.0000041438807,0.000029578046,0.00010767692,0.0000093536555,0.0015548766,0.9954738,0.000017255667,0.00096909504,0.00000456698],"about_ca_topic_score_codex":0.00052206876,"about_ca_topic_score_gemma":0.0005098911,"teacher_disagreement_score":0.0007961922,"about_ca_system_score_codex":0.0003242454,"about_ca_system_score_gemma":0.00010572355,"threshold_uncertainty_score":0.0026635528},"labels":[],"label_agreement":null},{"id":"W4402943571","doi":"10.1016/j.antiviral.2024.106016","title":"Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD)","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Virology; Drug resistance; Mutation; Antiviral drug; Drug; Biology; Computational biology; Genetics; Virus; Pharmacology; Gene","score_opus":0.11011392141884757,"score_gpt":0.432911242165294,"score_spread":0.3227973207464464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402943571","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018312711,0.0024912353,0.0012081118,0.0006204877,0.000094950745,0.000099823366,0.98012483,0.0034499583,0.010079333],"genre_scores_gemma":[0.010267422,0.003299386,0.006240071,0.0009493313,0.000104449806,0.00030481117,0.97401965,0.0006175727,0.0041973037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992778,0.00013494871,0.00019088987,0.00011519792,0.00018671081,0.00009455035],"domain_scores_gemma":[0.9951658,0.0018696166,0.0009985896,0.00046229147,0.00084658724,0.0006571345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012194396,0.0011315042,0.0019362761,0.00934653,0.0006476374,0.0021684358,0.0023325912,0.0016723347,0.13762957],"category_scores_gemma":[0.008106841,0.00052095926,0.0009585899,0.009143225,0.0002525474,0.0011706337,0.001724212,0.0009886025,0.033610687],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081535213,0.00009405835,0.00446859,0.0053687245,0.00023111614,0.00027117718,0.00007758664,0.000948482,0.0011870189,0.0037363323,0.92728275,0.0555188],"study_design_scores_gemma":[0.00069432444,0.00010105295,0.009295222,0.0018258434,0.0005302734,0.0006410135,0.00007944311,0.0016887208,0.0014775465,0.005026665,0.9785688,0.000071011396],"about_ca_topic_score_codex":0.006440412,"about_ca_topic_score_gemma":0.010038622,"teacher_disagreement_score":0.13762957,"about_ca_system_score_codex":0.0009287264,"about_ca_system_score_gemma":0.0030360406,"threshold_uncertainty_score":0.4604168},"labels":[],"label_agreement":null},{"id":"W4404564887","doi":"10.1016/j.antiviral.2024.106038","title":"Biological characterization of AB-343, a novel and potent SARS-CoV-2 Mpro inhibitor with pan-coronavirus activity","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Coronavirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus; Coronavirus Infections; Betacoronavirus; Biology; Medicine","score_opus":0.18140645004224987,"score_gpt":0.4345981075462438,"score_spread":0.2531916575039939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404564887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807597,0.0060192267,0.0055290316,0.0002737886,0.000059193044,0.00024283431,0.001443733,0.00013309409,0.0055394927],"genre_scores_gemma":[0.9870776,0.0026392608,0.0032037022,0.00015825103,0.00003064181,0.000067497705,0.0033420005,0.000024191953,0.0034568978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993587,0.000008640029,0.000004475374,0.000009392268,0.000016292985,0.000025218447],"domain_scores_gemma":[0.99995327,0.000007170286,0.0000070544106,0.0000035562243,0.000011529532,0.00001740079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017952677,0.00047270907,0.0003337169,0.00024453152,0.00023509368,0.0002218623,0.00033198588,0.0002388535,0.0015685563],"category_scores_gemma":[0.00012783229,0.00014024256,0.00031092987,0.0001878576,0.00013471219,0.00019000852,0.0000928477,0.00051902054,0.00056429516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047700462,0.00025351046,0.00020830602,0.00006828818,0.000022781762,0.00016876715,0.000019645775,0.00054059364,0.9931213,0.00011985978,0.00024920222,0.0047507766],"study_design_scores_gemma":[0.00034068813,0.0037718273,0.005679562,0.000009237382,0.00010026935,0.0012593302,0.000027903605,0.003459207,0.97570735,0.00010378556,0.009520566,0.000020347577],"about_ca_topic_score_codex":0.001553261,"about_ca_topic_score_gemma":0.0013606008,"teacher_disagreement_score":0.0015685563,"about_ca_system_score_codex":0.00026593448,"about_ca_system_score_gemma":0.00037468792,"threshold_uncertainty_score":0.0052473545},"labels":[],"label_agreement":null},{"id":"W4405596769","doi":"10.1016/j.antiviral.2024.106061","title":"HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cure","year":2024,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Nucleic acid; Kinetics; RNA; Chemistry; Virology; Medicine; Biochemistry; Gene","score_opus":0.0889990070505941,"score_gpt":0.37468070897946293,"score_spread":0.2856817019288688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405596769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98465955,0.0025658158,0.008143934,0.00010098265,0.00007026581,0.00006312707,0.000258345,0.00012376581,0.004014208],"genre_scores_gemma":[0.9955884,0.00049926987,0.0012860269,0.00006211591,0.000016252578,0.000030357065,0.00014558264,0.000025810039,0.0023463068],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997987,0.000069933645,0.00000856173,0.000030342391,0.000052524887,0.000039914838],"domain_scores_gemma":[0.9994566,0.0003077239,0.00008934275,0.000036682977,0.000070242386,0.00003938832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000502563,0.00029375992,0.00019824468,0.00031485193,0.00010802534,0.00046274293,0.00010943979,0.00029525114,0.002766688],"category_scores_gemma":[0.0011133389,0.00016955507,0.00018891323,0.00015093367,0.00023979155,0.00043962602,0.00012604213,0.00046686473,0.0007954259],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038249013,0.0001743664,0.00876856,0.00012828129,0.00003446088,0.00013664892,0.00015192505,0.0019546642,0.9600033,0.0003914753,0.00024970522,0.024181714],"study_design_scores_gemma":[0.000023238532,0.0023008103,0.010684955,0.000014383835,0.000045773722,0.00019110438,0.00006502557,0.010729604,0.9742654,0.00021993526,0.0014484709,0.000011374395],"about_ca_topic_score_codex":0.00036286755,"about_ca_topic_score_gemma":0.0003020583,"teacher_disagreement_score":0.002766688,"about_ca_system_score_codex":0.00023068019,"about_ca_system_score_gemma":0.00017694649,"threshold_uncertainty_score":0.009255528},"labels":[],"label_agreement":null},{"id":"W4407382229","doi":"10.1016/j.antiviral.2025.106104","title":"Antiviral mechanisms and preclinical evaluation of amantadine analogs that continue to inhibit influenza A viruses with M2S31N-based drug resistance","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Deutsche Forschungsgemeinschaft","keywords":"Amantadine; Virology; Antiviral drug; Drug resistance; Drug; Medicine; Pharmacology; Virus; Biology; Microbiology","score_opus":0.2674005673238715,"score_gpt":0.517625843708419,"score_spread":0.2502252763845475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407382229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981399,0.010348491,0.0013060458,0.0004643377,0.00014558694,0.000488846,0.0005774446,0.00005767531,0.005212742],"genre_scores_gemma":[0.9880706,0.0067621763,0.0017362515,0.00024812928,0.000095954565,0.00018563426,0.00080754823,0.000011918716,0.002081602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999742,0.000110634,0.000018151208,0.000023014352,0.000034385368,0.000071809685],"domain_scores_gemma":[0.9998286,0.00003527674,0.00003561973,0.000018016393,0.000032767184,0.00004973627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009963808,0.0005637339,0.0004767551,0.000363378,0.00030285702,0.00048441297,0.0005558859,0.0004809086,0.0021747074],"category_scores_gemma":[0.00042630234,0.00024706346,0.0006765128,0.00018532062,0.00037135213,0.0005435264,0.00013386438,0.0011145014,0.00039391097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0148080075,0.011715996,0.0018333623,0.0006277194,0.00030811055,0.00036906244,0.00023557061,0.003550464,0.89974356,0.001855652,0.002000993,0.062951505],"study_design_scores_gemma":[0.010382399,0.37577277,0.010412627,0.00018158375,0.00061482744,0.0014770043,0.00026204955,0.0046070605,0.574152,0.0010214286,0.021046672,0.0000695861],"about_ca_topic_score_codex":0.0007813199,"about_ca_topic_score_gemma":0.001667957,"teacher_disagreement_score":0.0021747074,"about_ca_system_score_codex":0.0003946307,"about_ca_system_score_gemma":0.0005393416,"threshold_uncertainty_score":0.0072751045},"labels":[],"label_agreement":null},{"id":"W4408907087","doi":"10.1016/j.antiviral.2025.106151","title":"Tenofovir alafenamide promotes weight gain and impairs fatty acid metabolism-related signaling pathways in visceral fat tissue compared to tenofovir disoproxil fumarate","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Tenofovir alafenamide; Tenofovir; Pharmacology; Metabolism; Fatty acid metabolism; Medicine; Chemistry; Endocrinology; Human immunodeficiency virus (HIV); Virology; Viral load; Antiretroviral therapy","score_opus":0.04103409760759242,"score_gpt":0.3564029374775032,"score_spread":0.31536883986991077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408907087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964833,0.0013122567,0.0005882955,0.00014677068,0.00013747781,0.000019433452,0.000255279,0.000051388466,0.0010058131],"genre_scores_gemma":[0.9959133,0.0007781325,0.0005653907,0.000061927705,0.00001672076,0.00003317914,0.0002835675,0.000010242293,0.002337408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997887,0.000037100464,0.000014476429,0.000038267426,0.00003751575,0.00008399896],"domain_scores_gemma":[0.99988973,0.000011467589,0.00002672032,0.000011385729,0.000008109095,0.000052546453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017162423,0.00052668335,0.00046610928,0.0003091313,0.00020343685,0.00038387906,0.00021903902,0.0003241097,0.0035829335],"category_scores_gemma":[0.00016801328,0.0001659552,0.00041493727,0.00017100367,0.00036877592,0.00040060937,0.00015849408,0.0008266163,0.0002762074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018218808,0.00066878385,0.0009194446,0.000120145734,0.000057127192,0.000121137484,0.000024280422,0.00013599686,0.96963173,0.0001538456,0.00019661056,0.009752149],"study_design_scores_gemma":[0.0011231519,0.013976325,0.022250475,0.00004163876,0.00020993779,0.0006988369,0.00037679798,0.0017543769,0.954418,0.00020879747,0.0049142577,0.000027436581],"about_ca_topic_score_codex":0.0016153266,"about_ca_topic_score_gemma":0.0026316878,"teacher_disagreement_score":0.0035829335,"about_ca_system_score_codex":0.00024502116,"about_ca_system_score_gemma":0.00039568476,"threshold_uncertainty_score":0.011986077},"labels":[],"label_agreement":null},{"id":"W4409973699","doi":"10.1016/j.antiviral.2025.106184","title":"Chemical arsenal for helicase Hunters: Striking the toughest targets in antiviral research","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Institute of General Medical Sciences; American Foundation for Pharmaceutical Education; Foundation for the National Institutes of Health","keywords":"Helicase; Virology; Biology; Computational biology; Genetics; Gene; RNA","score_opus":0.18112455032403105,"score_gpt":0.5172940450822192,"score_spread":0.33616949475818814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409973699","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08805208,0.45903593,0.027746834,0.36695337,0.012243661,0.00018417457,0.0009784587,0.001011709,0.043793842],"genre_scores_gemma":[0.5562969,0.29806608,0.022524292,0.07728181,0.0111653395,0.00024253155,0.00080099294,0.00041711755,0.033204887],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978684,0.0006170969,0.00010015139,0.00028542642,0.00074898306,0.00037991963],"domain_scores_gemma":[0.9949817,0.001673122,0.00059836655,0.0006449617,0.0010498397,0.0010519883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004637268,0.00074822584,0.0013571725,0.0013071296,0.0020710535,0.0053247125,0.0014112855,0.0036370594,0.014543764],"category_scores_gemma":[0.0063814237,0.0006367432,0.00078195566,0.00074554037,0.0056666536,0.01031692,0.003723967,0.0065752543,0.002603506],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017998375,0.000566243,0.011720016,0.0048514903,0.00062587555,0.0014355455,0.0020358413,0.0021238225,0.20126793,0.15846163,0.14129828,0.47381347],"study_design_scores_gemma":[0.00017358903,0.0017080336,0.005967812,0.0011310534,0.00017619641,0.002120246,0.004491222,0.0010472917,0.047698397,0.15634856,0.7789696,0.00016806302],"about_ca_topic_score_codex":0.0010879029,"about_ca_topic_score_gemma":0.0025105618,"teacher_disagreement_score":0.014543764,"about_ca_system_score_codex":0.0017461644,"about_ca_system_score_gemma":0.0029103707,"threshold_uncertainty_score":0.04865378},"labels":[],"label_agreement":null},{"id":"W4411125619","doi":"10.1016/j.antiviral.2025.106211","title":"Marburg and Kasokero viruses elicit differential antiviral innate immune control by their natural reservoir bat, the Egyptian rousette (Rousettus aegyptiacus)","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Prince Edward Island","funders":"Defense Threat Reduction Agency; Centers for Disease Control and Prevention; University of Georgia","keywords":"Biology; Virology; Filoviridae; Innate immune system; Viral replication; Interferon; Virus; Immunology; Marburg virus; Viremia; Immune system; Viral disease; Ebola virus; Paramyxoviridae","score_opus":0.029558243995364518,"score_gpt":0.356492189541267,"score_spread":0.3269339455459025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411125619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999571,0.00013505813,0.0000677521,0.0000064835376,8.7378805e-7,0.000003919962,0.000022886195,0.0000024840442,0.00018948903],"genre_scores_gemma":[0.99912876,0.0001106347,0.00027015037,0.000016731543,0.000001818496,0.000011928906,0.000090501126,0.0000015539655,0.0003679385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999069,0.00001612051,0.000007022804,0.000022895108,0.000013777757,0.000033215594],"domain_scores_gemma":[0.99994147,0.000009062325,0.000018601973,0.000006980086,0.0000083727155,0.000015565121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010109647,0.00015927476,0.00014964507,0.00013349281,0.00012475754,0.0002919476,0.000084143474,0.00025736124,0.0005650319],"category_scores_gemma":[0.00011469874,0.000118796925,0.00015780659,0.000045748588,0.00022831546,0.00024932402,0.00019884005,0.00026097946,0.0001542895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010986615,0.0000144799515,0.005573,0.00002016996,0.0000035635694,0.000057830002,0.00008372353,0.000029729665,0.9935062,0.00004351986,0.0000060221696,0.0005518704],"study_design_scores_gemma":[0.000037992144,0.0024234466,0.49068367,0.000024246336,0.000043755306,0.002016855,0.0018034285,0.001544143,0.49907652,0.00022259634,0.0021032293,0.000020085206],"about_ca_topic_score_codex":0.00028441107,"about_ca_topic_score_gemma":0.000710363,"teacher_disagreement_score":0.0005650319,"about_ca_system_score_codex":0.00016782532,"about_ca_system_score_gemma":0.000090895795,"threshold_uncertainty_score":0.0018901825},"labels":[],"label_agreement":null},{"id":"W4413270284","doi":"10.1016/j.antiviral.2025.106260","title":"Optimization of the monoclonal antibody 3E1 through W32I mutation enhances antiviral efficacy against influenza virus subtypes H1N1 and H3N2","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Department of Science and Technology of Jilin Province; National Natural Science Foundation of China","keywords":"Hemagglutinin (influenza); Monoclonal antibody; Virology; Influenza A virus; Virus; Mutant; In vivo; Antibody; Biology; Chemistry; Immunology; Gene; Biochemistry","score_opus":0.09963536486003413,"score_gpt":0.4710256397204209,"score_spread":0.3713902748603868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413270284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943591,0.00068823615,0.002701122,0.00009423131,0.000041093102,0.000065545966,0.00018346951,0.00006892151,0.0017982998],"genre_scores_gemma":[0.99411535,0.00038106166,0.0034336508,0.000081023645,0.0000096513095,0.000027662269,0.00029025314,0.00002364827,0.0016377828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981874,0.000023367982,0.000017116987,0.000034043915,0.000049433565,0.000057265133],"domain_scores_gemma":[0.99994314,0.000008804571,0.000016452166,0.0000051572074,0.000014102766,0.000012378189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021566896,0.0003445962,0.0003007124,0.00021474416,0.0001415599,0.0002382317,0.00027798352,0.00026901424,0.0022043516],"category_scores_gemma":[0.0001764079,0.00012649616,0.000250736,0.00016300025,0.00014876925,0.00017166777,0.00017835326,0.0004187548,0.0005112801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019717884,0.00012730896,0.000401109,0.000028365454,0.0000111281115,0.000035828718,0.0000068397394,0.00040075684,0.9944976,0.00010196417,0.00011029604,0.0040816916],"study_design_scores_gemma":[0.000058568923,0.00082912017,0.0015697089,0.000004570939,0.000031261497,0.00016476204,0.000008497329,0.0010663596,0.9939756,0.000027151264,0.0022588929,0.0000055818437],"about_ca_topic_score_codex":0.0009446277,"about_ca_topic_score_gemma":0.0013260198,"teacher_disagreement_score":0.0022043516,"about_ca_system_score_codex":0.000284259,"about_ca_system_score_gemma":0.00024990138,"threshold_uncertainty_score":0.0073742867},"labels":[],"label_agreement":null},{"id":"W4414555588","doi":"10.1016/j.antiviral.2025.106284","title":"Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Public Health Agency of Canada; University of Ottawa; Health Canada","funders":"Health Canada; Government of Canada","keywords":"Hemagglutinin (influenza); Influenza vaccine; Peptide vaccine; Immune system; Context (archaeology); Antibody; Immunity; Vaccination","score_opus":0.1849438717008265,"score_gpt":0.4615874212466871,"score_spread":0.2766435495458606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414555588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610496,0.0005376478,0.002194146,0.0000462304,0.000033450364,0.000055766322,0.00016420987,0.0000844682,0.00077905226],"genre_scores_gemma":[0.9955591,0.0003501127,0.0022265525,0.00010779865,0.000019603884,0.00003961941,0.0005719684,0.000020728787,0.0011045537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998325,0.000019911773,0.000012798621,0.000037924823,0.000043801076,0.000053170927],"domain_scores_gemma":[0.99992156,0.000014358572,0.00001854395,0.000011478152,0.000012158624,0.000021823414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017470235,0.00054305285,0.00031350672,0.00022936867,0.00009852531,0.00025524822,0.00021048854,0.00034937065,0.00057024887],"category_scores_gemma":[0.00014893828,0.00014396304,0.0003011838,0.000098131495,0.00018936879,0.00020892333,0.00025830447,0.0007626012,0.00021972135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007437088,0.00009981713,0.00013157139,0.000025804033,0.0000059470467,0.000018950173,0.000007860732,0.00011357067,0.99805534,0.00002497659,0.00003278211,0.0014091347],"study_design_scores_gemma":[0.000061117214,0.004067091,0.009033512,0.000016813485,0.000047837773,0.00030084985,0.00004029643,0.0033422946,0.98029625,0.000070799106,0.0027130782,0.000010114029],"about_ca_topic_score_codex":0.0003681863,"about_ca_topic_score_gemma":0.0007688737,"teacher_disagreement_score":0.00057024887,"about_ca_system_score_codex":0.00020886696,"about_ca_system_score_gemma":0.00019585779,"threshold_uncertainty_score":0.0019076467},"labels":[],"label_agreement":null},{"id":"W4416248423","doi":"10.1016/j.antiviral.2026.106463","title":"Drug Combination Treatment as a Strategy for Inhibiting Human Adenovirus Replication","year":2025,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Drug; Antiviral drug; Viral replication; Replication (statistics); Combination therapy; Toxicity","score_opus":0.08563366477006425,"score_gpt":0.4557436435268426,"score_spread":0.37010997875677837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416248423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707931,0.012022699,0.010178803,0.000341637,0.00040143268,0.00065233506,0.00050294935,0.00016989368,0.00493704],"genre_scores_gemma":[0.9784388,0.0055442103,0.012381304,0.00014638851,0.00006366633,0.00025385688,0.00046724922,0.000024882993,0.0026795631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996525,0.00007355834,0.000036322657,0.000088406145,0.00009491761,0.000054155764],"domain_scores_gemma":[0.9998915,0.000026814949,0.000023180919,0.000016982181,0.00001494509,0.000026615078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002945606,0.000567207,0.0007847351,0.0006382202,0.000249713,0.0004986794,0.0005179242,0.00039041718,0.0017448639],"category_scores_gemma":[0.0001948945,0.00018994312,0.0005064633,0.00040677292,0.00023752022,0.0003611102,0.00030387047,0.0008371247,0.0004196009],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013693052,0.0012072471,0.0008643993,0.00030723616,0.00012597938,0.00017273682,0.00005481908,0.0010501421,0.9455139,0.00037646593,0.00064871355,0.04830907],"study_design_scores_gemma":[0.0004095285,0.020717114,0.004269685,0.00002533275,0.00028434303,0.0011232115,0.000070426286,0.0026921965,0.9524154,0.00013029238,0.017823687,0.000038764338],"about_ca_topic_score_codex":0.00064708455,"about_ca_topic_score_gemma":0.0018612896,"teacher_disagreement_score":0.0017448639,"about_ca_system_score_codex":0.00034012456,"about_ca_system_score_gemma":0.0003470342,"threshold_uncertainty_score":0.0058371425},"labels":[],"label_agreement":null}]}